<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1207233867
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2023
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        Tezspire 210 mg per 1.9 ml Pre-filled syringe	
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        TEZEPELUMAB
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        110
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg/ml
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Subcutaneous use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Solution for injection
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        2
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Pre-filled syringe
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Biological
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store in a refrigerator (2°c – 8°c)
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        5804.95
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="AMGEN MANUFACTURING LIMITED" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            AMGEN MANUFACTURING LIMITED
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 583]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            ALNAGHI COMPANY
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            AstraZeneca AB 
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        R03DX
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p dir="ltr"><strong>What Tezspire is and how it works</strong></p><p dir="ltr">Tezspire contains the active substance tezepelumab, which is a monoclonal antibody. Antibodies are proteins that recognise and bind to a specific target substance in the body, which in the case of tezepelumab is a protein called <em>thymic stromal lymphopoietin</em> (TSLP). TSLP plays a key role in causing the inflammation in your airways that leads to the signs and symptoms of asthma. By blocking the action of TSLP, this medicine helps to reduce inflammation and asthma symptoms.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><strong>What Tezspire is used for</strong></p><p dir="ltr">Tezspire is used with other asthma medicines to treat severe asthma in adults and adolescents (12&nbsp;years of age and older) when the disease is not controlled with their current asthma medicines.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><strong>How Tezspire can help</strong></p><p dir="ltr">Tezspire may reduce the number of asthma attacks you experience, improve your breathing and reduce your asthma symptoms.</p><p dir="ltr">&nbsp;</p><p dir="ltr">&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p dir="ltr"><strong>Do not use Tezspire</strong></p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>if you are allergic</strong> to tezepelumab or any of the other ingredients of this medicine (listed in section 6). If this applies to you, or if you are not sure, <strong>check with your doctor, pharmacist or nurse</strong>.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><strong>Warnings and precautions </strong></p><p dir="ltr">Talk to your doctor, pharmacist or nurse before using Tezspire.</p><p dir="ltr">&nbsp;</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Tezspire is <strong>not a rescue medicine.</strong> Do not use it to treat a sudden asthma attack.</p><p dir="ltr">&nbsp;</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>If your</strong>&nbsp;<strong>asthma is not getting any better, or it gets worse</strong>&nbsp;during treatment with this medicine, <strong>talk to a doctor or nurse</strong>.</p><p dir="ltr">&nbsp;</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Look out for signs of allergic reactions.</strong> Medicines like Tezspire can potentially cause allergic reactions in some people. The signs of these reactions may vary, but can include breathing problems, hives and rash. If you notice any of these signs, <strong>speak to a doctor or nurse immediately</strong>.</p><p dir="ltr"><strong>&nbsp;</strong></p><p dir="ltr">Talk to your doctor about how to recognise early signs of allergy, and how to manage reactions if they occur.</p><p dir="ltr">&nbsp;</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Look out for any signs of a possible serious infection </strong>while you are taking Tezspire such as:</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; fever, flu-like symptoms, night sweats;</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; cough which will not go away;</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; warm, red and painful skin, or a painful skin rash with blisters.</p><p dir="ltr">If you notice any of these signs, <strong>speak to a doctor or nurse</strong> <strong>immediately.</strong></p><p dir="ltr"><strong>&nbsp;</strong></p><p dir="ltr"><strong>If you already have a serious infection, talk to your doctor </strong>before taking Tezspire.</p><p dir="ltr"><strong>&nbsp;</strong></p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Look out for any symptoms of a heart problem</strong>, such as:</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; chest pain;</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shortness of breath;</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; a general feeling of discomfort, illness, or lack of well-being;</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; feeling lightheaded or faint.</p><p dir="ltr">If you notice any of these symptoms,<strong> speak to a doctor or nurse</strong> <strong>immediately</strong>.</p><p dir="ltr">&nbsp;</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>If you have a parasitic infection</strong> or if you live in (or travel to) an area where parasitic infections are common, <strong>talk to your doctor</strong>. Tezspire may weaken your body&rsquo;s ability to fight certain types of parasitic infections.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><strong>Children</strong></p><p dir="ltr">Do not give this medicine to children under 12 years of age because the safety and benefits of this medicine are not known in children in this age group.</p><p dir="ltr"><strong>&nbsp;</strong></p><p dir="ltr"><strong>Other medicines for asthma</strong></p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Do not suddenly stop taking</strong> your other asthma medicines when you start Tezspire. This is especially important if you take steroids (also called corticosteroids). These medicines must be stopped gradually, under the supervision of your doctor and based on your response to Tezspire.</p><p dir="ltr"><strong>&nbsp;</strong></p><p dir="ltr"><strong>Other medicines and Tezspire</strong></p><p dir="ltr">Tell your doctor or pharmacist:</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you are taking, have recently taken or might use any other medicines.</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you have recently had or are due to have a vaccination.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><strong>Pregnancy and breast-feeding</strong></p><p dir="ltr">If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking this medicine.</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Do not use Tezspire during pregnancy unless your doctor advises it. It is not known if Tezspire can harm your unborn baby.</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Tezspire may pass into breast milk. If you are breast-feeding or plan to breast-feed, talk to your doctor.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><strong>Driving and using machines</strong></p><p dir="ltr">Tezspire is unlikely to affect your ability to drive and use machines.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><strong>Tezspire contains sodium</strong></p><p dir="ltr">This medicine contains less than 1 mmol sodium (23 mg) per 210 mg dose, that is to say essentially &lsquo;sodium-free&rsquo;.</p><p dir="ltr">&nbsp;</p><p dir="ltr">&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p dir="ltr">Always use this medicine exactly as your doctor or pharmacist has told you. Check with your doctor, pharmacist or nurse if you are not sure.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><strong>Adults and adolescents aged 12 years and over:</strong></p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>The recommended dose</strong> is 210 mg (1 injection) every 4 weeks. Tezspire is given as an injection under the skin (subcutaneously).</p><p dir="ltr">&nbsp;</p><p dir="ltr">Your doctor or nurse will decide if you can inject yourself or if your caregiver can do that for you. If so, you or your caregiver will receive training on the right way to prepare and inject Tezspire.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Before injecting Tezspire yourself, carefully read the &lsquo;Instructions for Use&rsquo; for Tezspire pre-filled pen. Do this each time you get another injection. There may be new information.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Do not share Tezspire pre-filled pen or use a pen more than one time.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><strong>If you forget to use Tezspire</strong></p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you have forgotten to inject a dose, inject a dose as soon as possible. Then have your next injection on your next scheduled injection day.</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you did not notice that you missed a dose until it is time for your next dose, simply inject the next dose as scheduled. <strong>Do not inject a double dose to make up for a forgotten dose. </strong></p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you are not sure when to inject Tezspire, ask your doctor, pharmacist or nurse.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><strong>If you stop using Tezspire</strong></p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Do not stop using Tezspire without speaking first to your doctor, pharmacist or nurse. Interrupting or stopping the treatment with Tezspire may cause your asthma symptoms and attacks to come back.</p><p dir="ltr">&nbsp;</p><p dir="ltr">If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse.</p><p dir="ltr">&nbsp;</p><p dir="ltr">&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p dir="ltr">Like all medicines, this medicine can cause side effects, although not everybody gets them.</p><p dir="ltr"><strong>&nbsp;</strong></p><p><strong><u>Serious allergic reactions</u></strong></p><p><strong>&nbsp;</strong></p><p><strong>Seek medical attention immediately </strong>if you think you may be having an allergic reaction. Such reactions may happen within hours or days after the injection.</p><p>&nbsp;</p><p><strong>Not known</strong> (the frequency cannot be estimated from the available data)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; allergic reactions, including serious allergic reaction (anaphylaxis)</p><p>symptoms usually include:</p><p>o&nbsp;&nbsp; swelling of your face, tongue, or mouth</p><p>o&nbsp;&nbsp; breathing problems, fast heartbeat</p><p>o&nbsp;&nbsp; fainting, dizziness, feeling lightheaded</p><p dir="ltr"><strong>Common side effects </strong>(these may affect up to 1 in 10 people)</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; sore throat</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; rash</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; joint pain</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; injection site reaction (such as redness, swelling, and pain)</p><p dir="ltr">&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Keep this medicine out of the sight and reach of children.</p><p dir="ltr">&nbsp;</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Do not use after the expiry date which is stated on the label and carton. The expiry date refers to the last day of that month.</p><p dir="ltr">&nbsp;</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Store in a refrigerator (2&deg;C to 8&deg;C).</p><p dir="ltr">&nbsp;</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Keep the pre-filled pen in the outer carton in order to protect from light.</p><p dir="ltr">&nbsp;</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Tezspire may be kept at room temperature (20&deg;C to 25&deg;C) in the outer carton for a maximum of 30 days. Once Tezspire has reached room temperature, do not put it back in the refrigerator. Tezspire that has been stored at room temperature for more than 30 days should be safely disposed of.</p><p dir="ltr">&nbsp;</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Do not shake, freeze or expose to heat.</p><p dir="ltr">&nbsp;</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Do not use this medicine if it has been dropped or damaged, or if the security seal on the carton has been broken.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Do not throw away any medicines via wastewater. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.</p><p dir="ltr">&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p dir="ltr"><strong>What Tezspire contains </strong></p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The active substance is tezepelumab.</p><p dir="ltr">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The other ingredients are acetic acid, L-proline, polysorbate 80, sodium hydroxide, and water for injections.</p><p dir="ltr">&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                	Tezspire is a clear to opalescent, colourless to light yellow solution.
	
Tezspire is available in a pack containing 1 single-use pre-filled pen.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p dir="ltr"><strong>Marketing Authorisation Holder </strong></p><p dir="ltr">AstraZeneca AB</p><p dir="ltr">SE 151 85 S&ouml;dert&auml;lje</p><p dir="ltr">Sweden</p><p dir="ltr">&nbsp;</p><p dir="ltr"><strong>Manufacturer</strong></p><p dir="ltr">Amgen Manufacturing Limited (AML)</p><p dir="ltr">Carr 31 KM 24.6</p><p dir="ltr">Juncos, Puerto Rico (PR) 00777</p><p dir="ltr">United States (USA)</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                	This leaflet was last revised in Sep 2024
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL"><strong>ما هو تيزسباير وكيف يعمل</strong></p><p dir="RTL">يحتوي تيزسباير على المادة الفعالة تيزيبلوماب، وهي جسم مضاد أحادي النسيلة. الأجسام المضادة هي بروتينات تتعرف على مادة مستهدفة معينة في الجسم وترتبط بها، وهي في حالة تيزيبلوماب عبارة عن بروتين يُسمى <em>ليمفوبويتين اللحمية الصعترية</em> (TSLP). يؤدي TSLP دورًا رئيسيًا في التسبب في التهاب المسالك الهوائية الذي يؤدي إلى ظهور علامات وأعراض الربو. من خلال منع عمل TSLP، يساعد هذا الدواء على تقليل الالتهاب وأعراض&nbsp;الربو.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>دواعي استعمال تيزسباير</strong></p><p dir="RTL">يُستخدم تيزسباير مع أدوية الربو الأخرى لعلاج الربو الشديد لدى البالغين والمراهقين (في سن 12 عامًا فما فوق) عندما لا يتم السيطرة على المرض بأدوية الربو الحالية.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>كيف يمكن أن يساعد تيزسباير</strong></p><p>قد يقلل تيزسباير من عدد نوبات الربو التي تتعرض لها، ويحسن تنفسك ويقلل من أعراض الربو لديك</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>لا تستخدم تيزسباير</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>إذا كنت تعاني من حساسية</strong> تجاه تيزيبلوماب أو أي من المكونات الأخرى لهذا الدواء (مذكورة في القسم 6). إذا كان الأمر كذلك أو إذا لم تكن متأكدًا، <strong>فاستشر الطبيب المتابع لك أو الصيدلي أو الممرضة</strong>.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>تحذيرات واحتياطات</strong></p><p dir="RTL">تحدث إلى طبيبك أو الصيدلي أو الممرضة لديك قبل استخدام تيزسباير.</p><p dir="RTL">&nbsp;</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تيزسباير <strong>ليس دواء إنقاذ.</strong> فلا تستخدمه لعلاج نوبة ربو مفاجئة.</p><p dir="RTL">&nbsp;</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>إذا</strong>&nbsp;<strong>لم تتحسن حالة الربو لديك، أو إذا تفاقمت</strong>&nbsp;أثناء العلاج بهذا الدواء، <strong>فتحدث إلى طبيب أو ممرضة</strong>.</p><p dir="RTL">&nbsp;</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>انتبه لعلامات ردود الفعل التحسسية.</strong> الأدوية مثل تيزسباير يمكن أن تسبب ردود فعل تحسسية لدى بعض الأشخاص. قد تختلف علامات ردود الفعل هذه، ولكنها قد تشمل مشكلات في التنفس وشرى وطفح جلدي. إذا لاحظت أيًا من هذه العلامات، <strong>فتحدث إلى طبيب أو ممرضة على الفور</strong>.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL">تحدث إلى طبيبك حول كيفية التعرف على العلامات المبكرة للحساسية، وكيفية التعامل مع ردود الفعل إذا&nbsp;حدثت.</p><p dir="RTL">&nbsp;</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>ابحث عن أي علامات للعدوى الخطيرة المحتملة</strong> أثناء استخدام تيزسباير مثل:</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الحمى، أعراض شبيهة بالأنفلونزا، التعرق الليلي؛</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; سعال لا يزول؛</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; جلد دافئ ذو لون أحمر ومؤلم، أو طفح جلدي مؤلم مع بثور.</p><p dir="RTL">إذا لاحظت أيًا من هذه العلامات، <strong>فتحدث مع طبيب أو ممرضة على الفور.</strong></p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>إذا كنت تعاني بالفعل من عدوى خطيرة، فتحدث مع طبيبك </strong>قبل أخذ تيزسباير.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>انتبه لأي أعراض لمشكلة في القلب</strong>، مثل:</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ألم الصدر؛</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ضيق التنفس؛</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; شعور عام بعدم الراحة أو المرض أو الافتقار إلى العافية؛</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الشعور بالدوار أو الإغماء.</p><p dir="RTL">إذا لاحظت أيًا من هذه الأعراض، <strong>فتحدث مع طبيب أو ممرضة على الفور</strong>.</p><p dir="RTL">&nbsp;</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>إذا كنت تعاني من عدوى طفيلية</strong> أو إذا كنت تعيش (أو تسافر إلى) في منطقة تنتشر فيها العدوى الطفيلية، <strong>فتحدث إلى الطبيب المتابع لك</strong>. قد يضعف تيزسباير قدرة جسمك على مكافحة أنواع معينة من العدوى&nbsp;الطفيلية.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الأطفال</strong></p><p dir="RTL">لا تعطِ هذا الدواء للأطفال دون سن 12 عامًا لأن أمان هذا الدواء وفوائده غير معروفة لدى الأطفال في هذه الفئة العمرية.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>أدوية أخرى للربو</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>لا تتوقف فجأة عن تناول</strong> أدوية الربو الأخرى عند بدء استخدام تيزسباير. وهذا مهم لا سيما إذا كنت تتناول الستيرويدات (تسمى أيضًا الكورتيكوستيرويدات). يجب إيقاف هذه الأدوية تدريجيًا، تحت إشراف طبيبك وبناءً على استجابتك لتيزسباير.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>الأدوية الأخرى وتيزسباير</strong></p><p dir="RTL">أخبر طبيبك أو الصيدلي:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تتناول أو إذا تناولت مؤخرًا أو من الممكن أن تتناول أي أدوية أخرى.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت قد تلقيت لقاحًا مؤخرًا أو من المقرر أن تحصل عليه.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الحمل والرضاعة</strong></p><p dir="RTL">إذا كنتِ حاملاً أو ترضعين رضاعة طبيعية أو تعتقدين أنكِ حاملاً أو تخططين لإنجاب طفل، فاستشيري طبيبكِ قبل تناول هذا الدواء.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا تستخدمي تيزسباير أثناء الحمل إلا إذا أوصى طبيبك بذلك. من غير المعروف ما إذا كان تيزسباير يمكن أن يضر بالجنين.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; قد ينتقل تيزسباير إلى حليب الثدي. إذا كنتِ تُرضعين طفلكِ رضاعة طبيعية أو تخططين للإرضاع، فتحدثي إلى&nbsp;طبيبكِ.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>القيادة واستخدام الآلات</strong></p><p dir="RTL">من غير المحتمل أن يؤثر تيزسباير على قدرتك على القيادة واستخدام الآلات.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>يحتوي تيزسباير على الصوديوم</strong></p><p dir="RTL">يحتوي هذا الدواء على أقل من 1&nbsp;مليمول صوديوم (23&nbsp;مجم) لكل جرعة بتركيز 210 مجم، أي أنه &quot;خالٍ من الصوديوم&quot; بصورة أساسية.</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">استخدم هذا الدواء دائمًا متّبعا تعليمات طبيبك أو الصيدلي بدقة. استشر طبيبك أو الصيدلي أو الممرضة لديك إذا لم تكن متأكدًا من طريقة استخدامه.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>بالنسبة للبالغين والمراهقين الذين تبلغ أعمارهم 12 عامًا فأكثر:</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>الجرعة الموصى بها</strong> هي 210 مجم (حقنة واحدة) كل 4 أسابيع. يتم إعطاء تيزسباير كحقنة أسفل &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;(تحت الجلد).</p><p dir="RTL">&nbsp;</p><p dir="RTL">سيقرر طبيبك أو ممرضتك ما إذا كان بإمكانك حقن نفسك أو ما إذا كان بإمكان مقدم الرعاية القيام بذلك نيابةً عنك. إذا كان الأمر كذلك، فستتلقى أنت أو مقدم الرعاية تدريبًا على الطريقة الصحيحة لتحضير وحقن تيزسباير.</p><p dir="RTL">&nbsp;</p><p dir="RTL">قبل حقن تيزسباير ذاتيًا، اقرأ بعناية &quot;تعليمات الاستخدام&quot; لقلم تيزسباير المعبأ مسبقًا. افعل هذا في كل مرة تحصل فيها على حقنة أخرى. قد تتوفر معلومات جديدة.</p><p dir="RTL">&nbsp;</p><p dir="RTL">لا تشارك قلم تيزسباير المعبأ مسبقًا أو تعد استخدام القلم أكثر من مرة واحدة.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>إذا نسيت استخدام تيزسباير</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا نسيت حقن جرعة، فاحقنها في أقرب وقت ممكن. ثم تلقِّ حقنتك التالية في يوم الحقن المجدول التالي.</p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong>إذا لم تلاحظ نسيان حقن جرعة حتى يحين وقت جرعتك التالية، فما عليك سوى حقن الجرعة التالية كما هو مقرر. <strong>لا تحقن جرعة مضاعفة لتعويض جرعة فائتة.</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا لم تكن متأكدًا من موعد حقن تيزسباير، فاستشر طبيبك أو الصيدلي أو الممرضة بشأن ذلك.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>إذا توقفتَ عن استخدام تيزسباير</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا تتوقف عن استخدام تيزسباير دون التحدث إلى طبيبك أو الصيدلي أو الممرضة أولاً. قد يؤدي قطع العلاج باستخدام تيزسباير أو إيقافه إلى عودة أعراض الربو والنوبات.</p><p dir="RTL">&nbsp;</p><p dir="RTL">إذا كان لديك أي أسئلة أخرى بشأن استخدام هذا الدواء، فاسأل طبيبك أو الصيدلي أو الممرض المتابع لك.</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يمكن أن يُسبب هذا الدواء آثارًا جانبية شأنه شأن سائر الأدوية الأخرى، على الرغم من عدم إصابة كل شخص بها.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong><u>ردود فعل تحسسية خطيرة</u></strong></p><p dir="RTL"><strong>أطلب العناية الطبية فوراً</strong> إذا كنت تعتقد أنك تعاني من رد فعل تحسسي. قد تحدث مثل هذه التفاعلات خلال ساعات أو أيام بعد الحقن.</p><p dir="RTL"><strong>غير معروف</strong> (لا يمكن تقدير التكرار من البيانات المتاحة)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تفاعلات حساسية بما في ذلك تفاعلات حساسية خطيرة (الحساسية المفرطة).</p><p dir="RTL">تشمل الأعراض عادةً ما يلي:</p><p dir="RTL">o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تورم الوجه أو اللسان أو الفم</p><p dir="RTL">o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مشاكل في التنفس وسرعة ضربات القلب</p><p dir="RTL">o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الإغماء والدوخة والشعور بالدوار</p><p dir="RTL">o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عيون حمراء أو حاكة أو منتفخة أو ملتهبة</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>آثار جانبية شائعة </strong>(قد تصيب حتى شخص واحد من بين 10 أشخاص)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب الحلق</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الطفح الجلدي</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ألم المفاصل</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ردود فعل في موضع الحقن (مثل الاحمرار، أو التورم، أو الشعور بالألم)</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يُحفظ هذا الدواء بعيدًا عن متناول أيدي الأطفال ونظرهم.</p><p dir="RTL">&nbsp;</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا تستخدمه بعد تاريخ انتهاء الصلاحية المدوّن على الملصق والعلبة الكرتون. يشير تاريخ انتهاء الصلاحية إلى آخر يوم في ذلك الشهر.</p><p dir="RTL">&nbsp;</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يُحفظ في الثلاجة (في درجة حرارة تتراوح من 2 إلى 8 درجات مئوية).</p><p dir="RTL">&nbsp;</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; احتفظ بالقلم المعبأ مسبقًا في العلبة الكرتونية الخارجية لحمايته من الضوء.</p><p dir="RTL">&nbsp;</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يمكن حفظ تيزسباير في درجة حرارة الغرفة (20 إلى 25 درجة مئوية) في العلبة الكرتونية الخارجية لمدة أقصاها 30 يومًا. بمجرد وصول تيزسباير إلى درجة حرارة الغرفة، لا تضعه مرة أخرى في الثلاجة. يجب التخلص من تيزسباير الذي تم تخزينه في درجة حرارة الغرفة لأكثر من 30 يومًا بطريقة صحيحة.</p><p dir="RTL">&nbsp;</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا ترجّه أو تجمده أو تُعرِّضه للحرارة.</p><p dir="RTL">&nbsp;</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا تستخدم هذا الدواء في حالة سقوطه أو تلفه، أو في حالة كسر مانع التسرب الأمني الموجود على العبوة&nbsp;الكرتونية.</p><p dir="RTL">&nbsp;</p><p dir="RTL">لا تتخلص من الأدوية عن طريق مياه الصرف الصحي. اسأل الصيدلي الذي تتعامل معه عن كيفية التخلص من الأدوية التي لم تعد تستعملها. هذه التدابير من شأنها حماية البيئة.</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>محتويات تيزسباير</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المادة الفعالة هي تيزيبلوماب.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المكونات الأخرى هي حمض الأسيتيك، وبرولين L، وبوليسوربات 80، وهيدروكسيد الصوديوم، وماء للحقن.</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>شكل تيزسباير ومحتويات العبوة</strong></p><p dir="RTL">تيزسباير هو محلول شفاف إلى غائم، عديم اللون إلى أصفر فاتح.</p><p dir="RTL">&nbsp;</p><p dir="RTL">يتوفر تيزسباير في عبوة تحتوي على قلم واحد معبأ مسبقًا مخصص للاستخدام مرة واحدة.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>حامل ترخيص التسويق</strong></p><p dir="RTL">AstraZeneca AB</p><p dir="RTL">SE 151 85 S&ouml;dert&auml;lje</p><p dir="RTL">السويد</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>جهة التصنيع</strong></p><p dir="RTL">Amgen Manufacturing Limited LCC (AML LCC)</p><p dir="RTL">Carr 31 KM 24.6</p><p dir="RTL">Juncos, Puerto Rico (PR) 00777</p><p dir="RTL">الولايات المتحدة (USA)</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            	تمت آخر مراجعة لهذه النشرة في سبتمبر 2024
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Tezspire 210 mg solution for injection in pre-filled syringe
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each pre-filled syringe contains 210 mg tezepelumab in 1.91 mL solution (110 mg/mL).

Tezepelumab is a human monoclonal antibody produced in Chinese hamster ovary (CHO) cells by recombinant DNA technology. 

For the full list of excipients, see section 6.1.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Solution for injection in pre-filled syringe (injection)

Clear to opalescent, colourless to light yellow solution.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">Tezspire is indicated as an add-on maintenance treatment in adults and adolescents 12&nbsp;years and older with severe asthma who are inadequately controlled despite high dose inhaled corticosteroids plus another medicinal product for maintenance treatment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">Treatment should be initiated by physicians experienced in the diagnosis and treatment of severe asthma.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><u>Posology</u></p><p dir="ltr"><u>&nbsp;</u></p><p dir="ltr"><em>Adults and adolescents (aged 12&nbsp;years and older)</em></p><p dir="ltr">The recommended dose is 210&nbsp;mg of tezepelumab by subcutaneous injection every 4&nbsp;weeks.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Tezspire is intended for long-term treatment. A decision to continue the therapy should be made at least annually based on the patient&#39;s level of asthma control.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Missed dose</em></p><p dir="ltr">If a dose is missed, the dose should be administered as soon as possible. Thereafter, the patient can resume dosing on the scheduled day of administration. If the next dose is already due, then administer as planned. A double dose must not be administered.</p><p dir="ltr"><u>&nbsp;</u></p><p dir="ltr"><u>Special populations</u></p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Elderly (&ge;65&nbsp;years of age)</em></p><p dir="ltr">No dose adjustment is required for elderly patients (see section 5.2).</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Renal and hepatic impairment</em></p><p dir="ltr">No dose adjustment is required for patients with renal or hepatic impairment (see section 5.2).</p><p dir="ltr"><u>&nbsp;</u></p><p dir="ltr"><em>Paediatric population</em></p><p dir="ltr">The safety and efficacy of Tezspire in children under 12&nbsp;years of age have not been established. No data are available.</p><p dir="ltr"><u>&nbsp;</u></p><p dir="ltr"><u>Method of administration </u></p><p dir="ltr"><u>&nbsp;</u></p><p dir="ltr">Tezspire is administered as a subcutaneous injection.</p><p dir="ltr">&nbsp;</p><p dir="ltr">A patient may self-inject or the patient&rsquo;s caregiver may administer this medicinal product after training in subcutaneous injection technique. Proper training should be provided to patients and/or caregivers on the preparation and administration of Tezspire prior to use according to the &ldquo;Instructions for Use&rdquo;.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Tezspire should be injected into the thigh or abdomen, except for the 5&nbsp;cm around the navel. If a healthcare professional or caregiver administers the injection, the upper arm can also be used. A patient should not self-inject in the arm. It should not be injected into areas where the skin is tender, bruised, erythematous, or hardened. It is recommended to rotate the injection site with each injection.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Comprehensive instructions for administration using the pre-filled syringe is provided in the &ldquo;Instructions for Use&rdquo;.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                
Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr"><u>Traceability</u></p><p dir="ltr">In order to improve the traceability of biological medicinal products, the name and the batch number of the administered product should be clearly recorded.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><u>Acute asthma exacerbations&nbsp;</u></p><p dir="ltr">Tezspire should not be used to treat acute asthma exacerbations.</p><p dir="ltr">Asthma-related symptoms or exacerbations may occur during treatment. Patients should be instructed to seek medical advice if their asthma remains uncontrolled or worsens after initiation of treatment.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><u>Corticosteroids </u></p><p dir="ltr">Abrupt discontinuation of corticosteroids after initiation of therapy is not recommended. Reduction in corticosteroid doses, if appropriate, should be gradual and performed under the supervision of a physician.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><u>Hypersensitivity reactions </u></p><p dir="ltr">Hypersensitivity reactions (e.g. anaphylaxis, rash, Allergic conjunctivitis) may occur following administration of tezepelumab (see section 4.8). These reactions may occur within hours of administration, but in some instances have a delayed onset (i.e. days).</p><p dir="ltr">A history of anaphylaxis unrelated to tezepelumab may be a risk factor for anaphylaxis following Tezspire administration. In line with clinical practice, patients should be monitored for an appropriate time after administration of Tezspire.</p><p dir="ltr">In the event of a serious hypersensitivity reaction (e.g. anaphylaxis), administration of tezepelumab should be discontinued immediately and appropriate treatment as clinically indicated should be initiated.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><u>Serious infections</u></p><p dir="ltr">Blocking thymic stromal lymphopoietin (TSLP) may theoretically increase the risk of serious infections. In placebo-controlled studies, no increase in serious infections was observed with tezepelumab.</p><p dir="ltr">Patients with pre-existing serious infections should be treated before initiating therapy with tezepelumab. If patients develop a serious infection while receiving tezepelumab treatment, therapy with tezepelumab should be discontinued until the serious infection resolves.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><u>Serious cardiac events</u></p><p dir="ltr">In a long-term clinical study, a numerical imbalance in serious cardiac adverse events was observed in patients treated with tezepelumab compared to placebo. No causal relationship between tezepelumab and these events has been established, nor has a patient population at risk of these events been identified.</p><p dir="ltr">Patients should be advised of signs or symptoms suggestive of a cardiac event (for example, chest pain, dyspnoea, malaise, feeling lightheaded or faint) and to seek immediate medical attention if such symptoms occur. If patients develop a serious cardiac event while receiving tezepelumab treatment, therapy with tezepelumab should be discontinued until the acute event stabilises.</p><p dir="ltr">&nbsp;</p><p dir="ltr">There is currently no data on re-treatment of patients who develop a serious cardiac event or serious infection.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><u>Parasitic (helminth) infection</u></p><p dir="ltr">TSLP may be involved in the immunological response to some helminth infections. Patients with known helminth infections were excluded from participation in clinical trials. It is unknown if tezepelumab may influence a patient&rsquo;s response against helminth infections.</p><p dir="ltr">Patients with pre-existing helminth infections should be treated before initiating therapy with tezepelumab. If patients become infected while receiving treatment and do not respond to anti-helminth treatment, therapy with tezepelumab should be discontinued until infection resolves.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><u>Sodium content</u></p><p dir="ltr">This medicinal product contains less than 1&nbsp;mmol sodium (23&nbsp;mg) per 210&nbsp;mg dose, that is to say essentially &lsquo;sodium-free&rsquo;.</p><p dir="ltr">&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">No interaction studies have been performed.</p><p dir="ltr">The use of live attenuated vaccines should be avoided in patients receiving tezepelumab.</p><p>In a randomised, double blind, parallel group study of 70 patients aged between 12 and 21 years with moderate to severe asthma, tezepelumab treatment did not appear to affect the humoral antibody responses induced by seasonal quadrivalent influenza vaccination.</p><p dir="ltr">A clinically relevant effect of tezepelumab on the pharmacokinetics of co-administered asthma medicinal products is not expected. Based on the population pharmacokinetic analysis, commonly co‑administered asthma medicinal products (including leukotriene receptor antagonists, theophylline/aminophylline and oral corticosteroids) had no effect on tezepelumab clearance.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr"><u>Pregnancy</u></p><p dir="ltr"><u>&nbsp;</u></p><p dir="ltr">There are no or limited amount of data (less than 300&nbsp;pregnancy outcomes) from the use of tezepelumab in pregnant women. Animal studies do not indicate direct or indirect harmful effects with respect to reproductive toxicity (see section 5.3).</p><p dir="ltr">&nbsp;</p><p dir="ltr">Human IgG antibodies, such as tezepelumab, are transported across the placenta barrier; therefore, Tezspire may be transmitted from the mother to the developing foetus.</p><p dir="ltr">&nbsp;</p><p dir="ltr">As a precautionary measure, it is preferable to avoid the use of Tezspire during pregnancy unless the expected benefit to the pregnant mother is greater than any possible risk to the foetus.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><u>Breast-feeding</u></p><p dir="ltr"><u>&nbsp;</u></p><p dir="ltr">It is unknown whether tezepelumab is excreted in human milk. Human IgGs are known to be excreted in breast milk during the first few days after birth, which decreases to low concentrations soon afterwards; consequently, a risk to the breast-fed child cannot be excluded during this short period.</p><p dir="ltr">&nbsp;</p><p dir="ltr">For this specific period, a decision should be made whether to discontinue/abstain from tezepelumab therapy, taking into account the benefit of breast-feeding to the child and the benefit of therapy to the woman.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Afterwards, tezepelumab could be used during breast-feeding if clinically needed.</p><p dir="ltr">&nbsp;</p><p dir="ltr">See section 5.3 for information on the excretion of tezepelumab in animal (cynomolgus monkey) milk.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><u>Fertility</u></p><p dir="ltr"><u>&nbsp;</u></p><p dir="ltr">There are no fertility data in humans. Animal studies showed no adverse effects of tezepelumab treatment on fertility (see section 5.3).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">Tezspire has no or negligible influence on the ability to drive and use machines.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr"><u>Summary of the safety profile</u></p><p dir="ltr">The most commonly reported adverse reactions during treatment are arthralgia (3.8%) and pharyngitis (4.1%).</p><p dir="ltr"><u>Tabulated list of adverse reactions</u></p><p dir="ltr">Table 1 presents the adverse reactions from clinical studies in patients with severe asthma, whereby, a total of 665&nbsp;patients received at least one dose of Tezspire in trials of 52&nbsp;weeks duration, and from post-marketing experience.</p><p dir="ltr">The frequency of adverse reactions is defined using the following convention: very common (&ge;&nbsp;1/10); common (&ge;&nbsp;1/100 to &lt;&nbsp;1/10); uncommon (&ge;&nbsp;1/1,000 to &lt;&nbsp;1/100); rare (&ge;&nbsp;1/10,000 to &lt;&nbsp;1/1,000); very rare (&lt;&nbsp;1/10,000); and not known (cannot be estimated from available data). Within each frequency grouping, adverse reactions are presented in order of decreasing seriousness.</p><p dir="ltr">&nbsp;</p><table border="1" cellspacing="0" cellpadding="0" summary="Adverse Drug Reactions reported in Clinical Trials" dir="ltr" style="width:100%"><thead><tr><td colspan="3" style="vertical-align:top"><p><strong>Table </strong><!--[if supportFields]><span style='mso-bookmark:
   _Ref48047997'><span style='mso-bookmark:_Hlk15569552'><span
   style='mso-bookmark:_Hlk65749535'></span></span></span><span
   style='mso-element:field-begin'></span><span style='mso-bookmark:_Ref48047997'><span
   style='mso-bookmark:_Hlk15569552'><span style='mso-bookmark:_Hlk65749535'><b><span
   lang=EN-GB><span style='mso-spacerun:yes'> </span>SEQ Table \* ARABIC <span
   style='mso-element:field-separator'></span></span></b></span></span></span><![endif]--><strong>1</strong><!--[if supportFields]><span
   style='mso-bookmark:_Ref48047997'><span style='mso-bookmark:_Hlk15569552'><span
   style='mso-bookmark:_Hlk65749535'></span></span></span><span
   style='mso-element:field-end'></span><![endif]--><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; List of adverse reactions</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>System organ class</strong></p></td><td style="vertical-align:top"><p><strong>Adverse reactions</strong></p></td><td><p><strong>Frequency</strong></p></td></tr></thead><tbody><tr><td style="vertical-align:top"><p>Infections and infestations</p></td><td style="vertical-align:top"><p>Pharyngitis<sup>a</sup></p></td><td style="vertical-align:top"><p>Common</p></td></tr><tr><td style="vertical-align:top">Immune system disorders</td><td style="vertical-align:top">Hypersensitivity (including anaphylactic reactions)</td><td style="vertical-align:top">Not Known</td></tr><tr><td style="vertical-align:top"><p>Skin and subcutaneous tissue disorders</p></td><td style="vertical-align:top"><p>Rash<sup>b</sup></p></td><td style="vertical-align:top"><p>Common</p></td></tr><tr><td style="vertical-align:top"><p>Musculoskeletal and connective tissue disorders</p></td><td style="vertical-align:top"><p>Arthralgia</p></td><td style="vertical-align:top"><p>Common</p></td></tr><tr><td style="vertical-align:top"><p>General disorders and administration site conditions</p></td><td style="vertical-align:top"><p>Injection site reaction<sup>c</sup></p></td><td style="vertical-align:top"><p>Common</p></td></tr></tbody></table><p dir="ltr"><sup>a</sup> Pharyngitis was defined by the following grouped preferred terms: pharyngitis, pharyngitis bacterial, pharyngitis streptococcal and viral pharyngitis.</p><p dir="ltr"><sup>b </sup>Rash was defined by the following grouped preferred terms: rash, rash pruritic, rash erythematous, rash maculo-papular, rash macular.<br /><sup>c</sup> See &lsquo;Description of selected adverse reactions&rsquo;.</p><p dir="ltr">&nbsp;</p><p><strong>Summary of post-marketing data </strong></p><p>The following adverse reactions have been identified during post approval use of TEZSPIRE. It is generally not possible to reliably determine the frequency because such reactions have been reported spontaneously from a population of uncertain size. The frequency of these adverse reactions is therefore &lsquo;not known&rsquo; (cannot be estimated from available data).</p><p dir="ltr"><strong><em>Immune system disorders: Anaphylaxis</em></strong></p><p dir="ltr">&nbsp;</p><p dir="ltr"><u>Description of selected adverse reactions</u></p><p dir="ltr"><em>&nbsp;Injection site reactions</em></p><p dir="ltr">In the pooled safety data from PATHWAY and NAVIGATOR, injection site reactions (e.g. injection site erythema, injection site swelling, injection site pain) occurred at a rate of 3.8% in patients treated with tezepelumab 210&nbsp;mg subcutaneous every 4&nbsp;weeks (Q4W).</p><p dir="ltr">&nbsp;</p><p dir="ltr"><u>Paediatric population</u></p><p dir="ltr">&nbsp;</p><p dir="ltr">A total of 82&nbsp;adolescents aged 12 to 17 with severe, uncontrolled asthma were enrolled in the 52&nbsp;week Phase 3 NAVIGATOR study (see section 5.1). The safety profile in adolescents was generally similar to the overall study population.</p><p dir="ltr"><em>&nbsp;</em></p><p dir="ltr">To report any side effect(s):</p><ul dir="ltr"><li><strong><em>Saudi Arabia: </em></strong></li></ul><p dir="ltr">&nbsp;</p><table border="1" cellspacing="0" cellpadding="0" dir="ltr"><tbody><tr><td style="vertical-align:top"><p>&nbsp;</p><p><strong>- </strong>The National Pharmacovigilance Centre (NPC)</p><ul><li>Toll free phone: 19999</li><li>E-mail: npc.drug@sfda.gov.sa&nbsp;&nbsp;</li><li>Website: https://ade.sfda.gov.sa/</li></ul><p>&nbsp;</p></td></tr></tbody></table><p dir="ltr">&nbsp;</p><ul dir="ltr"><li>Other GCC States:</li></ul><p dir="ltr">&nbsp;</p><p dir="ltr">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Please contact the relevant competent authority.</p><p dir="ltr">&nbsp;</p><p dir="ltr">&nbsp;</p><p dir="ltr">&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">In clinical trials, doses of up to 280&nbsp;mg were administered subcutaneously every 2&nbsp;weeks (Q2W) and doses of up to 700&nbsp;mg were administered intravenously every 4&nbsp;weeks (Q4W) to patients with asthma without evidence of dose-related toxicities.</p><p dir="ltr">&nbsp;</p><p dir="ltr">There is no specific treatment for an overdose with tezepelumab. If overdose occurs, the patient should be treated supportively with appropriate monitoring as necessary.</p><p dir="ltr">&nbsp;</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">Pharmacotherapeutic group: Drugs for obstructive airway diseases, other systemic drugs for obstructive airway diseases, ATC code: R03DX11</p><p dir="ltr">&nbsp;</p><p dir="ltr"><u>Mechanism of action</u></p><p dir="ltr"><u>&nbsp;</u></p><p dir="ltr">Tezepelumab is a monoclonal antibody (IgG2&lambda;) directed against thymic stromal lymphopoietin (TSLP), preventing its interaction with the heterodimeric TSLP receptor. In asthma, both allergic and non-allergic triggers induce TSLP production. Blocking TSLP with tezepelumab reduces a broad spectrum of biomarkers and cytokines associated with airway inflammation (e.g. blood eosinophils, airway submucosal eosinophils, IgE, FeNO, IL-5, and IL-13); however, the mechanism of action of tezepelumab in asthma has not been definitively established.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><u>Pharmacodynamic effects</u></p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Effect on blood eosinophils and inflammatory biomarkers and cytokines</em></p><p dir="ltr">In clinical trials, administration of tezepelumab 210&nbsp;mg subcutaneously every 4&nbsp;weeks reduced blood eosinophils counts, FeNO, IL-5 concentration, IL-13 concentration and serum IgE concentration from baseline compared with placebo. These markers were near maximal suppression after 2&nbsp;weeks of treatment, except for IgE which declined more slowly. These effects were sustained throughout treatment.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Effect on eosinophils in the airway submucosa</em></p><p dir="ltr">In a clinical trial, administration of tezepelumab 210&nbsp;mg subcutaneously every 4&nbsp;weeks reduced submucosal eosinophil counts by 89% compared with a 25% reduction with placebo. Reduction was consistent regardless of baseline inflammatory biomarkers.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><u>Immunogenicity</u></p><p dir="ltr"><u>&nbsp;</u></p><p dir="ltr">In NAVIGATOR, anti-drug antibodies (ADA) were detected at any time in 26 (4.9%) out of 527&nbsp;patients who received tezepelumab at the recommended dosing regimen during the 52-week study period. Of these 26&nbsp;patients, 10&nbsp;patients (1.9% of patients treated with tezepelumab) developed treatment-emergent ADA and 1&nbsp;patient (0.2% of patients treated with tezepelumab) developed neutralising antibodies. ADA titres were generally low and often transient. No evidence of ADA impact on pharmacokinetics, pharmacodynamics, efficacy, or safety was observed.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><u>Clinical efficacy</u></p><p dir="ltr"><u>&nbsp;</u></p><p dir="ltr">The efficacy of tezepelumab was evaluated in two randomised, double-blind, parallel group, placebo-controlled clinical trials (PATHWAY and NAVIGATOR) of 52&nbsp;weeks in duration involving a total of 1609&nbsp;patients aged 12 years and older with severe asthma. In both trials, patients were enrolled without requiring a minimum baseline level of blood eosinophils or other inflammatory biomarkers (e.g. FeNO or IgE).</p><p dir="ltr">&nbsp;</p><p dir="ltr">PATHWAY was a 52-week exacerbation trial which enrolled 550&nbsp;patients (18&nbsp;years of age and older) with severe, uncontrolled asthma to receive treatment with tezepelumab 70&nbsp;mg subcutaneous Q4W, tezepelumab 210&nbsp;mg subcutaneous Q4W, tezepelumab 280&nbsp;mg subcutaneous Q2W or placebo. Patients were required to have a history of 2 or more asthma exacerbations requiring oral or systemic corticosteroid treatment or 1 asthma exacerbation resulting in hospitalisation in the past 12&nbsp;months.</p><p dir="ltr">&nbsp;</p><p dir="ltr">NAVIGATOR was a 52-week exacerbation trial which enrolled a total of 1061&nbsp;patients (adults and adolescents 12&nbsp;years of age and older) with severe, uncontrolled asthma to receive treatment with tezepelumab 210&nbsp;mg subcutaneous Q4W or placebo. Patients were required to have a history of 2 or more asthma exacerbations requiring oral or systemic corticosteroid treatment or resulting in hospitalisation in the past 12&nbsp;months.</p><p dir="ltr">&nbsp;</p><p dir="ltr">In both PATHWAY and NAVIGATOR, patients were required to have an Asthma Control Questionnaire 6 (ACQ-6) score of 1.5 or more at screening, and reduced lung function at baseline (pre-bronchodilator FEV<sub>1</sub> below 80% predicted in adults, and below 90% predicted in adolescents). Patients were required to have been on regular treatment with medium- or high-dose inhaled corticosteroids (ICS) and at least one additional asthma control therapy with or without oral corticosteroids (OCS). High ICS dose was defined as &gt;&nbsp;500&nbsp;mcg fluticasone propionate or equivalent per day. Medium ICS dose was defined as &gt;&nbsp;250 to 500&nbsp;mcg fluticasone propionate or equivalent per day in PATHWAY and as 500&nbsp;mcg fluticasone propionate or equivalent per day in NAVIGATOR. Patients continued background asthma therapy throughout the duration of the trials.</p><p dir="ltr">&nbsp;</p><p dir="ltr">The demographics and baseline characteristics of these two trials are provided in <!--[if supportFields]><span
lang=EN-GB><span style='mso-element:field-begin'></span><span
style='mso-spacerun:yes'> </span>REF _Ref65751348 \h <span
style='mso-spacerun:yes'> </span>\* MERGEFORMAT <span style='mso-element:field-separator'></span></span><![endif]--><strong>Table 2</strong><!--[if gte mso 9]><xml>
 <w:data>08D0C9EA79F9BACE118C8200AA004BA90B02000000080000000D0000005F00520065006600360035003700350031003300340038000000</w:data>
</xml><![endif]--><!--[if supportFields]><span lang=EN-GB><span
style='mso-element:field-end'></span></span><![endif]--> below.</p><p dir="ltr">&nbsp;</p><table border="1" cellspacing="0" cellpadding="0" summary="Adverse Drug Reactions reported in Clinical Trials" dir="ltr" style="width:100%"><thead><tr><td colspan="3" style="vertical-align:top"><p><strong>Table </strong><!--[if supportFields]><span
   style='mso-bookmark:_Ref65751348'><span style='mso-bookmark:_Hlk85055460'></span></span><span
   style='mso-element:field-begin'></span><span style='mso-bookmark:_Ref65751348'><span
   style='mso-bookmark:_Hlk85055460'><b><span lang=EN-GB style='mso-bidi-font-size:
   11.0pt'><span style='mso-spacerun:yes'> </span>SEQ Table \* ARABIC <span
   style='mso-element:field-separator'></span></span></b></span></span><![endif]--><strong>2</strong><!--[if supportFields]><span
   style='mso-bookmark:_Ref65751348'><span style='mso-bookmark:_Hlk85055460'></span></span><span
   style='mso-element:field-end'></span><![endif]--><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Demographics and baseline characteristics of asthma trials</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>&nbsp;</strong></p></td><td style="vertical-align:top"><p><strong>PATHWAY</strong></p><p><strong>N=550</strong></p></td><td><p><strong>NAVIGATOR</strong></p><p><strong>N=1059</strong></p></td></tr></thead><tbody><tr><td style="vertical-align:top"><p>Mean age (year) (SD)<sup> </sup></p></td><td style="vertical-align:top"><p>52 (12)</p></td><td style="vertical-align:top"><p>50 (16)</p></td></tr><tr><td style="vertical-align:top"><p>Female (%)</p></td><td style="vertical-align:top"><p>66</p></td><td style="vertical-align:top"><p>64</p></td></tr><tr><td style="vertical-align:top"><p>White (%)</p></td><td style="vertical-align:top"><p>92</p></td><td style="vertical-align:top"><p>62</p></td></tr><tr><td style="vertical-align:top"><p>Black or African American (%)</p></td><td style="vertical-align:top"><p>3</p></td><td style="vertical-align:top"><p>6</p></td></tr><tr><td style="vertical-align:top"><p>Asian (%)</p></td><td style="vertical-align:top"><p>3</p></td><td style="vertical-align:top"><p>28</p></td></tr><tr><td style="vertical-align:top"><p>Hispanic or Latino (%)</p></td><td style="vertical-align:top"><p>1</p></td><td style="vertical-align:top"><p>15</p></td></tr><tr><td style="vertical-align:top"><p>Mean duration of asthma, (years)<sup> </sup>(SD)</p></td><td style="vertical-align:top"><p>17 (12)</p></td><td style="vertical-align:top"><p>22 (16)</p></td></tr><tr><td style="vertical-align:top"><p>Never smoked (%)</p></td><td style="vertical-align:top"><p>81</p></td><td style="vertical-align:top"><p>80</p></td></tr><tr><td style="vertical-align:top"><p>High-dose ICS use (%)</p></td><td style="vertical-align:top"><p>49</p></td><td style="vertical-align:top"><p>75</p></td></tr><tr><td style="vertical-align:top"><p>OCS use (%)</p></td><td style="vertical-align:top"><p>9</p></td><td style="vertical-align:top"><p>9</p></td></tr><tr><td style="vertical-align:top"><p>Mean number of exacerbations in previous year (SD)</p></td><td style="vertical-align:top"><p>2.4 (1.2)</p></td><td style="vertical-align:top"><p>2.8 (1.4)</p></td></tr><tr><td style="vertical-align:top"><p>Mean baseline % predicted FEV<sub>1 </sub>(SD)</p></td><td style="vertical-align:top"><p>60 (13)</p></td><td style="vertical-align:top"><p>63 (18)</p></td></tr><tr><td style="vertical-align:top"><p>Mean pre-bronchodilator FEV<sub>1</sub> (L) (SD)</p></td><td style="vertical-align:top"><p>1.9 (0.6)</p></td><td style="vertical-align:top"><p>1.8 (0.7)</p></td></tr><tr><td style="vertical-align:top"><p>Mean post-bronchodilator FEV<sub>1</sub> reversibility (%) (SD)</p></td><td style="vertical-align:top"><p>23 (20)</p></td><td style="vertical-align:top"><p>15 (15)</p></td></tr><tr><td style="vertical-align:top"><p>Mean baseline blood EOS count (cells/&micro;L) (SD)</p></td><td style="vertical-align:top"><p>371 (353)</p></td><td style="vertical-align:top"><p>340 (403)</p></td></tr><tr><td style="vertical-align:top"><p>Blood EOS count &ge;&nbsp;150&nbsp;cells/&micro;L (%)</p></td><td style="vertical-align:top"><p>76</p></td><td style="vertical-align:top"><p>74</p></td></tr><tr><td style="vertical-align:top"><p>Positive allergic status (%)<sup>a</sup></p></td><td style="vertical-align:top"><p>46</p></td><td style="vertical-align:top"><p>64</p></td></tr><tr><td style="vertical-align:top"><p>Mean FeNO (ppb) (SD)</p></td><td style="vertical-align:top"><p>35 (39)</p></td><td style="vertical-align:top"><p>44 (41)</p></td></tr><tr><td style="vertical-align:top"><p>FeNO &ge;&nbsp;25&nbsp;ppb (%)</p></td><td style="vertical-align:top"><p>44</p></td><td style="vertical-align:top"><p>59</p></td></tr><tr><td style="vertical-align:top"><p>Mean ACQ-6 (SD)</p></td><td style="vertical-align:top"><p>2.7 (0.8)</p></td><td style="vertical-align:top"><p>2.8&nbsp; (0.8)</p></td></tr><tr><td style="vertical-align:top"><p>Blood EOS count &ge;&nbsp;150&nbsp;cells/&micro;L and FeNO &ge;&nbsp;25&nbsp;ppb (%)</p></td><td style="vertical-align:top"><p>38</p></td><td style="vertical-align:top"><p>47</p></td></tr></tbody></table><p dir="ltr"><sup>a&nbsp; </sup>Positive allergic status as defined by a positive serum IgE result specific to any perennial aeroallergen in the FEIA panel.</p><p dir="ltr">ACQ-6, Asthma Control Questionnaire 6; EOS, Eosinophils; FEIA, Fluorescent enzyme immunoassay; FeNO, Fractional exhaled nitric oxide; FEV<sub>1</sub>, Forced expiratory volume in one second; ICS, Inhaled corticosteroid; IgE, Immunoglobulin E; OCS, Oral corticosteroid; ppb, Parts per billion; SD, Standard deviation.</p><p dir="ltr">&nbsp;</p><p dir="ltr">The results summarised below are for the recommended tezepelumab 210 mg subcutaneous Q4W dosing regimen.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><u>Exacerbations</u></p><p dir="ltr"><u>&nbsp;</u></p><p dir="ltr">The primary endpoint for PATHWAY and NAVIGATOR was the rate of severe asthma exacerbations measured over 52&nbsp;weeks. Severe asthma exacerbations were defined as worsening of asthma requiring the use of or increase in oral or systemic corticosteroids for at least 3&nbsp;days or a single depo-injection of corticosteroids, and/or emergency department visits requiring use of oral or systemic corticosteroids and/or hospitalisation.</p><p dir="ltr">&nbsp;</p><p dir="ltr">In both PATHWAY and NAVIGATOR, patients receiving tezepelumab had significant reductions in the annualised rate of severe asthma exacerbations compared with placebo (<!--[if supportFields]><b><span
lang=EN-GB style='mso-bidi-font-size:11.0pt'><span style='mso-element:field-begin'></span>
REF _Ref109220150 \h <span style='mso-spacerun:yes'> </span>\* MERGEFORMAT <span
style='mso-element:field-separator'></span></span></b><![endif]--><strong>Table 3</strong><strong><!--[if gte mso 9]><xml>
 <w:data>08D0C9EA79F9BACE118C8200AA004BA90B02000000080000000E0000005F005200650066003100300039003200320030003100350030000000</w:data>
</xml><![endif]--></strong><!--[if supportFields]><b><span lang=EN-GB
style='mso-bidi-font-size:11.0pt'><span style='mso-element:field-end'></span></span></b><![endif]--> and <!--[if supportFields]><span
lang=EN-GB style='mso-bidi-font-size:11.0pt'><span style='mso-element:field-begin'></span><span
style='mso-spacerun:yes'> </span>REF _Ref109220174 \h <span style='mso-element:
field-separator'></span></span><![endif]--><strong>Table 4</strong><!--[if gte mso 9]><xml>
 <w:data>08D0C9EA79F9BACE118C8200AA004BA90B02000000080000000E0000005F005200650066003100300039003200320030003100370034000000</w:data>
</xml><![endif]--><!--[if supportFields]><span lang=EN-GB
style='mso-bidi-font-size:11.0pt'><span style='mso-element:field-end'></span></span><![endif]-->). There were also fewer exacerbations requiring emergency room visits and/or hospitalisation in patients treated with tezepelumab compared with placebo. In PATHWAY and NAVIGATOR, severe asthma exacerbations requiring emergency room visits and/or hospitalisation were reduced by 85% and 79% with tezepelumab 210&nbsp;mg subcutaneous Q4W, respectively.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Table <!--[if supportFields]><span
style='mso-bookmark:_Ref109220150'></span><span style='mso-element:field-begin'></span><span
style='mso-bookmark:_Ref109220150'><span lang=EN-GB style='font-size:11.0pt;
mso-bidi-font-size:8.0pt;font-family:"Times New Roman",serif;mso-bidi-font-weight:
bold;mso-bidi-font-style:normal'><span style='mso-spacerun:yes'> </span>SEQ
Table \* ARABIC <span style='mso-element:field-separator'></span></span></span><![endif]-->3<!--[if supportFields]><span
style='mso-bookmark:_Ref109220150'></span><span style='mso-element:field-end'></span><![endif]-->&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Rate of severe exacerbations at week 52 in NAVIGATOR<sup>a</sup></p><table border="1" cellspacing="0" cellpadding="0" dir="ltr" style="width:604px"><thead><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p><strong>Tezepelumab (N=528)</strong></p></td><td style="vertical-align:top"><p><strong>Placebo (N=531)</strong></p></td></tr><tr><td colspan="3" style="vertical-align:top"><p><strong>Annualised severe asthma exacerbation rate </strong></p></td></tr><tr><td style="vertical-align:top"><p>Rate</p></td><td style="vertical-align:top"><p>0.93</p></td><td style="vertical-align:top"><p>2.10</p></td></tr><tr><td style="vertical-align:top"><p>Rate ratio (95% CI)</p></td><td colspan="2" style="vertical-align:top"><p>0.44 (0.37, 0.53)</p></td></tr><tr><td style="vertical-align:top"><p>p-value</p></td><td colspan="2" style="vertical-align:top"><p>&lt;0.001</p></td></tr></thead></table><p dir="ltr"><sup>a</sup> Time at risk is defined as the total duration of time in which a new exacerbation can occur (i.e. total follow-up time minus time during exacerbation and 7 days after).</p><p dir="ltr">CI, Confidence interval</p><p dir="ltr">&nbsp;</p><table border="1" cellspacing="0" cellpadding="0" dir="ltr"><thead><tr><td colspan="3" style="vertical-align:top"><p><strong>Table </strong><!--[if supportFields]><span
   style='mso-bookmark:_Ref109220174'></span><span style='mso-element:field-begin'></span><span
   style='mso-bookmark:_Ref109220174'><b><span lang=EN-GB style='mso-bidi-font-size:
   11.0pt'><span style='mso-spacerun:yes'> </span>SEQ Table \* ARABIC <span
   style='mso-element:field-separator'></span></span></b></span><![endif]--><strong>4</strong><!--[if supportFields]><span
   style='mso-bookmark:_Ref109220174'></span><span style='mso-element:field-end'></span><![endif]--><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Rate of severe exacerbations at week 52 in PATHWAY<sup>a</sup> </strong></p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p><strong>Tezepelumab (N=137)</strong></p></td><td style="vertical-align:top"><p><strong>Placebo (N=138)</strong></p></td></tr><tr><td colspan="3" style="vertical-align:top"><p><strong>Annualised severe asthma exacerbation rate </strong></p></td></tr><tr><td style="vertical-align:top"><p>Rate</p></td><td style="vertical-align:top"><p>0.20</p></td><td style="vertical-align:top"><p>0.72</p></td></tr><tr><td style="vertical-align:top"><p>Rate ratio (95% CI)</p></td><td colspan="2" style="vertical-align:top"><p>0.29 (0.16, 0.51)</p></td></tr><tr><td style="vertical-align:top"><p>p-value</p></td><td colspan="2" style="vertical-align:top"><p>&lt;0.001</p></td></tr></thead></table><p dir="ltr"><sup>a</sup> Time at risk is defined as the total follow-up time.<br />CI, Confidence interval</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Subgroup analysis </em></p><p dir="ltr">In NAVIGATOR, tezepelumab demonstrated a reduction in the rate of severe asthma exacerbations regardless of the baseline levels of blood eosinophils, FeNO, as well as allergic status (determined by a perennial aeroallergen specific IgE). Similar results were seen in PATHWAY. See <!--[if supportFields]><span
lang=EN-GB style='mso-bidi-font-size:11.0pt'><span style='mso-element:field-begin'></span><span
style='mso-spacerun:yes'> </span>REF _Ref105599429 \h <span style='mso-element:
field-separator'></span></span><![endif]--><strong>Figure 1</strong><!--[if gte mso 9]><xml>
 <w:data>08D0C9EA79F9BACE118C8200AA004BA90B02000000080000000E0000005F005200650066003100300035003500390039003400320039000000</w:data>
</xml><![endif]--><!--[if supportFields]><span lang=EN-GB
style='mso-bidi-font-size:11.0pt'><span style='mso-element:field-end'></span></span><![endif]-->.</p><p dir="ltr"><strong>&nbsp;</strong></p><p dir="ltr">In NAVIGATOR, reductions in the rate of severe asthma exacerbations were greater with increasing baseline blood eosinophil counts and FeNO values (rate ratio = 0.79 [95% CI: 0.48, 1.28] for patients with both baseline blood eosinophil count &lt;&nbsp;150&nbsp;cells/&micro;L and baseline FeNO &lt;&nbsp;25&nbsp;ppb; rate ratio = 0.30 [95% CI: 0.23, 0.40] for patients with both baseline blood eosinophil count &ge;&nbsp;150&nbsp;cells/&micro;L and baseline FeNO &ge;&nbsp;25&nbsp;ppb).</p><p dir="ltr">&nbsp;</p><p dir="ltr"><strong>&nbsp;</strong></p><p dir="ltr"><strong>&nbsp;</strong></p><p dir="ltr"><strong>Figure </strong><!--[if supportFields]><span
style='mso-bookmark:_Ref62228827'><span style='mso-bookmark:_Ref105599429'></span></span><span
style='mso-element:field-begin'></span><span style='mso-bookmark:_Ref62228827'><span
style='mso-bookmark:_Ref105599429'><b style='mso-bidi-font-weight:normal'><span
lang=EN-GB style='mso-bidi-font-size:11.0pt;mso-bidi-font-style:italic'><span
style='mso-spacerun:yes'> </span>SEQ Figure \* ARABIC <span style='mso-element:
field-separator'></span></span></b></span></span><![endif]--><strong>1</strong><!--[if supportFields]><span
style='mso-bookmark:_Ref62228827'><span style='mso-bookmark:_Ref105599429'></span></span><span
style='mso-element:field-end'></span><![endif]--><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Annualised asthma exacerbation rate ratio over 52 weeks across different baseline biomarkers for the Full Analysis Set (pooled NAVIGATOR and PATHWAY)<sup>a</sup></strong></p><p dir="ltr">&nbsp;</p><table cellpadding="0" cellspacing="0" dir="ltr" style="width:100%"><tbody><tr><td><p><strong>Tezepelumab<br />210 mg Q4W<br />n / Estimate</strong></p></td></tr></tbody></table><table cellpadding="0" cellspacing="0" dir="ltr" style="width:100%"><tbody><tr><td><p><strong>Placebo</strong></p><p><strong>n / Estimate</strong></p></td></tr></tbody></table><table cellpadding="0" cellspacing="0" dir="ltr" style="width:100%"><tbody><tr><td><p><strong>Rate Ratio </strong></p><p><strong>(95% CI)</strong></p></td></tr></tbody></table><p dir="ltr">&nbsp;</p><p dir="ltr">&nbsp;</p><p dir="ltr">&nbsp;</p><p dir="ltr">&nbsp;</p><p dir="ltr">&nbsp;</p><p dir="ltr">&nbsp;</p><p dir="ltr">&nbsp;</p><table cellpadding="0" cellspacing="0" dir="ltr" style="width:100%"><tbody><tr><td><p>Eosinophils &lt;150 and FeNO &gt;=25</p><p>&nbsp;</p></td></tr></tbody></table><table cellpadding="0" cellspacing="0" dir="ltr" style="width:100%"><tbody><tr><td><p>Eosinophils &gt;=150 and FeNO &lt;25</p><p>&nbsp;</p></td></tr></tbody></table><table cellpadding="0" cellspacing="0" dir="ltr" style="width:100%"><tbody><tr><td><p>Eosinophils &gt;=150 and FeNO &gt;=25</p><p>&nbsp;</p></td></tr></tbody></table><table cellpadding="0" cellspacing="0" dir="ltr" style="width:100%"><tbody><tr><td><p>Eosinophils (cells/&micro;L) and FeNO (ppb) at baseline</p><p>&nbsp;</p></td></tr></tbody></table><table cellpadding="0" cellspacing="0" dir="ltr" style="width:100%"><tbody><tr><td><p>Eosinophils &lt;150 and FeNO &lt;25</p><p>&nbsp;</p></td></tr></tbody></table><table cellpadding="0" cellspacing="0" dir="ltr" style="width:100%"><tbody><tr><td><p>Negative allergic status</p><p>&nbsp;</p></td></tr></tbody></table><table cellpadding="0" cellspacing="0" dir="ltr" style="width:100%"><tbody><tr><td><p>Positive allergic status</p><p>&nbsp;</p></td></tr></tbody></table><table cellpadding="0" cellspacing="0" dir="ltr" style="width:100%"><tbody><tr><td><p>Allergic status<sup>b</sup></p><p>&nbsp;</p></td></tr></tbody></table><table cellpadding="0" cellspacing="0" dir="ltr" style="width:100%"><tbody><tr><td><p>FeNO at baseline (ppb)</p><p>&nbsp;</p></td></tr></tbody></table><table cellpadding="0" cellspacing="0" dir="ltr" style="width:100%"><tbody><tr><td><p>Overall</p></td></tr></tbody></table><table cellpadding="0" cellspacing="0" dir="ltr" style="width:100%"><tbody><tr><td><p>Eosinophils at baseline (cells/&micro;L)</p><p>&nbsp;</p></td></tr></tbody></table><table cellpadding="0" cellspacing="0" dir="ltr" style="width:100%"><tbody><tr><td><p>Eosinophils at baseline (cells/&micro;L)</p><p>&nbsp;</p></td></tr></tbody></table><table cellpadding="0" cellspacing="0" dir="ltr" style="width:100%"><tbody><tr><td><p><strong>Rate Ratio (95% CI)</strong></p><p>&nbsp;</p></td></tr></tbody></table><table cellpadding="0" cellspacing="0" dir="ltr" style="width:100%"><tbody><tr><td><p><strong>Favours Placebo</strong></p><p>&nbsp;</p></td></tr></tbody></table><table cellpadding="0" cellspacing="0" dir="ltr" style="width:100%"><tbody><tr><td><p><strong>Favours Tezepelumab</strong></p><p>&nbsp;</p></td></tr></tbody></table><p dir="ltr">&nbsp;</p><p dir="ltr">&nbsp;</p><p dir="ltr"><sup>a</sup> Time at risk is defined as the total duration of time in which a new exacerbation can occur (i.e. total follow-up time minus time during exacerbation and 7 days after).<br /><sup>b </sup>Allergic status as defined by a serum IgE result specific to any perennial aeroallergen in the FEIA panel.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><u>Lung function </u></p><p dir="ltr">&nbsp;</p><p dir="ltr">Change from baseline in FEV<sub>1</sub> was assessed as a secondary endpoint in NAVIGATOR. Compared with placebo, tezepelumab provided clinically meaningful improvements in the mean change from baseline in FEV<sub>1</sub> (<!--[if supportFields]><b><span
lang=EN-GB><span style='mso-element:field-begin'></span></span></b><b><span
lang=EN-GB style='mso-bidi-font-size:11.0pt'> REF _Ref109290859 \h </span><span
lang=EN-GB><span style='mso-spacerun:yes'> </span>\* MERGEFORMAT <span
style='mso-element:field-separator'></span></span></b><![endif]--><strong>Table 5<!--[if gte mso 9]><xml>
 <w:data>08D0C9EA79F9BACE118C8200AA004BA90B02000000080000000E0000005F005200650066003100300039003200390030003800350039000000</w:data>
</xml><![endif]--></strong><!--[if supportFields]><b><span lang=EN-GB><span
style='mso-element:field-end'></span></span></b><![endif]-->).</p><p dir="ltr">&nbsp;</p><p dir="ltr"><u>Patient reported outcomes</u></p><p dir="ltr"><u>&nbsp;</u></p><p dir="ltr">Changes from baseline in ACQ-6, Standardised Asthma Quality of Life Questionnaire for ages 12 and older [AQLQ(S)+12] and weekly mean Asthma Symptom Diary (ASD) scores were assessed as secondary endpoints in NAVIGATOR. Severity of wheezing, shortness of breath, cough, and chest tightness were assessed twice daily (morning and evening). Night-time awakening and activity were assessed on a daily basis. The total ASD score was calculated as the mean of 10&nbsp;items (<!--[if supportFields]><b><span
lang=EN-GB><span style='mso-element:field-begin'></span></span></b><b><span
lang=EN-GB style='mso-bidi-font-size:11.0pt'> REF _Ref109290859 \h </span><span
lang=EN-GB><span style='mso-spacerun:yes'> </span>\* MERGEFORMAT <span
style='mso-element:field-separator'></span></span></b><![endif]--><strong>Table 5<!--[if gte mso 9]><xml>
 <w:data>08D0C9EA79F9BACE118C8200AA004BA90B02000000080000000E0000005F005200650066003100300039003200390030003800350039000000</w:data>
</xml><![endif]--></strong><!--[if supportFields]><b><span lang=EN-GB><span
style='mso-element:field-end'></span></span></b><![endif]-->).</p><p dir="ltr">&nbsp;</p><p dir="ltr">Improvements in ACQ-6 and AQLQ(S)+12 were seen as early as 2&nbsp;weeks and 4&nbsp;weeks after administration of tezepelumab, respectively, and sustained through week 52 in both trials.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Table <!--[if supportFields]><span
style='mso-bookmark:_Ref87890936'><span style='mso-bookmark:_Ref109290859'></span></span><span
style='mso-element:field-begin'></span><span style='mso-bookmark:_Ref87890936'><span
style='mso-bookmark:_Ref109290859'><span lang=EN-GB style='font-size:11.0pt;
font-family:"Times New Roman",serif;mso-bidi-font-weight:bold'><span
style='mso-spacerun:yes'> </span>SEQ Table \* ARABIC </span></span></span><span
style='mso-bookmark:_Ref87890936'><span style='mso-bookmark:_Ref109290859'><span
lang=EN-GB style='font-size:11.0pt;font-family:"Times New Roman",serif'><span
style='mso-element:field-separator'></span></span></span></span><![endif]-->5<!--[if supportFields]><span
style='mso-bookmark:_Ref87890936'><span style='mso-bookmark:_Ref109290859'></span></span><span
style='mso-element:field-end'></span><![endif]-->&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Results of key secondary endpoints at week 52 in NAVIGATOR<sup>a</sup></p><table border="1" cellspacing="0" cellpadding="0" dir="ltr"><thead><tr><td style="vertical-align:top"><p><strong>&nbsp;</strong></p></td><td style="vertical-align:top"><p><strong>Tezepelumab</strong></p></td><td style="vertical-align:top"><p><strong>Placebo</strong></p></td></tr><tr><td colspan="3" style="vertical-align:top"><p><strong>Pre-bronchodilator FEV<sub>1</sub> </strong></p></td></tr><tr><td style="vertical-align:top"><p>N</p></td><td style="vertical-align:top"><p>527</p></td><td style="vertical-align:top"><p>531</p></td></tr><tr><td style="vertical-align:top"><p>LS Mean Change from Baseline (L)</p></td><td style="vertical-align:top"><p>0.23</p></td><td style="vertical-align:top"><p>0.10</p></td></tr><tr><td style="vertical-align:top"><p>LS Mean Difference from Placebo (L) (95% CI)</p></td><td colspan="2" style="vertical-align:top"><p>0.13 (0.08, 0.18)</p></td></tr><tr><td style="vertical-align:top"><p>p-value</p></td><td colspan="2" style="vertical-align:top"><p>&lt;0.001</p></td></tr><tr><td colspan="3" style="vertical-align:top"><p><strong>AQLQ(S)+12 total score</strong></p></td></tr><tr><td style="vertical-align:top"><p>N</p></td><td style="vertical-align:top"><p>525</p></td><td style="vertical-align:top"><p>526</p></td></tr><tr><td style="vertical-align:top"><p>LS Mean Change from Baseline</p></td><td style="vertical-align:top"><p>1.48</p></td><td style="vertical-align:top"><p>1.14</p></td></tr><tr><td style="vertical-align:top"><p>Difference from Placebo (95% CI)</p></td><td colspan="2" style="vertical-align:top"><p>0.33 (0.20, 0.47)</p></td></tr><tr><td style="vertical-align:top"><p>p-value</p></td><td colspan="2" style="vertical-align:top"><p>&lt;0.001</p></td></tr><tr><td colspan="3" style="vertical-align:top"><p><strong>ACQ-6 score</strong></p></td></tr><tr><td style="vertical-align:top"><p>N</p></td><td style="vertical-align:top"><p>527</p></td><td style="vertical-align:top"><p>531</p></td></tr><tr><td style="vertical-align:top"><p>LS Mean Change from Baseline</p></td><td style="vertical-align:top"><p>-1.53</p></td><td style="vertical-align:top"><p>-1.20</p></td></tr><tr><td style="vertical-align:top"><p>Difference from Placebo (95% CI)</p></td><td colspan="2" style="vertical-align:top"><p>-0.33 (‑0.46, ‑0.20)</p></td></tr><tr><td style="vertical-align:top"><p>p-value</p></td><td colspan="2" style="vertical-align:top"><p>&lt;0.001</p></td></tr><tr><td colspan="3" style="vertical-align:top"><p><strong>ASD</strong></p></td></tr><tr><td style="vertical-align:top"><p>N</p></td><td style="vertical-align:top"><p>525</p></td><td style="vertical-align:top"><p>531</p></td></tr><tr><td style="vertical-align:top"><p>LS Mean Change from Baseline</p></td><td style="vertical-align:top"><p>-0.70</p></td><td style="vertical-align:top"><p>-0.59</p></td></tr><tr><td style="vertical-align:top"><p>Difference from Placebo (95% CI)</p></td><td colspan="2" style="vertical-align:top"><p>-0.11 (‑0.19, ‑0.04)</p></td></tr><tr><td style="vertical-align:top"><p>p-value</p></td><td colspan="2" style="vertical-align:top"><p>0.004</p></td></tr></thead></table><p dir="ltr"><sup>a</sup>&nbsp; Estimates are derived from a Mixed Model for Repeated Measures (MMRM) using all available data from patients with at least 1 change from baseline value, including data post-discontinuation.</p><p dir="ltr">ACQ-6, Asthma Control Questionnaire 6; AQLQ(S)+12, Standardised Asthma Quality of Life Questionnaire for 12&nbsp;years and older; ASD Asthma Symptom Diary; CI, Confidence interval; FEV<sub>1</sub>, Forced expiratory volume in one second; LS, Least square; N, Number of patients contributing to the analysis (FA) with at least 1 change from baseline value</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Elderly patients (&ge;&nbsp;65 years of age)</em></p><p dir="ltr">Of the 665&nbsp;patients with asthma exposed to tezepelumab 210&nbsp;mg subcutaneous Q4W in PATHWAY and NAVIGATOR, a total of 119&nbsp;patients were 65&nbsp;years of age or older, of which 32&nbsp;patients were 75&nbsp;years of age or older. Safety in these age groups were similar to the overall study population. Efficacy in these age groups were similar to the overall study population in NAVIGATOR. PATHWAY did not include sufficient numbers of patients aged 65 and over to determine efficacy in this age group.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><u>Paediatric population</u></p><p dir="ltr"><u>&nbsp;</u></p><p dir="ltr">A total of 82&nbsp;adolescents aged 12 to 17 with severe, uncontrolled asthma were enrolled in NAVIGATOR and received treatment with tezepelumab (n=41) or placebo (n=41). Of the 41&nbsp;adolescents receiving treatment with tezepelumab, 15 were taking high-dose ICS at baseline. The annualised asthma exacerbation rate observed in adolescents treated with tezepelumab was 0.68 versus 0.97 for placebo (rate ratio 0.70; 95% CI 0.34, 1.46). The LS mean change from baseline for FEV<sub>1</sub> observed in adolescents treated with tezepelumab was 0.44&nbsp;L versus 0.27&nbsp;L for placebo (LS mean difference 0.17&nbsp;L; 95% CI -0.01, 0.35). The pharmacodynamic responses in adolescents were generally similar to the overall study population.</p><p dir="ltr">&nbsp;</p><p dir="ltr">The European Medicines Agency has deferred the obligation to submit the results of studies with Tezspire in one or more subsets of the paediatric population in asthma (see section 4.2 for information on paediatric use).</p><p dir="ltr">&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">The pharmacokinetics of tezepelumab were dose-proportional following subcutaneous administration over a dose range of 2.1&nbsp;mg to 420&nbsp;mg.</p><p dir="ltr"><u>&nbsp;</u></p><p dir="ltr"><u>Absorption</u></p><p dir="ltr"><u>&nbsp;</u></p><p dir="ltr">Following a single subcutaneous administration, the maximum serum concentration was reached in approximately 3 to 10&nbsp;days. Based on population pharmacokinetic analysis, the estimated absolute bioavailability was approximately 77%. There was no clinically relevant difference in bioavailability when administered to different injection sites (abdomen, thigh, or upper arm).</p><p dir="ltr"><u>&nbsp;</u></p><p dir="ltr"><u>Distribution</u></p><p dir="ltr"><u>&nbsp;</u></p><p dir="ltr">Based on population pharmacokinetic analysis, central and peripheral volume of distribution of tezepelumab were 3.9&nbsp;L and 2.2&nbsp;L, respectively, for a 70&nbsp;kg individual.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><u>Metabolism</u></p><p dir="ltr"><u>&nbsp;</u></p><p dir="ltr">Tezepelumab is a human monoclonal antibody (IgG2&lambda;) that is degraded by proteolytic enzymes widely distributed in the body and not metabolised by hepatic enzymes.</p><p dir="ltr"><u>&nbsp;</u></p><p dir="ltr"><u>Elimination</u></p><p dir="ltr"><u>&nbsp;</u></p><p dir="ltr">As a human monoclonal antibody, tezepelumab is eliminated by intracellular catabolism and there is no evidence of target-mediated clearance. From population pharmacokinetic analysis, the estimated clearance for tezepelumab was 0.17&nbsp;L/d for a 70&nbsp;kg individual. The elimination half-life was approximately 26&nbsp;days.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><u>Special populations</u></p><p dir="ltr"><u>&nbsp;</u></p><p dir="ltr"><em>Age, gender, race</em></p><p dir="ltr">Based on population pharmacokinetic analysis, age, gender and race had no clinically meaningful effects on the pharmacokinetics of tezepelumab.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Body weight</em></p><p dir="ltr">Based on population pharmacokinetic analysis, higher body weight was associated with lower exposure. However, the effect of body weight on exposure had no meaningful impact on efficacy or safety and does not require dose adjustment.</p><p dir="ltr"><em>&nbsp;</em></p><p dir="ltr"><em>Paediatric patients</em></p><p dir="ltr">Based on the population pharmacokinetic analysis, there was no clinically meaningful age-related difference in the pharmacokinetics of tezepelumab between adults and adolescents aged 12 to 17&nbsp;years. Tezepelumab has not been studied in children under 12&nbsp;years of age (see section 4.2).</p><p dir="ltr"><em>&nbsp;</em></p><p dir="ltr"><em>Elderly patients (&ge;65&nbsp;years of age)</em></p><p dir="ltr">Based on population pharmacokinetic analysis, there was no clinically meaningful difference in the pharmacokinetics of tezepelumab between patients 65&nbsp;years of age or older and younger patients.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><em>Renal impairment</em></p><p dir="ltr">No formal clinical studies have been conducted to investigate the effect of renal impairment on tezepelumab. Based on population pharmacokinetic analysis, tezepelumab clearance was similar in patients with mild renal impairment (creatinine clearance 60 to &lt;&nbsp;90&nbsp;mL/min), moderate renal impairment (creatinine clearance 30 to &lt;&nbsp;60&nbsp;mL/min) and those with normal renal function (creatinine clearance &ge;&nbsp;90&nbsp;mL/min). Tezepelumab has not been studied in patients with severe renal impairment (creatinine clearance &lt;&nbsp;30&nbsp;mL/min); however, tezepelumab is not cleared renally.</p><p dir="ltr"><em>&nbsp;</em></p><p dir="ltr"><em>Hepatic impairment</em></p><p dir="ltr">No formal clinical studies have been conducted to investigate the effect of hepatic impairment on tezepelumab. IgG monoclonal antibodies are not primarily cleared via hepatic pathway; change in hepatic function is not expected to influence tezepelumab clearance. Based on population pharmacokinetic analysis, baseline hepatic function biomarkers (ALT, AST, and bilirubin) had no effect on tezepelumab clearance.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">Non-clinical data revealed no special hazard for humans based on repeated dose toxicity studies including safety pharmacology and fertility evaluations, and an ePPND (enhanced Pre- and Post-Natal Development) reproductive toxicity study in cynomolgus monkeys at doses of up to 300&nbsp;mg/kg/week (producing exposures of greater than 100-times the clinical exposure at maximum recommended human dose [MRHD]).</p><p dir="ltr">&nbsp;</p><p dir="ltr">Tezepelumab is excreted in milk in monkeys, although at low concentrations (&lt;&nbsp;1%).</p><p dir="ltr">&nbsp;</p><p dir="ltr">Tezepelumab is a monoclonal antibody, as such genotoxicity and carcinogenicity studies have not been conducted.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">Acetic acid 2.8 mg</p><p dir="ltr">L-proline 48 mg</p><p dir="ltr">Polysorbate 80 0.19 mg</p><p dir="ltr">Sodium hydroxide QS</p><p dir="ltr">Water for injections QS</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">In the absence of compatibility studies, this medicinal product must not be mixed with other medicinal products.</p><p dir="ltr">&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                36 Months. 

Tezspire may be kept at room temperature (20°C - 25°C) for a maximum of 30 days. After removal from the refrigerator, Tezspire must be used within 30 days or discarded.


            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">Store in a refrigerator (2&deg;C&nbsp;-&nbsp;8&deg;C). For storage after removal from refrigeration, see section 6.3.</p><p dir="ltr">Keep the pre-filled syringe in the outer carton in order to protect from light.</p><p dir="ltr">Do not freeze. Do not shake. Do not expose to heat.</p><p dir="ltr">&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">1.91&nbsp;mL solution in a siliconized Type I glass pre-filled syringe subassembly consisting of a 27-gauge &frac12;-inch (12.7&nbsp;mm) stainless steel special thin wall needle covered with a rigid needle cover and bromobutyl plunger-stopper. The pre-filled syringe subassembly is assembled with a needle guard and an extended finger flange.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Pack containing 1 pre-filled syringe.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">This medicinal product is for single-use only.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Prior to administration, remove carton from refrigerator and allow Tezspire to reach room temperature. This generally takes 60&nbsp;minutes.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Visually inspect Tezspire for particulate matter and discolouration prior to administration. Tezspire is clear to opalescent, colourless to light yellow. Do not use this medicinal product if liquid is cloudy, discoloured, or if it contains large particles or foreign particulate matter.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Additional information and instructions for the preparation and administration of Tezspire using the pre-filled syringe are given in the package leaflet and &lsquo;Instructions for Use&rsquo;.</p><p dir="ltr">&nbsp;</p><p dir="ltr">Any unused medicinal product or waste material should be disposed of in accordance with local</p><p dir="ltr">requirements.</p><p dir="ltr">&nbsp;</p><p dir="ltr"><strong>&nbsp;</strong></p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                AstraZeneca AB
SE 151 85 Södertälje
Sweden

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                	Review Date Sep 2024
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="data:image/png; base64,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&#x2B;4HC6Ha7iRzWEbPmCxWIb/M5kIqAAAAAB/MQZN0//u5wD/CxQKRUNDQ0NDA5vFDgsPa/spiqJIktS/ptPp9Dq9TqfT6XR6vV6r1b7&#x2B;26tbDJ/V6/UkSVIURdM0g8F4lSXYLDaLzWKxOK&#x2B;xOWxDhDD879VNHDaHwzEECWQJAAAAgLYQAOCfpVQqc7Jz&#x2B;AI&#x2B;g8EICAh447MURRMMgkEQDAbjn/9aFEUZgoEhIRiyhOGD1wFCp9PqDIlC//oPUk&#x2B;&#x2B;M0uwWCwOm8Nms985L8HmsJElAAAA4H8PAgD849RqdXx8vK2trbWVta2d7TuH&#x2B;BqdTqvTEwRB0zRJ0a0/bwzidSZgMAzxgMEgGASDwTB8bLih9eNXn2rzv38WSZKt8xK/xonXoUKr1bbNFa8&#x2B;1uv0Oj1FUf/wvEQrQ6JAlgAAAID/fwgA8HfT6XQqlSo1NVXAF0RERjCZzLcHsmqd7tLDF89ziv3dHV1sLVlsNk1S9tbm3s62LCaTomiKfhUGfv3D8PHrv7z&#x2B;79Wn2vz5plcxwhAM2qaI38QJ4vWHv37qL4oShGFS4vUKp9ZFTG1mIdqmCMPHpF6v05MkSdN0a5ZgsVhMFpP9arLhVckEh8t557xEW5iXAAAAgD8PRcDwd1Cr1Q0NDfX19TqdLjY29p3HLNl&#x2B;sqymcc&#x2B;yGX6uDnKVhs/l8Hncm4kZ32059u0nU8b1bl/XLBXyeTwOm8Nk2lmbi4X8tx/kdRAgCIJoHa23omiaJCnDjRRN0fQ7k8PrjEETNPHrZwU8DpPBVGq0TAZB0QRFUW0f&#x2B;XUsINokhNbM0GZq4rcxw3A5n8fj/ZOnl6bpV/MSOr1h5dKvQUKv1&#x2B;l0UrX07URhyBsUSf06u8JgsF57VV3NfjUJwePy2Gz2H8xLGPyTLwQAAAD&#x2B;k2EGAP4UrVablZXF4XBIPRkaFvr2AXKVZtm2EzllNdc2fqpQaczFotYx&#x2B;6LNRzuGer/ML2&#x2B;UyEf1iM4qqiyoqNt37aEtn9uzc8TMod19nO02n7r5/cFLAi6HYDBWTh&#x2B;&#x2B;eMKAtsPQVXvPK1UapUYrFvHtLc1GxEa72lsVVtY1tMgszUy4bJarnZWOJGmK5nE5rfdqDRFtVw3dSEzPLqmcOqBraU0Dk8kM83bJKa0W8rkOVuZylZrH4bBZTMoQC15PSrRGiNbpCA6bxedyFCoNSVHv/Bf0txc4tV3d1Gbm4q9a4GTIEnq9ntSThgmHN6cg9Hqd9rfzEq8jx7uzBJvFZv2aJdrOS7Q2d3rVzYnFZnOQJQAAAP5zIQDA36DX6RMSE0xMTOxs7WztbN85pCNJauHmIwmZRWe&#x2B;m&#x2B;9oY8Fhs1Ua7ZJtJx6m5lxYs6i8tvHTrcc2LZgoV2vaBXreeZYl4vPyy2sYDAaXw777LLNdoFeLVKEn6ILCCjGbdWDNwtZHXrLtZHZJ5aaFEymKLqtrnL1mv5O1&#x2B;byRvQuqagPdHdPyy0vrGg5efnRn&#x2B;4qckqqPNx/RNUsJDmfBpEHfzx1jIvj1kvy9F9lf7jnHkitDw3zTSyq6hQd0C/c/Hhf/Xo92z3OKn6Tnr5039rv9F/3cHRaN7c9iMk0EPMNAnKaJtwfk2cVVJ24&#x2B;njq4m5ujDU0TbNavy2/0JEW&#x2B;jg9vT0q8cQuXw&#x2B;ayWXKVpnVB1Nv&#x2B;oQVOf2WxBE3TrR2cWicl2pZMvLHYyTAjodfp9aT&#x2B;b8xLcDgc9uulTZiXAAAA&#x2B;P&#x2B;CAADvptfrNRpNelo6SZLt2rcztPP/g&#x2B;N1JJlbUp1XXiMS8KP83K3NTQy3v8grtTYTmwi4Ai5XplJXN7ZQFM1ls0xNhJ/vOt07Omhs7w48Dvvhy7yHL7K/mD6MIAi5Uq1Qa07dTVr887Gs42tcbK0apYrlO06ai0SjesV8tOHQ8imD9RTVJzr44uMUNouRXljhZm8tUyhlKm1JRa2diWDB5MGn7z0rra4zE4uWTByckleycu&#x2B;5nYunJWcUnLibtH7B&#x2B;OvxaTKlekLfDt8duDyiW6SFWLR4y/H9n8&#x2B;iKfqjTYfj0/IIpdre3fHkt/Njw/yq6lve&#x2B;/zn9LwSHw8ndwdriqSHdIkQcdhdIwOcbC0Jgqisb776NFXA4wp4HE9Hu3BfV4lcSVK0lanoj4fgT9PyXxaWzx3R8zdnnqQommYQBINBUDRNUW9XSrz66DdFFMRv/3iXP7fA6bfp4i8tlnhHQ9jWgok2uUKnbVN1/bqsgmoz2WIoO/kz8xK/ZgnMSwAAALyGAABv0ul09XX1jU2NLc0tXWO7vvOYvPKan07emjuyZ7Cn859/ZMPafQ6bRRCEVkfKVSqJXCUS8GzMxYYBZotcmVZQXtskiUvO/PC9PlKlqrK&#x2B;OcrX3cvZVqXWviwoszAViYUCsZAvFvJrmiRrDl&#x2B;xtTSbO7ynhViYVlD2PLdkfJ&#x2B;O/DargIqrGiZ/vXPdh&#x2B;O8nG0/&#x2B;vHQsNhoJxvzdUevLps0&#x2B;GV&#x2B;2d3n2d/MGrH60OVAD2cHK7OS6novJ9uEzMIAd&#x2B;fdJ659OHHQmYfPugT7fT1rBEEQNY0t8388TNDUxoUTzURCc7GQIIgrT1KO3HxqaSourqw1FQkJgnZ3tBnYMexEXIJKo/twVC9Xe2u5St3343UHPv/gWkJqY4v8ZUGpgGbs&#x2B;HL2go2Ht3827dTdRJVGayLgMQgGTRAmAv78Ub0IgmiSyrNLqk1FfCszsZDHFfK5XM47KnZaZw4MC5QYDAazzVCdomg9RRpWJBmqjdvWW79zUsLwYDwOR0&#x2B;SOj35zu9jmwVObWYe2sxIEATBfH0rs83sxdvlHP8wQ0PY39Dp31jR9OvURJvS7NaGsIbHYTKZTBaTxWyTJd6Yl3gdJ7DGCQAA/mcgAMCvKIrKzMxkMplajTYiMuLtA5RqzbWEtB8OXO4e4ffN7PduJqZvOX1rUr9O3i52O87d6RDkvWhc/9LahvpmGYfFapLKpUp11zA/S1NReW2jgM8zEwmYTAbr9/vVNEkVT9Lyu4b5GobXv3luNK3W6LgcNklRbBaLxWSQFKVUa1UaHYfNtDAREb8dWJIklVtWbWtham0uLq6qpyjKy9kus6hCLBKIBNzskmpPRxupUu3rYn8jPu3M/eR5I3pF&#x2B;LoxmYxjt&#x2B;JjAj2LqxtW7Dh5ce0iZ1vL4ur6j348pNGTtzcvefVkSGrjyRsypWrawNjyuqaXBWVn7iZv&#x2B;3RKsJdzUmbh&#x2B;FXbTQT8e1tXnLyTkJBRuGhcv4Lyui1nbm37dGqgh5NEoQwcv3T/F7NNRYLPd52eNii2Y7C3RqubsHInn8fuHOLTLFduXzy1tLph&#x2B;c7TeWU1OSVVAzqE2luZTRnUNcrPfen2k79ceiDgcU0E/IVj&#x2B;i4Y06dt4JGr1EdvxWcVV1mKhc62lgM7hTlYmStUmrLaRhaLaSoUCPlcsZD/N0fhyTlFJgJ&#x2B;gJtj2xt1etLw64KiacP4nqQomqIpom2ZxJu5giD&#x2B;aFbiTy1wai2iaE0Qf90CJ4IgXhVLkGTbSYm2a5y0Ou2vG9i1pgmdTq/Xt6Yq4rdZgsPmGP7/9rxEa3&#x2B;nV&#x2B;2ekCUAAOD/HQIAvJKUmMRgMpwcnaxtrLlcbttP0TSdW1bTJJGfvJtob2m2YHTf91fvfZyWN7xrlFSuUmo1dU3SYV0ihnSN9HSynbNuX1Fl/bIpQ&#x2B;Qq9ebjN1zsraYO7LJi&#x2B;2k9Rb3Xs11qfklCRsGJb&#x2B;brKGrO2v0qtW7J5IEmfP7ao1fXfzh&#x2B;cKew20kZ1xNejuoeYyoSXH2S2ismKCbA82V&#x2B;WVVjy7Fb8aYi/rp540SCf7bfzm9fHVHfIqVp2lQkEPBevfC6ZlmTVCZRqNsFej7PKYr292x7l5rGlvjMoqr6ZncHq55RQQIeJ7&#x2B;8lkEQ287F1TfLOgR7cTnsruF&#x2B;rrZWBZW1ey7en9y/c/sgL52eHLT4x07B3l/OGD70s01dwv0WjO7DZbP3Xn6QkFW48L2&#x2B;i7YcG9olXK3Vr5gyRKpQ7bl0Pzbcf9u5uI7B3kyC2HLy5qje7WmKJin68uNUJotxfvVCVzsrwzB46fZTMqXq50WTMooqH7/Mq2porm5o1lH0/JG9bM1MN5&#x2B;6kZhZlJyULrKzvLR2UaiPS0Zh&#x2B;bwNh/q0Czl3P1nI51mbiU98O7&#x2B;kum7hd3vM7CxtLc2&#x2B;mD5MKlM&#x2B;Scu3tTBls1mWYlHvmCAuh13V0KxQadYdvRrh4zFvVM&#x2B;3z&#x2B;cbKMqwiMnwc0Rw2Cw9SclVaoVKI&#x2B;LzuBw2l8NmMAiNTm/ICQyCEPJ5BEHIVWqSogmaZjKZQj6XQRAkRVEUrdHp9eQ7pibetcDpXSXX/7JiCeKNhrCt8xJ6Xdu&#x2B;sK2VEm1nLVqzhKEn7DuyxO/PS7zq88Q27EXBMlRN/CUvBwAA/lchABg1Q8fJnJycmpqaXr17EQTBZr9jnYlGp7/8OCWvrHrF1KGVDc2jlv00/70&#x2B;k/t3vp6QtnzHqW9mjdLp9PN&#x2B;PLj1kynv9Yh5nlui1evDvd0OXX/8JC3fykzk7WIfl5TJZDKiA9wfpubOGtrjwLVH0wZ2HdU9mqQoFpMp7vXB4ZWzl&#x2B;887elgY2MhbmiWm4oFpVUNfdoFafWUmQk/2MN5y9nba&#x2B;eNPXE7IczHdWDHsBa58uzd5JN3E&#x2B;N3f7Vy95nVu86uWTItxNP5h/3nGySKheP7R3i7rj96fWSP6LG92idnF&#x2B;eWVnUO8xXxebll1Z6ONk42lhKFikkQ3mOX7Fo2dXiX6N87RS8LysO8Xf7gHD5Ky/tgzb5F4/rNGtqjsr5ZLOSbigQEQVA0XdPYIhbyxUIBQRDldY0MBsPZxrK2WSqVK31c7AmCaJTICirqvJ1tlSotk81MyCgoq21aNLbfyOU/DegQ1iCRDe0aYWNuOuaLrR8M7zm&#x2B;TweCIE7dTcwsqlwyabCI/yqr3ErKnL12747PpkX6urFYzLWHr/C4HF9X&#x2B;7T8cicbi3Bft3Af1/spOe0DPX8&#x2B;fZvDYo7sHvPeii3XNy72dbVXqDVHbjw9dP3xwx2fn4hL3HD06t6l09UkrVCpTUS8u8&#x2B;yLjx88Swll&#x2B;Bzl08Z0ismUKZQl9U0PEjN&#x2B;3nRpF&#x2B;u3L8Rn&#x2B;5sbX7u4QuhgDuqe7sDn8/UkeTSbSfvPc/mstkMmlo4vv&#x2B;o7jFtFy8lZRX5uTpkl1Yt2HiIx&#x2B;VIFSqZUj25f&#x2B;evZ45sPebL3WcUKs2qmSMNZ7K2UXLiTqJMqXa2tWQQRJS/u7ez3a/zSAzidSfY1nmH30xEvOs/gviDbSWId3dwIn43Tvz1xRJvN4T9tVZCr29bI9F297pWrV2s2maJVxXVbJZhS4nfFE78dl6CxWa1Lb/&#x2B;C14PAAD8h0EAMFIURVVXV0ul0sqKyt59ev&#x2B;Fj2y4iEvTdE5ZdV2TtEOQN4/Lvp&#x2B;S8&#x2B;Pxa5P7d5IpNdeepn0xdWiEn9vqQ5cOXnt8Z&#x2B;uKupaWPh&#x2B;tPbxybvdw/10X76765fyBL2e3yJVbT98&#x2B;&#x2B;d2Hm05e1&#x2B;mobhH&#x2B;NU2SjsHeuWXVZiLB9rNxX80codHqP9tyPOXgd3qS2nv5waXHL1ZMGerv5nDo&#x2B;qOr8WkrpgzV68miqrprCS8r6ppcbS3FIgFF0QIeZ97I3sduxR&#x2B;5eH/80NhQb9eDVx7mlVRd&#x2B;2lpuI9r6wuZuXpv3/YhfWKCV&#x2B;09x2Wzu4T5tg/yfJpWIBLwe0QFcNlvDoyqmySJGQXbzsVZmJjsWjrNQixq&#x2B;9kWmfJ4XLyzjWXXMD&#x2B;FSpNfWRvg5mBnaUYQxLOc4g1Hr2UWV4pFgsXjBwzpHJFdWmllJnaysSAIQq5UN8nkzVKllZmJs63lW2ebLqqoS8wqoii6Y4i3h6NNk0QuUajSC8sfpub0iAzsFu5HMBgHrz1msxnvD&#x2B;62bMepfu1D&#x2B;rUPlSs18RkFX&#x2B;05E/fzssLKumFLN9/Y/FmLTLFi56m5I3q916OdXKVee/Tq1cepn44fqNSo88pqR3aP3nL6Vt/2IW721puO37i0fpFGpy&#x2B;prt96Ns7R0nzee70nfLU9r6K2T0xwhK&#x2B;bj4s9QZGONpaeTrZtuyTNXX&#x2B;Iw2b2axfcp10wl8P&#x2B;8MdDdpamX04fXlrTWNvccu7&#x2B;8xsJ6ae/ne9oYyES8D75&#x2B;ZhOT342cWBpTUNJdcPXe89rdPqfF00a1Dmcy2YTBKFUa6samllMJp/L4fM4himF35wfmn7nkFxPUq8/TxCvR/mGkus39qdjs1iGx9To9DqdjqL/rqpr4m8scPoXd4Ml2jSEfXcfp7cKJ9oWS7StvTZkCcOWc4Z5CUN19dvzEq3FEoa5C2QJAID/QAgAxigrK4skSZ1WFxIawuFw3visSqMjSXLx1pNnHiR1DvHW6SkBj6vT69sFeq2YMoT5949LKuoam&#x2B;VKkqLrm6V9YoL/5vGGZdUUTVfUNbk7WDdJ5Tfi00Z0jxHwOOcePLv7PGvZpME2FuIJK3cc/uoDIZ&#x2B;XkFn43YFLi8b16xUV&#x2B;CQ9/7Otx9fPH3f0VkJ5bcPxr&#x2B;flldesPnwl7lnm/JG9mUwGqdGW1TW5OdktmzyoqKre2kyckFGw5/L9S&#x2B;sWcVgsiqKZTMbnu043SpVr546e/&#x2B;Mhe2vzQR3DaJpukioOXntoZWbq62L/0eg&#x2B;bfcvo2i6orYxo6jywx8P3ty0xMnOks/ltJ6oxMzCvVcfzBnWK72wzEIsUqg128/dJQjii2lD&#x2B;7UPaZTI4zPyj9&#x2B;KL6lu3PDR&#x2B;A7BXn/vyE&#x2B;h0jRI5G72Vjq9nvN6AkenJ9VarZ6kBDyuoUhAplSrtVobc1OCIDRaXUFFrY&#x2B;LPZfDzi2vzSgsbx/k6WhtkZhVmFFYYW1m0r99SH5FXVphmaONpZDH9XO1P3v/WZSfu5ez7Ze7z66bP47HYRdX1d1KznieU/LV&#x2B;8OX7zjVKzJo2qCuaq1u8ZbjFXVNGz4a7&#x2B;1sZ3gyFx89P3Y78fOpQ0K9XCrqm8/cTapqaO7XPqRXdJDhgBe5JeV1TZ/&#x2B;dOzcmoWh3i4EQSzfceppZsH2xdMcrcwsxKJTdxIvP0ntGRng62bfIcjbcPn//INnLTJlfkVNbbP0RkJ6VVV9uzC/dgEe91JyCitrhSzWtqUzxvXpUN3YsmTriWe5Jd7Odj5OtjwuJ9DDcXL/Lm3PYW2TpLiqXsDnmpsIRXyepamodWfl4qr6977YEuDmuHTSoEB3RwaT2WYWgaDb/tlajd1my4i/2Qr2z9VK/P4Cp9/rBvsvKJZobeJkmJpou7nEO&#x2B;LEb4slWmuvX9WIv84Svzsv8dYaJ0OWaG0j&#x2B;5e8IgAAo4UAYFwy0jOampv8/PzEYrFQ&#x2B;GahbW2TJLO48sjNp/deZL/Y/43hGjZF0yq1VqHSHIuLZxKMBWP60jT9&#x2B;GVeXYtsRGyURqd7mJpb3dhiaSqK8fd0sDZvlikaJbJ1R69bikVfzBhmwn9zvb5OR64/ejXIy2lY16h/3StVqbUqrc7wEirqGsvqmsK8XTls1oFL9y3NTEb37iBRqL7dd8HRxuKTcf1b73Xu/rM9l&#x2B;4d/PKDk3GJ1xPT1s0b62Btbm4ifO/zLUO7RDjbWEYHeLxxaf/E7QQfF7vp3/&#x2B;y9/OZMf4eWp2ewWBwXs8P0ASx8/ydk3cSekUGuTnYvMgrdrAy43K4c4f35PM4NxLSqhtanuUUD4&#x2B;N6tPu12hkqLLdcOzGuqOXB3eKnD2s296rDxNeZA/p0W7G4G4XHz2XK9Ur3x&#x2B;h1en2XXlkZ2n65e6zib98JRII/smTptXr1RqdkM&#x2B;jKJrNYlA0zWKxVBqtIc/UNUttLUwNR8pV6oYWmbuDDUEQ&#x2B;eW1ZXWNGq3WycYywN2p7dxIeW1jbnlNXZOkor7Zzd7a1txUbMKP8HEzjOBJiqptkta3SFbsPDNvZO9BncIIgsgorJi1el&#x2B;3KP81c8fQBDH9&#x2B;z1SufKbWSP1JB3g5mDY6G3H&#x2B;bvNUoWIz/V2sW8X6JGcVazWaZOzi1fPGVPd2JKQWXDo2tOFY/sevPqQzWLtWjpdo9MXVtZ/uPFQTUPL2nlj7axMOwR5EwSRVVx1Kyl9QMewJqnip5M38spqUl5kevh6nF&#x2B;z0FwsHLF0c0p6gbmN&#x2B;cdj&#x2B;k0bHGtnYdq23vrv9WpxUuvHRJvAYPhbm0qJ1uPbBoN3t4J9nSp&#x2B;MxvxB1XXxB8ucCIIDpvF&#x2B;dcPr9s2hG07KdE6F/Frf9g2t786/o0swWKymK&#x2B;yBIfzKie8vb/EG/MSrcUSyBIAYJwQAP73URSl1WrLSssyMzOHDB1CvGuhv0SuOnj9kYjPSyss93C0EfF5uWU1aq2Ww2K916NdhK9rRV3z4i3Hc8qru4b77V32fllt44BP1i&#x2B;eMGjaoK5JWUX7rzwQ8XlBns6WZiYCLvtBSu6gTuG1TS3NctWj1Ly4Z&#x2B;mdQ3zWfzje1c7qwqMX9RJpv3YhNEUXVNTeTMqwtRD7utgP7BjOZjHLahulCrWFqVCmUPO5HDtLUwGPa7gqX9csu/csc1i3SP5vC5T/fzRJ5WwWy7Ak/Q2f/Hy0X/uwfu2DCYJQqNR3n2drdeSoHtHbz91Zf&#x2B;zanqUzYgI8pny7q6ii/vKGTxqlchtzE1c76xNxCan5ZS62lnYWpu/1bNf6aDKlurZJkpBZsOv83b2fz/R1cXiRVzLmi21r542J8nXPLqvefPJmj8iAcB/XE3GJI7pF3UxMXzljuGEp0Rt0evLSwxfLdp56r2d051C/n0/etDIXH/96Xmp&#x2B;&#x2B;bJtJ2Ij/AZ3jsgtrymrbpgxONZMLHyUmlvZ0Lzn4v1xfdpP6tdZ9FZyIwji4LVHyTklWz&#x2B;ZTBBEal5psJdL2&#x2B;U970TRNEVRFEXrSFKr01MUbSLgtW7Y3CxTcjistilRo9MlZxdX1bcEeTgFeToRBKEnSRaTaRjtldc2NcsUSrVWpdH2iAoorKyVKFQHrz7&#x2B;adEkmiCSMgt3X7o/tEuErbl4&#x2B;vd7diyZ0SPSv65ZuujnY0/S8w99Mcvb2c7R2oIgiMqG5h3n7tQ1SYM8nXvHBDlYmT1Jy/N1ddh3&#x2B;YFIyJ/cr/P07/e8P7jb5AGd/8ZPxr/Dr9MNbf745yclCAaDxWCwWSwOh/3XTBn8vyBfMyxbejtI/LqyqW2c0OtIPfnOLNF2rzo2m22Yl3jnGqfW1U3IEgDwXwcB4H9cVVWVQqEoKCjo1asX911DZ41Wd&#x2B;Ze8oOU7MSsoiAPpwEdQlkspqO1Rddwv4q6ZhtzE6VG&#x2B;8lPx9IKK4R8zv4vZvm5OIz5YpudpXjtvLE6PVlS3VDV0MJhs67Gp47p1eHYracOlmYeTrZZRZUrpg6prG&#x2B;2NhdPWLWjW4R/uLfr9wcuHVk15/Odp&#x2B;Rq7YopQ2iKziirfn/B2gObP&#x2B;saEbDu6NWR3aIomhALeP0XbYj29/xi2hAbC9Ovfjl791l2twjfle&#x2B;PtDEXf7n7bEZRuZ2l&#x2B;fxRvQd2DNXpybhnWdWNLTOHdGv7umRKVVV9C4fDFvG5ZibCf&#x2B;zarUypFvG5TCbTUKz8D34PCIIgCJ2ebJ0WoCiquLq&#x2B;ulHaJdTnjcNySqu&#x2B;P3hlxqCuPaIClGpt7wVrJvbvOH9kn4r6phW7zrjaWn4wvOey7SftLM0sxKJIX7f2wd5qjVYk5JubCA2DNqlC9bKgzMbcNCW/9OC1R5X1LWYmgvG9O04f3HXhpiNSpWrbp1Nqm6R8Lvv&#x2B;i5yv9pyb/15vHodtaWrSJJXXNUn6tQ89fTdpcJfwzqG&#x2B;cpV69cErTTL5yhnDTt5NOnMneWK/TrOH9Zi4cscHw3t0Dfc7cvNpfEb&#x2B;lAFdnG0sn6TlOdtZDukcUdcszS6tshSbuNpbcVgsrU4vFvHfefYaJLLTd5KcbCyGdInQ6UmNTp9dUlle29Q5zNf&#x2B;daShadqwLRqTySQIWqenSJLi8159NxslMiszseHjkpoGHpstVajuPMtkMBjmYhN3B6u6Zsmei/c/Gt23X/uQtvUATVLFibj44qr64bHRYT6ucqXq4PXHlqYmMwbHbjp5U6fTL58y5J/5dv9XeGNS4i9cLPRf6lXh9W&#x2B;bOL1Rb912mdOr/5P61izR&#x2B;lBts0TrvMRvskTbBU6vP2jNEiwWy8i/FwDwr4YA8D&#x2B;roKBAKpWy2WwPDw&#x2B;xWPwHR6o1OplSpdWTCpVGplS1yJVMBiPYyzk1r8zKzCTSz50giHsvshkMontEQE5Z9fZzcXml1W4ONh&#x2B;P7edia3Xo2uPukf4pBaVXH6d6Odudvpc8oEPI5H6dw33dNh&#x2B;/mV5U/um4AT&#x2B;evLZs8uDbiRkHrj&#x2B;5sXGxtbmYpulrCen&#x2B;rg46na73wrWnv/&#x2B;oUSIf3Dn8wLVHpgKBVKWUyFWx4f7f7D2/YGy/HpEBaw9fOXzj8Zp549oFeRE0rdPrLU1NBDwuRdM1DZLaZkmEr5vh5VTWN5mKhOV1jZtP3jhxO8nBxnz5pCGxEX62FmKVRvfjievn7iWbCPgLx/SbOrALQRCFlXUHrz2uaZKE&#x2B;7j0iQn2cbHPLat&#x2B;mJrL47IZBCPE08Xe2vzLPWfMRcIfPhjN4fw7CxlpmmAwCKlCpVRrLcRCmiC0Or1OT/K4HJPXrVEr6pqWbDse4uW6fMoQkqLmbjjoaGW&#x2B;cHSfHgvWhHi4rPlwrE6nn7/&#x2B;EI/L/mX5&#x2B;2sOX84vr1kxddjui/edbcxZLKabvXWAh1NZTUOTTHH54YsVU4eyWazPd5&#x2B;eOqDL&#x2B;D4dJ67cbmYimjm826Svdm76eEKIl0tJTQOLydx6Jq64qm5AxzA7C1OSoh6l5bMYzAB3B4lCuffSw4/H9f14bH8h79f8ue/Kw4PXHt3&#x2B;aWleeQ2TwQj0cCII4qs9Z5Oyi1xtLId3ixrYKdxwZFlt4&#x2B;PU3I0nbnC5nG2fTo7wdScIoqFF1v&#x2B;TDR2CvacP7JpZXHnk5pNNCyYEeTrTNH3xYUpWaYVSrfNxth3VI8ZEwCfehaZprU6vUGtIihYL&#x2B;YZ8qNHq6pqlLnZWbQ8jjH5YDP&#x2B;AtxvCknry10mJ34kTelKv1&#x2B;kpimrNEgwGg8FkvJElWre4fmNeAlkCAP48BID/QSXFJVlZWTHtYng8nqmp6RufVag0iVmFPA7bRMA3MxG62Vv/&#x2B;XeHByk5thamAe6OMqW6tQo2q6RqybYTo7rH9I0JYrKYSrW2prHFQizydXVgs5gv88vEQoGnk41cpT5791lKfkmTVN6/Q9ioHjE8DvuHg5e6RwYGuDsI&#x2B;dyCytr7z3O7hPoUVNQ2y5Un4xI/GN6jfaDX8dtP9RQ1qnuMn6vDznN3j8bFb/hwfJSfO4v5m4Lk&#x2B;mbZyr3nuoX7De4SIeLz7j7POhGXEOLlmpiRv2j8gO1n70T4us4e1oPBYGSXVjfJ5HVN0oWbjmz4aHyol0tFXdPqQ5fL6xofbP88raD84qPnno62d55ndQv3j43wO3LjyYLR/UK8nM/eT9p04mZRVf2IbtGfTRjk7mDV9uQkZBacf/CCw2FZmAi7hvm1C/QkCEKt0eWUVas0WnMToaGcgKJprU6/88K9iw&#x2B;e39u2/DffGrVm9aHLgzqGdQj2fvs9m6ZpiULF53L&#x2B;4ZXopJ5kslmMVyXCOrGQL1dpiiprQ71d88prHqXmjuvTQcTn7b/26FFq7pKJg/zdHBZvOWFtbrJs8uCjt57uuXD/&#x2B;qbFlx&#x2B;/WLj52BfThr4/pFtcctb3By98NLqPs43VplM3e0UG8rns6AAPW3PT9KKK7JKquhbZqveHGzr2kBTVIlf&#x2B;cPByVUPLkZUfSBWq1mqKXy7fv/rk5cKx/UiSbK0M1pPUjYS0qobm&#x2B;8&#x2B;zPxrTt2Owd32LbMvp27eT0n/&#x2B;ZEqQpxOPwz547fH3By5&#x2B;&#x2B;F6fqQO7Wpq&#x2B;erQrT1Pzy6rbB3n7uTmk5JYq1GoXO2sfZzuVRksQhJWZyd&#x2B;czKlrlqbklXYI9jZ716Kvd9LqSTaTyWS&#x2B;47uG4Rf8w1qbOJF6QzNYfWujpl/Dg/43zWFbFzgZQkjrW/yrnrBM5qsFTmz2O&#x2B;Yl3soSrQe31m3/e08IAPxVEAD&#x2B;dyiVysbGxsePHg8dNpTP57/ddK&#x2B;kpnHt4cv2VmZZxVVKjUbA5clV6sn9Ow/rGvEgNW/q1zsJJkOn1/eMCjr57Tw2i3XtSerCn495Oth4O9sxGESQh7OAx9l/9dFPiyZej08nKXLW0O6G1ecUTRME8Q80CJLKlXwe19BmkaJplUYr4vP0JFVQUUsQhL&#x2B;bQ3ZJVUZRRaNUwSCILmE&#x2B;QR7OBEFsPnkzyt&#x2B;9c4hP67tRZX3zhmPXnqTleTnZzh3ZKyWvLC2/rGuE/&#x2B;ieMRNX7sgpqz74xewQb5fq&#x2B;paHqTk8LnfV3rNfTR8&#x2B;qV9ngkGU1jZnFpVF&#x2B;LjdTcm&#x2B;/vTlB8N7GDJSz6ig/VceRvm78blcuUozc0g3iUJF0VRxZZ23i4ODlRlJUUwGQ6nRZhVXBXk4VTY033&#x2B;R/emW4xP6dJzYr&#x2B;P5B8/f6x4T6ed&#x2B;8dHzfVcfsViMGYO6OVpbmIuFi7eeOLZyjrlYeOTmk/VHrpubCEb3av8kPTfUyzXSz93H2c7D0eaNUWNmcWVRZd25h88txKLPpwxuXffyL6XV6d/oqmlA07RWT/I4bD1JtcgUXA7bVCTIL6&#x2B;haNrP1YEgiIyiigcpOQM6hnk62hju0ixTPEjN/fTnY6mHvhO/vipP0/SdZ1mTv9l55&#x2B;dlJEWFeL3ab4GkqN0X7zVJFBqdLtTb9b0eMTWNkn1XHhy/nbB50cTu4f4qrT6jqOLDDQenDOw8rndHC7HIsLzq2O34J2n5HYK9tFo9RVOXH6eai4UtMoWthZmHo21GcUV8Wt6aeWP7tQ&#x2B;Z/PWuvPKale8Pz6&#x2B;oPXD5obmp8NiquYEezleepGh15KDO4Z/vOp1WUPZe95ghXSILK&#x2B;tKK&#x2B;scbC1DfVxompAr1XaWZkI&#x2B;1zC4b/f&#x2B;qi5hPqtmjhQLBW2/ZxuOXesZFRju68pk/HvGTE1Sxco958xF/PH9uwS42bf&#x2B;RKk02tzSaj6P42Jn9c5KD/ifZCi8JknSUHXdurlE2zIJw6bXb0QLQ8cniqRaN6p7O0u83o7u3fMSr&#x2B;qzkSUA/pMgAPwvqKmpkclkJcUl0THRFhYWbx&#x2B;QXli&#x2B;6&#x2B;K9rZ9MuZ6QVlZdfy0&#x2B;/euZw2uaZVwOe9f5O99/MNrO0qxFrswtq1m559ySiQMX/HTk6vpPAj2cVGrN/quPNxy7&#x2B;sOcMfdTcsJ9XLqE&#x2B;X&#x2B;99&#x2B;yMwd1KqhvaBXiKRQKJTHEtPq22WfLt7PcWbz3&#x2B;Mr/cwcosraDMx8UhyMOppqlFodKymIyNCyf6udq3PqW0wvLy2qb5P&#x2B;zpGh20bOowG3MTWwtTkqRYf6uolCCIrOJKiULVIcj7jcRhGJgSBC1TqtUanbOtpUypzi6pqm&#x2B;RqTTaKD93D0cbgiBe5JXef5GdXVJpbWE6pV/nAHdHpVq7/fydByk5k/t14rBZPA7HydbCzET4y6UHR28&#x2B;mTE4dljXKHcH6/spOWYmwm7hfgRBKNXaU3eTlmw9sWnhxHF92jMZzKXbTxbX1H8xZegPhy91CfXvFOJtbWZCEERJVUNUgMenW44tnzS414K1H4/ta2YiPH474frGxXqSZDAYM374paq&#x2B;efviqbYWpmYmb7ZmyiquPHUnkcliypTqL6YONRygJ0mtTs9iMjnsV&#x2B;&#x2B;jarVu9eHLbvZWRVUN6YXlnUK8J/Xv5GRjmV9eU17XZCoS1DfLogM8bMzFFXXNSo1GxOeZmQhFfF7rOdx25nZyTvGBL2av2nteLBR8Or4/8ddJzCw8EZe4asYIM/Gb19Tb1vi2fh8fpuZKlaohnSMMt9xMTD90/fHXs0Z6O9l9sefMneSsC2sWti19vp6Q9uOJG9MHdAnxcnGwMlt/9Jq3sx2DwejbPrimUVLXIssoqlCo1GYi4dWnqXuWz/BytFNptcnZxZ/vPDVzaPcR3WK&#x2B;2nNmaJeI3jHBx27Gn3/4bHzfThRFcljs3Zfu2VqYKmVKe1tLW2uznOKqjKKKMb3aT&#x2B;jbcdPJmy9yS05996G1mZjFZLR9CfM3HK5palk3f6yXk&#x2B;1feBr/JKlCtWT7SZqi91950DHY&#x2B;8zqj23MTaQKVdyzTBaTkVFU&#x2B;fPJG07WFrNG9O7XPshCLOJzDRd7/8EBmWFCicNm/TNdkuC/yG8awraWS7QWWGvfWubUuk3dn8gSf2aNE7IEwD8PAeC/W3VVdUlJiaWVpYWFha3t7w41jtx4kpBd5O1kO6xrpKOVxcuCMhsL8Yaj1yvqm1bPHRPo7viyoGzzyVszh3Q7ERdfWd9y4pt5HA773rPsoUs3bf1ksr2V2eaTN3/6ZPKeC3cpipjQr6Naq2MymNeepga4O95MSh/VvZ1hq6Z188c0tMj3X31Q2dDyzcxRlqaiKd/sbGiRr5k/1sPBxrBqKKu48uD1x56ONkq1lsPlbDh2VanSjOnVfu6IXj&#x2B;dvMFgMdfMGWsmEjxKy12&#x2B;4/Txr&#x2B;dqdfqp3&#x2B;6hCSLQ3ZHBIBxtLNoHem09c3vaoFg2i8HncAZ0CmuSyBskMsOIViTg/fEaj6SsIi6HFe7j9sbtWr2ew2IRBEFSNJvFpGi6vlnaIJE1y5RWZia&#x2B;LvZtH7awsv7iw&#x2B;fVTS18DrtbZMCtxHRrc/HHY/unF5atO3K9sKq2nb/nzKHdvJ3t1h6&#x2B;0q9DSEpeWWyY78uC8llr98X9tCTU21WmUF95mrrz/N1flr/fLtDzVRlmGxK5atFPRzuGeNtZmvaODhK2uVjbJJVnFlWqdTq9nnS1s9pw/Hp9s/TSuk8YDKK2STr1u922FqafTRi49sgVN3vraYO6VtQ1jf5865czhs0f1fva05fnHjw/HZcwoV/HdfPHkST1sqBs7oaDmUdWX0tIS8os/HL68L2XHogEHDNTYUZhlUqjjfB1G/O6VVF2SVVds8TMRGRnaWpjbvoPjxr/ciqNlsVkcjlskqLSC8pNhHxvZzs9SV1PePkgJWdEt&#x2B;jKuqb4zIIP3&#x2B;vT0CLbe/nBmbtJ38weZWUmLiivWTJpMJvFfJ5TsmTbifF9O3UJ9XG1s1qx83SwhxNF07ER/gI&#x2B;92FKDkEwsksqe0QGNEll3&#x2B;y7eGn9J74u9iRFMRm/zn7dSEjbfu7OiO7RI2OjzUz&#x2B;2casf68WmfKrX86W1zV9PKbf&#x2B;uM3RDzOt7NGXU9Mk8qVH77Xp/3Mr3lc9sS&#x2B;HYO9XDoGey/demLv2bgOUQGmQkF&#x2B;RY2Ho13cT0tyyqo/3njExtKsoLzGTCyM8HFbM28MQRMbjl/zcLAZ1SOGIIiMwoq6Zqm3i31xVR2TyUgvKL/0OLW4uu7AF7Oi/T3&#x2B;ZBdRQ0ELGLm3G8L&#x2B;Jk68scxJ1yZI6N&#x2B;dJVivtZ2XeLXL9e/PS7TeC1kCjAcCwH&#x2B;rhoaGO3fudO/encfjmZubv32AnqSapHKZUi3kc23Mxey3VgQ1SRXNMgWLyXR3sDbcQpLks5zigoo6d0cbdweb6obmaH&#x2B;PR6m5bg7WrnZWuWU1B68&#x2B;kqrVn44bwCDo7JKq&#x2B;ha5o425lan44cuc6QO7kiR190XWzYT0r2eNdLAy33vl/qk7SbuXzHB7/fiNEvmkr3cOi40M9nCO8nc/fSeRy&#x2B;VI5Mq&#x2B;7UOrG5pnrtnr5Wh3Yc3COev3m4qEc0b07LNw7Z4l03u3C9bqycTMwjFfbP182lC1RpeaXzosNtLbyW73xXu7Nh/TlN14lJr7w8FLpTUNhQXlE4Z33/rJVC6bFTRh6aaFk0d0j8oqqfzwx0ObF07UkdTtpIz2QV4qrfZFTolaq/d3cxDxuRZik0apfN/lB33aBU/o21HI5wp43H&#x2B;m7Q9F0RqdzjAebZTI9SRpuFydml9a2yStbZLYWZppdLoQTxcPR5tp3//SLsBj3shebR9h48nrWcVVuaXVdhamAe6ONEH0jg7qHhnQekCLXPkkLe9lQdmGYzcS96z0drZVa3Vbz8adf5C88aOJW8/esTITzRnek2DQV568JGjCz83e3d4m0MPx6tOXTjYWZ&#x2B;8lK9WaWcN6zFqzd8Xkoa4OVhNW7Tj&#x2B;9dzKupbPtp5YPGnA&#x2B;N4dWCxWh5mr7CzN188ft&#x2B;bw5R6RgZ1CfR6n5d1OSr/w8MXQLhHbFk&#x2B;1MX/3YiSSpH44eMnfwzklt6S2SRIT4DG4c5izrRVBEE1SeVpBuVqrs7UwdbGzMjyCSqOrrG9effiys63lV9OH/ZM9l95QUFGXkFnQNdTXzcG6tlmy49xdJxvzWUN7vH2kTk/SNG1Y&#x2B;JRdUsVgEP5ujgRBZJVUxSVnzB3Ri8Nmjf9q26S&#x2B;nbpHBtQ1S9U6PUVTFEV4O9sWVNYNWfxj3M/LrM3Fz3NK88urR/eKsTL9/1isRRCEQq05eP3J7ot3180f1yXE5/tDl39Yf8A1xPfcDx8xmczFW497ONp0DPZOyCzqGOQ1sFP4veeZV5&#x2B;&#x2B;fJFXTBBMByuzADfH1fPGjP9yu7uD9dZPp5AkdS3&#x2B;5YRVO6ov/7z68JXy2sZPxw2wsTDlcznf7b/YMyqgsKr&#x2B;7vNsrU7HYjJqm6RfTB/q6&#x2B;Lw&#x2B;a6zd19kanX6D0f1WTxhoKHsftOJ61efvlRotMO6RnYP93&#x2B;WU5RfUcvncCYP6NoiVzAYRGyYH5fDVmm0VQ0ths6/aq2Oy2Zz3tps&#x2B;w/UNElKqhv8XO3NTYStUzGG/TT&#x2B;Necb/uO0beJk&#x2B;ODNTSTa9HT6TZD4e7JE23kJQ7b4dREUi83mIEvAfw0EgP8ycrlcLpM/fvy4S9cu9vb27zxmzaHLYb5uAzqE5pRWJ2UVxafnN8pkPy&#x2B;cYiYWNEjkNmZigiB4XM4//M5I0zRF0RRNc9gstVbH43AYDEKt1ZVWN3g42nA5bKVak5JXFuzlZCb6dUHLvec5IgE3xMuZIIi6ZmlVo8TBykyr0/u62C/dfrK0piHa31Ol1swYGutkbblw4&#x2B;HUgrKzqxdYm4kVKnXY1C9HdIuePqjrx5uPTOzbMdLP3cvJdvbqfaN6xCi12gl9OzW0SB&#x2B;m5FqZmVyNf9khyKt9oNftZ1mf7zwl4HGzj6/lslkJmQXLdpz6Yc7o7/dfDPF2&#x2B;WHOmPj0/MLKuu8PXGpRKD8c1ft6fNrxb&#x2B;cnZhQu2X6iSSqXNUpiO4Wd&#x2B;Hqeg5X522eguLp&#x2B;98X780f1craxLKlpuPjw&#x2B;Yhu0a52VvUtsmapwtXeis1ianWkkP&#x2B;OvqvldY2ZxZX924f&#x2B;zfNMUpRWp1dpdEq1RqnWWpmZWJmZEATRLFOs2nu&#x2B;d0zQxYcvJvXr/CK3JL&#x2B;iNszbZWLfjmKR4Gl6flJm0cfj&#x2B;hkaj&#x2B;aW1fxw8GJKflmnYJ&#x2B;R3aN7RARcfPLi4YuceaN6X3r8QqcjZwyJ/XTL8e4R/v07hH644dDQLhEzh3UnCGLNoctP0wvWfzTus20nekUGBXo42luZ21iICypqRQLe86xiDoc1dWDXN56zWqtjMZmjlv&#x2B;kp6ifF012s7dWarTDl2xiMBhr5o1Zc&#x2B;TK&#x2B;vnjTEXCe8&#x2B;zjt9OiEvO/H7O6Mn9O&#x2B;WUVF9PeFlR3zy6R0xiZmF0gOfgzuEEQTxJy3&#x2B;QkjNzSKxIIDh8/UlaYSmLyewZHTCiW4zhy&#x2B;WX19S1yEz4PEszEztLU&#x2B;67rj0rVJrvDlyytTBdNK7f3zznfxe1VsfjsBkMxvwNB6MDPKYPin3je8flsP/aJPNOlfXN6YXlTAYj1NvF3spcqdaqdXq1RiPi8zRanY6idDpSq9fXNkkCPZyux6c9SctbOLqvv7tjcnbRvisPrc3EK98fsfP8nWc5JXuWv89hMcvrmrrN&#x2B;/7WT0sziyoWbzl&#x2B;ZNVcsYBXL5V/vv30rOHdWQzGzaSM4bGRpTUNKq2&#x2B;f/uQKD/3R2m5x28myJXqZoXC2dZyYt9OX&#x2B;&#x2B;9EOnntnTSYFMRv65Zqiep7JLqjSeuO1qbv9ej3S&#x2B;X7/PYnKgAdw8Hm66hvin5pTo9eS3&#x2B;pZ2lWc&#x2B;ogK1n7pTXNVY1NM8a0n3F1CELNx25/SzTxc6qZ2TA0ilDmATRKJFfepySkFngZm9la2Gm15Mytbq4on7SgE7tA71YTKZMqVZrdYt&#x2B;OmJvabZ8ylDDP5x/jKER7f/D9xH&#x2B;cxgixNs9YX8zQdFmt7pXVdp6vWEzCsPmEoaHeiNLvNrT&#x2B;g/nJdpuMYEsAf86CAD/NZqammpra1taWhwdHd3c3ly&#x2B;YqBQqcd9tf3KjSc2rvY/fDB6YMcwRxuL/MraHWfvhHq5uDvYrNxzdubw7l1Cfd3trQmC8Ty3UCwQ&#x2B;Lk5Gu5OU7SeIgmCMEzi0zRhaJzyzoEsQRAV9c0PU3I6hnh7ONj8Xa&#x2B;FponLj1NW/XJ2TO&#x2B;OH4/t&#x2B;yyn2NnGwv31g2h1&#x2B;vyKmuScEmdrCxdbS6VGG&#x2B;Hr9iK3hMlkhPu4GfYFa2iRrz1yuUWuGt2rXa&#x2B;owKqGluU7Tk3u37lf&#x2B;5ANR6&#x2B;aiUX3XmRbmZlsWTS5QSKb/v0v/duH&#x2B;rnZT/t2z&#x2B;GVH4T7uFqIRYt&#x2B;OlZQUfvDnPc&#x2B;2nRk5tBuDc0yW0szW3NxRnGFiM&#x2B;7fj9p&#x2B;4rZ9tbmbz/5uKTMgzcedQzyaZYrPBytrz1NU2u0gR5O4T5uno42G0/eeH9wN4JBTP9uT2V9C4fN4nFZR1fOCfFynbv&#x2B;QHJWkY&#x2B;L3U&#x2B;LJnk7260&#x2B;dKW&#x2B;WepkY8nncYZ1jQxwdyyoqNXo9HqSIvR6f09n3m9XVBdW1s1dd8Db2e6b2aMyCsvbzgb84ammdSRJU3SjVMFiMW3MxEwmo6ZRUtMkCfdxfZlfJlOqu4T5JmYWSuTKvu1DCILILK64lZjZMzogzNu1uKpu04mbL3JLnO0sB3UKH9UtRkvqc0pr7jzLmDE41t7SvDVG1jZJKuqbD157fOZe0rUfPzWssPr51K3dl&#x2B;4d&#x2B;WpO/0837PpsmoWpSaSvG8FgbD1z29nWorpBUlBR2ysm6MGL7I/H9iuva5qzbv/H4/pPG9B1zpp9Aj539fwx3&#x2B;2/fPnRi8UTB3SPDKyoa9Tq9BZi0dFb8bER/sO6RCZkFtxKyth29naIp/Ohr&#x2B;boSZJBEMt3nZ4zrOfui/f4fI6Pk8PNxJf92oceuvG4V3RQ33bBw7pGMhgMtVaXmFlYWFlnYSqyFIv8XB3srcwMc2J6PZmSX&#x2B;bhaBPh6/rORNFKodKIBDy1Tl/b2CJTqnkcNpvFsjIzeeeGcX85pVqz59KDnlGBzVLFqr3nPZ1sQn1cFCrtzaT05hbF1k8ndwnzfWcDIpVGy&#x2B;Gw2W2GFNWNLYagS9F0cVU9m8l0sDanaLquWdIoUUT4uml1ZFVjs0qtFQp4bnZWd59nmQj47QI9v9xzVqHU/DB3jEKjPnLtSUJW4fGv5117&#x2B;nLJjpPHvpoT6uNaWFl3Ii5hQMewIzef1jfLZg/tJhYJTtxK0JH6zqG&#x2B;Xk62d59nqTXauhY5g6Bjw/1vJqXbW5l9NnFQSm7Jyl/Oq7TaTsG&#x2B;JE2V1zSeuZ/08dh&#x2B;MqWGxWRtWTSxQSJ7kpa/cNMREyF/bO/2XcN8&#x2B;7YLMbycJ2n5GUUVlx&#x2B;nWJgKc0qqXhaUzxvVe/6IXkdux9c3yb6aPsze2owgiHvPs648Se0eFfA8p2RMj3aBnk5vnKjM4konG4uSqoY1R67EhvlO7Nfp7RIdgD9gaOLUtl5Cp/u1/LrtiqY3q65fM0xKGB7tN1mCzeKwfs0Sb8xLsH&#x2B;7Vx2yBLwTAsB/AZlMlhCf4OnlyeVyXVxc3vgsRdENEtmBq498XOyHdY0kCEJPkhV1zZ9tOabSaK5tWrLxxI1gD6fSmob6FtmoHjFP0vIziyu/mz0qv6L26I2np&#x2B;4kph354eLD51OWbDr189L3usc8Sc9fsPFw3E9LLUxFWSVVX&#x2B;89N75Px&#x2B;GxUa1fsaiyjiRpM7FAo9U6WFkoNRqxUCBVqJtlCkszkanwHaMfpUZLEATvrQuiepJ8e23S7yEpSqHSCHlcNptluK9ao2MymYZ8Ilep5SpN6wZSqXml4b5u6YUVepKK8HUlCCK9sPzCg&#x2B;dsDmtMrw75ZdV&#x2B;rg4UTXs52S7feSq/vHbh6L5dQn0UGu31&#x2B;DQelxPg7uTpaP3GsyUpatfF&#x2B;yt2nrIwEZ79YUFds2z40k2mIuGhlR/YW5p&#x2B;&#x2B;vOxmUN6jO/boaax5VlOcWp&#x2B;mWFA//0Ho&#x2B;VK9adbjk0d1HVcr/YdZn5jYyGePaxHfmVtTknl/osP&#x2B;nUOnzOsR0lNg1KjtTE3zSqujIuLP7LxszAfV4Igckqrl&#x2B;84dfVpqqOtxbezRnYJ8ftm38Xs0konGwuFSjN7eM&#x2B;R3aIIglj5y7nukQHZJVUxAR4xAZ6tPxtylTqtsGLdkSs/fjTBx8XunSf2QUqOVk/2iQn6vTOvJ0mlRkvQBEmRaq2ez&#x2B;U8yy7uEOxtKOqoa5Zee/pSrtI8Sc/rFRVQUS/JLKwI9nKaPijW1d6KIIgbCWk7z9&#x2B;TKVX&#x2B;7g7jendsH&#x2B;h5MykjPi1v3nt9XuQWezvbezrafPXL2YSMwiBPJxtzce/okNhw34epuUqVpnO4L5/DuZmY/sPByxP7ddLodDUNLbGR/i62lsEezo9e5pbWNNIEHZecMWtYj&#x2B;1n7oiEvG2fTmmSKq49Tf12/8V725a72FpxOezLj1/MWP3L5oWTB3cOb5LIzcXC5zkl&#x2B;689PHbt8aCuUWvnjaUJetf5uw/T8rR6fadA769njRKL&#x2B;OuOXr38KMXURDCwQ9isId1sLH/TVPdZdlF8ZsHYXh3jkjMevcy99zybJMmlUwZ3DfO1NjMV8XlLtp94nlNiIuCx2OwvpgzuFOr7J3/U/5hCrTl9L6mitsnB2qJHVIDnb&#x2B;O3ocnPqr3nzcXCCX07VdY1f3/wwtZPp/WICug651utTr93xUwhn7f1bFyTVD5neE9HOwtvB1uaJgw9TCmKPnUnYfba/QM6hLUL9nqYmptWULbxo/HDY6N2nr&#x2B;79/Kj8rqGnUumjegWrdJotTq9nqSszExkSlWLTClVqF3srMQi3vPskpzS6j7tgu0sTQmCKKiok8qVTrYWthamFfXNN&#x2B;LTHK3NB3UO1&#x2B;j0B649FvA4PaMCn6bnl1Y3fDZxIEEQ645cuf8i56dFk31c7OqapRcfvRjQITQuKfObA&#x2B;d//GhiTKCnhYlw1tp9HBbzvZ7tzUWCruF&#x2B;htd&#x2B;5OZTmVJ18dGLj8f27xUVWNsskSs13x281DXMV65U34h/uWLaUGsz05V7z8WG&#x2B;U0d2CWntNrKzCSzqDLcx9Xjdceqm0kZDc2ySD&#x2B;3D9bsC/Nze/A8J8LXbc38MZZi0YPU3N0X7io1OqVGo9GSo3vGeDrZXH3yUqnWGn7g7S3NapslT9MKGiQyVzsrmqbFIkGAm4OlqYlKo9WRJI/N5v39pdIV9c00Tdtbmv1dy6Lgf0nbLNHKsLnE292c3lj&#x2B;ZLjX72aJ35&#x2B;XeHuNk6F1LLLE/wYEgP9cFEUplcobN25ERUVZW1mLf2cxsVqr23zy5vHb8VH&#x2B;Hg5W5hnF5XGJmavnjp09vPvG49eP3Y4f2jVyav8uG45fO//g&#x2B;dCuEdH&#x2B;HhwWe0S3qGU7Tun0&#x2B;q2Lp0ZM/aLg1AaCIDafuLnlzO3&#x2B;HUN5bLaJkG9pLvJysKUJ2sXOKsLHjSCI1LzShy9zHa0stpy9vXru6BM34xPSCw59M9fJ2mL9katn7iVnHlvdetFRqdZ&#x2B;vuv0mF7tOgb7NMmU3&#x2B;&#x2B;/1CHUa3T3mLbPXCpXcrkcLpvFZjElcpWVmSmTSchVGplKbWMmbu30f/x2gqO1eYiXy8PUHBdbqzAfF0PHdQaDkV5QnllSOahzmFjwD152Vag1cqWGpmkrM5FcpRUJuAUVdXllNb2iA8RtwgxJ0VnFlTVNEsNA&#x2B;Xl2cWlNY6CnE5fDNjMRKFWalXsvNEvl2z6dIuBzj92Of5FTsnBMPzsrs/nrD0X6u62YMuTHY9e3nY17vv9rsUjYIlP8cvkBh8MO9XLZfeFudICns41lTKCHr0ubRkkFZXUtsmO34n1d7WcN6b585ymtlty6eIqAy1FqtEOXbFZrtVc2fDJz9b4R3aIaW&#x2B;QB7g7nHzxvF&#x2B;T1/uBYgiCSs4vVWt1PJ2/27xAybVDXjrO/7Rrmezs5w87CPK&#x2B;8&#x2B;pOx/T8e1&#x2B;95bsm2M3Fr5o1JzCxks1jxmQXu9tZmIoG3s50hfijVWplSJeBxhXxu26im0&#x2B;kPXn/SKcQn0MNxx7k7B68/2fHZ1Na92N5Jq9erNToOmyXgcQmCKKioXbz1BEHQgztH9I4O2nYubmDHsB6vpzUepOSeuptYWd/EY3N6RQeN6dWOz&#x2B;NUNzZvOXX77vPsIC&#x2B;XvjFBI7tH55ZWn7mf3CnUh6aIlLziVe&#x2B;PbJEprsW//Gjj4WWTB38yfgBBEPllNbPX7u8W6a/V6lPyS39Z8b6zjSVN0&#x2B;uOXq2ub&#x2B;ka7kfRtE5P1jS2aLT6LmG&#x2B;thamn2451jsmuE&#x2B;7YJ2OJCiq/ycbJg/suvL9Ya3hVqnW/HT61rl7z1hs1uwh3dlsZnSA57Ps4rvPM&#x2B;eP6n3o2mM9SW37bAqTwZQp1SNX/OxkabZ18VQT4bt3Jfu76Enqfkr2vPUHK&#x2B;ubFo3tR9MEwWAM6BjSLsAro6jiaUbBpUcvbj9JCfH38HVxKK1r9Hd1&#x2B;OGD0T8cutQoVfz44Tg9Sf144kZpdf3sYT3kKk2ol4uZWOBsY9n2S8hVqhNxSY9T85pksk/GD&#x2B;geEUAQhEKl&#x2B;fbAxfsvsg98MdvSVGRjLm79l17XLD12Oz41t/TOs6zPpw2bObRbXHLGmsNXekUHzR7W/URcwic/HRvcOWLDR&#x2B;NbI&#x2B;jLgrKl20&#x2B;q1NqfPp4c7uuqUGsMDUnvPs/KLqnqFOLNZrEq65sdrMxDvFyYTAZB05UNLTml1Y42Zn6ujiqNNr&#x2B;8lqSoKD93wwMalm7/ePx6aXXDdx&#x2B;MMhUJbyWmf3/o0qr3R0T7e95KTt9y&#x2B;vbz7OLPJg76cvowmVJd3dAsFgkcrX/tmXbvRfaFB88n9eucVlj2NL2gV0ygj5PdtO/3uNlZfTd7FJfDnrV2/6R&#x2B;neaO6MlgMKZ&#x2B;t6ehWXbwq1nWZuLvD1766eTNHxdOqKpvVmv1C0b3ufg45fSdpOt3EkcN7HrlacqYXu2/njnq0oMXP5&#x2B;7XVRZG&#x2B;nrtmLK0FE9Yp6m528&#x2B;eYvDYepJqrFFHuHrvmBMHxfb33wv7qfkKFWabefveDnaLp00yMnGgqJotVbLZDKzS6qO3Hhibmry5bSh//zPFRiPtg1hDXvP/Wah0&#x2B;sY8c448UdZgs1isX4zL/E3s0RriQWyxL8FAsB/IqVSKZFIsjKznJyc/AP8//wd65olthZmbW8hKYqkKC6bXVRVJ1dpTIWCnNKqZqlieLcoAY&#x2B;7aPPRZVMG21ma0TR9Mi5p1d6zI7vHsFjMHefufDiqz4qpQ2iaNlyveplftmLn6YVj&#x2B;118&#x2B;Fwk4I3r0&#x2B;H47YT188dll1aVVTes3Hf&#x2B;/OqFDlbmNEEQNK3W6n48fv3ei2wHK/OYAI/KumaZSt013N/KTNSvXQhBEGqt7u6zLC1JLl13YFCv9kunDK5vkb2/el&#x2B;vyIAf5o5W6/QTv9ouEHCPfDXn&#x2B;K34tILybpH&#x2B;VfXNtS2yADfH4bGRcqX6fmqOv6sDh81ispjO1hY0TVTUN2n1em8nO61e33blRqNELhby2/azf/3Li/H2tk1ta0BJimYQ9J/8xaTV6RskcpKizEQCJpNZUFEb4unMYjEvPHzB57L7dwilaTqtsPz&#x2B;81yNTjeoc2iQh7NWp3&#x2B;eW6LXky72VjwOx8Hq129cQ4uspkmSkFlQ0yD5Yvqwa/Fp8zcc2LV0umGRw6dbjqXkl11YvXD693scrMwm9u3kYG3RWslNEMTNxPT88hqVRpddUrV8yuDvDlzyc7NfMWWoYWG028hF2cdWiwSCgPFLMo&#x2B;vXbX77MvC8tVzxtx/kZ1RVPEkPb&#x2B;2STpvZK8Ad8fBncJqm6SLtx6vamxplsj9XB1/XDj&#x2B;6pOXaw5fsbM0XTZpkJu9ze1nGTMGxbLZrPiMgkcvcz0dbSzEIl8X&#x2B;77tgplMZnFVvZ4kBTyugMflctgmAl7bRSlNUkVZbaOIz/u9qYm36fSkSqNVqrVMJsPSVMRmsXR68llOccdgb4IgpArV89xipUorU6nvPMs0FQre69nO8KlLj1P2X3koVai6hvnGBHo&#x2B;fpmn1ZHDYyMZDGLXxfs0TW/4cLyAz&#x2B;k&#x2B;7wdPZ9tV7490trG0EAsfpuaKBLzWUSZBEGcfPFu2/eSLfd9q9fqymkahgBc797sQL5flU4ek5pWyWMy6JukPc0artbrEjMKaJsn649d/WTYj3Mf1T77AP0Op1lY1NBtWKzVKFVKFytfVLsLX/fHLvAPXHhkaE73ML7O2MF04uk9WUeWPJ67vXDoj2MNp44kbJ&#x2B;MSV0wdEuXv0TrQ1OnJc/eSH6bludhZ2ZibqDS6YA9njU736c/HL61fxGGztFr9g5c5K3efK7&#x2B;4WaPT8367NcT8DQdFQn6Aq8P2s3e0JPnV9GGGTkH5FbVpBaV3n2XdTMz0cbH/bEL/2IiA0pqG9UevZhZXUjTVPSJgQIfQAHentgv0byVlnL6bJBJw5Qq1TK3hslgrpg7lczmWZiY0Te&#x2B;&#x2B;eG/pugMfTBy047NpbRc3nbqbeP7&#x2B;87G9Owj5nAepOVG&#x2B;nv07hrTuPD1rzT4hn7t27hg&#x2B;j0uSVItcqSX19hZmhpX9Op2&#x2B;uklC07SepO6/yO4a6ufr9iqEX3uadvlxSs/ogJS8EpogPp861ETA//n0rUcv8xaN6x/l5/4wNefY7YSRsVEypfr47XgXW0sHG4svpw0jCEKt1U3/bnfPqODCqrrc0upIX7cWudJcLLz2JJXFZn09c8SpO0mWYtHKmSNIktp65vbPZ27PH9V7wei&#x2B;rVt6P0jJKalpSMoqPHozPtjTedunk4V8nojPkyhU3x&#x2B;8dPzW0z7tQn5aNMnXxf7Kk5frj13Vk5SDpVmXCL9FY/oRBLH60GUhn0eSFEXTFmJh98gALyfbBomsvLbJ2dbSUHmv0eoYDEbr78asoopNJ2/mV9Z9NmHgoE5hf&#x2B;FPLPyveqMhbNs&#x2B;Tm&#x2B;WXOvaNHH6/SzBYrGYrze&#x2B;bs0Sv65uarPG6ddlTm2yhME/9lqMcNNGBID/LGq1Oiszi8PlsFiswMDANz7b2tSior5JrtSwmExTE76dhZlEodp14a6fq4NMqRzQMYLLZhnWZhje1ZhMBpPxmybl5XWNlx&#x2B;nvtczxtb8zX2Cf49Gpy&#x2B;pqnd3sCEY9Nl7zyb07UgQRItcufXM7Q6B3r3bvVo9olBrvt574eD1xytnDE/NKz37IFmuUv&#x2B;0cEpsuF&#x2B;ghyNBEHKV5pdL90mKUqjUgzuHR/p57L5477OtJzoEe4d7u8qUKnOxyMPRZkKfjo9e5n67/8LeFTM5bPa2s3F&#x2B;rg6GF0XStLlIcDX&#x2B;pZDLnTE09uNNR94f0m14bFRWSdXY5T8Hujtc2vjZgk1HVBrtjsVT2WzWqbikXy7fP7N6QbNUvuVMXKdgr5Hdo5Vq7bX4tA7BXs42lrVN0sziCkcbC38Xe0NjwvFfbvN0sP5u7hjDSVNqtBqNztRE0HZFEE0QJEkxGMTb1YGNLbLErCJbC9OoAI9/7NeJXKmua5F6OtoSBEHTRHlt4/Pc4sr65ih/j5gATzaLWVbbmFVc1TnUm8/ltq4KoGm6pkmSU1bNoInU/NIR3aJT88syiio&#x2B;nzqUomitXt/jwx8m9On00eg&#x2B;TsMW7lk2w9vZrt2Mldc3feZgZS4W8uMzCuKSMjqF&#x2B;W47G9cxyNvcRNgrJjDC1/1FbnG7QK&#x2B;8smoul3P0&#x2B;tNHaTk3Ni1Jziqeu2H/mrlji6vrdl24d2fLskaJPLes5uSdhINXHq77cEKMv0dOeY1MoSqva2yUKB6l5lbUN43r02Ht3LEO1mbzNhw8czfZ2dZSqdEO6xr&#x2B;1fSR/28dM2maoGhKqdbSNG0qEtQ2ScrrmhyszZ2sLRpaZOmF5ZnFlY1SRbtAz66hvm9cs9fpqcM3n5y9l6zUaD0dbWYNjW0f6P0wNdfJxiK/onbCyu2zhnQb0T0m1NslNb/0qz3nfv54kkjAd3ew/o9qeUlSVNsfWj1J5ZRUPc8tpglCp9cXVtZ7O9nNHNotJb/0l4sPymubMksqAtwdWQzmqpkj2k7yvP/9Ly1yxdyRvW0tTUO9XKZ&#x2B;u/v4rfjk/d&#x2B;8zC9TarU5JVWRvm58Lnf9sWtTBnTJL6upb5HOH9XryM2nBMH4dHx/Z1tLAe/X4qL49IJLj1/0bRfSIyrgQUrOkm0n&#x2B;7YPnjawa1lNw4w1e0M9nftEBx&#x2B;Li3&#x2B;666vWu2h1eq8xizuF&#x2B;GQUVeh0&#x2B;kB3pwGdwrQ6nY&#x2B;zQ2yEH4NgMJmM1rhS1dCcXlix7ewdcxPBunlj7a3N9STV2sS2dQqiraqGFkdrc62e5LJZBEHQNF1QWetia8Xnckg92ShVyFSqn07eepCau3ruaDc7K0MMPnT9ydQBXaYO7NIgkc3fcGhs7/YjukUzCOLy4xR3R5sQT&#x2B;ePNh4WC/k/zBlNEERccub3By/1iQmaPijWRMg3/IqraZR8tPHwsNgImiaSsgqP3Yof0jnyp0UTt5&#x2B;7k5JXEurtWl7b1CHEe/rArnXN0hsJaTll1XKV&#x2B;sLD59am4ts/Ldt&#x2B;Lq6uRRbo5hjh55aYWbBk28l&#x2B;7UMWjO4rkatKaxsq6pr6xoR0j/LPK69Jyiy8&#x2B;yx7eLeoVXvPldc1mvAFk/p37t8xJDmz8HF6PpvF9HN1mNK/S5CnE0EQZbWNiVmFErmSz&#x2B;WG&#x2B;7jamItlSjVF0QSDEPN5ZmKh8M9tKvc8tySnpKpPu2Bbiz/77gPG4I2GsIZ9r99o/Kr7bQ&#x2B;nN7IERVGtj8Z8tbvEr1mibWmEoeqay&#x2B;XSFM0T8Nlsdn5uXmy32H84PPyXQgD4T0GSZNztOHcPd6FA6OL65kJ/gz0X7n2378LlTZ8FezhtOXNLJODNHNJ9wqodjS2yTyYM6BkV&#x2B;P2BixRFfDNrZHZJlUSh6hDkVdskufc828xEEO7jZiEW1bVIZ63eN2tY937tQ0iKrm&#x2B;WGi6&#x2B;6vRkXbNUxOdyOWweh/NnduP689o249OT1MuCMpIk2wV6EQRR3dCy&#x2B;vAlZzsrf1fHCw&#x2B;f0wT988eT9Xpy&#x2B;NLNi8b1G9o1cvGW42W1TRsXTKBo6kVeaXJ2cc/IgJKahkuPU0qqG1bOGG5nYSpXaWqbWm4nZ00e0PncveTEzKJeMYEsBoPDYdlamHUP988przpw7fGMQbFylcbXxY6k6ZyS6t2X7k3q17lnZICOpLafjRPweT/Mee9UXMLlJ6kHPp9VVtc49qttH4/p98HwnkwGY9FPxyiK/GnR5DvJWU8z8vvEBLcL9GiQyDV6vYOVGZvJIilKplRtOxN34eHz5H3f0ARd3yyzsTCVK9Xi14PIRolcJOC13SzJUNBs&#x2B;Df4J689aPV6pVrL47AFPO7bw0qdnpQp1ZamIoIgDM1GDbf/culBRV3T4okDPtty3M3JdtnEQQRBFJTXXnj8vKpB0iXUe3hstFanr22SmAoFuy7eT84unDW0e6dQX5qiv953fkD70KTsohuJ6XE/L&#x2B;Vx2L0XrBnaNWpin47Bk5Ytmzpk&#x2B;sBYkYB3KzFjy5lbHwzvWVHXlJhV2D0iQKpUfTCsR2FlfV2T5FlOiVyl&#x2B;nzK0HkbD6XklY7v3SHc1zXM243LYVEUZWYi/O/qskLTtEanZzIYHDbL8I2rqGuqbZLWNLVw2ezOoT4EwRDyudcT0vZcuH9uzYJ/9/P9l5Ar1Qq1pvVnrLiq/kVuSXSAx5O0fJlS/cHwHgRBfLjxcG1jy8&#x2B;fTHawMv9yz9mckup188e2rra/lpC2YtORmiZJt46hKrU2IbMw2t9j7fyxIZ7OT9LyT99N4nJYdc0ygkHUt8gcrMwWjOnr5&#x2B;LA47AbJfLBn20c0il89oiefC6nUSKLnPblp&#x2B;MHzhza7e1hZXpheXFV/aO0vMq6pg&#x2B;G93yRV3r&#x2B;3vPV88Z0DvUuqWn4fNeZMG/XzyYMGL5kc0VD86fjBnQI8T54/bGzjfmsoT2yS6qepud7Odn5uzlUN7aYCHiONpZqjZbFYpoIeGwWS6nRVtU1sdksQw&#x2B;DFrnyWXaRo7VloIcjSVEarb6mSWJmIrAQi5gMRrNMqVCqne0sCYIoq20kKcrKXCzm81v/FWv1&#x2B;tLqBlMTwePU/F7RATqSup2YUVRdp9OTo7rHhHg5/XDwirW5SZiv28bjN0I8nb&#x2B;cPqyivuX7gxevPX25e&#x2B;n0mibpkZuPx/ZqH&#x2B;Xn4elgs/vSPZGAR1J0k1TB43Aq65s6Bnt3CvHJr6hhM1nzNhzY9/msaH/3gPHL9n8xq2uYn05P3nuRnV5Y3ixVxD3LTCssnz2s&#x2B;5xhvTaevDGqe3SQh9PDl7kPU3IUak2Ej3tpTcOLvBKZUlNS3TCgQ/CQLpE7z9899OVsd0cbgiBW/nK2ukGye9mMg9cexWcU6vSkq72Vl5OtTq9vlikbWmQqtW54t0itTm9mIhTyuR4ONiIBjyAIPUm9safe2yRyVXxGvqO1eaj3rxNrNE1kl1Y521j8/5Tgw38y8rXW&#x2B;oe2aIqmabqysrK6upqmaZFYrFOptVr9uInj2EZWY4MA8G&#x2B;m1&#x2B;vVanViQqK5hXlAQACPx3s7g&#x2B;66cE&#x2B;l0fq5OjzPLX2Snvsit8TN3ubahk92nL&#x2B;bV169d8VMBsF4kJJz6MaTFZOH3ExKe5Caa2ki9Hdz7BTiU9csLaisyy6tmty/85EbT0mK7B7h/8vlB1/PHNkzKrCkuqH7/B/ubl3u6WhT09iyZNvJMB/XhWP6tq72zi2trmuRtgv0Uqg0OaXVKo3W08nWw8GaIAgdSdY2SflcdrNU6WpvyeP8Oq7V6HRqjY7H5bCYTDabxfiLJtckctUvVx7klFROGxRbVd&#x2B;cW1p94k5ioLujlZnJ&#x2B;4O7RQd4LNl28nlu0Xs92iVnFd9Lyf550ZTBnUJ7L1jTPsh71rDuHBbrzP3kh6m5LrZWKXmltU0tlqYmthamQR5O/dqHNEnlP5&#x2B;&#x2B;/eOC8ZV1zSt/Offl9GFDu0SwWCw9SXWd&#x2B;/37Q2KbpcrU/NKxvdo/zy3u0y64y&#x2B;uCTpqm4zMKGAzi/e9/id&#x2B;zSqvXj/1ia3ld06V1iwLcHRf9dCw5u&#x2B;jAF7O8ne2q6lsmfbNz15JpPi72v1y&#x2B;72pn3SsqkMlk3E7OIGhGbLgvn8fNq6jRaPQB7o5vbLB173n2uQfP3h/SLdzHtbi6/tjNeBMRf1yv9rYWpm&#x2B;f2BaZsqi6js1k2VmampoI&#x2B;BxOcnbxnWeZMYEevaODDcfo9KRGp2czmRwOq&#x2B;0EEU3TMqW6QSLX6fWONhZigWHvtqr0wrKxvTtkFVcyWQx/V0eCIOqbpWfvPSusqov2d3&#x2B;vZ4yepPPKqgsq63xdHFpkcj9XBwGPW1BZm1NaXd8kfa9Hu2U7T8cEuE8bFCvic28mpM1cs&#x2B;/OlmU&#x2B;znb/k7OuzTIll80SCf7UNVGjRdG0QqmWKlUkRev0pFKtJSnKwcrc7nWxdYtcefD6Y09H2yGdw0/eSdx/9dE3s0aFe7ss23HyVmKGo415cVVDtL/7d3NGMwjC2kxsKhLIVZrtZ&#x2B;Nyy6ptLEx1erJDsJdGp3&#x2B;cmjs8Niq9sGLXhXvLpwwe0S1Kq9NvPRuXll9&#x2B;af2ijzYdLq1p2LJoCkVRlfXNX&#x2B;4&#x2B;42pvbW1u4mZn3ad98NUnqRZik0hft0uPU5KyCyf36/SyoCIlr6R/h1BvJ9vjtxOKquu&#x2B;nTWqvK7p6K349R&#x2B;ONROJrj5JtRCLxvRu984uUmmF5S0y5YZj1&#x2B;qaJf3ah0gV6sKKuqziymHdon78aHzbVYhtKdQakiRNRUKCICQKZVVds4WpyMxE2CJTmZoIBDxObmm1l5OtUq3lcdkETVQ2tFQ3NIsEPF9Xh5NxifkVNUsmDrQ0Ndl04ub1hLSP3us9pEvEpK93dg33&#x2B;2BYj2U7TsSnFy2bMrhf&#x2B;5Djt&#x2B;LnrDs4tme7mcO7bTpxg8VkDuoU7utqH&#x2B;jpfCshfUS3qOc5xRkllS9ySiJ93QZ0CE0vqjhy62lMgOe8Eb0apfITtxOO3Hz686JJaQXlx&#x2B;MS&#x2B;7YLHtU9&#x2B;lFq7oZj17pHBvSKCXyYktMx2CentMbSVJiUVXj48sPencJnDu3WLsDT2tzkZFzSppM36pql1hZivU5va2765YwRvWMCDW9JKo12y&#x2B;nbLXKlr4u9v7tDhyBvw8lJyi7iczgfrNs/qFP41AFdTEV8LofD57J/73eLTKnad/mRq73ViG5R7zwA/odRFFVVVV1VWVnXUK&#x2B;QyrUNcumDYlEnt0kLprP/3CaG/zMQAP5tdDpdVWVVU3OTVqNt36H9Hxx5Lf5lUWW9rYVpg0RW3yL7fOrQ5zklPxy8eGHdIgZBFFTUTvtuz9JJg1gs1pJtx8N9XEtrmhgE3SCRR/i6URQd6OEU7OV86k7SyhnDe3&#x2B;0pne7oANfzD58/cnynacm9u1ka2nKYbP0esrMROjjYmtnaebn6kAQxM2E9KrGZh9n&#x2B;zP3k1ZMGVrd2PIkPX/TiZvbF091sbMIHPnJp9OHLZk4yETIZxAMw1Xtxy/zDt98smvJdIIg4jMLz91PGtI5Ijbcv6qhJaOo3NPB1tLMxEIsbJTKNVqdk41lRX2zuYmgrllqYSIiGISFWGR4vSqNVq3VCXlcgkG05gqapkmKapDIaxokZmKBh4N1s0yZklfaMdi77UKCP0ATRJNUXtMoMRMJVBptVklVfYsswtctys997ZErdc2y1XPHlFTXL9h4yM7SNMjTZffFew425ue&#x2B;W1ha0zBp1c7v5rzn62of6O7Ymo4oitp14a6bvc2Rm0/H9GwX5uu6&#x2B;8I9tVa3aeFEmibGfbnNzESweeEkJovB53J2X7z3OC1vVPfok3FJvdoF1TZKXOwsXWysyusa7z7L4vM4s4Z2t7cyG/Pl1nb&#x2B;Xmvnj32j3UeDRHYrMcPF3vJxap6VmZim6Oomyafj&#x2B;7dOLyhV2jMPkuevP3Doqw9GdIuuqGua&#x2B;vVOJ1ur3ctntJ1zuPjoeX553cyh3ZgMRmJWUXJ2YVFlvaWpaMrALsEezn9w9hpaZKl5ZWIRn8thifg8OytzUyH/7fdXnZ5kMAjDKVKoNc1ShbOtJUEQZTWNpTUNFfXN5mJR//bBhjueupsY6O4c/Fb7xf8l1VW1haVlBEHb2Vj6eHu13e1Zp9MwmToWi08Qhq67tJbUs1lMJoNF/LnAbISLVt9GUTRBEK31PHqSyiyqKKqq0&#x2B;j0FXXNrvaWI7vFsFnMs/eTrzxOsbU0lSjUcQnpoe6OJ9cu2nf5wc4Ld57t/1ar00kUqimrdkX4u47p2eH&#x2B;i6xfrjzU68mJ/ToymazBncLCfFxvJqWv2HHa2cZi8YRBhgWNqw9eziuvXjd/nJuDzc&#x2B;nbh6&#x2B;Ed8olcWG&#x2B;301fbithamNhfiNea0HKTlqrW7TyRtdw/0&#x2B;n/KqcvfAtUc/HLy0dNKQIC&#x2B;nMZ9vebzzC1c7a61O99Gmw34ujp&#x2B;M7387OfN5TsmI2Eg7K7MHKTksJrNndKCeJLOKKi1NTZxsLBgMgiRpmkH3nL9644IJsRFvlo1pdHqlWsPjchgEwWQyDL9UEzIKeFy2s42lRkeqtRqFSutgY87ncFrkSg6LZSYW8rmcJ2n5aQVlfWJCPBytdSR5KzG9faDXphPXWRzWislDxUL&#x2B;x5uPlNY0HvxytqlIsOP8nc93nvly&#x2B;rBJ/ToN/mxTtwi/mUO6mwj5287EKdSaKH/38prGBqnc0drC2txk6sAu8ekFFmLR2qPXRnWPjs/Iv3D/2eKJg2YMjpUoVJ/8dDS9qOL&#x2B;1hUanY7H4Rj6vG06cSMpqygm0DPE07lLmK/h135mcWViZmG9RKbVaif07nzxyYsXuSWNEllSVrGno/WMwd3VOt2pOwkqldbX3WHjggnONpYrdp0KcnfOKqk6eO3x4M5hwR7OHo62gzqHVTe0FFXVMZlMEwHfycbCMI9qqBZr&#x2B;4&#x2B;srKbxxxPXvZ3tpw3sLH5Xyzv4j0VRVG5ubmVllUarkUtk2ial7H6x7EEJpdY5fNNz0ocIAPD/IjkpWWQi0uv0oWHv2BCqdYOhf&#x2B;CRKZrW6vQKlaZBIuNzuTwuOymzqHdMoJDPK6ttXHv48vxRfRgMxqq955xsLAQ8/oWHz3pGBW75ZDJJUa1XgjefvLn28BVPZ9shnSO0Ov3onu0SMgu3n7x5dt3C9z7fduirD/zdHNp&#x2B;0bWHr9x7kd23XXBdsyzc15WiaMPFuVAvF41e//nO0xK5cs&#x2B;yGbPX7t&#x2B;yaLKHs8289YdyiquOrJoT4eMan1k45vOf72//vLCqfvu5uA0fjvd1sU8rqPjp5I0pgzqHebomZxf1igmWKlQZRRU0QTlaW7o5WLGZLIIgZCp1ZW2ThalIwOeZCHhv7Pr5sqCMJKlIP3eCIAzVyX98Sivrm&#x2B;qaZb/XyoaiqDcKgimaPnM3yd7SLDbC/8GLnNvPMpdPGSLic6VK9Xf7LlxPShvcKbKmsfnozSfr5k&#x2B;YOTR2xg&#x2B;/WIhNxvRoZ2Mp1mi0Z&#x2B;4l&#x2B;7o6qLS6sb3aZ5dUxT3LrGuSrv9wnGFML1ep&#x2B;VxOTaNkwcbDWj352cSB3SL8dSR573n2vedZ/u6OthamDlZmIV4ux2/Gj&#x2B;geXVRVP&#x2B;6rrVZmpqU1DRwW6/jXc8J83LR6vUjAN7zm/p9smDqgq72VOCWvbMqALtavKy/PP3z2zb6LX0wdNqpH9Dtf&#x2B;K3E9M2nb302YaCIz9Pp9RRFpRWWP8spmTW0R6cQb4IgaJogSZJgECwmE&#x2B;PR1yiSpjQk88r1G1u3nhnQs&#x2B;OgAe1DQ0Mpii6vrq6ub3ZzdEp&#x2B;lrHv8MncouII/4CF86a0bx9CEzRBEAziTw39pTLFrbj479ft/vLz2aOG9CEIQq/SlFTXenu6EgRRUV5lZiUWC39vH&#x2B;LWX/v4fr1C07RErqJo2tJUVN8iyy6p4nHY9S2ywsq6CF/XSD&#x2B;P8w&#x2B;e5ZRW87mc3LIqnZ5ePH6gu6P1Z9uOJaQXBnu71DQ0Mwhi8cRBPDZ72fZTK6YNGdPr18s6iZmFN5PSSZIiCGJIlwhLUxMGg3CytuCwWXqSup2cuXzH6W9njRjSJYIm6O/2XXz4Mu/AF7NnfL/by9lOodKU1DT4udibCPlcNrtFoXKxteBzOafvJnk72w3sFFZR3xSXnMlisT4a1ctCbLL7/L3yhqZJ/TtHeLseux3f0CL/YETP9oGerU&#x2B;mrkV6/sELEwFn94X7/doHy5Takur6/Ira0prG9fPHThvU9WFKjkan79MumHj1hkLyub8OjNQaLZ/HNZyx&#x2B;haZTqfn8bgsBoPFZpkK&#x2B;VX1zQwGw9bSlMVkavR6NoOp05MNEhmTyVBrdM0yRZS/B0EQCo32/P3kH49d37Vkxo3kNI1W3ysygKIJc7Ew1NvljZmTXy4/OHc/uXd0UEygZ6iPq5lQQBDEi9zSy09Swrydz9x7NiI2Usjn7bn8cPPCiWIhr65ZuuX0bSaT&#x2B;fOiSUq1dteFu7su3ju6am5mUcXdF1nvD&#x2B;nW2CI/ez/ZzETo62J/4eGL4uqGHz8cl1tadTX&#x2B;5ZOXuQIBf/7IPpP7d3K2tVRqtfsu3d998T6Xy/ZwsKEp2spcPKFPxxAvZ1d7qz/eJwT&#x2B;o5SUlBQXF2s0mpamFlKikjwslT0oIVvUTBGHwWbaLe0ycf40DufvbtH7Xw0B4P8VTdMJ8QksNsvZydnaxprLffPSdX5FTV2TdPfF&#x2B;wwmsWH&#x2B;eEtTEyaTMWDRerlGe/KbeW2b1v1LyZXqJqmcYDCapIqKuqZgT2d3B&#x2B;tDl&#x2B;7ZWVv2e6s7xJYzt3dfuh/g6sBg0Hee53w6vt/oHu3nrT/YJdT3q/eHH77xZMonG45uWtKvY8ij1NzT95IyCitv/7SEy2abCPnLdpzMLq3uFxNy4NrDFwe&#x2B;rahrsrMyO3k7ISGzwMvJbmzv9qXVjUMXb/hi5khvJ1shj3vnedaEvp2O3nx6/0XWqW8/crK1SC8sn/j1ro/e6z1zSLfW0WdKXunJO4lh3i63kzL7tg8J83bxcrIrrakvrKwTi/jBHs5vbOhTXtu0&#x2B;vDlmAAPV3srVztrG3Ox&#x2B;esD9CSpJyk2k8lsbUr6j9LpSYVaY3jkmkbJy4Ky3jFBLCbzZUHZraSM4bFRPs6/NsPp&#x2B;eHq3LJqHxc7gsFQqbUKtWZ0j/YrZwwnGIREoSyuqpfIVelF5Q9Scs5ce7rn6zk25mJbc3GQl/OHGw5H&#x2B;rl9PPbXXW&#x2B;XbDuVml&#x2B;y6v0RYd6uol97jGQ/SMn9asbw33u2FEWX1NQP&#x2B;GTDvJG9e8cEudtbG&#x2B;6bU1q1YPPRSB9XRxsLrU4/tncHF1vL4qq6p&#x2B;kFQV7OYV6ub58kw564So1GrdULuFwB7/WsDkGotVqCJnhcTtsqEcM&#x2B;ygTxjoUQ5XVN&#x2B;RU1YV6u/8zerv9qm348fvbGi7u313/15b6E3KzNX3ygaFGmFpbPnz6AIFhHLt6cPGP5j18v/&#x2B;TD0a130ag1HB6P8cbYnyYJxm8mglov&#x2B;dfUNX3/4974FzmXT/xsKmBfvvpo&#x2B;Tf7p03qP3fWoAnTvuvaKfqzBSM5XBaH/epUl1fWHD991c3BmmLQ40YPYzAYBEEThJYgsEjpL9MgkSfnFPeNCapplAh4XMMlZIPcsuobienjenew&#x2B;22JgkanP3kncdvZOBGXKxTwM4orKJL8adGkTiE&#x2B;28/f2X3pnplQSNOUTKl5f0g3M6GwqKrO3cGmWa6I8fcY2T06Ja/01N3Eq09eph3&#x2B;Pr&#x2B;8dtjSzSO6Rn0xfQiPy5EpNQs3HckurZo3sueAjmGG0giZUn3w2qNGqaJJqugTE&#x2B;RmZ2Vtbspms5ZuO6HSard8MvnnU7fuPsvatWx6k0S5YNOhEG/nif261DdLriekrZwxorZRsu/qg0GdI8K93ZQaTWJmYbCnU8dgn7Yvp0Wm1Or1izYfySqtmtK/C5vJOHU3eWhs5BdThz7LLtp08paHo3WPiIDi6npD9wU/F4chXSNsLUw1Ov2aw1euxb/8ZFz/2cN6CHhcJpPBYDAUKnVVfYtKo7E0NeFxOCYCnlDAIwiiuKr&#x2B;fkr2xL6dOBz2pK93bl44wcbcVEeSs1bvs7cyXTN3LEEQ91OyP9p4&#x2B;JNx/Qd3igif&#x2B;vmBL2Z5Odt/vvtMgKtD75ggmUqdVVyZVljp62In4HIYBEOl1VXUNeSX1/J5XKlcGezl8v0H75kI&#x2B;Qq15tt9F88/fL5l0aRwXzcrUxNsyPBfpKKiIjc3T6VSKeUKnUQpfVwqu1&#x2B;ib1AyxTyCIAiaZrCYdku6TPwIAQD&#x2B;BUiSlMvlpSWltbW1sd1iORzO280lX&#x2B;aX7b3y4O7zrEB3xw&#x2B;G97yVlP4kPf/njyeHeLkYGim&#x2B;yClZtOVYYWWtg5X5rCHdZw/vQRBEs1Rx8Prj&#x2B;haZo7V5iLdLbJgfQRCp&#x2B;WXOthYURQt4XBGf93azS4IgWmTKx&#x2B;l5/duHsFmsy49TOoV4W5n93sXCv4&#x2B;hsLWuWarR6lzsrDRa3el7SeuPXNu9bPqh60&#x2B;cbC0crSwSswqziiu/nD68d0zQoWuPv9p7rluEv1KleZ5b8vX7o/p3DJ61er9UoewWGdAolT1&#x2B;mS/icYO9nHtFB158&#x2B;OJ6QtqMIbF8Fkcg4HI5bDORcNqgriRFGdp9SBTqeRsOTOzbUUeST17mrZoxfP2x635uDkM6RzxMzT1w7ZGepDZ/PMHF1srwbBVqzeDFG3U6/c4l072cbfdffZhTWr1u/rj49IKSmvrJAzpTJJWSX5aaV9bO3yPMz02h0gh4XIVKXVbTSDAZAi7X3FRobWpCEMTX&#x2B;y/KFMrvZr/H57D/FT1f3i75rW2W3k5Kt7M0ZxBEcnZRfnnttx&#x2B;McvptSswprZq5em96YcWQLuGO1hZ3nmXVN0vPrlloZSq6/yLnZmL6pH6dh3QJb3uX0ppGpVozfuX2SF/3nz&#x2B;Z3NqX8GVB2ZDPNp34eu65hy9aZPLVc8ccuxU/snuMTqe/8PDFzcS06ACPr98fYZhFVWm0DS2yEcs2czicsz8scLQ2PxWXuPXsnRubP03NK9t57u7cUb06BnvLlOoDVx9ZmZpM6NdRIlcWVNZtPxdXWFG3e9mMtlsiVDe1LNx0ZFiXiIn9OmeVVlmbmtiYi5VqbWueUWt1zDYNDf8taFrHYHCuXk98EP/Y3dM3Nac87u5tBikc1T82Ozc98XnJiGGdvb3t/D39vt6439PVbv6MIUKh2NzMVCJTLfrsm56xEau&#x2B;&#x2B;JTBIDKyCj7&#x2B;cuPQQb0XzBhZWFC8evP&#x2B;qA7R5pbm5y/cWv3ZHC8fZ4Ig9pyMW79p7/wJQ/wDvDfsuWRpYrL6y0mr958oz2nc/v0CazszU9NXCba2oTY/tyojozgxPSUs2LeltmnVyoXNLc35RdWODg6O9hY0RUllcjabLRS8owDpb2puliiVCibB0mg1zu72cqlK0iyztDY1EYkYDBZBUwSD8dt5Bpr&#x2B;7SyHoZsWGoG3MnRNkChULXIlSVJShapRIg/xcrYQi87eT&#x2B;Zy2CO7RRMEkVFUufrQZZqgu0f694sJ&#x2B;eHw5fzyWhtzk6ySagGPs2nBxGBPZ5VGa2km4rLZKo12w7HrGYXlo3u153LYQ7tEXIt/OejD1ROGdNu3YmZpbWNWUeXZB8nt/D2zy6qqGyTLJg9uF&#x2B;ipJymSoholsq92n6MI&#x2B;qPRfRtapLYWpi/zy0/dTWySyqcPjJ0xpDubxVBqtCXVDfll1Z/vOrNx4fi&#x2B;7UIJgmiWKRZuPlLd0KLSaCP83Mf16kBRlFDAyyis&#x2B;O7ARSdry1PfzWcymQ9SclLySl7klgR5Oas1&#x2B;mdZRbGRfl3C/O49y6Jpgsdlc1isK/GpDIJYPnWoWqstrWpwsrEwMxEq1OrkrBI/d4f5I3sRBNHQIieYhLWpSVVDM03TQj5PyOPyuJy8shpLMxOxkM/jsGubpElZRYGejl6OtnKV&#x2B;urTND6HPSw2kiAImUKdmFXYOyYoObt404kbI7pFju7ZvlEiX3/02p5L91bPHTuhTwcBn/vf1a7AyDU2NObm5LRIpQqZXCtXyR6VSu&#x2B;X6GrkLNM2Fz4QAOBfp7CgUK/XV9dUd&#x2B;3a9Z3vr3nltfM3HBzRLdLO0owkKQaDMeazjcfXLhrXu/3Dl7kUSX265fiMwd3cHay4HM6F&#x2B;0mJGYXfzR238KdDk/p2CvNxK6qsO/fg&#x2B;aNnGb989UF9syzS1&#x2B;30vaTe7YL3Xrp/&#x2B;2ZCx65ROxZPCfV5dV1WrdV/tefs2fvJfA5n59Jpd5IzbS1MVx&#x2B;&#x2B;0iHIq2d0UJ&#x2B;YIG9nO4IgWuRKpVor5HNNBHz2P9cRqEWmEAn5T9Py2wV4Cvh/arE&#x2B;QRAypaqhRU5SlEanq6xvCXB3cLG1epyWdysx3cfVvqZB8iAle87wXoPbjFzlKvX8dQduJ2as/nB8pL/bDwcvXYt/OXtodzMToZWZycCOYfuvPozwdTdsllzV0KLT69ceuSpTqA6vnEPTdHZJ1dIdJz8dP&#x2B;DK49SqhpYAD8eahpb&#x2B;HUNNBHytXv8gNUej0feICjhy82mvyMCxvdsTBDFq&#x2B;c/tQ7y&#x2B;m/Xe2fvPlm8/eWHtwgaJomOw93/sxSGappVqrVSpMjcRGlbQnr2f7Olo&#x2B;8aqpx3n724/F9c51Jeg6Yr65sTMApKkr2z4tF2gR22TdN&#x2B;Vh2sOX24f6DWie8yz7KIwH5dBHcPPP3w&#x2B;sFNYqJcLQRCFlXVylWbnubtiIW/VzJFCPre&#x2B;STr6y60zh3TTk&#x2B;Tey48ur1&#x2B;UVVwZ4O4oUSgP33haWFET4uXiZGPZKFMkZhQunjAg1PtVFyxDH5Uvd5/R6PRLJg4sr2tavPV4iJfzjwsmiAWCXy4/aJDIPxjew8JEWF7beOHR815RQYEeTvUtMh6HLRYK9CRZWFHL5nC8nV61ndHodEq1xsxEyGQw1Vot8bp8xfC1dHqSw2L9JS2wSJLafeBkfHwyi8Ho1at7cKCvXkdW1DSqtJogX8/yypotO3Y21NbXSdkUx3z&#x2B;jMHTxvYWi0XNzbI5Cza9yC1xsCX0pMDeyUlSX5NTmBfbteuiDyY9TYxPS34eGOJnamJWL2OolRIXZ/v7z9KWTh9a0ihZv&#x2B;3ckfWfBod4GJ5AZnbOms0n/AO8Pv948rZ9V3bsuvLDN5OG9utCEERxeeXmHYdSM8pWLJrbr0eoXCH9Zu2ejJRiT1/vsHCfsACn8IggNsHYvfNIZZPubsKL9V9/0inacJVXp1Sp&#x2B;XwRk8EkCEIh09yLT6mtkW755eT338ytzK/45qfTsyf1XjR/jImJkEEQ71hy96rjFc0gmARBpKblylVqG0tLc1O&#x2B;lZUpm8WhKYLBYhoOpGiKxWQRBKFQKFqkMjsbWxaLYXhYmiZaL2uoVCqBQEAQBEVRDMbfaCBjPN64XkBSVFpBeW2TpH&#x2B;HUIIgKIoqr2vaffF&#x2B;gLvjuN7tx3yxfWCn0JlDut19lrVq3wWSoixNhUVV9Z1Dfb&#x2B;cNiwps&#x2B;jTn49yuawwHzcum92/Q0iQp0taflm4r2u4jxtBEHKV5vyDZ59uPd4rMmDdh&#x2B;P4XK65iXD66j0iHr&#x2B;uSdIklX86fkD/DqFcDjujqHLtkaseDtYDO4X5udhbmIo2n7oZ7OHsYmu559J9d0ebD0f1NjzbZpmCy2bvunhv&#x2B;9m4b2aN6h0TRBCEg5U5SVFxyZnfH7ioJcm5w3s2SOQWpqIZg2INL/Pu8yyNTrfvysNof8&#x2B;lkwYRBEHRtEare/Qy7&#x2B;PNR76fM2Zwp9Bv9196kJrTKzog0te9pLrxWW6RuYlowXt9PZ1sCIJoksqfZZdU1Da42Ft1DPFhMBhypbq11RX8t1DIFS9evKivr6dJSitXSZ&#x2B;WSe8VaytlLDHvzWWPNM1gMuyWdkUAgL9SRkaGSqUSiUTu7u5CofDtAzQ6/S&#x2B;X7gn5vLG92jMYDMOY7LOtJ8tr6/csf7&#x2B;&#x2B;Rd7/k/UBbg6fTRzULsCTIuirT1K7hPh&#x2B;sP6Am73V2nlj2SyGVKk5f&#x2B;9Zj&#x2B;jAjcev60mqR1SAh71NuyDPM/eSGQSRVVwZ5uM6tGskQRAypVqt1X6555yFqfDr90d&#x2B;u/9iclbxh6N6h/m61jdJ28/&#x2B;ZvKATgGujjwOJzbC92lGwdGbT58mZ9g52v20cPyYXh3avq2O&#x2B;2pbuLdrcXV9Q4vcz9VhYr9OQZ5OqfmlWp2eyWTqdPp2QV40TShUah6Xw//Dfe/zymqe5RR3DvWxNBUVVtaF&#x2B;7gp1BqSpP6ZVm4UTRs64uv1lEanq25oUWq0vaKCuJxfx&#x2B;UHrj46/&#x2B;j5udULWAymVKEatHjjsK6RC8f0/fHE9a2nb3s42FhZiFPzSif36zwsNvLozae2FqYpeWXnHiQP7RwR4O5YUtMgEvA&#x2B;nzJUS&#x2B;ojp36ZcXSNs62FkVwZMmx5xmWzFGpNUWU9m83sGubX9oDTd5MSswq/mDbMsNhpzJdb/Fwcv5096vD1J9N&#x2B;2N0rKjg23PfOsywrU5M9y2dcfZoal5xpa2GqVGkHdQ4f0PFVSUyLXNnYIrv4OOVhau43M0c6WpvPWXfA391xVPdoM7Ho6pMXiZmFdpbmhZW1AzqEudpb2VmYbT51kyTJWcN6bDp5o6ZRcvCL2W721hmF5RNX7Xh/SLelkwcbHlmuUu&#x2B;8cDejsGLDh&#x2B;PFQv6Ba4/cHGz6tw&#x2B;hCfrus&#x2B;zyuqaeUQGudlb/0LmhCYIiCAZBMAzDL0M/axaLzXlrrXBa2suWZklBWWNGYW2zTCFprA0J8Z4yfqSX468buml1eqVCrVAoaYJhb2/FZjHu3Hva2CylCUaQf0BwoBtBEA11zR9/u332&#x2B;H6xnaIJ4tW472VW&#x2B;Zdf7K4sK9GxKf/IgCFdox/fe5KUnhcdG&#x2B;Xo4FxfJTlw5GR0hPe0iYPdnF2D/V3sbG0kCvWKb3fvO3qDx2Ic2LK8uqrpXlzC&#x2B;u/m8K3Em3cfb6lu7t6lQ9yzJ2PHDe0dFa6Qy7efuOVmYXf60v1eseE21sxvt1/tFu67&#x2B;fu5DDanbX99gpAlJOTQFFeqkHTsGmXKf7Uq5mVqzt0neeWVVSw2&#x2B;f7kwf4&#x2B;bgRNEgzm46SXq9buCfb13vzDIoKgt&#x2B;0&#x2B;c/b6k&#x2B;WLp/bsFMZiMgmCImiGYWCr1&#x2B;tOXHjg6&#x2B;nk4WJZVy&#x2B;nKILPY5qKBRaWZlwur/Uw&#x2B;GcYhgcanb5RItfp9XKVpr5ZamlqEuzl3PbXXYNEdvpOckJWoZDHKaqs43O5n08f2i7A80la/pd7ztU1SzgcFkVSI7tFzxjcraqxRaFSX3v60sbSdGr/LgeuPbI2Nxnbq4NYyK9qaMkqrvRysn2WU/zt/ovzRvaeM6JH61dRqNQfrDsgVaiXTh4kFvBkSnWnEJ/WN6as4srCyrpr8WntAj2nD&#x2B;pKEIRaq5PIlUWVdXN/PDg8NnrF5MHnHz77et8FLpsV6uXaLcK/c6ivRqerqGsS8nlh3q5JWYXNMkWXML8FG49cuPpg4nu9180b52jz/7TsFv4SFEUpFMr8/LyS4hKaorRytTSxXHa3WFMmecfQ3&#x2B;B1AJjw4dS3V2X/b0MA&#x2B;IvRNE2SZHFxcU52TqfOnUQiEZ/P/9t3a0OqUFEUbS4WShWq3LKawspaAY/bMyrQUBta3dhy5Gb80/Q8jVa/eOLATkHez3KKF2w&#x2B;Ehvm&#x2B;yA110zEn/9e36GdI24nZ&#x2B;hI/YjYaIIgNDp9RmHFppPX2Wz2hg/Hl1Y3fLrl6IqpQ3tGBbFZzOHLNhs24Tpy88mU/l2aZApXe6tmiYLP5zxMydPq9d&#x2B;8P5LDYSlUGq1e//Hmo3Ut0p2fTbO3NKtpkoz5apuLjeWMQbFXnqa62Vt1DPZOzCpasmrnhV9WudhZfrXn7NWnaYRev2B8/xVThtlZ/br4tb5ZtmzHiezSamcbSzcH6&#x2B;Kq&#x2B;iUTB&#x2B;6/&#x2B;rBTsA&#x2B;Xw9598f6WT6f8fOqmVKn&#x2B;6eNJhk0r/9jz3BIBj&#x2B;vnav/Pj8IpitLpSZVW1yiRm4oENubijKKK5zklXs62Oh2ZV16dnFPcIypwYp&#x2B;Oo5f/JFNpVs8ba2Vu0v79b3YtnTa0S8Q/&#x2B;dX/5xm2JJPIlQqVxtPJliCIF7kl6YUVI7tHi9vsupWcXbT1zO2pA7r0jA5asu1EWV3ThvnjHK3NGQzGil2nNxy71j0y0NvJ7np8qout1dezRvJ5vMTMgu3n4miC8V73qKKKehMRP9jTxdJU2DsmyNHK/ND1pz&#x2B;euPHhqF4fDO9R3diSnF10&#x2B;XEqg8mQKVRiIX9Qp3BTkaC8tvF&#x2B;Ss7QLhFDu0T821aktP2FzCBeV&#x2B;saluz/5inRFMVgMN/1lka3LrnR6rQ6PclisjQqdVllnUyjpikWqaMb6uvUakVJbaNYYNY5OjQ81L28omb7njOVpdUUi9tEMxT11UyaIaEoe6G4urKO4vNs7G1SEpNi/N2iOkX16tEpLbeopLjMz9k&#x2B;Pr3URCBcvXSiha2lnqJbmmRnzl1fu/7oF1/OnjyuP/d18ei9Bw/W/XTiq&#x2B;VzXe2c9529JDbhi9hWDs4WbEIX5Ofu4upAEERjS/3H3x3NyS85vemz4rKKJat2jR3Tf/bkQXKJTCVvZos4ZmYO5qYigiAOnbqVnl3kYG&#x2B;n1WncnR0Tkl6WlpUuXzQ9JjKAwWC2PQO/d5ZbD6AoMjevpL6xhSfgONnZ2thYcthslVojEgpogv4zBdnwN2l1eqVaSxO0mUjIZDJIkrqfkkMTdLsAz7bXes7ef3b05tP&#x2B;HYJnD&#x2B;vZeiNN00OWbC6rbdi9ZLqfm4NcpbE0FbXdtY2kqNyy6iVbTzxOy1s3b7yPq51SrXW3t6YJYsuZWzKlauNHE6zMxEwGg8Vi6kmSouiUvNJv918M93FZMXVo3LOsc/efaXT6uOSMBol03bzxTzMLKZJa9f7w32sIAf&#x2B;BKIrU68m8vLyc7Fy9Xker9bIXldK4Ik1xC8uES7xrIfQrNE0wGfYIAPBPamhokMvkL1&#x2B;&#x2B;7N2nt0gkeucxmcUVlx&#x2B;niEUCU6HA380hJsCTpKiq&#x2B;mYOh02SlK2FKdswz93Gql/OsdmsL6YNe/vR2k9Y9tXc0YO6RhEEQVG0Uq0hGISIz2t7wV6l1d1ISEvJK1k8YdCDlBwrM1GnYB&#x2B;CIM49fFZe0zB7WA&#x2B;CZlx49GLlL&#x2B;dFfO6EPh2nD4llEERNkyTIw4kgCJVGd/d51ouc4p9O39r66ZRRPWLYTObqw1duJWV8P/u9zaduRPt7xob7ejva/XLloY&#x2B;LLU0z2CymrYWZUqPJLa169DJ3wZh&#x2B;NE2k5ZcxGIz&#x2B;HUK0Ov2cdftH9&#x2B;jQq13AlG92TR/UNcLPY9f5OzMGx16Nf2luImwf6PXN/otzRvQcHht14lb8D4ev5FfU&#x2B;DrbLp44&#x2B;P3BsQRB3HmWteXMbYVS3btdEI/LJQhardHzeOy5w3saJhyapAqNTifi80QC3t8VCeqapXwuB1vJ/CcjKUqmVDMIhlavr6hrYjAY4T6uJEVdfpyaU1rVKdi7rK7pTnJW13DfGYNj56w7cOHBs6GxEeYmIplSxWNzpg7s4mBtMfmbXfdeZA/tGklSZEpuyZie7YZ1jVKoNXXNsnaBnr6u9v9kwfe/D/Wbv9GvX8Ufvhyaohi/88&#x2B;EpmmVWqPVkRqtTiaVKyRShVbv5u7sZGeZ&#x2B;CzzYULq2MHdXN0NDWTpFpl8y7bL164/7d3Hv2fPjkySd/XajWOXbvp4hy5fONnD1SLxZfbtmymP4pN9gj3GDO1ra2764FGSiENHhvtyTc2y88quPUjyDQ5pKqoJDXDp3b/T7HmrP5gxpktswIJPvh/Uo93ij2ecu5rw876TS&#x2B;aMa1IoKioazMXi1PTsaaMHdGgfYHgODY21fJ6pSMhnMCmaYPwfe2cdH8XVtuFzxtY37u6EYCEJ7u7uBQpFSt2Fur3U3r6lpU6LlLa4u1vwBOLutpF1Hz3fH5uEQGmBFihfmau/Amuzs7PJzHOfR24g4LDF7bdWZ2EsyE0q8fT3MFrMJ89kWfTOnt3i8gpLdx04Wa&#x2B;t75uSOHHciKioUAwiABAA92kt34PJHw29FRCqqtcevpRrsTsYhtfojRUaXbf4iCUTB3m5Kasb9S9/s/FcVlFEoLdCJqvXGQkcf3h03&#x2B;Lq&#x2B;p2n0pdMHDyud&#x2B;K5nBKrg&#x2B;YFoaKucfm6PW5e7j&#x2B;/9ai4mvP/BgRsdltdXV1RYZHVahWcnPVKrfloubNEf5PQv/nlogAQ&#x2B;XtUVVUZDAaH3RETG&#x2B;PldX39AC8I9XpT/8eXff/yvH5d2ulMlnd&#x2B;2n7oYu6G9x4vqKzTmaxxYQEanWnRRz9tePfx3p1jX/16U2FVXbuIwJoGg1ouXfbYNBLHDl3IziiuCvHz8nZTju&#x2B;XFOTjUVipUcilZpuD54W4MH/XSLLWs&#x2B;SGwxfc1bIR3W8wZvSGcLzgpBmG45UyiauZkuX497/f7O6mZBEI9fMyWu3nc0riI4MWjO3v46bady5DozPNGNKTInCSwIuq6hcs&#x2B;7HBYJ42uPvckb3D/X2yS6vDA7xae4sdNKMz297&#x2B;cZtaJv382Ye&#x2B;2HTw5JWCla8ueO27zRKSeHTioPdX7xiU1N5kdTQZTf0T4/edz&#x2B;rdMcZTqaRIbNvJ9Ev5pRP6Jh9Nz3t1zpgBXeMdNPPV5kMfrNn19qJJnaNChiQn4DhmdTh3nEoncLxco92dermuyUDgxOvzxo3vl/j4J2s7x4YunTMWAHDgfNax9Lynpw3beyaDJAgCx5QySXiAj95syymvrW7QzR3RO8TPC8Og9GYlTCL/H0EAWO1Oi90pIQmDxVbdqA/z86zQaE12R35FfWJM6LBuHe6sGfZ9jatc6Y8uBNdkIf7gUooQQggCBDBXxCzYaBtAmKKl4IehWQAhRRH1Ddr33l1u1Bs1TdqUHikvPbfIx1t95vT548fO1ZptWiuT0iF&#x2B;3Iiebm7Kk6dyV284wNptJpOzzlSnojiZ3GPk8KHzZ40oKqs4dTrNz8eb5tieXbsM6t8ZAMBx/NFT55VyZU5OUURkYL/eyVKJBAAkIPDz2kOrtu176dnpGk3D3gMn3391caeE9giwT7zx7dbNx7d&#x2B;82afwV1d&#x2B;2m3MBl5Be3ahXq4qRHgEc&#x2B;yLJJIZLBFQ&#x2B;hNRovOjIDg7uvtrlSmp105dS4fI6jQUI&#x2B;RQ3tKKfnvjsutOnzfCpraRqVaoVIpaLvTYLR4&#x2B;XiQt9D1LppFtIXjBSfDYBDjeL7RaKYIom29H88Lq/eeUsqlw7t3bPWlEbmfsdls2iZtXl6eTq/HeGDP1JiPlTsKtJiChLd4DkcIQOj/at&#x2B;ZTzwsuTVPoX8NogD4u9TX16dfSm/fsb27m7uHxw3qBQ1mW8c5rz88qvd/Hp0KADhyMeetn7Z99cLcDYfOm&#x2B;yOCX2TMQyYbA4Cx8rrmnomRPXqFJtXXltvML/53ea3F0zecTrNaLF9//J8Hgk5pTVPfrZu1vCeroqdfontfNzUNVp9vdb09NShPh5qg8V24EL2B6t2GG2Op6cMfXbGyNSswh92HpeQpLda0TcxzlUU1EpZXaPZ5lDJZRgGVXKpWiG7brBxbmk1ACAhKuSGn53jeYbj5S0zoR00Y7Y5HTTjoVK4q67vebiYV5ZTXvvI6L5Wu/O7HcdmDu1pstnXHzr/yuzRR9Lz8srrpg/p7nTStU2GJZ&#x2B;sjg0NeHzS4IFJ7TmOu1xY6emmev27TQE&#x2B;Ht&#x2B;/PA8CmFlaNe21FYsnDJo1rKeXu0pGkQCA7NJquZRKL6woqqynWS4swHvh2P4AgJyymplvfj1pQMpbCybOfe97N4X0m5fmLf1m09HLeV8&#x2B;NyfAy&#x2B;1IWu5/1ux6fd54hmU5Tgj288wrq3NTSpet3a3RNM2bOPD9RVODfNyPpeW99eO24irNxAEp3u4qN4Xs5dmjAQDnckrOZBUpZJJQP6&#x2B;EiODwAO/fHSfw7PJfvdwVb86bcNMfJ4bjGJaTS6/3NBC521TV60gSD/By//OnORmWIogbTtZ6cEGtFTXXDvhxXVwgBIADAAMIIoTMZqvTSTscVrVa6enl03Yzp89cWb39oM5mgxznTknbx8ePHNWnY2QgAIDlBZZxsCyvUiowDM8tKLPb6JSkeAAALwgYBIjHPvjsJ4fTMWvaCBwTHLTdTaVUKDy2Hzy7b/sRvcGpsTgpDFfirJs7ppD7dOnSReElXbtxa5fI8H59ukplMDA0zEPpvmr15kXzxiYldjQarPlFVR99vk7u5bb0yckvvff1wH69xg/rtfyr9X4K9XvvLMwqKnjl7S89VP49u3dWueFzpw&#x2B;vqtKnZxZ2T&#x2B;ngrlRWVtaFhqsNBpSTlxkY6B0XkyCTcgBIAMAFAKDAQwgE0HayMALIdayuqV&#x2B;iacZktL32/g&#x2B;VTdqfv3zlxJncL9bsfvShYTPG9pNIqT8vVKtv1OMEbjdbKAnl6&#x2B;/TnFn&#x2B;XXkUQgICCIKrJh40wyJBkDbPbBB/1EXuR&#x2B;x2e319Q2VFhUajgQKyZTeYj5Q585qgnITE7SzfIAQg9Hu176wn5kokD9ZYZFEA/EXsdrvVaj129NjAgQO9fbz/ZHze5cLK87klpTUNFic9Y0iPQV3js4qrtp1Knza4m6&#x2B;H2kutzCmreXHFeo3O9NJDo9wUcqVcsvdMZpe4MKvdsWbP6e9fmd8&#x2B;IojAsQaDWSGVlNY1Pvv5L/NH9YsJ9WsXFtg6DZ3l&#x2B;C3HL7EcdyQt96kpwwReeOunbc/NGO7KAHyx6eBH6/ac/f7NiEBf1/PPZBZtO5U&#x2B;ILFdo9FM4Nj324&#x2B;b7Y5XZo8Z0DW&#x2B;tsnw484TsWH&#x2B;hy5k/2fJ1Kggv7d/3Gpz0CF&#x2B;XqF&#x2B;XgvG9IcQfLH5EIHhGAbDA3z6J7YzmK1yKSWXSm7qX&#x2B;ZgmJoGfUybCY/XYbLaa7XGRr1JQKhjVIirAaCstnHDkfMV9doAL4&#x2B;4UH&#x2B;VTDq2T5fWqgaTzfHLwTOr95xSyKSjenZ6dvqI8trGiwXlo3p0Wrnr&#x2B;P7zmdEhAWH&#x2B;3inxkcO7dTh8Meflbzb&#x2B;tHRhh8gghuNeWLEhKtBnbJ/EZWt39ewYQ&#x2B;L4yJ6dAQA5ZdW1TcazOcVPTBz0wooNz88YOaF/VwGhVbtPffLbvpWvzD&#x2B;WnnfgQvYb88ZptMbsspr1B84YTNZd/3tpdItPgoNmGvTmI2m5u1OvrH590b5zGZuOXBiY1H7TsYskifdoH/XcjBFtw83TGYU1jfqqRp3eapvYNync33vxx6v9vdx&#x2B;eOWRm/84itx9iqsbGJZ74r9rPdWKb1&#x2B;ed91gkM83HkjNKl7z&#x2B;qK2nQwiN&#x2B;O6q89fiTURQhBcrXEqLa/&#x2B;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&#x2B;5lLv&#x2B;8DmW4z94dArN8GNf&#x2B;qxnh&#x2B;gPH5vm7a7KKKqa/58fVr2&#x2B;qGeHaNfzi6sbnvvyt&#x2B;mDu8WE&#x2B;HWLj6pp0q3Zm5oYG/7TnpNTB6YcvpTTNTZi7qg&#x2B;Gq3xxRW/9ewY/ca88bwgnM4omPjqFzs&#x2B;fq5jZPDk176cOrh7eV1jXkXde4sme6gUX289XFipKapumDow5Znpw73UyqKa&#x2B;s/W769t1EspMik&#x2B;4o2Hx/&#x2B;46/ihS3m&#x2B;7qqE8KBJA1P8PNUAAI3O2Kg3Myz3wooNVfVNq99YPDAp/i98KTwvWJ201eHkOH77yfSdqVdS4iNemjly3YEzfTrHdWtxwfxux/GuseHd2kcAALYeT6us1z42adCmoxe1RsvYPokAAB9P1cHz2Z5qZZPBPLpXp5nvfkdi2I&#x2B;vLWRZ/mRGwfINB2cO7T4kpcPsd7779KmZPTpEAQQqNNrjl/O7xYc1aE1jByTjEBMEtCv1soNhd6deHpKc0C&#x2B;x3YhnP13xwpyRPToDAD5at/vzDQcv/vSOn6dba33R8k0H957JiAz0rdcZY0MDEmPDvtt&#x2B;bNrgbh//uremXjdreK9PnpgR5OPRoDf999f9x6/k&#x2B;birU&#x2B;Ijpg/pHh8e1DZXwHK8Rmc02xxqhcxdKVfKpTfNJJhs9vI6bWSgj9j58EecySyyOJw7T1/5bvOhxPaRP7/1aHSwn5NmlXLJis2HNhw&#x2B;n5FTvPKdx7u1j/L3VpfXaM/mFEMI48MC20cE&#x2B;3mqAACFVfUquYRmOLmUkkooi83&#x2B;0&#x2B;6Tx68UnPjqtdvdGQfNCAKSyyRi5HUDfm&#x2B;WcRVXd8Q1hUwIcZVVVVqtpa7BotHqdSaz2Wjw9vQxGE0anQ7hpKZBTyE2ODhi4vA&#x2B;fbrFkxTupOn0jLwVK3&#x2B;rrDf4&#x2B;vhEhfkH&#x2B;PuXlpTvOXTR1135zquL80vKjpzKigsLMJuF8qI6NzenEYMBoeEfvbIwJsSL53mCICCEFy4XrFi1WYLD&#x2B;HD/K8UVffv1WTJjBACA47mS0oqSMo3ZbF3&#x2B;w94nFo3rmdjl0Ze&#x2B;ioxSvP7M9NCgEKLNlGHGyX&#x2B;/aruRNgwc0PeX9ftHDezaq1vX7ftTLRZmz/HUD16e1ys5ofmDIsgJAEGBwgAAWHGRZu1ve8rLC3zDQyaMGtS/e6fUsxm7j6c3NhhCAj2mTxycEBfe/BYMqzWYflq1&#x2B;Yd1u5M6xtOmpv8se7Fr11utLL1TCIIgIETcvk&#x2B;FyL&#x2B;M6qrq6pqaeo3GYbPTxTrz0XJ7Rj2U4JD8qz8bLgHwat&#x2B;ZTzwslYoCQOQPsFgsaZfS/P39lSrl70N/hJDRas8prZ3y&#x2B;pefPDljaEpCk8EiIETieHxE4F2dEWmxO2sa9V5uSl8PdUlNY2FVXZPR4nSyvTvHdGyp3tGZLI0GywdrdlVomgYktkvNLooNCXhs4qDwAO&#x2B;vthzleW58/6SC8rpZw3tZ7PSEV5db7Y79/3tRJZdpTeZHlv2UEh/59iMTui94Z9mSaZ5qxcHz2Z7uyvYRgd5uqoSIIJrlGJZLfuSt9xZNPnm5wMdT&#x2B;e6CyQCAopqG3NKasX0S57z3nZQkZ4/sTUCsQ2Swl7sSAHA0LW/LsQtWJ02zfLi/95KJg/6zZpevp/psdvGa1xfpzdaPf91L4oS/pyoyyPeJyUMBAIcv5hosVn8vd0EQCByPCfGzORmFVCKhCJVc6jrIFruztsnAcJxrLP2klz/f9OHT1Y36PakZT00desMDyAuC67U0y1VomlbtPV1Vr8MgSC&#x2B;sYHl&#x2B;0bgBPu6qK4WVX70wFwCw5fjFtfvOaPSGTpEh7y6eHOjlbrY5XAWjvCCk5ZcVVGpYnq/TGueP7vfRz7t7dYh5aESvJoO5ptEw6OkPizd&#x2B;6qlWtObud56&#x2B;vPds5tg&#x2B;XcIDfDYcPj&#x2B;&#x2B;b9ef9595c/44P0&#x2B;3o2l5Tob5dtvRr16Y&#x2B;9zyX/Vm69KHx1mddL3W&#x2B;MKK9X06x/60dEGYv7drUW/HqfQKjXbhuAHbT6b9vO/0yYwCtUL&#x2B;3ydnThnUrbZJ/9zyX&#x2B;eO6jt1UDccgxdyS7/YfPCjJdP3ncs6fClbJqG6xIbNHt7LbHOU1zUppBJfT7W/p5uoBwAAlfXaZWt3J7cLl0mo9KLKY2l5UwakTOifRBLYtDe&#x2B;7t4hisAxDGKfPz1Lb7E5GS7Y1x2HeEZx1fhXP5/Yp&#x2B;sXz8/Zc&#x2B;bKmcziYH&#x2B;vHu0j957NvFJU0Sk65Of9Z/d8&#x2B;lxCZHCjwbzxyHm5VPLwqL4mm&#x2B;PUlYJzOSWh/p59O8fFhwVRJL73bGZOWXXHqJD24UHhAd7lGu3BC1lv/rDl0ydmzhnZ&#x2B;wGZPHvfwAKEIYAhJFhtdoPBbLHaGZbjEdTq9Q4n7bSyDU16DILoduHD&#x2B;yYRJFlRU71jx95HHn5IrVKBqy4IAEDopJkaTZPeaLZY7JeyCxiATRjczU0hl0pleQXlv27cN3pY34nj&#x2B;n357Z7TF89/&#x2B;t7C8JBw0FLQf&#x2B;z4pa&#x2B;&#x2B;WlfdqHPz8ygtrvZS&#x2B;7&#x2B;xdGGlpjL1dHpcbGxtk27K2H6jB3UDAGiNZo1G4&#x2B;Wm9vf3xzDIcfzPW48&#x2B;/9ZXw3p0mTK9X/t2sSoKNjVi7332bXxsuJ&#x2B;v&#x2B;6ihPdpFBwMA6nXG3NzyqGBPpUq55fjFE2lnBndNmjV2rEJBIITOp2WvWrvVx9f3sUVTQwJ8LU7HilVbczNKowKDElPiB/Xv4qZUAACsNntZebVcLg8LCcBxzOlkcBynqJtkia&#x2B;jvkFbWauTS0hKRqolUgKHFietVCp8vNzFMskHivr6&#x2B;qqqKk2dxmI2MxUmy5EyW3odJHFI/T1ZiAAAwO/VPqIAELkBPM/TNH3wwMGOHTv6&#x2B;fsplcrfn79SM4tqdYYvNxwc3TvxtYfHNhnMPEJSknBXKYqrGxZ99BOBY2P7JeWV1cQE&#x2B;704a1SFRnvwQpa/l7taIesWH9lqaPpHmKz2Br05NtT/dju6eEFgWF4qIdfuPb3lxMU9n77Q9iGEAIFjLMdX1Wujgv1c91fW6y7mlWqNlga9KTGu2TnreHrep7/uH9I94ekpQ1OzSz5cs9PJsintIoamdBiUnGB10AzLvv7dlrO5xWvfWBwZ5AcQ2n0mo0dC5Lr9Zwqq6te&#x2B;uQjHMFlLh82pzMIdJ9P7dIpzU0ovF1ZOG9ztqf/98sKM4dEhfgVVms9/2//4pCGjencBAORX1LWf/nLexo/L6pq&#x2B;2Xr0vUWTcRzbcuziqj2nZgzt/vCovmv2nd556nL7iMDF4wddN7chcvILv7yzxOGkj6bnLRg74GhabnxYYEG1xtddFeLrhQDw93QL8vHQmixao3Xhhz/NGdH70QkDAQD1epPOZJVS5JWiyvWHzq56fbGb8paiYYSQzmRtMlriwwPLahvrdMY&#x2B;nWJdDy1bu&#x2B;uh4b3C/K92CGiNluUbD&#x2B;w9m/navHEMw/m4q8x2Z1JceESgz4bD59pHBH&#x2B;wZtfPby/&#x2B;9Je9K7YcyV63zNdTDQE4dDFbb7L27xovl1AqhQyDMKu0euk3m95eMKG0tnHm0J6NBvPpjCKCgJuOXpw/pt/OU5dlEsknT0zjeN5Bs9FTX9z0wROxIQGvfLvJbHM8O23Yt9uPldU2fPPS/It5pVuOXzqRnkeQxPJnZo/q1clid/y486SHSnHgQhbD8ae/fV0pa65vMdkcO09fPnAu012liA31H5rSISEiiOX4Ck2Tzcm4KWTNLSV/0KRoMNtOZxUlxoSF&#x2B;HneyoG99wiCMPqFz2YM6eHr6da7U8yPu0&#x2B;&#x2B;/eO2Dx&#x2B;bxrJcaW3jgK7xMgm5ctfJ71&#x2B;ed&#x2B;xS7qx3vnllzriX54z2VCk&#x2B;/mXv7jOXd3z03MnL&#x2B;Wv2pY7v24Vh&#x2B;TF9Es/llOSV157PLfH1cAvwdruYV/7ctOF9usSeySp64/utSyYOemzSYLuD3n0m49Wv1785f8KCcQOe//I3ndkaHeTrplRcyiubO7K3zUF7qJUB3m6nMwp9PNSV9dqjl/LCArznj&#x2B;nXJToEAGBz0ueySs7mFIf6ewZ6ex68kB3k7f78zJHXfTqa5Zw0iwDYcSrt5wOpL84aParHbazpIoQ4XrhvDe/uV64d0NQy19VJ0yzLMSxjdzAEhstkUvc/NmV/9YNv1/x68KM3H5s8to/ZYnMyjNPhhAgPCvR1c1ccPXXRZLZOGjMIACAAHiC4/3T6B/9bHebtu/Tp2ZGRgRIJRZFERkHdosc&#x2B;7hAR&#x2B;OJzk5ev&#x2B;k0h9&#x2B;gYH92re8f4mGDXXhYVVa/9df93K3f0So5/&#x2B;93FMgo8&#x2B;8oP7dqFv/3KTJWSl0q9yiuMI&#x2B;e9OLBH/Mg&#x2B;fX/deioo1H3c2D5frTq4Y8vRn795&#x2B;qGpI1x7&#x2B;/Xa3d9998uIwT1eeW4&#x2B;RVE//rTrxMkrSn&#x2B;P9l0juseFduvc0a2lhLUZXkAAAAxBiAMA9FrLlkOn8nOL0nLqUjrFPjyj/2uf/CrHiI/emB8VFXwnv5nrQM0qDQAABGS2WNVuKgAAz/OCIBA4Ae9VC5DYwO1Cr9cXFBQ0NTXZLDa6ymA&#x2B;VGZLq4M4hJI7Yf2OAEDAb2mfmU/Mvd2h7f/fEQXAn2G3201GU35Bvp&#x2B;vX0KHhBs&#x2B;5/ClnE1HLsRHBLEcv3Bsf7uT0VusLMfLJZI1&#x2B;07nltesfn2Rl1ppp&#x2B;k3ftiWU1rtGj6TFB9hNNtYjjfZ7E9NHRbq52VzMlUN2nUHUj/8cfv88YNrtYas0qqT37zuqVYOfurDg5&#x2B;/nF1WvWbv6biwgO7toxw0Y7LaHx7Vl&#x2B;P5mkYDhMDbXSUhybauvdml1f9dv/&#x2B;1uWPjQgPuxsGhWc7hpCGGqeVSCKHRas8trzWYbRqdMSrYb1DXeCfDfvLrvgadcdmSqW7K5p5gjc748/7UxJiwsADv/WezOkWH5FXUDuvWMTbUP6u0eva730UG&#x2B;i5/5iFPN4WEINrNfOWdBRMHJrdPnvfW0RVL/b3capsMX2w60Kdzu3ah/r07xb7xw5Zxfbuu3Xf6i2dmuzLjjQazIKDFH62KDPT&#x2B;37Ozuy9459U5YyCEH67bvX3Z01KpJK&#x2B;i9uOf99Q06pdMHlyvM/bqELP/fKaT5tyV8qzS6kaDecmEgTOH9vxhx7Gvtx8N8vF8YcaIsX0S7&#x2B;pZWBAQw3Isz7eWj5&#x2B;4kp8cF6GUS50Mt/1kWk5ZTWW9rnenmIdG9FLLrj9DLd9w8JP1&#x2B;5LjIgYktnt4dB&#x2B;r3bl676lh3TrtOHlpzf7UQ5&#x2B;/HBXsS7Pc4Kc&#x2B;mjW05ytzxry3euepKwVblj1VodEu&#x2B;WT1j0sXaI2WMH9vvclaodFiBL7&#x2B;0NnBSe2NNseF3JLvXp7v66Fu&#x2B;3avfbfp&#x2B;JXC09&#x2B;8Xq83ZZdWn0zPVyikE/slBXi5GS32VftO/3rgTGV&#x2B;hUeY/1NTBi8aN1BCkR&#x2B;s2aWWSa8UV1bW6wYmxx&#x2B;7lO/joRzevdO8UX3zK&#x2B;tOXM6XSajoYL92YQEdIoIBBDqzFSCgkElIAv&#x2B;TRe7S2sbUrKIpA1MUd2fZxmixXSqoSIwN83ZTHr&#x2B;crzVapg7qBgDgBX7Bf3764oU5bnLZmz9sOXmlwN/TvaJBGxXgczyj4Nz3b0spfPBTH70&#x2B;b3xkkG90sN&#x2B;ZrOKtxy4O7dFBozP6eagXLlv17PQR/31qxo7T6QuXrZo8MOWr5&#x2B;fozVaSJARBkJCkzUH/uPt4TZNx/ui&#x2B;4YE&#x2B;BRV1R9Ny24cHZRRVJUQGpReWl9Vpv33xYXelvKSm4dNf9goAfPjY1GVrd5vtzjVvLKIIfM&#x2B;ZjBdWrJ84IDkywIfluCenNCe&#x2B;BAFdyi/z9VDrzLY5730/pnen9YcvvDRz5FNTh2EYFAS0fOOhkb06xocFup6/5filwckJBos1NbOIIomOUSGRQb4arbHBYPrPqt2&#x2B;XspvXpgnlfyVMVlWu5MkCcktDLF5EGmZy4QAcFXt/87k&#x2B;AblTNdtguVpiOEWk9NosqVdyS0pryFIys/Hc&#x2B;CAZG83JUaSPM2SJN6kNdAsGx4ScHXjCOQVVqWeyTYa9Q0GPcNjs6YODVCTK35YdzG7qtGIOsaGvvrszK5dIiHEeA6eTc1547&#x2B;rQtuFvLpo&#x2B;ptvf&#x2B;bvp/QOCA0N9sOgZPnK7YzV&#x2B;eLT05ISY/193QP9fAAAB45dfOWjldkFhUN7dtr2/Ydam33OU2/3TE4e0C/55PGTPTrFTRg/wqAzrdt2PCe/rMlsCvT1WPLQ2M9X7zE26t99ZU7HhGjQbIIBNU3GoyfSL13IwYGgDvDpnBAzanA3CXX1jGFz2C&#x2B;lF4SHBYSHXHMRRAgggP68PPLCpcxjZzJ7deuc1DGirsFQWlYXGOzprlT6e3lKZJQAAQbvlgCuqqiorKxMSkqSKZQPePxvs9qKi4tramstRhOtMZsPltou1iIAMOmtzL&#x2B;6th4QgeahBPDaoFcUACLXwbJsZkYmRVEESbRv3/6Gz7HRdH55rVoh1xktiXHhbedFNhktk1/7on&#x2B;XuPcXTwUALP1u87G0vBPfvPbM/9ZJKXLJxEE&#x2B;HupWf6vLRZXZJVWJseGr956q1RoFXpg&#x2B;uPv4fl15QRj&#x2B;3KcLRvcflBw/9Y0VT0waGhPqR5HE&#x2B;6t3QgApHPNwU/73qZkfrdtzLrs40Nvj6KVcCUUO79X5y6dnjV/6xYS&#x2B;SdMHd/v4131ZxZUjenR2DRF6be6Y1j5gAIDObLXanaH&#x2B;3vf4JONa2DDbHAghlzYQEKpu0GeVVjfoTFqjOaV9ZL8ucSRBvPfTjqHdE3p2iDFY7Gv2nfZ2Uw1KilcrZJuPXfR2V9gdbHJ8RHSwHwBAZ7IWVNZdKao6fClr1euLlm88ZLban542bOTz/33t4fET&#x2B;yW5KWUXckvfX7NzzvA&#x2B;ZZpGCEGwj2dxdf3rD4&#x2B;tatDXaY2bjl1IjAkd0zvx6c/XRQf5Pz9zOIZhCqnkj5ax7xM4nrc6aNfB9Pdyk5AkAKCmUX88Pb9eb4wM9AUAkAQxrm8iAODNH7ZuO3Fp3/9eCvXzWrsv9X&#x2B;b9ktJskdC9KPjB0UH&#x2B;5zLLtZbbCq5LLOkatbQXoE&#x2B;7m3f6LfD5&#x2B;a9v7Ju95duChmBYScu5x&#x2B;8mDN9cLdl63Z/8&#x2B;LDCpkUh3DTsYuZxZUIgbBAn5HdO63Zd/rk5fxtHz3j46GGAEx4ZblaIf/y&#x2B;dmf/Lp35c5jTfu&#x2B;LapuyCqp2nX6yrodR1e8tmBcn6SM4qqc8hpNk9HXQ71880G9yTppQPInT8yICvJtuzNPfb5uXK9Ek91eXNOQHBdBMyzD824KeXiAV1SQ3187kjYnrTdZfT3dPly3Z8OR82aLfe7I3i/NHu2lbl6nLK9rollOQhIRgT4AAJ3ZermwomNkiL/X1YZg18&#x2B;2zUHjOOY6J9Q2GfIr6oakJAAANDrjrwfPCgKaMrDbukNnTl4uIHGstskAIHxp5siHR/fNLa&#x2B;d&#x2B;OoXBou1Z4foL56b88gHK5&#x2B;bMbK4WlPVoE&#x2B;IDC6ra1w0bkBUkO/eM5llmsZdp9KfnTHC19Ptobe/K66sCfL1lkslQ1I6vDBrBMvxCpkkxLc5wbLr9OXTWUXB3p7f7DgaFejz6ZMzAIKP/3dt384xr88bb7I6Fn&#x2B;0ytdL9f7CKQHe7gCAx/&#x2B;7JsDLY/bI3qcu5286ciHM39vf211rskglVIVGK/DCK3NHr92Xml9WO2t4r4n9kjzdlACARr3pZEZhWl65t7uyb2JcbIi/p1oJAEgrKFcrZGarw9NN4aFUWB30q99sPJdb8u1L84Z16/DX1DXHC7wgiBLij0G/N49reeCGBmetCYo/1BUc41zx3erN&#x2B;y/SDlKGULvYoJkPjezbu2tjk1FvtrSPCq2qrMrKL2s02CmJFHCC0WRmHM6C8hpcQiR37jBycA8/T/nPG/Zv3HkA2I01Zj4gNMRh1BWVaWLbd6DkkrKifH8FNXBgn3bt4uxOurSyKszX28fHZ&#x2B;uBs0/PHTVwQDIAgGdZi91ZVVP/1fcbajTGKVNG7zx6NDc7&#x2B;/O3Xxw8oNv6TYfsNseCh8dTOLZn/1kH4zRabQLkeid3bBcdpTforVa9f0AowCUHT17ctekIx3IDx/WaPLyXisDmLXwxpmtvCWcZ1H/AvnM5NdX1XdsH&#x2B;/qpOYa4lJZXpal/ZO7IYQO6/97V&#x2B;2&#x2B;DkIBcRhwHT2VkZxUlxPh2aBfm5x9IXZ1K&#x2B;cDpACSgrKysyspKu83u1Jgsh8us52qQIGCym684IAQxTOAYAqc4JGCuiF/gMamcdtglCAGSFK5Gvi0CYMbjc2W/W1/7dyMKgOtBCB09etTb29vPz8/X1/eG4304XnDQDIFjUoq84dWL4XiN1lDdoAvx8w7z9wIAIAHllNV0jL6&#x2B;c4DnhQMXsjYcuTBlYMr4vl0FQXh2&#x2B;W/9k&#x2B;J5jjt4Ieen1xbM&#x2B;8/KMD/vdxdOdLWWrt5z6p2Fk57879qxfRLlMsnTU4cVV9enZhVLKOJoWt7SuWM3HblwLq9k5cvz2z/0eo8Okf6eapYTDBb73q1Hvv7s&#x2B;cn9k13TSwxm256zGYKAjqblrn1zcb3OVKszvvXD1lnDeozvnTTs&#x2B;U/8PdVdYsKOXMrt3Snmo8enWx30mr2nFVIqITK4Xm/ydlOmxEf&#x2B;nRoAjudxDDNa7SzHe7upbneuos1JcxzfmlgAAGhNljOZxQO7tmN54ZeDZ&#x2B;JCA&#x2B;JCAy7mlf5y8ByOwZ4dow9dyB6UnDCyZ6fTGUVRwb5yCdUxKoRmufM5JQ16s4NmBicnrDuQWq83/WfxFD9PtVRCPQizOB00w7AcRZIyCcmwXGldo7eb6obuyxuPnt97NrOwQtM5NuT9xVO81arjl/O&#x2B;2Xr08KWcGUN7LBjb/1xOaXpBebCvx9wRvQuq649eynt&#x2B;xvCoIL96nenNlVur6rUb3nuiQW/s89iyvf99PjrYz8tN2ag3P/X5z3NG9Kmob7pSWNk/Mf58bslrc8e6KWWV9bpdpy9X1Os&#x2B;fWJG2xKs8a8s75/YbvKA5BWbD0MIeneK9fN0q27QTX/jq2B/7xdnjnhm2vDbOgK8IOxKvawzWYuqGr7eeuSNeeOmD&#x2B;6x8OMf3eTy716eBwBc&#x2B;NFP4f5eK56fa3PQh9NyPRWypPiIlTtPFFbXOximc1RoiJ&#x2B;n3cFEBvv6e7qZrQ4bTXeJCSdxWFzVYGcZD7Ui2NtD3iZNISChqKrBYLFfzCv1UCmS20VADMUEBwAAMAxiEDIsx3CchCTLahujQ/xwDNt3NqN9y5DZ0pqGF7/a4O/pNn1oj3kf/MBwfHSQn8XuoBnW0035xKQh0wd3czWZnM0ufv27zY9NHhzi63ngfE6wj4dMRtVrjXvOZl4uLH980pAXZoxcsfnQqn2nDi9/OT48iBOEFZsO/Xb43MpXH2nQm7aeSIsLC0iMDgvx9TxwKdtksRdXNzw/Y0TnmNCM4qpj6Xmbjl748LFptY36N1Zue&#x2B;PhcQ8N70kSeE2jftizn4zpk/i/p2Yt33igpLaxY1TI4KT4LUcvHbuSP65P12Afj3H9uuqM1u93HqtpNCpllJQkaZYdnJIwokcng8V2NrvkSmGFu0reISokKS5cJZcW1zSkZhaqFfIuMaE&#x2B;7iocw87mlLz41fowf89ty54Re0PvEDcMBlozAwhAGoCrEZKAeCTwOE60yIybGjAL16kLluMcDqfDyXA8sjtoi8VqNposNmdwaGBiQhQA4K2Pf&#x2B;rRMWbUqH4AAJpmyyrrystr/vf1b37&#x2B;gU8/PnX1&#x2B;g0X0&#x2B;oDJEqLo4bydQ8N7nAl7Xx9Y92Avv0UcvmxI2eC/QJnzh199MypzKzsZx6dd/rClZ3bUhc8NO61V&#x2B;YROHzn/XW5&#x2B;dU///CMjALzX/96SPdOw3qmPPrOF1HhoeOG9cUhadAbyirKbDaQ0CF84awR13wQxAsCZBjeZLZyNO0X6InjOIQkJ4Dz5/P27T/tcNq7dW&#x2B;f2DkuPNRfKpECIAABgDb5TCQgAAFAHEQ4wLH0jKqFT33YPTn2iUXjAv29va4ZMoYEhDCI1dVpLBabTCZjGCYgwFehkAu8QNOMRCppbipD187hvckX3bYb/j6qNWJZtqysrLio2Ga10Y0Wy7Fy86lKxPKY/FaTjTyHRXWq9Qo0lmcHNlR7EqSAYSgiobZd98pzezrWFPkq3R3XCgDkt7TvjMfnyGQPVuebKACa4TjOZrPl5uYKvJDSLYUkyd&#x2B;PWM4srjqXWzJ7eC8Mw3afvnI2u9hsdTw&#x2B;dUhKu4g/2qzF7iys0iT/8RMAADTLWexOnue93JSuK1m93uTv6YYQqtBoXWuNLMdnllRFBvnKJKSTZo9czKk3mJ&#x2B;aMnTsy58P797RyTCjenZx0szmY5c&#x2B;fGzqWz9uO5aWm/rdmwCAtILyxz9Z89kzD8WG&#x2B;Pl6uEEIjFb7p7/t91IrFFJqUv/kjJLq2kZ9g8GcVVK1cukjvx48//2Oo2qFrFNU6PQh3duHB73&#x2B;/eaL&#x2B;aXJ8ZHFVfVKufRKYWWd3vj0lKFvPDzeNey/XKNVSiVXiiofWbYyLMA7MTb8yKXcoSkJK56fk1FU8fYP26JD/ZPjI&#x2B;USKq&#x2B;8du6oPkE&#x2B;HleKKjOKKz/bsP/zp2YNSfmLS4B/gp1m3l&#x2B;9y2C2Dk3pcLmo4kphxdsLJnVPiGw94IKAZBISANBktFTW65LbhQMA1h04a7RYF4wbcCmvbN&#x2B;5rCenDA3xvYGxg0hbHDRjdzIsx0slZHWDHgEU5udVWKUJ8PZwLT9bbM51B88eS8tZOndcUrvw3WcyVu05VVbbGBXo&#x2B;/Ls0Untws9ll5zKLEyKC7c66Q4RQbEh/mdzSnLLajKKq16cOTI6xA8A4GRYXhDe&#x2B;H6LRmv67pV5q/eevpRfPndkr0Bvj05RIT/uPoEQJDDYPjK4e8vEp1vh621HL&#x2B;SUPDV12JWiilMZhTKphBeEE&#x2B;l55ZWa&#x2B;JiwVa8t6BQdml1StebAmYt5ZdWNusFd2//2zuNrD5zeeeryQ8N7&#x2B;rirvdxVm4&#x2B;eD/b1OnA&#x2B;66FhvcL8vTQ60/ncUrmEXDJpkN3JfLHp4OGLuSe&#x2B;es31y8Jw/PaTaVuPpz02aVByu4iNRy5UN&#x2B;iS4sM7RYWGB3gXVTXkVdRgGOwaFx7s4wkAsDpondFCEjhCAGIAwzA/DzWEECH0&#x2B;H9/lkjI7vGRKrmssLJu3/lMD6Vyy7In235AmmFzymt9PdStqQAX&#x2B;85lns0ueWfBxO93Hf95X6q/h9pgdUgIzGizf/TY9K5x4Z/&#x2B;un/jkfMCEBaPGyAgVNtk7BoXlhgbnhQXfiQtN7u0Ji2/fGyfxNgQv6HPfDx/dL&#x2B;3F0ySSUgCx1btOfXdjuMfPzbtUkHZ&#x2B;ZySqYO6ebkpEyKCd5xKZzmeYbnEuPBgXw&#x2B;j2d4xOsRssz/12TqO5z98fHr78MDK&#x2B;iZeACE&#x2B;HhiGnbiS//hnPw/q2v7blx7ecSr9&#x2B;50ngnzc3RVytUJustkeGtrrVGbx3JG9PNUKjc5wJrtkd&#x2B;oVHMNGdO/YLT4yPNAHAHDwfDZFkhCier1JIZXEhweGB3hfJxU4XrA76cMXc345dPbhEX0m9E9qfai60bB676l&#x2B;nWP7don7ozo0jhcgAA&#x2B;QZ9zNQS1/tp7SYZv7wdXQs23ccePzP9/qxCwIPMRgo9b85ocrtU36pU/PSUluTsuXVTat&#x2B;PIHAhPyi4sfemhWu3YRDofDYmMtNgdNOzgHqjc5TDaj2WaQCohlOIYDRhMSVJJGS7WjTiNh5QyUqdzdKnIvu/kF&#x2B;oSE52WkQc46auzI4YMH6poMAuQWzBwBALDb6fSsQoVS1jE&#x2B;ksRxgIBObzTZnZ6ebu7XzEvg7XZbbl5tSWn1uZz8/PLaCF&#x2B;/CUMSR40aBAA4fS5TrVSoVcra&#x2B;kalUh4XF4nxXHlp&#x2B;dPLfrZz7GuLp6V0jvbxdgcA2GzOs&#x2B;eyMjPLhg3t3alTCABAQGD91n07dxz08/RRyuGUqaODAgN0JjRt/htd2gd&#x2B;&#x2B;PaS0NDAW/6OXNkeHABgMludTsZhs8tkEjcPOSWhMEAAhAAEN0wf3T0QQoIg1FTXZGZmWixWXm&#x2B;3nKi0nKoQHBymuL06wyEzL0UnVjNOojQz&#x2B;NyeTvoGtVeAafbS/ZSCPbyue86ZKImMgVjLjyACQEB&#x2B;r4kC4EGluKjYSTttVltKt5QbLvkLCH348&#x2B;6P1u0WBLTs0alTB3cL9PagWe75L3&#x2B;TkMSTk4d4u6nkUgpiEMcwm4NWyCQmm&#x2B;OJz9Y&#x2B;MrpfiK9XTIgfy3FtU4dCy&#x2B;zq24p8Nx65uO3EJamEqNdbBibFPTdthEZn8lDJ3ZRys82hkktd26vXm0pq6gmM6NY&#x2B;4vcyplzTtHrP6TB/z4dH9W0yWo5cytGZbPNH933nx20kib&#x2B;9YJJCKln28&#x2B;78irpnp49YsGzlwrH9Z4/ozbDcZ&#x2B;v355TVPjK6r6ebcmDXeABAUXX9oYs5aXnlEUE&#x2B;S&#x2B;eMAQCwPP/B6p3F1Q2fPDn92S9&#x2B;Hd6tQ9/OcXKp5Lvtx3edTn92&#x2B;oharSHY17Nea4wM9tFojUcuZn/7yiPuSkVFXdOjn6yeMaSHy11L5IHCaLXzvOAytTBa7dmlNSF&#x2B;nuFtGqYziitPZxY9NLwXzXCbjl3o1j6yY2SwjKLSCysuF5aH&#x2B;/u4qeStg25vBR4JAIGy2qaiak2XmLAgn6tKb&#x2B;&#x2B;ZjOOX8zleyK&#x2B;qSwgP6hAZXFLT8NXWI&#x2B;veetTPQz33/R8SY8NkEurhkX0&#x2B;/W3fnBG96poML8wadehCdr3etO1k&#x2B;qkrBW5Kube7MsBLnZZf&#x2B;eGSaQ&#x2B;P7lOnNUx982tfN9X2j54xWe2pWcWxIf4xIX4frdvDctyW42ntwwOfmzGCZpnzOSU7T2c&#x2B;On5AVKDvpNe&#x2B;SGof8fULDyvl0p/3pq7dd/qn1xcmRAT9Z&#x2B;2urrHhkwYkAwCOX87PKq2ZNbSHj7uqtsmAYdBLrSyra6xu0MtlVJBP82HkBaFOazRZHT7uKrmU&#x2B;hOzAoblCBxr0ltOZRcmx0WoFbJGo1lKkREBPsXV9VqjdeOxCwCA5c88BAD4YtPhE5fzAEC1WgOJk2/MGzeyZ6e8itoRz/533VuPxoT6BXp7rNpz8nRGYZ/Ocb8cPJsYG5oUG7Fq36lz2SULxvZ7d&#x2B;FkT7WirK7p8f&#x2B;uvZBT/O7CyU9PHeZk2Xd&#x2B;3HalqPKlh0bbHc4DF3NiQvwiAnz6dIo9mpbboDedyy0b17uLm0r&#x2B;/uqdT00ZNmNwd4gBBMD4V5Zb7Y4jXy79atvhlTtOLBrbf&#x2B;qg7goZ9dLXG46m5b0xb9ysYb1aS4Y4Xqhu1J3JKl767aYRPTqufHVB6xFACMx8&#x2B;2svtfLRCYPUCpmUIis02tK6Rl93dWyon4&#x2B;H2mV9WFmvzSiq&#x2B;vlA6qDk9k9MGnLdYSypbvhsw4GRPTqN65P44JVv/E1Qmz8xhJCAOAxi8A9q7jleYFmWoWmZTEpRf8XJlWE5p8NpdzJ2J0vbbU6H3WRnAwL84yKbOwe0RuuaX7Z/&#x2B;vWG0IjQD16aFx0exPO0UqnmePDlTzs/&#x2B;&#x2B;q3rgkhUAocECZ3iJs7cdTgnp0btKa3P1m19rfdmAMkxETOnj/F3Zt6/T9fucvcJwztm1NRqvRSfvLKoi&#x2B;/3r961/4t377RpVPEtePC&#x2B;crKpsy8ilPnM1iI3n1xXlV52Ypf99ntwogeiUOHpNTUa5d9uK2uturr5U8ndY07kXpp3caDFhMzsE/y6BGdQ0N9ALjWi/N3E3LrG021Gu3W7YeOnLj4wZtLhg3u7jrqCNxaFuGOQtO0y9C3qamJNzotJyssJyt4C4Mpb/sLVftYZr1wWOHuYBncbpHlX4g4vqlrUJR2&#x2B;ouH7BZp&#x2B;tH43LORTjtFkHzzC0QB8MBy&#x2B;fJlhJBapQ4JDbmu/wMhZLY5TDaHyWqPCvEHAtKZLVKSXL7x4L5zWfv/90JVoz63rIYiCIZhpw7pkVtWU1CleX/ltrSfP3j9200/7jj&#x2B;zpKpw7t1OJKet&#x2B;X4xdNfv55eVLFu/5k5I3r7e7kfuJDtoZBPH9Itu6wmxNcLxzGlTOJaZzLZHG4KmcXhXPzRqskDUqYMTHHtD8Nx1B2qPhQEgRcEHMcZlnOVKTtopsFgbjKYPdSKiAAf157YHfSlgrKKOm1iu/CEiGCe521Ouq1B&#x2B;oW80v&#x2B;s3TW5f8rckX0gAG&#x2B;u3JpXVrv1o6f/s3ZXaU3jqtcXIoSuFFXOeff7418v3XzswqELuS/PHkWzXFSQ7zPLf9l7NlO3/5udpy7/dujs/s9fuiMfTeSBguMFJ838uc/GbSGgP2sNZDneybAIIZ4XIAYziqs6RQV7qpUAgZW7T5TVNg1OjidwfMPhC7ll1RMHJidEBi967wcBw&#x2B;aM6sPzvM1BuyllBEaM6NmRIvDnV6zPKasdkNjOXSVLzSyJCfXrHh&#x2B;lN1sWjO3/7qodgd4eXz43GyFUVtf0yH9&#x2B;bBfu/&#x2B;rsMVNe&#x2B;yoswMtip33cVf0T25ltDpuTtjpoh5OZ1D/ph13HQ/193l0wQWuypmYW5pZrnp42NLO46lh6/kePTRUQWn/o/PJNB5&#x2B;bPmzGkB7XLQ1UN&#x2B;jMNqdcSj3x2dqzWSUh/p7PTx8xf0w/16Pvr9kBEHxh5ggAoFRCXsor/27HsZE9O00b1K3tRix2J4RAKZPaafrQ&#x2B;ZyiqvoQP8&#x2B;48ACW5bsnRJXUNPyw67jOaCMInOe56gb9pP4p8eEB3&#x2B;08Xt2gc1PIDRYrTbOe7qoF4/oPSopfsfnwj7tOySXUtMHdOkeFHDif1btzbGSQH8/zo17474wh3d9aMIlluQBvj7NZRS98tf6t&#x2B;RP9PFQvfbNx3sg&#x2B;Q7t1iA8PrNRo3/xxq0Im7dUhunenmMiW9qe0/PK0woojl3JKquvd1QqnkzFa7bwgkCThcDIRgb6rX1u4/VTarlNXXps/LikuQmeyltQ2vL1yW0p8xNsLJ1ZptFYHve7AGQLDPnlyhkxC6c22PWeuHEvLD/R2ax8ZdOhCNkkSb8wbj0FMJiULKzQV9U2hft6xof6B3h4EjgmCoDPbCBzDMYwiCQlFihrh7nIrcc4NfvF5gKAAMZ3Rum79No1GH&#x2B;UXwiFnndGYmpbb2NC06KHxLzw5GwDAcLzd7nAy7M/rNgJemD51rK&#x2B;fX1FpdW21hqNZrZFu0NNOh55lrZCQDh/et19yu5Opma999t2cyUOWzJ7s2kUA4OVLOS8t/dDB88s/f7tbl/iLF7K/Wr3BiUvGDh988tCh7buOTZg86qGpQzfsPr9yzZan543/dc/BuZMnvPT4TD9v9Rdf//zDLzseXTzj2QXTmxq1yz//ISW5Q3h01MXMwvaxEX16JJ69dPnMxcw5k0e7eXhcuJy/90jGlfSyiSM6LHykD45JMgoa7UZ7aFR4gLdacnWmvoAEB8DkzX2zEAIAGrWmujotxzISCeXp7e7j6UZRBM/zgoAIAr/dfD5N01arNSc7p7q6WrBx1uPlllMVvIn&#x2B;C6E/AIBhyJHzznTpX8LSOIQIQFCeHXj5aLvg2MbwhDq1p7221OfklkRDg5qUcM2vQQDxyP&#x2B;1vtMfny2Xy/908/82/v0CwG63F&#x2B;QXUBRFEARJEgRBEgQBAKirq9PpdCndUpRK5Q3t31iOX7s/9esthxdNGNi9fRSBYfvOZa7dd/q9hVP8vFTPfP7LpAEpPh6qyCC/PWcyerSPOnQpu2tUiICBX/afS1/zHsvzGIAf/rz7THZx&#x2B;/CAwqrGTR88UVLT4OWmVMmlJ68ULv541bZlT/24&#x2B;&#x2B;QTk4cGeLnRLPvYJ2s6xoQsGT/onZ92lNY1/Lh0QaPevHzTwQVj&#x2B;g/o2u5ibtnGw&#x2B;ffXzJFJZMcTc/3VCujgn3dFLLSmgaZlArw8pC1jONgWA4hgSJJcG2OgRcEV3Bzp0puWI7XW2wmi93HQ&#x2B;2hav7NySuvbR8RBADgeD6ntDYswFutkJ7LKunZKVprtPh5un299cju1CuTBiZbbM5JA5IjAnxciXiG473UivunElFE5Bb5M/upNvCCwPM8wwkYhBzPZ5VWS0jSU60wWu3nc0o6RIX07xL39dYjl/LL1ryxGADQaDA//8Wv5fVNR75Yml1WPf3Nr5VSyYgeHS12ZseptMSYsKenDavXmzJLqn85kLpkwsC5o/pqtEZ/LzeVXOakmSOX8h777&#x2B;qYYL&#x2B;4sAB3hTyjpKpzdOgz04b5eqpDfL1cu1Ra27hm7ym1UrHnzJXUjKKDn7/II/DYJ6vnj&#x2B;n35vzxLMftOHV5wYc/DegcixNEoI87SRAEhg1Obp9TUefrrnpoWE9XUQ3NchdzSxd/vBrH8XVvPdopKhjHsfSCitX7Tg9JTpjQr&#x2B;vBC9mHL&#x2B;Y8OmlQhL8PxwtWu4NmuUaDBYOgU0xI2wXHVg2m0RqPXMprHx7o66nGMKjRGmJDA0pqGw9fzLlcUAEAqNMb1TLpk1OGjuzZCQDQ89H3x/Xq/PS04VIJiWPYhFe/UCukM4b0jA72jW2xHk8vKD95paBCo&#x2B;ME/rkZw2OCm&#x2B;83Wmybj1/8bvvxN&#x2B;ePV8ll7/60beaQXsO6dwgL8CZw7HxOya7UKwSOC0iICvItrq630cyj4wcWVtZ/sHbniB4d/7N4KkKoXKOd&#x2B;/73dpo5&#x2B;NmL3&#x2B;04ceRS9orn50QE&#x2B;VbX63amXl6&#x2B;8eAnT8yYPDDlRHqezmxzMixFELVNeruTeXzS4GDf&#x2B;3Qe7gMMalPL9Ce/3q5ymmY5bbfZaCctk8ult9NOihBASIAQchzf2Kg1ma2BQf7uamW9RtvYpPUN9K2o1edkl1r1TTqjtlijpTBllI9nQ53GItAaJy9XewlWp7mx2mbTckDm5x9qsVprKitDwyLlElhWkOPh47Hw8XmhQYG7DhwL8XCLiArdd&#x2B;py946xowZ2W/vrwc07Tj719DST2bR9&#x2B;9mPX58/cHDyL1v3bNxyeMLoIQtmjwWIAwhzdS9czipMyyxEgCwqrj5y&#x2B;GhERPjo0QP7du/o7aHIKyrfc&#x2B;CUj7vkpeceBQAKgMcABoCAAF9Q2ZR6JkuvqYuLiw6JDEuICZGSOACA5ThtY2NlZVVFRQVnoS0nyi2nKjmdHVP99aluPIvNeOlwUEyj3SxTuDkwHFmN0poif0EATpukU9&#x2B;ShgqvfWt66urcrhUAgv9r/aY9NluhEAXAvwu9Xr9/3347JBkEcQgwgVdISG&#x2B;1snef3kql8qYvF5CgNVplkmuS5g0Gc0VdU4ivh7eHW25pTWldY7i/V5e48Oc/&#x2B;1mpki2dMz6nvPbLzYfCA3w&#x2B;XDJl6LMfh/p5PT1leLmm6ZVvNry/eAqBYVuOX&#x2B;wYFRIZ5COXSAoqNXIpmVdeO3t4b63J9s5P2w5&#x2B;/rK3u3LVnlPvrtpuMNunDU45lVn44oyR/p7uF/LLQvw8y2ubfDxUQT6eBrNty/GL7SMCX35ozNs/ba1q0H&#x2B;wcLJaJXvnp&#x2B;0hPp7/e&#x2B;ah9UfOHTyfs3j8gMggnxNp&#x2B;XqLbeG4AUar3WCx&#x2B;bqrCJJUtVgQWO1OpeszIkCzrIQiHTQr&#x2B;92Mvz9fIv0jaJYf/PSyAE/3z555SCmVGCy21qEuToatbTKE&#x2B;nnehekKIiL/n2jbivc7UYEEBOxOBoeQ5rgmg5nA8YhAnyajeduJdF8Ptb&#x2B;XW3F1/fHL&#x2B;V1jwwUkbDp6cUSPjnFhAXtSMzYdOR8R5Lf9w2cCfNzdFDIAQGW97pnP13WKCZ05rOe6facRADTD2xzO3w6fs5ptCyYO&#x2B;ujxafnldeNe/t&#x2B;m/zw1OCnB1aNfrzclzHo1Otjv8Bcvq6&#x2B;9UjoY9qO1ey4VlnupFQCAcH&#x2B;vZ2eMdP27XNM08ZXlOIH7eqijgnwDfTwkBD6pf4qru6ktDMev3nvqu21H3VUKThAGdm339vyJrtzOrwfPZpVWPzZxkL&#x2B;Xu5PmGI5lOZ5mWamErNDoPFRyjuOjg/0yS6oCvT2DfDxwDFrtTobjPVSKtodx5&#x2B;n0r7YemTm05yOj&#x2B;7XeeeJywdJvNw7r3vHdhZN0Juv7q3eu3Xc6yM9LJZdISfLJKUO7xoSlFZafzCgsqKjlBfT1i3ObjNapr6&#x2B;IDwv84rmHvNQqq5P&#x2B;9cDZA&#x2B;ez31owDgPw/bU7FowdMK5PV3elTEKRNgdNEvj2U5fT8sp8PdRF1Rp3peLZGSOC2xSeifyrQb&#x2B;7eVfK6xmGpRnW4WCsdgdNMwyLLBar02JsNBoplfvIAT1r6&#x2B;uGznjaTSZ/&#x2B;6UFvt7eG7cfK82vUcuVaXW1cqfNU6awACwszHfB7JGd2kVKSNLPr3mlYOe&#x2B;E6dSs/0CfIsqyzX1hhCfwHPnT/Xv3&#x2B;nh2TN1WuNnn6/18fV&#x2B;8ak5dTW1q9Zue/b5h9vHRr739lqpjHzqmTFBgaGXsyqeff17k67&#x2B;44&#x2B;eDA/y0jVppRQJgFBaVOSw2O2nqy0nK9hGG/43Qn8AAALQP1Q35dnjOM4VXApXe9mCYxsEHreapJV5/uU5QWMePd1U7bF/TS9ttTtBXS0BEgXAvxa9Xn9g/4G4jp0YluNZxkOpiIiMuIOJHtc1u/XKzXIcBrHWggSEEM1wZrvDx0PlWuViWL5c01TVqOvePpJmuKzSqvJa7ejenSGAr3&#x2B;/edawXoOT2/da/N7YPokLxvTX6Ixz3/9erVCsfm3BLwdTqxoMM4b1CPb2kEqpzUcv&#x2B;nmq8yvq4kIDdp5ML6ypD/J2b9CbKYqw2JyvzxtXXF1frzMte3ya1eb0clN&#x2B;vfXIgXNZUwd1c7KcSi4trql/edYoJ8M1GS3vrNrep2PMlIEpc979/tmZw/t3abdy14kjl3KPfPFK2wmY6w&#x2B;d69&#x2B;1vZwi3NUKu5NmWB7HMYrAJRQJALA5aAlF0CzXdii7IAiudIO4ri8icj&#x2B;AABAEgWH53LIaBEDXuLC2Ha7f7zqRX173/MzhS7/dVKc1juvT1WJ3GMzW1MySck3Tf5&#x2B;cMXVQt&#x2B;UbDxZWN7w5b5xCRn22fr/dyfTtHBsR6Ovn6aYzWSiCOJdX8ukv&#x2B;z9aMnVIt4ShT388IKndczNGeigVGAbNNkeT0WyxO8P9fdrOTnXRoDcZLPbtp9IvF1Zsev8J10nj14Nn57/0P0WgDwZhSrvI2FD/od0SxvZutvyrqNcuXPZjQXVD56jgqGDfZY9OU/7OVPFcTvFnvx0Y1zdx7sg&#x2B;AIANR8//fCB14ZiBk/onXcgthRC6qxQsx1vsDoPZBgDAcKxH&#x2B;0iKJOxOxuJwerupXNs8m1Ny4FwWy3HtwgNMVkd5XRPD8fU6I8NwBI51S4haOndsXZPhrR&#x2B;3bTl2MTTASy6RCDyaPbLXwnEDLhdW/HbwXJeYUHeVYtKAJHFskchf589jNgj&#x2B;KF/BsnRqWvbxMxccDK43WK0WS6C3ekj/lJFD&#x2B;2EAXLqQvmv7wR49krr36aZ2U7ku/Tabc&#x2B;eBM9t3H5KQMDoyauK4oWp3atP2w4ZaTiVBTYaSPDOgkFwOrCaLzcFIeIBqGxtkEjLEnTLW22wMntAlKiDCT2&#x2B;zFl8p09cbJkwc1LVTUG1NFeJYXw83&#x2B;9kay/Fyps6CqyR/v&#x2B;1A4LGoxOpxi09Z9Mpd3/eN7lydNKSAoHiBx4ozQpxmabvuFSa9/PjG5JoiX4LgWxvUWwTAQwqF4ibv8e/i3y8AdDrdwQMHCYKgGUapUPj5&#x2B;ZMkgeG4hKIoiqIkFElSFEVSFEUQJEkSBEH8vnH2LtF2wc9sc6gVMgCA3cngOIZDSBC42e6QEgRFkQaLTSGTCoKA4xjNsBa7s6iqoX14oMsWoGdC9ORByRnFlR/&#x2B;vGfuyN6je3UZ9NTHgT5uHz82Pbu05tVvN04d3P3hEb2f&#x2B;t86pVzap1OMn6ebyeqwOxmaYzcePv/LO48JvPDKNxuPpOXSLDd9SI9lS6YIAgptUf&#x2B;r9pykWd5ssT08pr&#x2B;nWrH9RJq3u/KNbzcd/PLVWe98iwTh/cVTIIATX/vyy2dnj&#x2B;ub&#x2B;N/f9rMcP39MXylFfLPtaICXx7RB3W7qdiwiInI/s/1k&#x2B;gdrd/64dIGHUuHjoYIAHEvLq2rS&#x2B;Xqo3ZUKmmYPXsiu0xpfnTs2uV34hz/vXrXn1IgenXw91HaaARCarbYBifFj&#x2B;yS2WqZojZaLeWUMz9kctMliv5hfdiGvdO0bi7u1j9LojASOuyvlJIGzLIcgKKlunPfBD0ar/dDyl13jUC1255ebD/XoELX7dMbyZx9qu6sCQq4Gp60n0t5aucXmYJLbRcgkpLtKMa5vV73ZuutEGqKZixUaLzf5B4un&#x2B;Hu5hfv73LA3&#x2B;nxe6UsrNswZ0Wvx&#x2B;IEAgNzymk1HL3mpFU9PG&#x2B;Z6AsfzNicjl1J2By2hSNenYzne5qSdNCuTUm4KmclqzymrjQz2Tc0sjAzwSYwLfxBGDIvcB7Sdv/RHDg8ICABgEAAeAAQQLiAgIBYCgBBRW9&#x2B;UnVvk7&#x2B;uRnJhwi3YENMM6HU6GZq12mma5mjrNngPHdTUaCUVhUkXPlBi1lDBcrDLsLmSqzbiKuqUCyltA4LGug/P6Tsw0NqoO/txTJmd6jsv2DtJLFYxJq9Rr3L0CTDwHTm9PzLsQgRM8bBUAnOD/er&#x2B;pSx5SKkUB8O9Cr9cfPHCwT58&#x2B;gUGBHMexLMswDMuwNEPTNEM7nTTD0E6aZmiGZlwPchwnCAJCiGjRBBRFURRJkiRFSUiKdIkHsuUPkqRcyoG4V0UsrZWJAkIIIZ5HJIG1agmeF2iWczKMXCJx&#x2B;XS6npZeUG62O4ckJ9Q06U9nFBos9scnDX5v9c688pqPHpvurpJ/v&#x2B;N4TYPuo8entwbrV4rKp735zbyRfVLiI508v&#x2B;a3fa8&#x2B;Mf2lFRvH9uz48NgB&#x2B;85l/LjzZGpablCw7w&#x2B;vPNIjIar/Ex9a7A53hYwkcG93lYNhQ3w8R/XqMrZPF&#x2B;UDZrEhIvLvAyGEALhp8MoLwnWjMxFAAo8EhAi8&#x2B;UzFI2SzO4uq6vUWa3WjPr2g3N/TLSEyyNfDTSGTfrxu75XCihnDeni7q46l5V3KK392&#x2B;rD5Y/puPZZeUd8kIfFL&#x2B;eUUhZfUNj4zddiCMQPa7pHBYksvqJz7/nczh/d6Z/4EhUwiCOibrUfe/Wn74gkDP3xsGgAgq7jyxPlsT1&#x2B;vjKKKLzcfigjy/eLph0b07HTtPoNdp9Kf&#x2B;vyXmgZdr04xE/olje/bNSbE32R1VDfqzueW1jTqBycnsByXU17DckJOSVVSfOQTk4fYHE65hEIA1jToa7WGYB8PluNWbDlMEsSIHp1iQvwCvd31ZhvH8SqFlCIJkiBch5TnBQAAhsHbTZlqTRZBQN5uSgzDBAHdrq2KiMjvQAjdLHX/J9EjBADwADRHRLVVNamp581Wo1IqtWU3GHcX0RVGXEmBO/SDihAECCCAZr5yyD9UX3gpTKJgVB52QYBIwELiGhwWic0kwymeknJntndOPxaH4cJVAcAK/m&#x2B;IAuDfSKsACAm93oTrFkEIXVUOLMvQDO2CYWgn7aSdLMPQNMtyDMdyPM8LgoBhWItycMkGl4CgKAkloSiSar2HdD2NJG9sKHbHua5gyQXH8Swv/L7cHyFUpzM16UwhAV4yiqxpMhSXVnfrEsfywtvfbRrdJ2lkz04lNY0/7j35xKTBNQ36xz9b&#x2B;9TkoeP6dj10KfelFb/NHt5n0bj&#x2B;vp7qG7pKiYiIPMjc1DXqOjgeQYCcLKs3W&#x2B;1OprJey7BcWICP3UGHB3j7eqhbz2lHLuW&#x2B;s3JbkK9H/67xNM1uOHKe4/n/LJnSoDcvW7s7Jsx/yoBuFIHnlNcCJIzrm5RVUkVg2LzRfTEMExCq15mMVruXWuGulEsoUhAQQojh&#x2B;Gmvr9BbrB88OjW7tEYtl4X4emaVVvVPjI8N9d93LiM1qyintGZCv6SRPTsvXPajIKC1by3GMGhz0DPf&#x2B;o5m6M3LnmrUWdYeOD19cI8xvbs4aHZ36pUTV/LH9ukyskfnrJKqep1ZpZAopFIEgNluL6pq&#x2B;PDnXR2jQt5&#x2B;ZGKXmFAAwNns4tyymvjwIILAeV7o0SEKx7ByTVNGcWVpTaPV4VwycZBKLnv049Up8RGzhvb08VDfhe9NROQWQQBAnuNLy0qrq6p1jVprQYNha76zVH8HQ38AAEJAEDBKwkZ1qe09JtPN29pY5RUQ2WQ1yc16uUWnDIhoUnvZGZrACR4J2KltXdIOx&#x2B;OEcHULjCgA/qX8fQHwd&#x2B;A4juM4pjm1wDidNMMwtNPJMIyzWUQwLMOyLMvzHM8LEEKXHiBJgiBJCSUhKdJVpURJmsuVWpIRJEmQBEnc0LjgruIy0WZZXkISba/hdpqmGU6tkP2Rb46IiIjIPwJCiOOFRoPJ6mDkUsrJsKU1DVqjpXtCVEzLjCAAAMPxvxxIfWfV9riQgIFJ7ZUyaWFV3bYTaZ2jQz9&#x2B;fLpSLv143d5Ve08OSkpYMnFgk8FcpzUmRAZX1msr6rXd4iPe&#x2B;2nH6F6JHyyeTBAYw3A7Ui&#x2B;//sPWdW8sqm40bDlxkcQJvdkWEejTKTrEZqdxHDpoluW4ztGhF3JLTmcVPTZpSK&#x2B;OMXVNxg/X7XLQ9Irn5gb5euIQfr7pwJheiZ2iQoxW&#x2B;8e/7LmYV/b2IxO7J0T9evBsVYPO7qQHdI2PCw0IC/ThOF5GkhIJgRCorNc26E1SivL1VHupFTLJH85VdJlOQgiCfDwBAudyS05lFMgk1KCk9omxYffk&#x2B;xH5F1JWVlZYUGQ0GOz5jcY9Rc4CLaYg4R01zkMI4lAIjGvs0L0sMForcDgAgtMhsRilEEGIAYCQh7/Z098MAEAC5Dns6PqU7DPRV30AXALg9b5TH3voVgbD/JsQBcB9Cs/zvy9YYmjGSTtpJ824YBmWYTmOFQQkCAKO4wRJUCRJkCRFtuQZSJKSSFoSEBRFUQRJkmRzaZPYmysiIiJyUwQBQQgghBqdsbbJIJdSEpIoqqovq2vqHBPap1NsbZPhg7W7CAwbnJJQWKnZcSItK69kwdThXz43&#x2B;/jl/Iff/wGH2Pj&#x2B;iQDAXaevqOXSJRMHQQyU1jbhEEIIX5492l0pP5qW98POYzmlNT8uXZAcH5ldVvPK1xtyymuDfTx7JEQ5GLa4SjM4OaFzTEhJTaPebFPJpaH&#x2B;Xj7uKobhXlix/v0lUzqGB4568X8dI4PfmD8hISKwqkG/4MOfogJ9vnphjvoPJpwghA5dynn6818a9aaVrz4yvHsnlVyqN9s2Hrmo0RsXj&#x2B;snl0gsDjrMv7klzGR1OGja213lamV2MiyOYSSBAwA4XhCQgGPYTdeAGg3mM1nFfbvEebkpxYvQvw&#x2B;Npi4/v7CxvsFe0Gg&#x2B;Vm5Lq8PkJCTu8MqgIECpnIlOrEkaku8Xpq8v9fLws2jKvXLORpfmBE147ETBxYjIDjV5FyJ7jsnyCTLhFK&#x2B;rU&#x2B;38bkBDuRfeVgCwvP9r/aYseUilEgXAv4v/pwLgL3PDgiWGYWiGoZ1OJ00zrhssw7M8x3OucqBWk4SWBAPV3OrQmnUgSZJyiQuSJMl71ictIiIictsgAMCtuTPcE5wMSzMcxADPCw16M8fxsWH&#x2B;Rot995mMDpFB3dtHAQAu5JZ&#x2B;vvGAjKLmje6bX1G3/vA5i9Mxb2T/RoNp/aHzZRW1/bp1eGX26KLqho3HLni7qcb27hLs45VdWmW2O9qFBVgd9KvfbAzx8&#x2B;7WPspsdzgcTpmE8lArRnbv1C&#x2B;xnaeb8k86N77beezk5UKX/ROOYQ8N6zkoOQEAcPhS7sJlP761YMKCMf11JsuCZT9Z7I6pg7rNG9UXx7Af95zqGBXs7&#x2B;V&#x2B;KqMwNsS/T6eYWq2xoLLObLWH&#x2B;nknRAa1dnvbabqiTgsACPTxKKpq2H82Qy6jwvy9&#x2B;3aO8/FQWx1OCKCEIggcwzH8vvnSRG4bjuPMJvOVK1cam5ocxVrzoVJ7eh2UkpC88wGDIGA4wScOLOzct9gr0AQQLMkKju5cc/lY3KYVQ0fPTfXwM1flB/iEGI6uT&#x2B;42PC8msSowWpt/Ifzguh6Iu8brGDG8/&#x2B;uiAPg38qAJgL&#x2B;DSzmwLOfKOzB0s2ygaZqhGZd4YF3P&#x2B;OM&#x2B;abJ5uhJFUiR5TbMDSZIkjt&#x2B;2U6CIiIjIH4NYjtU2GASEIQQ9vdVSKY4BCBC8g3XG/ywcLzhplhN4d6XcandmFFet2X/GYLLMGdHbYLHNH9NPZ7K8t3qnyeaY0DeJ4bmjl3JzSqp/XLogPiKo7XY2Hruw5/TlJyYPbRce9Nlv&#x2B;8s1TQMS28WE&#x2B;Pp7uQMADGab2e5YvuGgXCr58vk5OaU1H6/bPbJn5zJNk8Fke3H2yJe&#x2B;3hgT4q&#x2B;SSe1O&#x2B;vFJg3advnIxrywy2PdEer6bUvGfR6eo5BKrw/nCivUeatWGdx9bufPE5xsPPDdj&#x2B;NRB3dyVim0n0pb9vKtH&#x2B;6hHxvYvqWl00PToXp0DvD20Rkt6YXlxdWPfLnFd48KdNGOnGZPVjhDyUivL6rTuSpmEJAN93F15BpH7EJZlTSZTUWFhRUUlXWE0Hyi2Xa6HJAapu/KVIQTcfax9Jl4JjW2SyBkIkaFJoW9wC49rXLdsOI6jkY&#x2B;kHvq5Z9dh&#x2B;ZcPx9eVeqs97MFxDd5BxryLEQbN9b0xD6wAEK2XRK7iGmQkk932CwVBYFtgXAOVGJahaYvZ4qRdTdMu5cCwLCcIAhIQxOB1fdKuIUvNg5Xa6AbX3/dyPKuIiMh9TsskAx4AHIfYpYxMmUQxcEBPgsAA4AFyjTUETdomQQDeXp5/s1fKYLJAhFRKBYZDCDEAAEICAAKE2F0ydWoLgWNKuQQhlFNWa7bZO0aHvP3I&#x2B;JLqhr6dYwkCBwB4uam&#x2B;eHZ26/OnDex23Ra&#x2B;3Hxo&#x2B;4n0D5dMe3P&#x2B;RG93lUxC9uoUpVZIZRLS5mAKqjQlVfVH0/J6dYrZ89kLGIT7z2e98Pm6&#x2B;gbd0B4dv3h2dnZp9VOfrT2besVj4pBHxw/UaA0analOZ0wvrKhq0CW1C9doTUs&#x2B;Wd0pKtRTLf/qhbn7zmSmLHz7P4unFm/61JUHeGvltvO5JYvGDZBS1O7UDJrlDpzPqmzQJcWFy6VUaW3j4YvZAhC81Iqvth39dtuReaP6Lp0zxk4zm46eW7Mvde9nL4b4i2bJ9yM8x1tt1pLikoKCAmeDxbK90H5FAwkcU1w/VuQOwjJ45/7FsYnVEAM2k6Sm2P/KsbikIfk2q8SiVw6acbEyP0CncVe5OWuKfTEMmQ2K/AsROME7bJRUzt5wm//61fDfI2YARP5JEEKufIKrZsklHRiGoWnaNaHVdcM1m7Vtn7RLORAk2drecHXWkqRVOVBky3zWf/qDioiI3BkQACzDFJTWjZu1NCUxftTwfu9/uXLr1y93aB&#x2B;/4vvt7l7yR2aNdT1z3ZbjOVk5k8f0joiMqKzUhAf7KlSkyWxXKdwkUglB4gAABBBsNQS60VwircFUUFSz/2BqTk7ptCmDSorqaIdz0YLxEZFBAAh/Hv1fzsz19HAPCQrQ6vVSGaVWKCEAAkAAQMz1XreZDhUExPE8jl31mrxFEAIOmpGQxK288LpBoshV2mF1mm12iGGh/l4YhHqzbe/ZDCfDdYwM5pBwKbesrK7x0fEDO0QFf7n50PKNB6cN6h7k45lfWbv56HmDwfLxMw9NGZhyKqPwte826y22KQNSFFLJmewiO81M6p8SGejj5aao0Ggv5JXOH91/VM9OCKG88tpXv93kplK8u2BisI&#x2B;HhLqLAaXIX0Ov09fW1hYVFZuqmyw7Cm3pGohDKLm7F1yEoExFT3zihG&#x2B;IHiBQmRdw6NfuxkbV7KUHnA6yodLLL1S38/t&#x2B;XQcWuflYDq/rTko5JECXIwKG3yDmdWUAJj86U61&#x2B;sAZniQJA5P8rVwuWWOaqeGgZ0dpq7MCyHMdxPM8jhFr7pEmy&#x2B;Y&#x2B;rfdLNKqK1WIm6x65wIiIitwIvCFVVdWXlGi8vj4PnrxzadcoJOAxg77&#x2B;&#x2B;pLK4YvvuM4CUjxvdjSDgyrUHTAbbq8/PSuoSs2P74aDQQBZxr737bUhErL&#x2B;PW21V2ZZVnwQGKVesXA8p9xcWT37/k7XTxw8O9Ja9&#x2B;tnaycP7pHTt8NvO0xaTbu&#x2B;xrKhA32HDeq/asPOlx6cM6t0VIAFBrL7JkJtRJDBc736JCpUcAcDzvKs1Ni2zOPV8vsNhqqnSJid3TruYYbPbXn1&#x2B;TmRkEEmQAN4/7Ql3HUFATobFMCilSJ3ZmltWS&#x2B;CYv5e71e7Ir6jTmqyPTx5iczgXf7JmWHLCvNF9AQAGi3X5xoOr9qSWbPoUxzHijs6NEbkjGI3GhobGgrx8XW2j/VC55XgFggCT3ou1Np7DVB72sUtO&#x2B;4fqcJI36xSXDiU4LJKBM9Jyz0aFt687uKZXfbXHtOeOnNvTsarQjyCFP98gojn/1/tPXiIKgH8dogAQuY7WCUuugiXGlXtoGctK03SrsYOrT9pl7NC2T5psUQutdUttxMO9doUTEXlg0VRXZucUGw2sXCUZOKgnQeB6valJb4UYLCguy7iSf&#x2B;xcdkZp7bCBPeZO7F9WUppTVEXJ5QVltVaD0U&#x2B;p4jkBYlKL04EwpFbIa8p17TtES0hm664jvVOSX375kePnrhTnFsydOfrXnccWzx4zpF9XAIDJYCQlUplMYrY5LmYUb9h05EJa/rwZg158ehYAIKew5Ivv9/bs1fXQ/osD&#x2B;ifxdvuxcxfeeeXhbb8esToZQ5N1zsIx/ft1cO0/L3AYhrE0XVNVbTCzSUkJ131AdB91Mt8jEBIAuG0rNJF7ht1uLysrq6qqbqrUWI&#x2B;Vmw&#x2B;VIgFhsnuXn&#x2B;E5TK6iRz1yJjimiZSwCGKmJoWhXhXSrr6x0qu6xPfob918g/XjFp/esmKgwyqF8CZRruDkAt54EAWAGKOIPHDgOI7juEQiud0Xtk5Yah3P6mqMtlitrbOWaIZmGZblWJ7j2/ZJX80sNOcarilbIqlrlIOYdhARuRUCQsICQloH1QsIoIAAr4AAHwBAbGRA/x4dR43olVFUodGaL13J9VVJn5w7LiWl8&#x2B;&#x2B;3Q9Osw0k7HAzNsCaL9dnHptocfEio//ABD&#x2B;89eNZmcWz64S0AgMPJpmcWfvrlrzwPF80bo8Csep2&#x2B;fVzA5cyi1av3nr2Y1SkhZuSgnj1T4gWeUaiI5577&#x2B;KVn53736UvpGVdIb9WsYd0TEyJNJsv8RW8fOJn2/ptLFs4ZCwCoaTAu/XSTwIPpk4zlFeWRof6NZltsROTgXh0hBHV1GoBj7io1QzMyiYSUEhiGAwAFADDEAvi7wMslGhAA8HbN1m6I4CqOEhDEIESABwhBSACAAECuCiiEEITgTrwXAAC4WixE7kNYlq0or6iorKwrqbJf1hi35CFWwOTkPdZqEAKWwUsyg2Uq2jfYAAFSe9hoB8kypMMqOb4xCSf49t3LGms9tTUeKk8bQre0g//2xfAbIGYARETuBddZwrn&#x2B;d/U5uIwdaJpmOZedNCsIQrOxQ4srXGtLA9l2wlLzvFaKaPGFu/eucCIi9wGuqxi8NXth1FLuf1txiwAA1qC1fPDp2sqqxr49OyjV0rpGvd1mHdIvqX/PRKvNYbVZEUKBfj4yuSyvsOJ8er4UIz7777c2zPOxxSP6pSSEhQYXV9Q8t&#x2B;yndsFBvdqF7j9xplpn6ZGUMn1M38hwz237zm/dcaK4strI0larNTk2fvL4/nGxQTt2HGJwmNIlIe1cbpeOET36Jn3xzQ67wfzjVy8EhfjnFlWGBPiqVdeMbkBIaA7&#x2B;rw2mEQBA4CGGAQAFxGMACgCDAEAIEOIhxFzHhGPZWk0jQriPj5dCTjIOtrpBl5aZ//X3m7f98qG3p1tr88Oy/60OCfKfM30kAMBJM5XVTQaDgeOZAF&#x2B;v8PCQv&#x2B;cIeUfUi8gdo6y0vLSstKlaYzpXZdpWIDi5u9rm&#x2B;ycgBFgnSSmYdikVXfqUuPtZ5Era0KS0mWQ8j185Flt8JWTi4ycrCvwv7E&#x2B;QKZibbtCVAZi4eIa7u9s92P/7B1EAiIjc17gKljiOa7WEcxUsMSxLO13NDrRrOivHcTzH8wJ/wz7pVm&#x2B;HVvHgcoWjqOa8g5hzF/nX0yIUbuMFPAIQAghdq4g3fGmromiNWa8&#x2B;bc&#x2B;uzefydJomqxxDwwb1GdovSaZoduStb9K&#x2B;9eGXK9fv8/EMbR8ZGRrg3rN7l44dIhv0eoFhEC1U1msZnrfqzTwkbU6GMdONNvOIUV0fmzl22/bU5Ss2z583ZvasQTigMULucDhXfPXrlIkjIqOvjv4sLqzIKatUq9WBPp4KhVQuk&#x2B;XklK79bW9CQuSLT83iBI7ACAAA7WQkUrJJa9i046ibu2f/Xl3MukajyeEXEGJn7Dm5Nf/7fvNn7y/q3yOhNfR//f3vzTTZuV3wqfPp7v7ei2aOig32LSvXlNVV6wy6QC/vvj2TJRLK4XBarXalUi6TSf/8SDfp9Dt2H4uPi&#x2B;zTM7Hli7pl/YAAQMg19&#x2B;nCpRyFnIqOCpVKb/KOIreIpq6uqLikvrLWeK7CdLCUq7diyj90lb5XQNpOklI2IqEuvkd5YIROpnRKZCzLEnaTrOhySFTHml8&#x2B;HMlxGLiF5X/BwQW82X/i4unu7u53f8/vI0QBICLy7&#x2B;T3BUuuDgemxQyurbEDz/OtfdKunAPRaupwNe/QknVontDabAEhph1EHhh&#x2B;f7mEbR76fajBA3DNbwdyFcyAtiUzgsPpdDhYnucVSplcehtjmHmex3CM54TcnMq1G/ev23nYzUMVFRkYEugT5OWV1LGd2WjafuxCg04v4RhOwEKjw6dNGDB2QAoQGAR5lqd6j35izoQRTy2ZACFgWW7LzmMffLG5fXz0Oy/MAQidP5eTV91AY5av3ngCAACQwPHCodSL73&#x2B;45ZUX5owa2Jkisefe&#x2B;PLL1Tv/t&#x2B;yZZx4e59qry2kF3l7K0IjgkpLaoqLSM&#x2B;cuBQX5jhszJCDAD8cgAAJoSTVkZGSr3NV&#x2B;Ht7Lv92u0TYRuDCgT/LEsf1dIxkdNqfZ4iAIXC6XyuTUH6xQXNV0ly4XVlRoDh0&#x2B;4e&#x2B;nXrxgakiIeMX/u&#x2B;j1&#x2B;owrmU2NTcbUMvPBUrbOch&#x2B;E/s0gBDkWFzjoFWzq0rfE09/kH6FVe9ppmoA8KM4O2bp8kFzlvJVNiQLgX4soAEREbperBUssw7Jss2RoGczqqllqa&#x2B;xwwz5pV5N0c6tDGzEhusKJiAAA/iAhIQD0J0OCeAAAANi1wgMwDK/VGXQmc71Wr9NbrHaaZwRfT/fu3dsH&#x2B;ngAAHJy8gicahcfDQBAAhIAwjBoZ9Dan/ecO3OZ55i4dlGTpgztEBt66ER6bmF5r&#x2B;TOTU3m7Jzc116aCwAASAAAAIh9&#x2B;f2&#x2B;ffuOW&#x2B;x6hCEeUeNHDmoX67t9T2qTxtktKVLmIWOt8Mj&#x2B;s/4h8qmTR21YfyTI3/vVpXPyC0p3bDs8alSfkSP7AgBop23Nr7ve&#x2B;fKXd555xKizbzxwZsqofl06Ro8a1g0AoDdaPd2Vdju9&#x2B;bfDBbk1HAJ&#x2B;vl5jx3WLiQ/G/mCtobCs8pdNJ2mLJTjQb/LEPkGB/lYHU1lVq5BJQoL8xBWK24XnebPZXFBQUFleaT5baT5SxlSaMNX9Evq3AjGAeGA1ylWetqAobUB0U0yXSooSpErn0fXdiy6H3LT914VLAExYNN3Dw/0u7/L9hSgARERE7hjXFSy1GDm4OqTp5pwDw7Asx7Isz3OCgNr6SbdpdSBbx7OSFHmddBD7pEUePH6vFhAA4GqFwx9IBgQEeLWWRgAuj2TQ3CLM8bzDQVvMNp4X1G4qN7X8FveG43mng&#x2B;EFRBF4Vk7J4QNnDUaDf5i/n28QhWN1Bv2ltAIJgWnq9QQlmTlt0KB&#x2B;nRRSqUwizS&#x2B;pnvfcZ8G&#x2B;ypSO0cdPXpk/a1RUXESv5PY5xSXrtx&#x2B;trzaqlKr49kGAwTauPzJiSMLcBeNIQvbI/Hdnzh0pAdJDe88uXDQKyiVPPvu/GaO7P/PC/CUvfaXAKd8A9wE94rt37&#x2B;javfzy&#x2B;q9/2GA1NX7y7rO&#x2B;Pr6IFwDWPFmouqamtKiRYYCXlzIuLlCp/iPz19tuQuA55sz5jMAAP/8AP4vFimPA09OdwAmEeAQABrH7v6uB53mn01lYUFiQX2ArbDSsy2Ybbfh9s&#x2B;p/QyBELENAKFByNji6iaR4kmKzTseQEu4WtyA42IA3&#x2B;k9YPEMUAP82RAEgInL/01KwxLlyDgzD0s15h&#x2B;aeB5pl2hg7sIKAWvukW5RDyxjW5laH1lFL1ygHcTyryANDq2Zovcr/URXN73TFrYaqCADAcZzNamMZTi6XypXN8XR1Xb3d6WzQGrceOHX0fCbjAO2CgqYO7zt18kCpnLh8seDVt344nJbuGeU7pXvHMcMGRMSGXM4p1tToFTKZlXZY9FYJImp1NSaWsVmRgGiOgxiN19drfYM8nn9qWpCnx6qf95gttq5dY5O7dOjWLQ4AcDmztLCgsE&#x2B;vTiEhwTqtDuC4l4c7AEAQeEEAP/xy4Ie1OwamdDyTkx8dHfHVe08hxr59&#x2B;zEPH3VISMiJtNzkDrFWq4miJEmd43y83Z20zWp1yKQyUkJSBHFdT0JNnfbQoXONDbpuSR27dIpMy6s8dvaSTavngSQ8PLhR0&#x2B;B02B97dHJCfCQQBAQxAO/38N9kMtXU1BTkFxhyag1rsxiNBVdJ7vedboHnMCRAHEc0TUgoFuDgFpf/AQCCnQ14o/&#x2B;ER0UB8K9DFAAiIv9uritYalYNLcLB1STNMCzL0hzX3OrQ2ift6na46h1NtelyaO5&#x2B;oFryE2LaQUTk7&#x2B;NyZRKcTpvZypntDoFhFXJ5gL/PLf5&#x2B;8byAACJwXG&#x2B;wNGmN4SG&#x2B;EqkEAB4ALCO7/OzZdAiAwew8nnrJQy1b&#x2B;sL8wEDf8pr6DdtT87NLLbS1rF6nxECIj1f/vr3GjurmpuJPni84dDx31/5T/gFBNdU1cgItenj8jGnDi0oq1/12oGPnqJQuIQd2pi99ZYGFNix49tu5M4bPHNv/wJ4LVZr6Hr1iM/IrTpzO7N6ty4ELmTNG9NHUG0oKSp5aOKbfgOTWj4wQglczAFxRUXVDo5GSS2OjItyVlMlkranTEhQMDfGXy26jCQQAIAjCzv2nPNXy3j266E22ioramOggN7XKaLTK5RJKQjY7TkNXHdSN0xpGo0nb1JSTlaMtqzNvyHPkNuEq6v&#x2B;fAwUEiIcAAxCh29ItogD41yIKABERkRvS1hKOZTmWabVzuFqw5Kplamvs0OonTbQYv13tkm7pdbjaJS26wok8qNwolYCu/n19fHm7I5pQy0ii1hRHsy/BubPZazceDgjy79ouVGdorKrTnzibUaOzPTVt3PxFY7Lys86dz99xKC31ck5QkG&#x2B;/&#x2B;GgJTlFySe9eCVqD2W53SDBoMDpNDp5hGZvJziHMwRutBjPA5SQFGmobCZnU28fX3miWEuTICf06tPc/k1aob6J9PdW19Q3D&#x2B;3ecOGEQAEBvtjmsVl9vT5IkAGIAJimprP70&#x2B;601VUbE0AxjnTltxIJZowEATpsjM6e8VqtjeCAhiEA/VbuYIJVSDTEcAMDxHIZjeEv&#x2B;4Vhqxtc/bPz4nWeiI/3XbT6cmVYUHubh4FkApRiOZebmxgQH9ezZdfVP22OjIhc8MjY4xAchAbpmVcHrT0R2u72qqqq8rEKTX2nakme/Uo8rKdc8pQcHlwAYv3i6p6fHP70v9xRRAIiIiIjcHm0nLN2gYKlZODAMy7QaOyABQQy29knfqEmapChJsyFcG&#x2B;Ugph1ERG7EdXVNbeud/jB&#x2B;FZCAkMDyvNVKG0wWi9XG2BkMQR9v94iooD96VSs8zztpxuFkbHba6aBtVgeCWEykv1qt/G3rKZKnp04dAiDUGcz5JVW/7Th24sSZT5c&#x2B;OXhIdygwp89lrvz1aElpTZ6mkaGZaHdFeEhgYlL7qJjAHkkdO8aH25zCjv3nN27Zr5KhJx6d2iulEwAcy2Fbd6euW3Nw1NBu/fqF41Bw8whsNFiKKxuPp14J8VHLpUqMIK1Oe35ReVxo0IjhvX74caeNpl9/8aGwEF8MQzIJBSAOABAEJwIChlEQEAAAjuWqqqvKy8oq04ttF2vMe0sewNDfhWBjA97sP27xNC9Pz396X&#x2B;4pogAQERERuXe0KIfWbgeGYVhX6oGmaZqm2easA8O7prMKPISwZTxri3qgyGurlVpLllo84URXOJEHC3TdZKQ2wDb3IQB&#x2B;n3xofR26E3UvKLeg4suVGyqr64b27eWudm9oMly5kp&#x2B;ek9W/f8qjcycHBfnY7A7EsSaj3Wh1SKVEoL9PSJCfTHqdrxbD8fyFyxU//nawtLiYcEJIyAQF3bFTaMeYhF9/OZxXVN6jfezixyfVGcx6jbZdtM&#x2B;FrOKffjr8/DOz5j00cNeOs&#x2B;8u/wnJoAxKukZFvvnavE6dYgASXGKgory8vLyiJr/CeKTEvL8EU5AQf3AXGgQbE/DmAFEA/AsRBYCIiMi/gNYJSyzTLB3oliFLbUqXbmDs0NZPunlIa4sd3DXigbqadxDHs4qI3C6o2Ywa/FEKgudZCDEM&#x2B;yvKnOd5p5N10DQncAIH6uv1LMPotBZfP8/kpFgAwM59J09ezJRjska9VWfTShzAysHE5HYzJ/WLDQ8CALjeV6PRlJaWVueU6Y4VW09WIlaAxIMb&#x2B;rt4YAWAWJkqIiIi8v8AHMdxHJdIJEBxey9ECLmMolsLltiWPgejzdZasOR60NUnLQiCq0&#x2B;61RXuap/01TYHgmy1lW5RDmLaQeTBBv7JyCUcJ9v4Rt8eOI4rFLhC0WxvHOjvdd0Txo/qP35U/z/ZgslounLlSn1dg35nnuVUhUDzkMTE6L8ZBP71q&#x2B;G/RxQAIiIiIv9mIISu&#x2B;UZ/4bXNOYcWP&#x2B;nWgiWr1crQDM00u0q7BIZLOfxRnzT5uwlL141nFdMOIv&#x2B;vgdf8dZNn3TMEQbBYLAX5BRVl5dodebZzNbyFhhQOSTH0bwEBANANbL7/7YgCQERERETkxrhCc6lUersvFAShOe1wbcESQ9NWi4WhGZplaCfNca5ncX/SJ&#x2B;3664biwfU8sU9aROT38DxP03RhQWF&#x2B;Xr45rcawNhNACAkMUmKaTgQAUQCIiIiIiNxxMAyTSCR/o2CJ57jmDunWgiWz2dwyasllJ32DPukW6UC2Fim5BrS6ypUoiiLIq7bTOI6LaQeRfyUWi6Wmpjo/K6/pYoVu5WUIAZSI8d6f88ClAMQfCBERERGR&#x2B;4WWgiUAwO05IoHfFSw1u8I5aZvdztDNw5Zc0sHF1YKlFj9pkmyTebiacKDaNEmLrnAi9zVmk0mr02WnZzQU1BpXZ3BaByYVI72b88CF/6IAEBERERH5d/CXC5auTlhq0yTNsiztdNpsNlfBEkMzLMdyLMuyXKufdGsDg0sluNqlbzieVXSFE7nbOOyO6prqspLS2sul&#x2B;nVZbJ0Fk5Fi9H9TEAIAiT0AIiIidwGhsZzLPwPsJoATQCKHEgWUyEHznzJIyQElhZQckBQkJP//DNhFRP6fc3XC0m0iCALP883NDs05B9bVGG2z2WiDgXY6m0VFy3hWASGAUItsINr2SRMkKaGoZiXRIh5EVziRm8JzXGVVVWVZRenJbMu5asf5WkxOYjLy5q8UAeCB7QIWBYCIyN2EdjBnN3NZh5BFj2xGwHOueWOgdeIYxACGAZyEBAkICaSkgJRCStYsDCRyKJEDqQJK5FCqBJSs5U8FpOSAkrjEAyAkEBd/l0VE7jUYhmEYRpLk7RYsIYRcaYcWN2nWJRwYmnE6nWb6qp20K&#x2B;fAchwSBCQgDMeu65NuMXe4pmaptU2aJEicwMW0w7&#x2B;Y6srq0rLSqvQi/YEi&#x2B;7laTEFicjH0vx0euMi/GfGkICJyt0C0gz31K3P6NyDwkCChVHmzFwiItgOnDSEBIAEIAkICEHggCMB1z1XZAAHEAEZAggCEBJAUJKVAIoekFEgVkJJDiRxI5FCq&#x2B;OOEgwyQEkhQAIpriiIi9xqXzcLfK1jiWYZxOUq3TlgyOxxXjR2Y5nYHV9oB&#x2B;12fdOuQJYpq9XS4fjwrjuNi2uG&#x2B;pbGhsbSkpDytsHF3Ll2gQwyPKcTQ/y8i&#x2B;gCIiIjcMfiis9yFrRAJgLyd0gIIAcQBwAF&#x2B;yyOjORaxDLCbkHCtcmgWEujqEgfEAIYDnLhJwkGqhJQMSJVQIm9JOEiBRAFJqZhwEBH5Z2kpWAJAIb&#x2B;tF7YtWGrJOTQXLDnsdhPDOmkn69IOLMu5CpYEAQFA4DhBEgRONPc5XNsnTbT83aIsCNd/oivc3cNsNmdmZNZV1Db8dsWR04gY/p/eo//fPHCxPwBAFAAiIncJ5LDw5ZmC1QhlqnvxfhACAAHevFZ3S8rhryQcSECQgJQ2KwdXnuFWEw5SSJBiwkFE5J/ibhQsMSxrtVpppsXogWVZhuV4TuB5BACOYa40wlXlcDXzcM2EJYIgKIoiWhDHs94QnuftdnthQUF5ebnmp3RnbpPAcg9o9HrHefAOoygARETuCsiqR/pagN25NTCEgNCyzIPhd6xX&#x2B;K8kHBjE0gAY2yQcWmSD4JINt5NwkCmhq7dBooCUrLnhgZIDiUxMOIiI3A/8zYIlnufZVtoULFmtNtqpd41npWmWZRme43mBdy09XNMn3SbvQLX4PLQtW2pVDv/WtAPP806ns6y0LPtylul8pWF9DiYjgfDgBa13iQfyQIqXVRGRuwPHINp&#x2B;5xa8EcQJoFADgAGAEO0APHuHtvyXuAcJB5yAuKvDQQIpKaBkkJLdTsJB7HAQuWNwvOCgGQgASRIUIdqH3QaugiWXs8Nt0VKw1Oon3dLXwDBOmjabLTTtpOnmga3NrQ6CAFvesW1JUhu1cHXCUvOApTbi4b79Wi1mc22tJi8zp/50kWF1Jq6gMAkhRv93FrEHQERE5L6E54CbH9l7GpSpEMfyGQf56ryrCYH/R/zlhIPV2EY53HLCgZJBUno14SBVAokMXu1tULqyEOJIJZE/p9FgWnfgTEl1o7tKLpdScolEKiHdFPLEuNDO0aH/9N79O2lTsHR73LBgySUgaIZx2O1OmnY6m5MOLtNpJAgAgOv8pAmSoFoFA0FQEsm141mJe&#x2B;AKZ7Vam7RNORczatNLzdsKBaMTV962lBK5CQg8mCkA8TonIvL/AYSARE7E94FKTwAA0lbxtQWA5&#x2B;6waQDXklXAsDtZvPT3gRBACMBfSDhYEUK3kHDAAY5DnAQE9TcSDqKHw78Wo8Wx49Tl8&#x2B;ezgFKO4xhJ4BiGeamVT00ZIgqA&#x2B;407UbDEsSzTWrDEsixD0zabzel0Ol1TlmjGZSeNBMElHlr94K4VD1e7pcmWSUstz2kuWPqjtAPDMNVV1WUlpRWnco07C/kGG8CgeIa5WyDRB0BEROS&#x2B;BQmItrsEAOCYO799DMO8QxDPAoEHjAOx9K3tFQI8iwQeAAAxHODE/VV1AzEAwd1NOBCkq1SpWQZIWmzdpEpISYFMCZt7G5TNQqJthwMpAaRUTDjc/2AYlEkoIKUokgAACAJiOdZid9idd&#x2B;E3UeSfo03B0t&#x2B;asMRyLE03Kweapo1mM03TNE27lAPPcRzHA4AgAi5jh2u8HUiCIAmnky7enWbJqGMyGwEGASaG/ncPBAB48CqARAEgIiICAAAASpTSuR8hhgaMncs4yKbtvXkSgGcRxIiQ9kDhAXgGGRoEbRXimJs7HtzGbkEAQHP87eoNuAf8xYSDDTgtyNyScHCNYb2LCQexw&#x2B;EfBkJ431aNi9xj/vKEJQAAx3GtBUscyxn0&#x2B;gup54x7im2p1RAXQ3&#x2B;Ru4UoAERERAAAAEAIPQJdlxpYk3&#x2B;z9RAEcIroNIQa&#x2B;HCzTuBZZDcJjZVc5iGu6DyUKO7ALvEc9AzAIroApxXYLUJTNbLrAfwTWYKAIACcBDgOOO4GZZ0C31w3BSHAiDufT7/bCQccBxgBXbKBlLSRDbLmlgap/OpIpesTDhJAycQOBxGR&#x2B;43rCpYghJBFbLkRiqH/PeABPsbilUBE5L4BCQC1Lj//cwj8zUcMYSQR31sy7jmAX23Rgx4BWFA7LDAG8DxXfhmSt12Aex2IZ3D/KOn4lwAAyFjPHPqBzTj4h9KCYwGGQaU7HpwAfcO53BNIWwPaBrsIAbkaKjwASwOOQbQN8Ox9cfr/CwkHgb/a4SAIAN39hMPf/jZFRERE7l8evBogUQCIiNwH8BzmEQg9/JDdhOxm5LD83Qk/ggAAAhC7K1oCIShTkv1mN0f/rJO9vB9ScqLLcAAB5hdJDZ7P/3gFIPS33x0CQWj&#x2B;J04CnLjxOZpjkCBgHv54cDu88zAivo9rL5lDP0C5W&#x2B;s&#x2B;A54holOInlMA4xC01dzFnYKmGBB3dKSGy6vBtWyP4QAj7u5wCVfCAcPBreuYaxMOqLUr2rXbqOVoAwgwCDAc4CTEyWbZoPQkI5PxpJGYb/hd&#x2B;TgiIiIi/wgPYAuwKABERO4HkNOCt&#x2B;9NDX/MddO5/g0&#x2B;7wwgbnv&#x2B;HQAACBxAEMpVQBAEcxNAApQowB2v&#x2B;pCpMZ9QAABiHNyZTUzqBih3Q1YD2XcGAAD6hGEB0UJDWdv8wF2BYxHrxDyDiJgUPLYHkdC/9RE8IhF6BAK76epnRwgqPfHAWAAA5hnE56ei6jx4BwWAwEOlF/QOAoIAWCeyaJHNdOfL9BECOAEAAiyNOAbwXPNoI4AAgADDXK3JrkGozQLsusxSm4TDrcoGgUdOG3BYGWM9VnqJSB5D9ph0hz&#x2B;XiIiIiMg9RBQAIiL/NAgBQoIFxDbfdFoBbQcCD8DtRM8IAQihXyTVdyYe3gUABBgnclj40jQ2dT1y2u7kWE8Mx9z8mv/NMXxFJnDaEUtzuSdcAgBAiPlFCnXFd00AQCBwyGmDbr5k9/F4VBLRrldrbwCym5Gxns87DXkWXZeCaMmrIMYBBP7OpkcQ48SD4yXjXwAAAcbBpG5gUzdCmeoOvgUAANE2MmmMZMprQOAR4wCMA9EOQNsQbUd2E7IakM2ALHpBV4UaKxHjABCHCg8gkQPG4Xo&#x2B;wPC/mOyGELCM0FTBnl4PMILsNu7OfjQRERGRf44HLgcgCgARkX8ansV8w6CHv&#x2B;sWV5GFTE23Ha/zLNFxIDXhFUi11GorAPTwx3zD8OB456b3kNN6x3YYAoC37B4CiHECHAMQIsbRfCeGA6kSAeHm8bWrWuZ2l8kFFsrdiJRxRHxfLCQeUs1jN5BVL2hKuZxjXMZhwDqBRH6v3QwghBIFwHEgd4NydyBwd&#x2B;MtmmUMhkOpEkiVNzjIHMtXZTH7vkL1ZUBCkl2Gk0MXuh7hq3IcXz4MVV5//d0hgawG7uwmIjoZegb&#x2B;xe2IiIiI3Ecg0QlYRETkXoM4FvcJbx7wD4DQUIqsBnBb1pIcg/mEScY8A1qif6G&#x2B;DPPwAxIFICgsogvZbTxzZiPg71A8igTgtDX/m6SwgGiu6DzECeCwNN8JMSiR34JTPQIAAI5FDjMgJFCqvMVPjTgO94&#x2B;kBs&#x2B;HMrXrHqGpSqjK5ssuczknkMMK5Wogub0x3ncOBABo7sT9pzqMCRKq/RDPN8&#x2B;3Zp3XPPr3r3MYFCw69soBavAjf3dTIiIiIv8s6AFc/QdAFAC3i11nhhASUkrgeEJK4ZR4AEX&#x2B;NgKHeQZChbvrFtJWI7upNZS/MW1jOIQQ4qkhC4FUBQAAguDcuowvTQMQyB5ZjvmEAwCIpNHsua3oTgkAQRD0NYBjAEFBSiYZ/igRkyJY9FDdsq4M4c0bGJAAKBnRZTjZdQQyN/EV2VzWEWTWXc0t/NlrEZAoWqN/AACgbez5bXzJJajwgAr3B&#x2B;d0Lhg0XNZRCDEgkQFSisndgMoT941wNSHctQQIBAIvlKQBUQCIiIj8v&#x2B;dBuV5chxi/3h4HXljtNFgjBnWqvVTcaVa/6GGJGIEDADgHY9dbJCqZRP1PrTuK/L9F4IHSs7l0h&#x2B;eQzYgAgH&#x2B;&#x2B;eNwmsEOMHW/XC4/q6rqTyzwklKYDpw2wNFdyifIMBjgB1d6AoMB1K8G3Bc8hjgE4AQkKAIicNubMBqrPLIATQKLA43rhSLi9in9BwBQeRHxvzD8a&#x2B;EcDlTeXtucWT8QQxwVdrVCTjwXHu&#x2B;7BAmMlY55mrxziSy4iUxPAyTs//kgQABAAxP/hIa3Xgiw69sJ2yNKAIAFGAIKCMhXmEwowHLD07eWRbu&#x2B;NBcFmuFsbFxEREbnHPHgqQBQAt0d9VoWuSEOpZOm/HvWKDowa1BkQOADg0nf767Mr/TpF9Hp27D&#x2B;9jyL/3xAETK52lYsIpkbEOG5qLwplSsAyiHFAgCAppfrNAVSz8uSyjyHG3jzpxWm7misg/sYvu8BDhTsR2RUhgc85CXAcsE7uxK/AYSNTxkCvEIDhANzmYjMSgNwND&#x2B;3YfMugEUwNUK7&#x2B;8xc1Q5BIX&#x2B;fcsgwP60B0Ho5HdgEYjoV1loR15nOOMWc2CfWlAAl3bAIP60QsDSVKQEmR3Qx4FkqVd2LEJ7oDNUIIAY5uafJGAAlIJ/CVWQAAKFW2Get5sz1hGcQ6XSOGIEHd0nTUB69kVkRE5N&#x2B;K8OCd0EQBcHvM3Pqqw2AlpFTi/CHe0QG4tHnJ88z/dsVP6CFwnMNglXkob3ezAi9AACCGtcYDToOtqaAGAOTfOYKUSwAAFo2eo1m5l1qilP0&#x2B;bDBV63iGUXi7MTYnKaek7re9DyL/DAi5jF2bb9mNgHHcNHIlEgYiY6PQWIY4jmjfFw&#x2B;Oa12WJvvOFBorkFWPGCfuF3l1DZi7mbfXHwKh2ocavoSI78NXZnFXDkJcASCGkMCe2cSe3QwoCSZ3RzwP/cJlcz&#x2B;5pU0iBAgK8wxyzehETqtQk&#x2B;96r1vcJSDwSF/LGeqEqlw8KgnvPAQPSQAA4B0GSUM60nu/5IvO3QEjAiQABPCYHmTPyVAiRwKPLDq&#x2B;/AqXdwrZTJCU/hUNIAiAZwGGNQfZd&#x2B;Cq4zI2dn3ROMABbPlxuiWQgHge840gY5IATgkWPaorEhrKwG1tREREROT/J83nYFEAiPw5HhF&#x2B;HhF&#x2B;AADG6tSVamSeKkolBQCog7xM1U0cw2T9crL7U6Nva5ucg64&#x2B;X8hzgsJbzdqcHpH&#x2B;qkBPfXnD8XfXO4z2yWuf8Y4LAgCkrzxcm1aStGBIzKhknLxmtRUJKPWTraXHsno8OebyT4dDe7Ub9eWiO/ehRe4yOHG1pIdlAH9zCzDoFUQOWYgsTQBBzD/SdSdinJCk8IhEyUPLhJI0zMMfj&#x2B;7m2jIyNaKbmvv&#x2B;4e6RZNJoosMANnUDm3EQSlqaE1oL/XlesOgAz92kb6EtCEGZEguIar7lsAp1Jbc9kh8nAEKCtkpoquIrsoiuI4jOQ6HCHbr5SCa&#x2B;Qu/6L599/G9FsQgBjiW6DKdGPXHVUAwAvF0vzN2fOfUrYOnbNlhgaSBVYMHxUOEOKSlgHIKuVjA13LH&#x2B;7NsFIYCTRGx3sv8c3C8CEBLEc0JFFnPqV6Hs8l90ohARERERue8RBcBtQ1udEqX0&#x2B;Nu/aYvqZu96wychBAAQmBQp8ChyYIfIIYm3u0Gn2XH60&#x2B;26Io1/p/DSI5l9X53c/7UpiBes9UZzrZ51Mq6n1aWX5u0&#x2B;G9ozLnpYV0BeX24h8MjWaHboLDXpJa15CRdIEDgnCzEMwzGEEEbgELuPipgfdCBEPNumUOdPitevWZ&#x2B;AcvV1BTPcpd3QO5CISsEDovGA6Lbr3&#x2B;ylneAvCgAECQKP6Yb0dc7NH0BKClVeN14puboIfUubBaQUc2&#x2B;efApoq9BY/ldMAyAEBAUQEjRFzMEK1FhO9JmBeYdCmZIa&#x2B;iht0Ag1BX9dA3AM5h9JdBrcHP2zNOI5KFVASkb2miJYtOyZTRC/nVQb64QegWTKOKLLMKj2br1bqMphDv/ElaZBifxeF6IKHPQKkox6Gro3GztAnMCjuko8A5yrnkfmxns9R1VE5P8JCCC&#x2B;4BywGzG/SCyo3T&#x2B;9OyIit40oAG6DK2uOpf1wkLY6pB5KfWGduUHPOhmEEISwz8uTVP4eAMLWuUACx0MMu5VQm5RSoT3ayTxVSj93dZAX4QruIYA4hpF4azk4IaMkUjkuIX9fJQExOGbFoqEfzsEw2GXuQJy65ppt0RjOf7HbPdzPKybAWNUUObCjR6T/9Zu4m/As15hThUtIpY8bY3PKvFQSlexe7sD9jsC3TtXEvIKA3A3wHCDIa&#x2B;phkAAJKWwpDeKLLwpmHZSroUQKIA54VjDUsSd/Rk4bGPc8Ht8XSuSty7fsxZ3clYO3klj4I6BcBQgpNXQRshn4vFMA&#x2B;9vnDYQAQUF33&#x2B;ZbDC3oa6HsT4NpDP/DwnQIASUDPMde2Ik4lhr9NJSpMM8AauA8529vAUH4a72wiOegVyge0QUAINSXMsdWI5uJGvIIHpEISCnZdRRffAnpam5RYCCWxtTeVP/ZRPKY5rtcTmQQw0I7SCa/CnZ/zuWfhhLFX9jVvwhCACdxv8jW6L8VTO1D9phI7/3inu6PiMj/E5DdxOz4L99QCjgGKtzJ5HFE4nCxau7/MQihB68LWBQAt0r1haJL3x3QZJa7h/saijUCLxAk2RrfW&#x2B;tNR9741T3Ee8iyOQAAjuEKdl6waAxhfeMDE6NaN2KsaGzKr&#x2B;FZTqKW&#x2B;3UMlXupAQASN/mAt6a7njDys&#x2B;axeoi/xe69ZiCOSd3kSEDV54tsWrN/xzDfDqGuh2yNpiOf/uYbEho1uFPGLycmrHzyHgsAp8G&#x2B;&#x2B;aH/YTjWefaAjHXHezw5OmXJiHu5A/c7GC5oqwBHA0IC5e5E5yGsQYNMjQAAgGEAQgAg4ljMKxi0OF7x&#x2B;alc/llAEoCgAM8jhxmZmqBUATDcufl9zDsMC4yGSg9E24X6cmA3Itp28/J6hADHAIIEGH59ZQskoMpTMuYZQVtlzzgMpX//vIEgTrS65CKbHvDMn&#x2B;8hlCigVwgAGAAI8DxAAhKEZh&#x2B;xVhgHX5ElaCvxkA4AACwikew1mTmxDkoVAACA4deuZ9/sgEAAFW6ui7qgreKyjwJB4Nx8MP8YKFNivhFk4jB6/3e3VHCPEAAQj&#x2B;2JdxkGAACCwGuK&#x2B;apszDOQiEwCpAS6&#x2B;xHJo/iic0BA4F4m6DCseXrs9ffj0Df8HytMEhG5j0FOC73xPb4qG/AsABAZ6ummKiwgEgvp8E/vmshf58FrARAFwC1Te6HQUNEQ1rv96BWLSDn1y5gPHIar1qrG8obcLWc8w/1dAkCguazfTlWczO6/dEpgYpTA8uWnci5&#x2B;u99UpXUYrLTZLvdUBSRGpjw6PLx/BwAA4oXsTWcqUnO6PjwkuFvM7e6bwAsczdjrTZDAcrecKTue3ePJ0a0CwC3UZ/ynj5MKqcrfHZeS7mG&#x2B;d&#x2B;iQ3CoYDmUeStps5xy0saLJXH91eiDPcA6dhVBIpCpZa72KwPEAgFvMn9y/oFt1FoSUjMs/SyQOx/yjAQBk0mio9OAvHxT0NYi2A5ZGtA2P7kb2ntbqFSA0VSNrE4BY80kLYq3lQFDuhqx6vugCgBBgOEDoFnthEWN3bv/YNQFGaKq8ZtW8tRb8zyPClneBlMxVmfOnT27TBeu0AXCzRXqCJLuPxz0DBG01YB2IZQDrRBwDWAZwDOI519gfLDAWqrxbdkNKJo8V6or4iiwAACRlV0v5kYDQTVIiUKLgrhzgck9AUgo4BiAAEOKyj2Hhnclu4wFB4jHdscsHkL7upit/iHHgATFE15GuPgehsZzZ9TmXcxzzjwBjnye6DAMAYG7&#x2B;mH&#x2B;MoCkG2L1aR4QQcKxgarrRHiPAOP4xIzMRkfsW2u5c/45QlQMAaq5axAlkNXAllyi/6NvogxIR&#x2B;acRBcCtwtoZzsl6RPmqg70kKhlOEQih1ggVo3CJWn7VBAACQkLiVHM9t11nSfvhUN7W8wofVdyYbiG94nK3nLuy/pjTaPOOD1b6uiOESg5lnFiz3rdd6F8QAIW7L&#x2B;17eiXnZHAJiQQEAGCsVye&#x2B;y71UvZ8fb6xuAhDGT&#x2B;xxzSv//piUW0DmpVp05iMkCAIn9HxuPCm7WurdVFBzaOnaiH4dej8/ASNxAABHs7UXiuwGqzrQk3Mw6mAv9wi/m47FvA&#x2B;xMLzdybtj4OapHIJC&#x2B;mrmxK&#x2B;S0U&#x2B;4glcirhcR1wsAhMxawPNA5Qld8TSEAAC&#x2B;KluwNAL4u3X6Vlpj92Z5cGtHj&#x2B;f47OMAYgDHAYAtk4ggQkjQ1WCIAxAiq/4PtwYxYDMxx9dCggQQE6rz4J&#x2B;0kCIAIAZwqvkGz99KqAlJKd6&#x2B;Hw4AQALgOcRzQOAAzwGeBTyPkAAJCqp92u4h9AqSPvQfLi8VWXSYbxge1jx1FLA0cFjgrZQGOazI6cACosn43pCSI4cFCDzgOYATmF8kmTiC3v8NdGktgQew5WhDDGBYc3ZC4CElw&#x2B;N64KEJAABE27nsY3xZGuYbCmiHoCkBXYYBAKBEDtVeqLbgHv&#x2B;sI11VW0eF5js5mstPBaTYBCzyZ3C88H/snXd8HGed/79PmbZFWvUuS7Il915jO3Z6LyQEAiShh87d7xocHAfcwcHdcYUSOkeHAIH07jQ7duLeu3ovK2n7Tn2e5/fHrGRZlmXZkWU7njfBL2l3Z/aZ1c7M9/OtpmUjBAS7IHKac2rjnqMbdhz0qUoo4Mvya35NKcnNnlNTpilyNJHCmPhVWZUv9u&#x2B;bMFPmb/&#x2B;Jdx0d1cMXqX52ZItYdCOSSy/g8jzOncvP/Q&#x2B;eAJg4/qKQmuXr3FYfbQkXza9EJHOZc21TKksAyLEydZaYkszFQQAAqNn&#x2B;hfet57bd9PLBaHPf6r&#x2B;7s3Tx9P6jHdG2cN/B9sA1IUAgabICPnes2FnBdOuZz/zYsZxgaa4vP6t7T6Mc0IaVCTPthg17d/9sQ6Q1jAguX1G76P3XlK&#x2B;sdZfdd6Sz6eV9&#x2B;TPLKtfMlv0KAPQf60x2RfPnlAWKQmZc1wcTVJN9&#x2B;VkYYyupA4DkV8/NMY8wdgzj0CNbECUzrl&#x2B;YVZYHAImuwc3PPpbqjq36q9tdAWAljW0/fK7&#x2B;&#x2B;d2Vq2d1bK&#x2B;f/94rb/mfj6Cz&#x2B;ViOPrX96JM7iuZNW/qR6&#x2B;TABfPHdJo0ppNVGNITeTWV2dHXTUeni27CZTNRMB9Rye2/eeI1CAGAiPZYL/2fiIXPS3WmqyhG5dXYpvXs95AaAEkBZiPptIn4wkjabzwCGCOEBXPG6yWPAIQDZhp8WYAw&#x2B;LPBcQCh0UED17B24UxYOiCMJMWtBxjVNWjkl5KHW3m0l5TMQIFckDW66HoAGHnP5rGw6G44Q9mx4EAVuvA6ad19SA1mRiswB2BINlOZLriW9TSInkbBOahBHCoZXjBSs4SpI6pwM0VnraEr35F5d8HBTLut9wFjGP48EQJEpvpGhImI9ZrP/UC&#x2B;9bOktC5z3HqC7X6WHXgFUc&#x2B;d6TEeLd3hJzbtdpgT0FSfqvhUWVMVmdKVc6bnnDwTc9exln/74Z/AsDLuCcPKrav83Vc/Mbe6/F1femjb7sPBUJZfUzRVyQn67lq39EsfvPPCHNLpEemY8Yev8K6jwE/x6hCJdxzh0T6S4wmASxLhVgFcZngCYKLUXDt/329f69rT&#x2B;KubvkIV2YgmZb&#x2B;y48cvzHvXajnga9iwF4RID8R797f6C7LMpG5EU4KLRDjGHUY1adYdK2qunv/G/z75ytf&#x2B;sOunL1asnKlHkwWzyvJrSwAAkyHBMMq0nsAXsu9Ih5U2Jb/64JZ/Rxg99sHvNm86OPxsrL3/&#x2B;b/9RaS5t2TpdCLT7T98rv3No&#x2B;96&#x2B;B8KZpUBQM/exmf/&#x2B;qdz7r6icHa5KwD2/ubVXQ9vuPlrH1nwvnUdO&#x2B;p3//ylUGXBmr&#x2B;7U8n2b//xC7G28JWfuzurPG94//pAovGl/bZhFswqL19ZN&#x2B;YKrYSeGkhYCZ05bOf/bXAMK7em2BUAZctrP/Xr/9VyAsPF01SlFVfMYpaTXVmQ6ovJvrNOh4g09R5/ZofeH19437oLKAAGmbLfCM61QVHBOePfEWEQ3Dm0ibUdJpVzcXEtLq5BwVykBZHiA0lFzGYDHezQ66x&#x2B;O4/1TU3oJoPgvOu44BwEB4SQ4hsvt8cxQYBwTe3xVoiEqfPBTpJTDAA4twyXzBCDXaCOKDnlHGGCtUxqk0gOWq//nnccw/nlQGWQVCQpIClIUkHWEMYCAGEKjiWstNOwkzfupPOvkda&#x2B;FwVyQVYRlYbNfda0x974G8Hs4ZqKMeAcMJZW3Cnf8OA4mTAor1y9&#x2B;wus8wgYaRTMw0XVw0/R&#x2B;ddolLKu40gNkDlX4uyhNjtqgC67jUe6eG8LyikezhsWlgFGYtKGl00cAbzrmPmXb5KKOThUBELw/nbn8CYQU1uN4HEJ0tQZ/pdfPJHo6wdJAoyBEkoJsZynvvv561eclBCvypIvJ8uwbEoIAFimXRAKypRihFRZAoxN2zEs2xmMtxE0e9rFZ0anIuYf/oV3HBn7royQcGzedpCUz/ZKgS89xGVZAeAJgIkTqiy8&#x2B;X8&#x2B;vP1HL7RtOTzzlqWOxXb//KV9v32tccNeqimxtrCVMhBGj33ke3kzSqy00bb5CJLI0ce2&#x2B;kJ&#x2B;LTcLS0QwlugexBgffWJ744a9kiqXLKqxDSvS0pfsiSY6BymWUr1RM54miqRHk8y0qSrhM2UpMMtBCBFKJFV2LJtqMvBMXEJw0V/f3V3fPGPNolu&#x2B;9yAmZMM//rJ548FDj2y56p/fDZk8eyw4H9a&#x2B;6XC8t6kl1RcFgGT3YMPzu3Jqipd//EbZr&#x2B;1/eFPj7j3z33PlsABo3XLkxc/9Mt4x4FhOdkX&#x2B;nLtWrfvCPaOWZ8TSr3714a0PPSNpMlVlwUWgOMTtTPo1VaTyZXW&#x2B;wqxhQ0P2a1f81W1X/NVt3GHnEA8BGD72s6uinnQogqf6NMXyfaTGEQyzCWgApAbASDqHN8H&#x2B;l4HZQChSfICJ4A4CDEQCQoDzEx7oKYPKJ97vDBdKBAjOnDuOiUjFWPNeMn0pAODCaeo9XzKf&#x2B;l/WfgiEAIxBcIQprl5E5lyZeVszzTuPseY9vOsYIJyp6MUYZUp7EQgOggsjBemYoBKSNXv3c86&#x2B;l3BxLQoVgqIhhIRtikivSPQLIzl&#x2B;tq6wTVK3nC69JXMsnLO2A6xhp7ANRBUUzCXTFuCSGQAAio/ULB25KXAOmKBAiC65hcy/BhBGypA31Epzy8TF05V3/TNrP4JzS3BeeWazeJj1taBz6IX6FnHPl3CL3deMqOxWViAlcNYjDjwuPyRKcoK&#x2B;lO53zXoA4EKYlu2cU88xhBAhWKJEOqcr//lDxPrMx/6DtR0cr5&#x2B;YrLHjb9J5V6GhM9rj0uEy9XR4l/izoHhh9R0//AQAcIcxm1VdOaftjaOJ7oidNooXVBUvqg4fbu873Nazv1lwUbSwSvYpkabeN7/z9LB5zR3GbRZp6UUIqdn&#x2B;&#x2B;hd2d&#x2B;yop4qcGogP1nerxL/vtxvjXZGcqoLmVw7EOgby6krxKS3/R5FTVYgptnXz4J82T1s3l6gy59zSTQBAGMk&#x2B;RQBXc/yli2sAoHLtnCPPbTeHKwROsSMRwQQkIlEAwBKVA5rs5vwgkP2qAr6RadMbPv&#x2B;r3gNt1VfNy64s2PubV7d&#x2B;5&#x2B;l571qTO6Nk&#x2B;AWC8&#x2B;7dTVu&#x2B;/XhORVHB3ApmOZ3b6xFCw6db78HWP334v2Zfv/Laf32vku0HgFRf7NjTO5pfO2jEUjk1RfPvXVexsm749XbKbN540IgmK1fPDlVNdTXzWSET0aqTb7VmlQaMq/MMHxEmR26nsfEsaEIRoTDsQhICABAdOk8zqubSv1ohBFaKHdssVtyJsvIBYVw1X/3At0S0h/e1iHRUMIYUHy6bSaoWuluIWJj3NLuKCMAtA&#x2B;DgCAEjcpaEAITBH8qE09QACMH7GqG3MZNNhDEI4ZYLn&#x2B;Fj5A7OKRu2zu1tj1kv/hRkGTgHzoAQnFdB56zDhVVIywJZA0lGhALCIhllfc2krA4XVgOhIwcFiGTEevn/ABPlho8jNUBrl594t&#x2B;QgO75dxPpGThybUoiEQLhZT0jyMn88PDKIaK/59LdZ4xnm4iEqs9aDPNZLPAFwaeKlAHlMCEwJpmTm7ctrrl3gGDazHQCUVZarR5LRlj7HsJjNskpzc2eUNL68P9ba55i2bVjAuBYKhKYXJXui7W8cTUeSZjRlJY30YAIJMW3dHCLTSFNP/bM7mc0wxdx2Zt62LFiS676po1umkWbW6DYs/uLQzNtWNGzY&#x2B;/jHfuBa/AihY0/vKJhV7i8KxVrDoYKCSHPvkce3ajmB1teP&#x2B;LNDsl/RIykQwoylhRBW0nT0zLgxTDAACAQAQAgWAhDGRJaITEdV4u740fOxtv5ASc6t3/uYkqV17WroP9rZvu34SAHAHNa1q1H2&#x2B;YoWVt//1D&#x2B;leqO/uvGrw6PNAMBKGp1H6nNLih3bUQDstLnnly8/9/mfB3JDvoKslo2H9v3mtVu/8&#x2B;CC&#x2B;9YDQKo39urX/3j40TcxwlnleTd&#x2B;64PTrpwz6X/cSSRAxY64/LHD2t9MS6zPNXMkrmEhIUExUCQoAoIEcXO/R2zlRiM5gADgArm/nkE2XIoQmfe2mX/6V&#x2B;Xer6BgHiCMsgtQdgGunAfcAUJHGugi3u8ceFUkB4b7IGXIVNye3pRH6KRE/6GmSWdanECYDrvt&#x2B;WAna94top101T3y&#x2B;vuEqfOeevv1P5jPPoRzSpDqB0nNTHBLx3mkG4wkCuTispm4oAq0oOvUF6kI721iLfsAU8QcPGMFzisFSQFAwko7259wdjw93Bf1DJyvNKHxs7bebpiWYzNGCSbjVq96TAqGZacTabBtS5IAI7CY7TDX5LqYr2x8sMt64cfs8GZQRqQLuvVIzMkEad3zESFhpljHUVK5wBuhfUlyMX8Rzw&#x2B;eADh3MHU7/5x4RMsJaDkZh9&#x2B;eX70yUN9de/OS4WeFEIJxN&#x2B;Wm9sbFtmEz02a24xg2t1l2Rb6/MLtnf8tgU4&#x2B;TNgWHgjllhXMqqZqpEay5biH1yXkzy06twb39h5948ztP9e5vQZSs/ORNv7rxqwMN3c/9zf8RmQJGju4MNnQ/9akfabnB8JFOf36wbcuRdDjuWE737gaqSL0HWl7/1mPTr18QbQ63bz2uScGWTYfKl9e2bz/uGGa8c3CgoTveNWDrJsE00thTNLeCc77r/17SY6nZV80LTSsAACpLiGAjmjppZQK4YyOC1CwVBDhD6mVYS2CKKchUyUxUiHX0N768X1bUpR&#x2B;5ftEHrtn&#x2B;4&#x2B;ff/N4Tx5/bNf2GRf6C7OPP7Tzw&#x2B;02ly2dQWap/Yffr//6XvNqSQHHOpP1FzwdEdOj07w7nlvntZVl2icKChKtEaFj4iPARrmGhYqFgUIiQkZCxkBC4/1L3XyQoAgkJioDiIdngpqWIoa4zQwphSC0gPmTrXtTXNEJY20H9oQ&#x2B;TeVdJ867GJbWg&#x2B;keZ7CLWy8Ot9v5XnJ1PIV9oihbmmiXDDiGEgXHggIK5bqtWXFTlHN4MAx0iHhax3iG7GQHGgCmoAeFYrPUAaz&#x2B;cyVMCJGwDLB2oDNyxtj2K9r6ICypA9ol0XPS3A7NB8Z1uOSeBsDCSPNqL3MlojnXmTUYm80x9jcHFyks7D&#x2B;042JAbCvo1RVPkgKZQSmaUF9VVTOmYlCnGsOzBRErCmAwpH4QQwViRJXw&#x2B;5d/C2sr7b1sXTaZN29FNK5ZIlxTkqIqMMfIpMiWEcc5sBo7jYJTSzfO3konDI93Whp&#x2B;xfS/CSGXOHFxYTZffhnwh3rTb3v08iKFRg4qPNezgc6/CeWUXas0e54SAi12Knhc8AXBeSPZGf/bBL5Tl1H6&#x2B;&#x2B;5dEyXzICCG3mw3CRMsdexZu8YKq4gVVY&#x2B;5zyYeumfeuNZJfOTUpiMh07T/cNfzrJ3d/&#x2B;&#x2B;jjW5N9MStlOLrFbIdzoQRUV2ZYSSPZGx1s6OaMU1UumFVupfRjT&#x2B;44&#x2B;tR2YOBYNuKo/rndfQfb0v3xVDiWCsdf/tLvhOCDDT2SLG/85iNdu&#x2B;q79zXHOsJUlY49teO1f3tEDWqRlj7HtLPL80cuDFOSP7vS0a3OXY2tbx6lEsEEcZuZSd19gWAAIDDBsk91PyIrZQZLcqZft7BwbsWs25YdfuSNROdAqjfmL8iOtIStlLHkQ9dOWzPnsY9&#x2B;78jz2xZvvnbuPVdc5CkxMhGCiE6DduoUBAIkAAFGICEhYaFgISFQsJCxUJBQMMhYqBlVIDQiVCy0IcGQ&#x2B;ZdwBYkCWdRotg2ICyAIKAKKBBmSBwSAIIGR&#x2B;5T7iMAIEIxI0R9LNsAURxsIFZbu7HneOfAqUjTkywJfNg7kIsUvMEHM5okB1n5IDHSO9v2fVxASnIlUNDNbIKeE1C5zDrzs7Hyatx9Bsgac8Y4jYKbBHwI1C5g99n44A&#x2B;6cqIp2U2sQIDUInPHuRgABCAORJu4yRJLCuo6aT/wXEhwkVZgpYM5pW0IhABAi2st7GgFjkFSRHHw7aQDGeXd/FABkicqUuunjEqUTMWWf3Lz7Jz/4E&#x2B;RlAyFAsCRRZJgfe89N3/vb90/K2oQQSd2Mp3RKCCUZg9v9&#x2B;QLmuO9vaP/kt37hU5SAT/Vrsl9VVEUqL8j98G3rywrO2pniMK6bFrdsWwKM0TgSYs382gU15Q7jjHOHMdN2MMLFedmKLH3j4/d85p3XmZaVMqy0aemGNb3swqd3imiP/fLPnV1PIX/uiSuiEHjaAvWef0L&#x2B;bCCSqFkMWtDe&#x2B;SRYBiCMqMxa9otoD3gCwONSwBMA5wXZr6y9&#x2B;y5fXtYkttGQA5ocOH3TkhHkVBeu&#x2B;uvbme1w22E247bDHU41mVASa&#x2B;&#x2B;3UgazmWNYjmHLfqVoQZU&#x2B;mGx4aa8xmASESpdMxxQ3btgXPtJesrimbNmMwcaezp0NTtqsWFknZ2sD9d0H/rQFYQyA1vz9nUcf3771O08BAiOayp1eMm3d3JErwQRPWzN72pVzwkc6fnHVP0l&#x2B;RQlqzHS2f/9ZZljcYfXP79bkQLQtfOAPr5evmqUPxP35Wb0HWrr3NRfOnxZp7rWSuhTQsEwB4Oovv/uKv77NjbHMe&#x2B;fqjh3H9/7mtenXLVRD/rE/iIsGBCBj9xZywrQWABZHbmEABxACneSDECd/c5BwEzRkJCQsZAQqFlmUK1hIGFzB4CoEjbiCgfvJCc3gRhtUfEJpSENpSKNkA878ehayYRKSlIQA2xCWLuL9IAR3H7It4AwwQZKM/DlT7Z6hMgu3sp5GUlILANLKu0jlPNa0h8f7wUyD4FJJLfJlgT/Ewy3OzqeBs9MY1qepih49lnjCIAzpOD&#x2B;&#x2B;NfN2hACmp0/dwcA5a9nLoz0AAqgCtol8E0s0uhQQQnznTy8eb&#x2B;8O&#x2B;jRVljVF0hRZkWhxXujuq5aW5IXG2davKpAdkAMnAi&#x2B;W7aTN02i5s8dm7OVdh3/73Oag3&#x2B;c2udcUxa8pRTnBD9565fizTRzGIok0AGTEA8aEYPeHt7iqtGHuPtwEjANC4M7Stp2s4oIbVsw7BwFQnJt97dI5jV19umEldSOlmwnddBzmnDLJXpWl07X5X1w3bXHdNCEE44Jzzjg/Y&#x2B;uL842Iha2Xf25vfRxl5Z6IBGJMyueo934Fhgp1kD8kXfke5&#x2B;hm0d8BBAPCkBrk3Q2kaqFXQ3/Jcdn5/z0BcJ6QA9p7//KPcOG&#x2B;UggjqkigjL7gFsypGPlr/7HOzu31JUtqVnz8JgAQPDM1tmx5rZXQAUGwJNeM65HWXjtpZlfmZ5Xl9RxoGWzoZaYVmlZQccWsVZ&#x2B;9/cDvNvbXd2k5/rpbl2s5o21xX37w3Q///Y4fvRBrDxfMKs&#x2B;fVfbHe7/Vuauhe28TwshKmdzi4WOdL//z77MrC4hCU70xM57e9oPnOrcd7zvaaaVMZtrHn9nZ/JpCFVkOqFSRJJ9CFClUVtD40t6t33tmxSdv8uVnwaWJm8ODAQCN&#x2B;rKM/d3JyAaAuIO6LSJGygpXMwxvl0lLEYBAxkLBQsHC1QCuYBgZXtAyaoG7msGf0QzCzVBSiZCxkNFJiUnjyAYMAiPAZysbMo3wM69G6shv71SfSUiSRdcxZ&#x2B;tj&#x2B;NbPIlkFhHFJHS6sFo4N3AEhgMpukQDvOs4OvS7iYaBTZbVgMl4D01MQ6biIDwACEAAYA1XeNjc7Skg4En/y1R1u5yXACDDGCCNmzygvGF8AjMkkBhM5F0dbu//y5GswbPgiBBiXlxW&#x2B;/5a1ZFwB0B9L/Nfvnoum9KCmuk56n6LIEn7nVctL8kMjXzkYT/VHE4CQTN04AyEYKbLkVxVKxvhCIoSoLAkBZOhZh7HcrBNtfM6K&#x2B;TPKH/7XT504ZCHShpU2rMDZt29GCFGCYKw1TzEiMWBt&#x2B;Jm9/TGUlTPC&#x2B;id42jz13q&#x2B;CctI9DmlZpHQmi/UJzgAQqH7WuJPOXou8IMClhlcE7DHJXMy5KVZCf&#x2B;3rf9r02z&#x2B;/578/t/pv7wQAhDOuXiWoKUM5SkqWVjy/anir4vlVI3&#x2B;VVGnxh65lliOEkLSxBz8FikJXf&#x2B;Xe4V8//ua3mjceSPcnbN1Ss7SCuRXxjsHm1w5aybRj2L68YNX6eSBErHMAE5Q/qyx8rLN7XzNkqjcxJhhRjAmWfAq32baHnqm9eelIASC4EK5n6&#x2B;3LkGwQJ3/DxjtkkyODo6gADsBHSoUzyQYZCwWDik&#x2B;IgZHRBh8RKhZ&#x2B;wodDDa5&#x2B;UE9se0I2kBGlz3hYPyAgkJETJ8sGcV6iDRMFAaHO7ud4Iqxc/yAuqQOETp0&#x2B;BgDC0pEvS8R6z/uKzhlMQB5p3r2tTo17r1u1ad&#x2B;xlu6wRE/czqy40dDRd&#x2B;PKC7guAABFohD0yyd7vicy7zaRMn7zwua&#x2B;1l6QCCAEGAFCYFizppWOEgCv7zv2w8deSetmwKf6VEWVqUTojIrCe69dOaO8aHIP54xghAKaEtAu4Ub4IhUxX/iJs&#x2B;MJ5M8ZOlEEEEqqFirv/dqYowPJrNWsZS8kBgETRBXWul9Euj0BcInxtjYYTocnAC5fsEQqVtbNOrRiuNHQuYEwoupZND0oWjCtaME0wTizHcEFVSVms9nvWMksJ/OfbStBn5Lti3cMxNr7Hd2ydcvRTVu3rJRhpy0zlvLlB6ffsLhty9FUb9Sff1JKgxLUfPlZkk&#x2B;9qOXXheA00YYzywZxNrJBwkI9WTbIOKMTXJGgYOEnQiPCh4WP8JGyQRna1i2DlvBJSUp0pGyAE/oBI3HmaMOQcjibzwsDxbxhl358G8oqwKV1KJgHqh9RBQDAsYRtIs54op&#x2B;nInBODlSPt87qBbWFoazmjt6T7maUHmnpiiRSOcGLPT9wTDBG2X5fOMs/XC3AhTg1rwYA&#x2B;mOJNw80xMODQAkIAUKAbk2bXb1sVvXUC4BLHZGOWs//0Nk1oh&#x2B;XEEAorV6mvO&#x2B;rQ/HJ0ZAZy0ENgDudHRMRC7OeRlyz&#x2B;LwMa/c4f1x&#x2B;GsATAJcvVJVXfubWlZ&#x2B;59YJEvhDBlGScqVTB2RX5p74mWJxTtmzGyEc449x2mOUAQkpQK1s6g5m2cnINQNXV87S8gBTQZL/XznwSmDLZoLi1DWREDfSIDCV1hGzQCPeRTJxhONqgnEY2EADyVmQDoYJQoSdY025AGDAGhEEAMFtYOtgmEIokFbD0NvOsXypk&#x2B;7WK4twdh7EYGXGl5Hh7TziavEQFwMQhGPtUOe5TZSlzN7ckKcuvnVtKz1TiMGbZDh7qwXrh27CmYtYLP3R2P4cUX6aoxrX&#x2B;a1cp9355nA65SA3gwho20Jm5Aig&#x2B;1rKXzl2HckpOt4nHxcXleuX2BIAHjF&#x2B;OdlGBCcZEHm6NKgdUCIy28nNrinNr3s6N/C4JzkE2DNc2TFw2UDdigDKFDRrJyAZ1hDYYzlbyEz5cFT0cbVBwpqiaDhVGD6ckYQTU7aQEbvxBEHAwAwQCgUAIQJFAlYfarXKekRDoXKINlyDoogmxLa6tennn4VhSP5H1TnBHeDCeTI&#x2B;zle2cy7Raj8niSEv301v2&#x2B;FXZr6l&#x2B;VfGpsipLuVmBWVUlAW2qfTciFbWe/5Gz9wWgUqa8nnMglM5Zp9z9&#x2B;TPOx6C1K1jrfkgOAiZIUljLfjbQST0BcEnh1QB4eHh4XDCmUjZIKNM9SRmKOQznKWlE&#x2B;E&#x2B;ujc60VCJCGxFtcGXDibFuQ7JhdNjBLW84Jdrgro6fUt5wScAE6mfStAu9DJdZVaUhvy&#x2B;aOGHuI0I6egcTaeN0m1i2k0jro7u0CRizcBYACMGyRE/984xvNJyza&#x2B;VScco4jPUMxBBCikQpJbJEZUomGHzYV9/6xW/9CggGWQJKJEowxvOqy3/0uQ8um119vlc&#x2B;EpGKWht&#x2B;5ux7ARAGTAEAOANM6YJrlTv&#x2B;biJtc0ndSrTljyLuZgFREenmfc0wfcnbqeXu25xL5co7qXgCwMPDY0JYpgWmBQIAIyngu3hslHOWDQkHjW7AOq5sUJCQMbhBhpGyQcFuYtIJzeAfaqnk/pfZBAsZgTRiGvTJOmEM2YCGjs5d1elkwxmOdrJBABaHNyLyRSIAKgtzfZo80haXKEn0DvREYqfbpKkr3NY7eErlhpClscuZFIkGNXVkljACZNvOYDx5urcQAgxzjDFtjJ/5b2U77JJwRzIu/v03z3QPRPyq6vZgdduwFuZm37V&#x2B;yfhdmGSJoiw/Rmi4H5Fp2Ym0bk1tZEakY/Yrv7D3PIdgaGQec4BQuuRm&#x2B;ZbPwMQSk5A/hPMrWLgNhAAEIGu8db&#x2B;Yuw5le2UYlwyXwgk3yXgCwMPD48xIlN65fumq2dNjqXTvYPw3z2&#x2B;xGbtYFMA5cQ6ywRbIYpBgiItxZUNm7wIQEOSWNYMyargbFuqwYDgRanDFQyZVSR0ubxiWDSdqG04rG/Dw6IbhP8&#x2B;I8gY&#x2B;GbKBAXQYtM2&#x2B;WP7&#x2B;edkBRZZG1/Bp6s&#x2B;efO3KBXXlhWM0OXh556EDx1vx6EbJSD2ldbKLRIlfU04SAAjSptXYFT7dqjjnnX2RU6MA/bE4F2J8J3kiZTB&#x2B;UskvQghMe9SDAG7m2eg/oxBivNAEQpNV76hItLN/8PGXt4M7jxBjhDHGmFh2VXFeyerQ2e4QnQ&#x2B;/AmfC0sGxwZ27hwkCwRODIjHAY72scTc7vBEJDkQCQOBYQCW6/A7lho&#x2B;dVS9/OmsNaz8MiUEgBMkKaz3A&#x2B;9uJJwAuFS4JwT3ZeALAw8PjDAgASvDa&#x2B;TMevOMaxnnvYOyPL2&#x2B;zbBtNcd0eAsY4sx3AmLjFg1NugroueYzOVTYAEmJCssGdCT0cOnAbsPpGyIaRqUrufGjfUCcltxbCjTbIp5cN&#x2B;ERj1hGyAcariuYCTIFiFtocUX4aCXx&#x2B;cj/cc0WSCEFo1B9B1pTX9x678W/&#x2B;6&#x2B;aVC5bNqSrMyfIrCqE4kTYON3f&#x2B;6PFX&#x2B;geiSsA3bCgzzqXsQEFo7IkiPkXOyfLDCPsbIcS5aO4Kdw9ESvLGGKFFCN60/zg5JafIMO2W7v4Z5UXjfHm7BqK2w0Z&#x2B;vREAcK6fElIwTMt0nJNOBIxSppk2zDH3zDhnhkmU0Z06z9nwfuDG1TsPN3cNRuiIpjdWWm/oPM&#x2B;NcbmTmWsxIs1GGCkR7xfpqEjHwEwLywDBwNSFnhDpqEgM8Hi/iPWBlQZJA0IBYWA28GHr3wQiS6vulq/&#x2B;AJzS8Hd8UCAXyZoADkAAUzHQzvtaSM3Sc88D85havBoADw8Pj7GRCNEUCQDMoO&#x2B;C3NSYw/NDwZqywmTaSKSNwXjSMK3x769CgG3bwDmRpQvYZuSEbDhpdMN49xtHgM1QkrnNlM5FNsgj4gzDE9&#x2B;GKxkyrVcp9w0XPxAhI6Hg0dEGOiQbMIAlYGtUadXJ15uC2aGLxbLRXdf4KctBCDV09Py0b&#x2B;APL6s&#x2B;VdEUSaLEtJyjbd2Obo60/gGA2ayiLLe6JG/Mtwj41OllhWCdNCdYoqSlO/ylnzz6f1/4yKmbPLZx54GGtpHTCYZX9djGnX/3nptP1QbD7DjSlDLM0QKX4vbeQSHESGM9HEsmkvrI0bmI4P7BRM9gfMw9J9O6SJv45CpbjJGqnJ29O8xVS2bnZPk6woMw8mgkeqi5cyCezMsKnNtux8axhW0Ac4RtiHhYRPt4rFdE&#x2B;3i8FyK9glkACIQA5ghbByMlUjFhGwgTIBSIBFRChAKmQGTgDDjL&#x2B;H0xyVj/kiyteqe8/v6JDNoTzBbd9byvhfe3i1RMJAYgHTvRKpTKvP2wmLseZRVM5ifg4TF5eALAw8NjQgzbSmysfuRTALPsRbWVv/inB9Om1RmOfPuPzz/20lbZd9pbtWVawNjs2mml&#x2B;aH9je3ReGpUyIIxzgwTuAAEoMqKJF1UTqBhfzw5z7LBzVAaTlI6qSR6RGGDjIQj0I648sagQpATGj27&#x2B;oIRiacs&#x2B;7SJ47pppXSTCQ5D2TJEoopPHf23dpya0qI5VeVj7oRgPKO8kGgqF2LYLkcI2Q777fNb9je0v/PqZZWFeZosSRKNJtJ7Glofe23X6Rol/dfvn7v1ikVzqsvGVK9tvQMvbD2QTBujBYAk7zzW3BdJFOWeCFN09A44aVMKnjgLKCGJSLy&#x2B;vWeUVAAAy2ZNXQOjNLMQQDDO9p/FbOmR5GYFygpyDzV3nvQoIU2dff3RxKQKACGYLZL9fKBbpCLu0AOk&#x2B;FFBBQoVQvEMYabBMoRtgmOCYwFjgtvAGDAbHEswBxwbmC2YDcwB5gB3gHMhOAgOjo38IWnVPdKV7x016xcEF7YJgiNMRSrKuo/xjmOs8xjoCXBMYaREol9YJmCMZHW4ZgBRlbUe4OFW4gmAS4aL5YI2ZXgCwMPD4xJBCJ&#x2B;mupNQC3KyinKz4TRSxLIdSBtlVaV3r19659rFc2vKv/ijR37xl5fkEV3hrbRx7RULP/3O63oGoy1d/U9t2XOspYtKk3lJdIsEzne0RACAEMM5HOcgG5iA1ERkAwIAQETIhF8gDTg2HeHBtGGe7oNGCBGCyEkO6tEfhxCCACyYUT6nuvR071JZmDd37oz9R5tk9UT&#x2B;jPup729oO9zcqUhUlqgsUSHEQCyp66Z8moqCSCK14iNfee8NqxbWVuYGA6osa4qkyBIXvLmr/&#x2B;ktew41dQghRulVrCl/eXXHAzeuLsqd5z7y5sGG7UebgZ7UzAgBIIpf33vsUHPnvJqT9ExXf&#x2B;TVPYfh5FUJITBCuVnnPjBh&#x2B;ezqbYcaEmkTDy&#x2B;EkM7wYCypj7MVE0JwPqoOG2NE6ekCIwgpPlRQjQtO7hEkBHBHMJZx6nMHOBPMAc6AOcBswRxgNjg2OLZwTHAsYRtgm8I2wf3BMsExUWGVtOSWEyPAAIA5wkiIxADrOMJbD/G2gzzeBwgB58I2wLHc8y4zHgQAbBMQBoTcB3lPI&#x2B;9pJtOXwml0oMfFgxijlObtjycAPDw8AAAsywYhECEEY4wv0jsWH0rCNq0xCiIBwGGMJ9P5pQUfeeC265fPu2rxLDfR4n03XvHoC2&#x2B;mGMfDeRcOqykruH3tYsZ5U2ff4ZbOI8dbYfIEgBBCkSRZIoblmLYthKCUTvpNRgBQjBWZMsYZ52MOi3UY547j2iUYozG7NJ6DbLh4ONbWE0uflAZzttiGNX9Ozc2rFo7zmqqSgrvXLd2/&#x2B;zCooxPoAcBhzHYckQYhhACBET6d9Q8AGCGb818/t0XasFWRJIkSRZZkSilBg4l0eCBKJXrq4VCC04b1wL/8&#x2B;J5rVy6tq2zp7n9qy56jrV3Dc1GGIZq67WD9137x&#x2B;L9/6t787KDbo5Mx9vimXS9s3EVPzv8hGOdlB7RzTQECgDk1ZX5NjaV0DJmvFqa4tS8yvgBIpg1IpfHIogshCMa&#x2B;U&#x2B;oTzgBCQCRETvq0J3T9Yg5wJriTUQ6yhiR11At4f7sY7EREIjWL8LR54FhgG8I2wTaFY4FtgmMJxwLHGvphKNrAbKCUD7SJdBz5ss/uiDw8pgRPAHh4eAAgVFtZQinuG0wk0uPdts/IUGbFVLcJFULYuhHKCX3i/tveedWy2VWl/iFDbSCWbOsdLC4rON7chUckXiOEKMGUYL&#x2B;qSJRMrnVum9aqeTO&#x2B;8MBtPlVJpPWHN2x9&#x2B;OlN0rkmWpwOx3Zqq8vuvmppPGkYlt3SE37zYINu2DhTcAAIUE7Ql5cdMCxbCNBNK5pMX4Dq6fPJ3uOtsUT63Go8BIBt2UG/9v6b1tywct44r/Sp8u1rFv38iVfaegfksTQAyrSwmdBniwAAIYdx2zEEgOCCC&#x2B;Em7UiKfLpdSJQMJlI/e/LV30gSAOimxbk4Va5jAEmW/vT8lo17jt66elFVcX5CN9440LD7WDOjZOTrueB&#x2B;TVlS95YaulYW5quKNPLsoYSk&#x2B;wZ7o9HTbWLZTmt3GMTorj&#x2B;U4IDvLAXAOUMoEIrg9G8nq2TaApi24KQHORsdcGBMcCeTVsQcwWw34CAsHU2glsDjYuHyCwF4AsDDwwMYY//56Xtzgv623oHdx1q&#x2B;98iLZGLTfEbCuXAY82uKKkuMc8tmDpuilt62w3Ky/B97380fvnVdcV4o6Mt48gZiyWfe2PPi9oNPb9kXiyUU7ZTMb3fl47dNPDcYDwV9Vy6a6Y41PdTc&#x2B;XvTgskWAMKyZ1eVfu3Be9xf9xxve8fnv51I9cuYAoDgglJ8/fJ5n77nukTa0E1rb33b1374Jzngm9xlXEA6&#x2B;gaPtXU7liOPcIQLAIIRH7fjPhfCsRwQoig369PvvvH/vfvGM77X3OllX/zIO/7ff/7KsGxZPq2D/6zImMAETfx841ykDQtAIIROF6xDCMk&#x2B;LRxN/PzJ1wBjQjAlhHOOR5fBiICm3rRqwZg7mSD52X6JkNFnkCr//MlN6xfOqigao656X0Pbhh2H0KjYhQBCSdZknyOTDCaACTrZdHpb6enLk4uq/Guq8ASAh4cHVBXnv2PdUvfn6pKCb//h&#x2B;bMVAIxzisnKedMXTq9cUFtBMe4eiG7Zf/zFbQcAIYmSiVxfCcaAwHGYAJi4l9rSzTVLZv/k8x&#x2B;uKStQh8yygVjy189teXnnwU17jyX6BnGW/3TW//mDc2EPTTU6XwERhOwRg5NOTYtCCEoLctYuqHN/raso/tp//RreRgLg509vbO8dwNKJryvnQghx59qljZ29e440AxMA4qQkXwHgOBDQqsqK6iqLP3Tble&#x2B;5dtVE3kuRpPtuWN3SPfDjP78USaSoIk3wW2pZNnAuKfJkfQ0mGGqghAwn2Z9aE&#x2B;xSWhBav2TWW1mMqsinJizJmrrlQP1d//idm69YsGRmVWFOlqYoEsU2Y93h6K&#x2B;f37J9fz0d5ewXQqVS6G305fS4NMg0Pr7sJIAnADw8LncQgquWzHZ/dhj/xbOb8ekbFI4J50KRpI/ctu4rH3lHXnZw5FM7jza//2s/OdLYMU5KNABwISjBq&#x2B;bOuH7l3DcPNhxu6uzsj4zvwT2BEFl&#x2B;daT1/9TmvX//0MNNnb1OykCaouRmCXF5ungAAEbGYeIpHS7WAo9z4GBTx6Mbdw3GkiP98Y5lz6wp/8L771gyc9qR1q599W0t3f3xpJ42Ld20DNOWKPH71fws/8IZlTevXiidjdYNaOo3P/6u0vzQTx97pa0/mkobgE4rVhnnzLLBdmbMqCzMzXpjf72bdTZxGeAOvsASGbNy4y1i2U4o6PvwbesCJ1cFnC26afOxCnKEEPsb2xs7&#x2B;0JBX9CnaYosS5RxXt/e0987IAW0kV2SuBCSKleW5F08I8Y9Lhcu0zuDJwA8PDwArVs0c/iXV3YdOqt0aiGERMkdaxd9928fcB&#x2B;Jp3TbYVl&#x2B;TaJk6azqX3zxo1d/9puW7YyzW8ZYSV72g3esf&#x2B;8NVwDA3vrW93/tJweOt8oTqU1EyDm5DfyqedP/6l3Xf/dPLx4/2iyEAECX7zX&#x2B;7Ut/LPEvP3/8aGs3pScbx6Z108p5lUW5ADCrsrS2vMhymBsWcBhjTCgSDfrfgsmL4LP3XH/P1St&#x2B;8OjLz2/d19ozYFi2admW44DDgHNgHBgHziHoXzp3&#x2B;poFM29YPnd6eeHXf/nk9sNNXf0Rw7QxPsPQW9thQjf8OVkrFs883tbTMxBDGI0TcLDSBtgOaMoEc5MY5xij65fPe&#x2B;CmNWf9CZzMYDxpj5Xs5x5gUjdjKV3wE21YgZJTk9AY48W52SvmVJ&#x2B;6nwxCgGWLpC7caQwIIVUBVR6dR&#x2B;ThcU5chncITwB4eFzuCIDls2sAQAjR0x9t6QrLZ9MMhwtRmJv1lQ/f5f7aER789sPPH27t&#x2B;tCt6951zQoEUFdZfP&#x2B;Na3765xfJ6Xv2C8ZL8k&#x2B;kIgzEU4ePtZCJmTJUUzbuPnrTX3/rSx&#x2B;587qlcwGgIBT81N3Xrl1Q97sX3/jx46/FB6Ny0D&#x2B;JEV4hhO0wYAwAsEQlQt4GNw8hBOMCAOhZxn8uCMdae77680ef2rzHsh1phABgjPkD/htXLsgPBQEAIaCEUELcguhxyHRTnXCyVkle9tcevPtrD97dMxA/3NzR0R/VDTOlm7plc86y/FpAUwtzssoKcpbMrHI3&#x2B;e1XPrFxz5FHXtmxac/RcCyRMqwh2cCBs4x9LAQwDgJySgsWL5l1zbK5f3PvjX96Zft3//RifUevadmjlsc4Z2kTbPvGa1fOqS57dOPO1qZO8CkSpeMchs2YcNg1y&#x2B;d97cF3vkX3PwB09g1alnO6zw1jhDEBOEMEQzBenJ9908rxGjEJ2&#x2B;G9A6yllzV3smPtrCsMtg0IgSwhVUYBDfnUE//5NeRXwa8i/4jHNQXlBJHvrR6yx9uNyzJE7AkAD4/LHYzQjPIiABAC9ja0TmST4Wsl50KV5Xdds2JWVSkAJNLGd//04n9//w8Q9B9r67597WJVlrJ82ur5M3768LOn3RsAwqgkN7s0PwcADMvefbSZGdaYvVbGWD8AAGw5WH/b3/3Pkrqqf3r/7beuXYQQWlhbWVdZvLB22n/86qkDRxvlwLl3Oj9x1AhpsjSnumz1vBmEksaOvld3H470DijZgXO&#x2B;fXAuHMcBIQBjjBHBZ5Ei8tYRAAghieBQ0FeWn9sZHuxs7UZ&#x2B;Vb7IxqINkzLNH/zl5Udf3bnzWDPnXKYn1JcAYCnjve&#x2B;5cVFt5aitvvJ/jz710racwpygTw1qqo/S1Ytnvef6VR19A9sPNxFMQkFfQFN8qhwK&#x2B;opyQ9qEa3yL87KK8&#x2B;YAgNuGlTHOhZApGVNFr188e/3i2QDQ2jPQ0h1u74ukdCNtWmnD0g0rqRsYI02R8kNZxblZa&#x2B;bXVhbnA8AHb7nymqVzv/&#x2B;Xl554fXdn36DNmGnb4DDQDTUvdP36pbeuXnjDivnVZQXXLJvzk8df3XaosW8gCgIQJRgjjE5EG7gQTspAqvTxu67763tvmDmt5Bz&#x2B;BKM40tqdMqy38qVljPv8yhXzamdWFp/2RQihgI/MqSFzak5seLzNOdLCjrawIy3sSIuwHcAYYQSEgBDAueAjaj8chvw&#x2B;9f03qffffOZEOAHCMEXaAIeBACRTUGWkKed9roeHx1ThCQAPj8udkrxs14cqQBxp6TrzEACE6JDPmwtRmh/6m3szHVQ6woPf&#x2B;u0zuDAXhECAmjr75lSXEYJzswLATmtNci4Cfm1OVZn760Asuae&#x2B;HaSzS3rGCAkhdh9veeBrP1q3ePZXP3LXotpKTZHvu&#x2B;GK8oKcv/7vX&#x2B;872iz7fecc6RUAtsPmVJV985PvvuPKxZbtOIzrptXeN/D1Xz75l&#x2B;e2SEE/OsudCyHstAGU1FQUB32qZTvRZHoglnQYnxo3vFsYOqeq9D8/9Z6rl84yLCdlmK/vOfq333u4vTusKPKUKYAv/OgR3bCqSvOrSwrys4OhgKYqsixRiRKZEk2RO8LR3cean31j3&#x2B;5jLV39kUgiTTCmI2MvCNlpvbi86IO3XOlOixtJ90B0z/7jEPQD58A5xBL13VfetX7p9iPN7/vnH0A0DooMBAPnFdVl3/2bB4Zr4icOwZhgDEPCwXacP7&#x2B;y45k39uZkBYJ&#x2B;NcunBn1awKfmBv23r108rThvWnEeuC58xp3MGAeGENJkWZFH35ori3L/41Pv/o9PvftIc9fRtu6ewRgGNKOiqCQ/5FeVyqJc1/6&#x2B;bfWiNfPrHtu4a&#x2B;OeI8fauuMpPZE2DMs2bce0Hcswc0LBu25e&#x2B;55rVy6qnVaQE4TJYNexlkRaJ&#x2B;daW8K5EJyvnDP9i&#x2B;&#x2B;//WxVBKmrJHWVcMtqYVh8MMaOd7D6Ntbey5u6hGGeFM0xbQho2n03ye9YN7F9C6FbrKWbN7Sz4&#x2B;3OsTaRTAMAUIJUBflPhBrApyI3zhDQkKaioIZUBQU05FNAU5EqI1V5OxXevD25KJ0d5xtPAHh4nBcuIT9RblYg85OAjnAEnam7iCbRtQtqH3/sFSZRJT/05Q/f6XruAUCV5FlVZUcb2oBgTZXzcoIAIAC44OPslXOR5fMNOyMHE6n9jW1Az3B1GvOCLYRI6Oazb&#x2B;471NTx2Xdd/1fvugEA1i&#x2B;e9Y1P3fuxr/&#x2B;kazAujVuLPA6MsVDA95l7rrvjysUAIEtUlsCnynnZgW9&#x2B;4l2D8eSrm/co2cGJe80Z44yxK5bOuf&#x2B;mK6pLCrP9mmHaLT3hl3ce3rDjUDSRmoI4gMN4XUXRQ3/7wJoFdQAQ0EhAU&#x2B;5avywr4HvXF7&#x2B;bMu1zturOll88vam3oxcUOS83Kyfozw5oqkwxwrplD8QSHX2DAEiRJcGFadsCQBqV94/AMq2gLP/Lg3ctnzVGHjnBGGRpuFWoBZAd0BBCqizl52b1Y&#x2B;Q67C3LpoTwybAGHMYPNHX87s8bgFLgHITIfGWDPmfLr4brYVzZMPGeorOrS2dXlzLOORdj1hPnBH0fvu3KD992pWk7zZ194VgyntJN25ElUlNaUJybTTDOnrxOOz0DsaOt3ZZty9JJx&#x2B;A2pBqn7EcAcMYZ5wola5bM&#x2B;s9Pv6esIOccFyFRJFES9JGyQrh6ifHb58zmrsyYXgBASKQNnBVQHrhRvv3Kie4TIZwbxLmzYGkmL1GEo/ahJudgIzvcwo63CtPOjH7ACBACLsTwXxkBIOQGIoTDpJVztU&#x2B;/k0xGsMXj/HFxBjzPK54A8PA4LwQ0JSfguyT8CtlDjbcFQCSRPmN3wYBP&#x2B;/kXH/zCA3d0DURCAf/ahXXDT1WX5v/qnz/2jz/4g2E51y2fWxTKAgDTsjt6BwGN49IWPlUqLch1f0mk9Ob2PkzHiwBkJteO9fG6oYDGzr6v/OQvhu187n23AMANK&#x2B;Z96j03femhh7mg5zYGi5v20iVzblg5HwASaf0PL23ri8Q/edc1uVmB2oriT9517Z5DTQnLmmD7VC4E4/z2K5d&#x2B;4xP3zKspH/nUh29b//imXZ/4j1&#x2B;Go/HR5a2Tittrtba8eM2CupGPE4LXzK/94G3rvvv7Z8lbThCfCMfbe2yHSVl&#x2B;IWAgnhyIJDJ/WQSAMcHYHeds2Q4AnNpxEiFkGqZMyafuv&#x2B;Xea1aeVQXLeUWRKAT9o6pysyejzz3BZ&#x2B;7UpUh0VlXpyAafwybxJPKjx1/pj8ZHfe0t275&#x2B;&#x2B;byW7v764y0A6IT/G6HMCrgAieaEggU5wWuXzPnyR&#x2B;4qzpuMcbmUOFsPOruPg2FmLjgICd3AoYBy303KbWvfyvGjgpB81RL5ykXCtHgsyY61seOt7Hg7b&#x2B;nhA1HACCkKogQoGfkuyGGspZs1d3kCwONi42K5UHp4vM3IywqW5OfAVE3CeiuM9HdOZHQXQpCT5V8xt2bkg0LAX17bcc/Vy1fMqXnloS&#x2B;OfGowkXp1z1E4JathxLZCkeXC3Cz312TaSA9EpJzxDAK/phblZINuWYqFyOhEZ4SQREk0lvjVM5uuWTJn2awqSsmHbrny5Z2HX9m8Ww76AQDweO7JMeC8MDdrWlGe5Tgb9xz90o//HA1HYon0f37mPQBw8xUL7rp&#x2B;5S9&#x2B;/xzNC53Rk4QAnLSxfFHdf3zq3tlVJQCQNq299W2FoaBbjPGOdUt7I7FPffXHkPVW6xbGQQihyLSkcAy3q6bI1y6d891fPglTMpRp&#x2B;&#x2B;FGzjkAwhhkTM/qvoQQmPFkMCfr43df&#x2B;8UHbr/Yx0hdUCbd&#x2B;j/W1v3Hl7cNxlMjW6lall1RnP/FD9yxuG7agcaOfQ1tbT0DsZRuWLZuWrppC8EpIUGfOqe67K71S2dWTppl7Ow9bvz&#x2B;RdbcBXgokOkw5FPVe6&#x2B;Xb10zOXk4BCOfSnwqKcwVS2eJaJKHI6yjj7d2s44&#x2B;3hcRg3Fh2YjSzNtRIsJR3twFV511UpnHVHIJ&#x2B;OomG08AeHicF3Kz/Mvn1Pz6z&#x2B;JM3UcuPJFE2v0BITStKJ/ZjChjWMYn6gg5txymjvBrtvUO/PrZ17/9pxebuvref9PaYWce4zxlmC9tP/johjclbbyKXonirCFncySRBi7GN1Y0Rbpz3ZL9jW2D8VQybSYNI62bSd3UTcu2bLAd9z&#x2B;fog6bJiX5oS9/6I7G5o7WrjAQglQlPzswvE6HncE7ihWpsbPv&#x2B;4&#x2B;&#x2B;pMjStoMNfeEIYPTklj23rlm4fvHsgKbevW7pky9vj&#x2B;omOZPb3nJYbn7o3mtWudZ/JJH60ROv/vapjdUVJV/5yDvcjkzLZtZU11Y2tvdM1sTZU0EAtsMj8dRYz4kpS/4BgB1Hmh3Gz9Y8RQiZlg3x1PyFdR&#x2B;769qPv&#x2B;Mq6fRpY7ppQSxhwVAeTjKdSBtuY9C0YYFpW26&#x2B;yqUQsrtIGIgnv/STP7d09xOCT7rGGdb1y&#x2B;fWVhRnB3xrF9Ytn11tWI7tOM5QtQMluCg3a9InG7D6DuM3z7GWrhNxBgChm/L6VdK1y2DSi2oIRkEfCvpwRSFdMhMsm3X3s9Ze3tDuNHTyxnahWxkNIBHW0sN7B/BYQ5E9LgIER9hLAfLw8Jg01i&#x2B;auWL53G37j0&#x2B;wm82ForGz1y0GJRjdf&#x2B;MV//3ws1YyDYqMMcYICRCcCyGL4Qzd3kh89r2fz8n2Zwd82X6fqkhpw9zf2B6Ppf7pR3/ee7ztuuVzK4vy/D6lbzD&#x2B;l9d2/ua5zVRVxstoFwIjJA9V/ZqOMxFf5bJZ1U/8x98AAOeCcW45jmHaadNKG2Y8pduOQzAJ&#x2B;rQZFYXDm6xfPPt7//iRhx55MRpPFhXkXj00/syw7JRhjP&#x2B;mkixvP9iwfedh0BSfqmh&#x2B;TTetY/uO/&#x2B;TJ19y&#x2B;LusXz7r1qmW//sPzND9HuIPHTjN7VZjmylXzP3L7evfXl3Yc/M&#x2B;fPxYdiB&#x2B;ub68pK3AFQF62f05VaWNzB5w/AYCQZTsHG9u7&#x2B;6OjqmZNy9l&#x2B;uAXOZwLSSLYdbByzkfw4WLYDsWRWWeEH7rn&#x2B;vTdcccW8GeO//lN3X7diVrXNeSJtpAwzGk3MrqmQJFqWn3P10tnd/RHbYSnDSiTTmiJfQgU8F4r6tp5//93TT27a7XAxsmCdc04lcvMVC0qHLheKLCnn7Ts8jOgd1H/0KKtvH2n9AwA4DqkqQUNS/zwiS2RaCZlWAusWARepr/3c3rLP7TeKJMqau52GTtkTABcjCACEVwPg4eExicyrKf/Qbet2HmrkXJy5tc6Fw3bY02/svX3NYgCYW1P&#x2B;8L9&#x2B;&#x2B;v&#x2B;eem1/Q/tALGU5jk&#x2B;VQwHf/Onl1y2f575&#x2B;MJaKDUZTptXaM5CZ7wOAJaqossP5w09tfPjPGwAyPdhBVcafAezCODds2/1Zk6XTxWPHtMzcRuMSJX5VyRtq6D7K8o4m9VBAA4Db1yy6fc2iUXsIRxLNXf3j&#x2B;wgZY7IsVZYXX71s9t3rl82cVhoKaGnDMizbdphESdCnvf/mNS&#x2B;8vru3tRsUGWwn6Ne0oapT/9BEM8uyy8oK771uVSjoA4CUbm7cczTa3ieVFdqJVEo33ZdRjDVFhgnOQj5XJIm2dPd/&#x2B;r9//fMvfjTLrw6n1&#x2B;842vz9P79Ip2TE0mA8ueNIE0&#x2B;kgBAgGDAGjABnUrqG/slEoDjnju1AWq&#x2B;qq3rgQ&#x2B;&#x2B;4ctHM1fNn&#x2B;CcgsJfOqlpYWwlCcCGEa6dirMjS8lnVv/rnB22bOYxbjmPYtmC8OO9cq1FHIIRIGSZEE5Yig1sqijFgZF40JQrnRtqwfvnspr&#x2B;8uvOVXYcwxqMc&#x2B;Y5uvvOm1Yvrqqb4epf&#x2B;3p9ZY8do6x8AKOEdfZA2YCp7/2NEqkvtnYczVRcS5V19rKkT1iyYujV4TBj3G3PZmf&#x2B;eAPDwOK88eMdV7b2D//azRyVVvmhH3AshvvDDR25bvchd4TuvWra4rvJoa3dbz0A4mqAEVxTl3nvtKrfvimFaz2/dD25/8ZPn&#x2B;wi3NjHog&#x2B;BZ9hhBSDfs3oH49NIiAKguLfAV5hqWfZJtIQAQyEM&#x2B;6Vgq/cquw719kbLi/JygP&#x2B;hXs3xall/za4oqS8NGQDydPtzc/cyWvbsON95wxcL3XL&#x2B;qOPek0gLbYbppvbTjYGtzhxQ8bcK9EIJxvnLejP/89L2r59UOP55z8iZr5tf96mufeX3X4f5kmjF&#x2B;yxULlaGklIV106rqprV39xNC7rl65buvWeE&#x2B;Lkt07cKZvykvinf0oqJcd5wCANiMG5Z9vptJIQCH88c37WrrHfiH&#x2B;2&#x2B;dWVEUS6SfeXP/b194YzCZGiejZhLxq&#x2B;rv//VTjR29rb0D3eFofzyRSBkpw7RtBxDinAOAzbhp2wThmVUlVy2adc2yOdNKCsryQv5x88pGkunReQqSRPOkyemGOQpZkm65YiEXwrTslG6mDDOpmynDPLca9PPKQCz57T&#x2B;9UBjKqi4tKM4LhQKaX1UUmcoSVSTJPfE7wpHdx1pe3nFoX0Pb4ebO8GCMStIov4Zj2cHswMfuvHp6WeFp3uq0MM4ROmnUcVN3uLW7P5ZMr5o3Y9RpO3rblh7eHQbGx9DwmmJvO0hqK6Wrl0zl/C86t5puKWDtvZkIHsK8tYfHEjj7vHzZPDzOAU8AeHicRzBCX//YO3OCvi//7NF0PIUVmUxlbvWEaejoveoz3/zOX9&#x2B;3qG4aANSUFtaUjnELtx12tLX733/7NFEm0zdMMO6Lxt882Lh6fi0AzK4q&#x2B;8qH3/GvP3qEIcQ4FwCCC2ZaVFUWzpjmbjIQS33vkQ2vPvka&#x2B;DUABAgBwUApyFRW5IBP9auKX5UVWbJspzMcifdHthxqfONA/bLZ1RWFee7UJ85FS3f4Dxu2vbD9AAn4xvm7OLYzrbTg8/fd6lr/jHPHYVyIZNqQJBoaaqqoytKNK&#x2B;bduGLeqXtYu6Cu&#x2B;S//E44kAImApmlDURGJkjuvXCL/yyff3Hk4vzDnnquXu49HEqnW7n6Y7DzpU8EIYUp2H2t5zz99j1KqyBQhpJvW1Fj/AKDI9N3XrDBtJ2WY8aQeTabiKWMwnkrrJkcCCRT0qTlZvqrigrKCHCY450KR6EUrp4ehBK9ZULdiTo0QwIXb7J47jHMOeLyOWBeA7oHo17/zOxBAcrMqCvPysv2hoE&#x2B;VJIRwyrQisWTPYJRgLATEU3oyrSOC5VOuAMxhsoCvfOTuNSMU8ukwLDsST6UM02EcI5Q2rbaegabuvpbu/tae/vbewbRpUkxMy1YV&#x2B;Uf/8IHxBQBQDJyP&#x2B;QyilA8mjIdf5OGItGIOyg&#x2B;hoA/J0uSXBJwMqatEpQWiqQvJEgAgibC2Xt7QiZfOOuO2Hh5TgycAPDzOO3/33pvvuHLxQ39&#x2B;6bGNu9pbOsGyM1FHBICHch4IAYyBYIyRm3w/lSsUQmw71Hj3F7&#x2B;7ZGb1NUtnza&#x2B;pKCvI8WuqX5Mdxm2HpQ0rZRjbDzd/4Yd/HIinpEm9fRKCI/HUs2/u/dCta3OzAn5V/tz9ty2fM/03z7&#x2B;xv6G1ZzBOEK4qzb/nquXvvnalu0kybbT1DqLSAkkeQ4ok00Y8pXMuuOAggBAsZweSuvHIc5sfeeJVYDwTUKAEJIpUZXRT&#x2B;VM/H8tePrvmmqVz3M9qz/HWf3zoD6/sOSpLVJMlWSLXLpv35Q&#x2B;/Y9Ypnf76Y4lwJJEfChaEggAwavTS81v398eS99&#x2B;4&#x2B;u51S&#x2B;8eMXlKCLGnvm3fsRZ6/pOnXSSaCebYDoNx27efD9x&#x2B;/Kos5WUFAArGeSWBi8t0Hh&#x2B;JkjN&#x2B;tS44DuMNHb2AsZyT5TDe0tXX0un2YEUIY4Kx6&#x2B;bnQzUtY1al245DBXr/3dc&#x2B;cPOaU8MyQoj69t7DrV39kXg0mU7qZiKt90USXf2R1p6B5q4wT6RAVYhMJUIQQg7njsOEEMB5TijofifHgZQVoLJC6ItkUq1Ofm/kU0U0YfzqGeM3z&#x2B;HqUmlBLV1cR&#x2B;dPR6HzWBiAgj5SUWgTnBkLIFHe3svq26knAC5OhFcD4OHhcX6oLS/&#x2B;1qff86UP3jkQS/QMxgZiyUTaiKf0aDIdT&#x2B;nRRDqe0uNpI5ZMJ9NGPK2ndDNtWLphgu2Aw4CxE&#x2B;ngw/nEBAPBgAkQRBB2s6bPeYVCiLaegfa&#x2B;wdf3HS3IDuaHgjlBf262nxLCGO/qj&#x2B;4&#x2B;1tLb0UuCvsm1/l0IwTsON33jV0/9/ftucZsIXb1ktlukq5uWbloO40Gfqg35HV/dfaSxqYOePqaPEcIEwbC9KIASAuc8/4iLgtws17KJp/QfP/bqyy9sWXrlktvWLDJtp6mz742D9Xd&#x2B;/tvTywoLcoI5AX92QMv2a7JEDzR1vL732OKZVR9/x9W1ZUVBnxrwqQAQjsQf3rD1O3960eHcMK0Hbl6rDKWG90cTm/Yd&#x2B;&#x2B;FfXkacX8ylIx5vD9KmuftYKygyAFD3kjIW&#x2B;NT0&#x2B;iEs3fT51Xddt&#x2B;rfPn5P/ljltknd&#x2B;P5fNjz&#x2B;8nZd8HAkAZmRuhQoBkopITSUEcZcCBACDQ1645zLE4lEIeT72/cZP3nMfnWXMG2QCEj0RCNOIYASlB0AIUTPgNkVNp/dghSZVJXQZbPoglo6p/ps545PBDJzGi4rED0DIFFACBzHaetRDAumpLTG4&#x2B;wQ4jLsAOYJAA&#x2B;PKUKWaEEoWBAKzppWesYXcyEM00qbViJtJHUzmTZiyXQ8bUQT6Xhaj6f0aCIVT&#x2B;nxlBFLpl0tkdSNlGGmdNO2bLBsYBwYPzFQCaFMtCEjGzKBhpHt8wnBQkB/NNk3EAPGgfOMsxwhIATJknzemmkQjBO68b9/eKEzHP30PddWFednB3yqLFGCNUXWRuYbCPjun1/8zsPPYkKmMk4i4YyJMBhP9UVigPDsqrKvfORuzvmh5s6//t/fvrZl7/HmDnBY5qNzcxIkCVT5SH3b7x99GTAGiRJFCmiqKks2Y7FkGgT880//8uTmPTMrS3Ky/BTjY23dz7yxt7erX8nyn9kpJcTIuVeKRD3FcM4kEslUKqmqmqapinJRd&#x2B;6aRNK6ued46zkkmyEElu2ItFlTU3bfTWu&#x2B;&#x2B;IHb1bHCcQDAOO8ID7a1dKLsICUE52QNPyXcmmwhhsq8gQvhOAwcBo4Dpt3LJ1QIj3OD2mffpbz3Bna0xTnUxI6385ZuYVoZJUBJZl4vJWiobIm1drPOPuvFbSjoI5VFZN50UjeN1JSiSQrakJmVuLzQ6ehD7hlKCW/vcxo76dwxJlV7XHAuO/PfEwAeU0k6nX7&#x2B;2ef27dvn0zRCKaU0Ly9PkiVFUWqqa&#x2B;YvXHDqjM/LFoyQT1V8qpJ/NkVjDmO6aSd1I6Wb8ZSe0I1EynCDDCdFG9J6ImXEUplYfFq30qbFTQscJ2O8utfC4QwlBCCEcJglxPnLUJIp5Vz84ZmNf3h206K5M5bNqZlXVVZWEMoPZfk1OaWbfYPxPQ2tu4&#x2B;27Ktv6&#x2B;0bVPzaFAZtRUo33J/yQ8FZVaXPqXJLd/i5N/eFAr7W7n7dtAAj4AIIkfy&#x2B;0R&#x2B;PLI1sQqKbVtowYSjTpi8Sf&#x2B;rVHU85DAQHh4NEwadMyPoHILJ0pLnzh4&#x2B;9nO33ZQe03sG4zdioQNDIiQ0FoeDpsqU9tu/Y8ZOf/ExV1ezs7LvvfsdV69dd6BVNBWnT3nakcfzB26diWTYk9aySvBuuWvHh29fdvOoM/W0oISBLGCOHMbAYcAFCAEaSqvhVRaJECGFYtuCiICd7enlBdUlhRWFOaUFOQU5wTnXZRJaE/Brxa6S8gK6YK8JR3tPPGjtZSzfv7ufhiDAs5Lo/0IipBQ4T8ZSIJnhn2DnQhPKySUkenlZCqktIeSEqzEFvodgJ54doRaHzRuZ0Q5LE23vZ0RZPAHhcJHgCwGPqCIfDTU1Nn/rMpyORiKHr8XjcsqxkMtnb0/P6xk3XXHftbbfffqHXeGlDCQn6SPAsm124EzpThplIGQndSLjRhiHBMJyhFE2mE2nj7DOUMAxlEp8xQwljJAd8XIi9x1v2Hm0CACBElqgqS4osEYzShhVPphHG8pRa/wCUNneHeyPxopysoE/97D3X9wzGn9q8&#x2B;x3/&#x2B;G0AxBlHGJWWFS6bVZ027df3HeOcj3&#x2B;wI5&#x2B;lhIBvtPk1waMjsnSoufNTX/o&#x2B;CAEggFKaHZApcTfGGDmM//SJ117YdiDo07L9GuOcTkFP9EsTWZazsrIkSZLli7dn16TT0h0OH2yAnGyLYiAEMEJD&#x2B;YTo5C&#x2B;qEMJ2GJgWGFZF3bTrl89dt3jWPVcvP2MbViFENKVDX4SVSSWFucV52aGAz6fKskQDmlpemFNZlFdVUji9rLCiKIdzYTlMCCER4tfGnR8yJoTgnCDkBEldhbRuMe&#x2B;LsJZudryVNXXx3kERTwndhJFFBQgBISBAxFMiEmdHmgEQLsollUWkrpLMmoZL8nF2APlUkOjZznQktZW4OE9EEm4IQqR03tJ1drvwmBouQ/&#x2B;/JwA8poxwOPyH3//&#x2B;vfffn19QkJufP3J0fE9X138e&#x2B;9brm16fP3/&#x2B;tKqqC7fGyxS3/jIn6B&#x2B;3/PIk3Ayl5FBzw3hST6T14QylofQkPZpMJ1LGOWYoUepmKMGQRHGHKmdqEKc2X5Mo8u6jLb9&#x2B;bvM/vO8WACgvzP3Vlx4EgETKGEwkJYlyxi3HUSTpzYMNBxrb&#x2B;yKxKeqi46YAnTzGa9RHk9SN/Q3tgmdiO7JfnZTxApflHfOCwTnv6uoGEIqiBoMBRVEnS6FUFed/7v890JtM9QzE&#x2B;mPJRErXLdu0bIdxLrjDuOMw03aEZYNE50&#x2B;vWDVvxso5NTPKixbVTcv2axN5C1WW//bem969fmkoK6gpcijoyw8FywtyfKdRDudaqTMGuDAHF&#x2B;ZIK&#x2B;YAAO8ZdA43sf0NzuFm3hcFwYGLTGoQAvfKg2QJhBCRuB2O2FsPCs5JeSGZXUXnz6ALa0lZwVlNxyO1FaSy2O6LZNKKCGGd/aypk9RMKKbhMYUIcZ6HrlyEeALAYypwHKezo7N25szKiop0Ok0otd2uzxhjjHfv3p1Op997332bNm16wBMAlwLDGUpntZXDWMqw0oY5nKEUS&#x2B;oj05PcaEM0mU7p5llkKGUCDuT89VCiFEeiie89siE/O3jN0tlFudmKJCEEQb8a9J8Ub1k6q6q6tKC3bwCmqo3mGUEIDTf5AYDJGi5GvYS9KcSyzJ///BdHjh4TQly1fv27331Pbu4kTCsDgJqywm/89fsSKT0ST4WjiYFYMpJIDcSTqbRJKRYAOQF/KKBNK84vzAkihH2afFZ5iQCgytJ1y&#x2B;dOcWupU8HFuXJxLlyzDABYRx/bfczeW&#x2B;8caBDhCFAKlCBKgBJ3dBeSKGgKAhDRpL15n71pLyAgJQVk4QxpcR2dPwPlZp35HUvzcUURvHkANAUAEKWsM8wON3sCwONi4GK5RXm8vRkcHHz66af/9u/&#x2B;Lq3rI1tJYIzbOzr27ds/f8FCRVECgYCAs42yelwyUEKy/doEvYbDuO7/RNpI6aarGRJpfXQDpdNlKFk2OAyGxhUDnGOGkhCg&#x2B;NT2rvCH/&#x2B;2n16&#x2B;cf/PKBYtqK6cV54eCmiJLjItk2uiPJTv6BncdbY7Ek&#x2B;j89&#x2B;&#x2B;/sBBCCkLeSKOpAyEUCASys7MZY5OeoUQQCgV8oYCvunTsIODIIt1zACFELrKUKlJeSMoKpJtWiZTO2/uc/fXscAtr6GC9g4hgkCVECRCcqRse8vrzSJxv3OO8cQA0GRfn0dnVZG41rZuGsk87QxCX5qGgDzgHjIFiEYmzho6pOkoPj/HwBIDHeceyrPrjx1evXq2qajqdJkNt5twbQntb26FDh77yL//a29tDKWWM0be78eRxVpzIUJowwxlKwz2UEmlXMBinZijFUnoybSR1I6kbacMaL0OJYLBhw0tbN7zwhmsZgCIRRfYpsk9VZIkAIMOyk2mDSm/nS6sAkAmeP738Qi/EY4q4CKcXTwIIIVlCsoRzskhthbguyfsirL2XN3aw1l7e3c&#x2B;jCeACUZIJM7oIISwbDItFkry5G23Zh/NDpKwQzygjVSW4JB&#x2B;dXGODAIAQsJ3M7xixrjDrGSDFeVN6sB7jw5G4/LIa3853KY&#x2B;LhFQq&#x2B;crLL//jP/1TKpVCJ7v/TdNsb22VJTmYld3e3s45fzveZzymmuEMpcKcM4fph7Ec5vbncSMJbrQhmkwn00Y0mY4mUvGUEU/p8bTutl4dzlBKGWYimsjUQ3MOaCireKoylKYYwbkqa&#x2B;&#x2B;97ooLvRAPj8kBaQrSFFycRxfMEGmDd/Wzli7W0MFaesRgTCTSwrAyp7YLRgAgDEukDdbWa&#x2B;84gkIBUlaAq0pIbSWpKsEFIaQpoJv2wSYRT6FAJuyJKOHdg&#x2B;xAoycALhKQAJljgQRjZ5g39/bDEwAe5xfHcVpb2tauW0cQ4pzTERVUCOPmpqZdu3Zfdc01aT1tWRZnjHjuf48LhEyJTLVsv1ZyNrdm3bQMy06kjRH/jW6gNCpDKZk2UoZlmhbYDtjOW89Qmkq4EAJg7cLaa5fPvdBr8fCYfJBPJTPKyYxyuG6FsBk73sYONzsHG1ljp3D7nomMAACMAA8lCJm2c6wNDjWB&#x2B;RrKzSKzqnB&#x2B;Njvaxnv60cgyIUp5OMKOtMD1Ky7M4XmMQGLYkdFgHuPUQJdf9rEnADzOL5ZpvfD883//&#x2B;c8lk8lTn41EIi0tLfe9/wO2ZYnLcBK3x6WPO6fsrDKUGOe6aacNM2WY8ZQxMkMpmkwNz2qIp/Szy1DCQ5qBjDHlbVJgjDPHWbWg7msP3jOJu/XwuDhBEqFzq&#x2B;ncauVd14Dt2Aca2YF6e189O9wGtg0EAyWZkcMEIyIDyBAAYNzZXw8CkETh1GxALnhXmEcSOMerorlgUIYFhlS2aFcje3uPXsNnogtdpD71eALA4zzCOY9EB0vLyjBClm3L0omhKhhjQ9fb2tpUn0YJBSEuHh&#x2B;nh8d5hWAc0JSAdnY9lCyHuZoh00MpbSTSJ6a8nYg2jJWhJCz7rfRQOtEAXpLuXL/sb95zk1cA4HHZIVFpyUxpcZ1i2TyWYkea2cFmdqzFaeiAtAkSAUqRRDIKnJx2ghiSCA9H2aEmvHbhVC7fwwVzRAQyA9DtSzQ5vR3GQKfd5whniltLXwx4AsDjPGJZ1osvvPiOu&#x2B;5KpdOjjHtCSFN7x&#x2B;5de1avXWcYhj/gB0AYLjsJ7uExQWRK5IAvFDi7Jum6aaVNK6WbKd2MpfTMlLf0SblJwxIikTbcMdJJ3TyRocQ4KFJJadHq&#x2B;TOuXTb3plXzT9crxsPj7Q9CSJFJoUzyssWSWTyS4H2DvLmbNXaytm7eMyhSOmCUKR0e06VFCAtHnP0NkicAphYkQGLY0qA/aDaJvmazN8l0GzGBBCCvCNjDY1IRQjQ2NuXk5PSFBwgZfSmMRaNtbW233323ZVt&#x2B;8CMAgS67M9DD47ziZijlZZ3F9F83Q2lYCaRNEwQQjEvysiuKvMpFDw8AACAYBX0k6COVRbBsthiMs44&#x2B;1tTJGjt414CIxHkiDZYNAKNlAEaQNnnPwAVZ9WWLxDCTIBpiTaS/ye6JsIQhbIIwQRm34&#x2B;UXAPAEgMd5g3Pe2tq6fv06y7YZZ5RKJz0reCwesyxTkWXHtgUXAMJrAOrhccE5twwlD4/LGZSbRXOz6IIZAMAjCXa0xTnYxA418d6IMC1wO8wMKQHBxeVXcXrBcNP909miTYk02b09RsQQFiAYNv0BXPP/slMAngDwOF9YtvXs009//BOfMHT91PyfcF/4wP4DVTUzHMdBAJZlMocF/Gfhp/Tw8PDw8LjYwDlBfMV86Yr5ACAGovae42xvvb23nnf3AwCYNplRJt&#x2B;8&#x2B;gKv8jIgk&#x2B;7vhx5/son1thn9OjcZ8DHLnLwIgIfHpIERDof7/YFAb28vQicl92OM&#x2B;/v7jx07dvX1NxqGociyZVtM8GD2WXRt9/Dw8PDwuJhBeSH5uhVwzTLVsHhnmB1vAy5IXQWZUXGhl/Z2ZjjdfyBoNom&#x2B;JrM3yXVLOARhPFbw5XI0/z0B4HGeEEJ0tHesuuIK23Fsx5Hlk9IJEELpdLo/3F9YVKindYqJ4Jw5LBDwIgAeHh6XDIyx7p4ex3YURdY0n8&#x2B;nyfJp27&#x2B;MxLKsZDIFALIsK4osSdIZN3mbIYRgjHHOMUburAv3wbdnLziMkU8ltRWkqiQzRNzjvDGc7t9M&#x2B;pvsnkGWNIWFR6T7n4bLTgN4AsDjvMAYe33jxptvu9U0zVMv6IxzXddNy8IIIyQwRrZlccaCQa8vsoeHxxhEIlEhuM/nk2UZXxwduzu7urZu237s6LFwuJ9znpuXu2DevKuvXhcK5Yy/4fHj9fUNDY2NzYlEXJHVupm169etzc7OnpplTy779h3o6OyQJAkjtGzZ0lAoNMENDcM4ePBwR2dHTii7pmZ6ZWWFntZb29oIJX6/v6iw8O05FPLUsQAek8dwun&#x2B;HEm2ye7vMQYNbAIDPYPoDeEXAHh6ThRBi375993/wA/39A6MEAEIolUi2tbXl5&#x2B;dzzt2HLNvmgnsCwMPDY0yefOqp9vbO6qqqefPmzpkz64K7zNta2x/&#x2B;4x8PHTqsaT5KKULQ19v3fNeGbdt3vP&#x2B;B&#x2B;&#x2B;bMmX26DV/buGnDiy/19PZKkuQqmYbGhk2bXn/wox&#x2B;eObNuCo9gcjh&#x2B;/PjLr7yq60Y0HvuXL39p0aLQBDc0TXPXrt0bXno5Lz/vtltvrqys6OsP//RnP0&#x2B;n05WVFR//2Edzc3PP58I93lZggQhHph96/akm1ttmhNPcZMAmYvojuCzNf/DarnucHyzLKiwqAgDDMEYJAIxxLBZrbGicPqPWYQ4AIADbshhnfi8FyMPD4xQYY62tbe3t7a&#x2B;&#x2B;9tof/vinSCRybvvhnE9Ksm8kEnn08ccPHz6ak5Mjy5IQnHOOEFJkOZlM/urXv21qbh5zw9c2vv7oo49HolG/308pRQgRQmRZtizr&#x2B;z/4UX1Dw1tf2xRDCFEU1efTAn7/WfnsEUI&#x2B;ny8nJ5SdlaUoivsIpVQIYVk2F/y8LdnjbQUCkB3MZRTOt/ZqHVvMo8etrjhPCyQmYv27CABvDoCHxyTAOT9y&#x2B;PCatWsdxzn1dosQSqVSvT096666xnEc9yHHcQQXF0lk38PD46IiEo0xxiilADBnzmyf7&#x2B;ymoQ1z&#x2B;MjRp556Jh6PAaA777h91aoV57AT07T27Nu3f/&#x2B;B7OwsxhjGuKysjBAci8WTySTGOJ1O/&#x2B;EPj3zxC58buZUQoqen55lnnuWcU0odx/H5fH6/3zTNdDrtvuDnP//lP/z93&#x2B;fmhs7t6C4IWVlZhYUFuq5TSXL/QBNE1bRFixdqPpVgUlpSAgCaok6bVjkwMJCTk0PQ2zH/x2OykRhmFGJ5rIUONFo9AyxhCgudOd1/LC47&#x2B;98TAB7nAc759m3b733ve0zTGuNpBJZlJhKJ/MICy7IxRgCIC&#x2B;71Rfbw8BiTVDLJuUAICSGyglnnnB0uyxLnbHAwoutGT0/Pue0kGo1ufn2LLMucc0mSFi9eePVVV&#x2B;Xl5R44ePipp56ORqMIoUgk8sYbW1evXjW8Fef89c1vpFIp18mdm5e7&#x2B;opVdXV10WjkhRde6u3tRQhFo/HnX3zx7nfcoarqua1t6lm0cEFZWalhmul0uqiocOIbKrK8YP68BfPnDT9SUFjwqU9&#x2B;HAAcxyHYEwAe40E5Fgj0LNGuxprt3i5jUOcWwFl4/T08AeAx&#x2B;Qghjh87FsrJGRgYHKulAxJCOIxhRISwQCCEEAgAfvkJcA8PjwkwfBkRQhBK0Lne41PJlGmYhJAxJcREXBDufMPW1jY3ClFdVfXOd97t9/kAYOWKZaHs7P/53&#x2B;8oimxZ1r59&#x2B;04WAGzv3r2ujxxj/I47b1&#x2B;2dKn7VF1d3X/91/9GIhFJoptf33LVurWlpaVne2gHDhw8fOSopqnBQHDOnNmjbHHbsfW0jjGWJEmW5UnstJNfkJ9fkD9Ze3M5q0iCx&#x2B;XGcLp/nz/VzPpajb40N51Muv&#x2B;5fLFRZg7AZWeBeKeZB/T29nZ3dyuKommaoijuHUKWJUrPLqQ7jJvcCQilUqlTb7TuycZsZ&#x2B;hUFQgBIADshQA8PDzGIBAIuDYrIaS3p8e2LVU960HFnPPWtvZw/wClhHNOTrm4YYzd6xXnPNOf4BTi8cSRI8cQQpzzUCh79epV/hH5SOXlpbUzappbWhFCXd0nRRhSKT0ajblX1MrKimHrHwCygsEbb7juscefNE2TMWffvv15eXluWvzE6ezq2rhxkyRJgYA/KxgcJQDC4f4nn3y6p6dXkujMmXX3vPPuU/dgmuahQ4cJpYqihLKyikuKz2oBHh7nGwRAHWyrEAlaTSjcZPYkuG4KmyCM31pF62Vo/YMnADwAYOf27YePHJ0&#x2B;vWZgYMCt2VVV1b3dujVqhBBpCEVRZEVRZNn9QVUURVVlWR5WDpTSrq6uBYsXcc4ZY2MH6xEaUxh4eHh4nEpubo6maUIISZL27tt/1VXrhiXBBOGcHz5y5OChQ66rz&#x2B;fTsrNGjx10W/I7DtN1PRaLj7mfeDx28NBBRVE456FQaMGC&#x2B;aOXmpfX2NRMKOWc2bbtdisSQqRSqeEF11RXj2p4v2bN6hc3vGSapiRJu/fsvWL1FaMEwBkPlnNu2zbnXJKo21xhJI7tDAwMdHZ2AsDpmq0ZhvGXRx&#x2B;3bIsSOr2m&#x2B;qMf/fD47&#x2B;jhMZW46f6JXN4iuen&#x2B;cUNYCKFzSfcfi8tQA3gCwAOi8biqapIkJ&#x2B;IJSikh2Ofz1dXNUjTVsW3GmOM4juPYts0cx3bseDzBHMdxbIcx5jDGGWdsZAStsaHxvfe9jzmjb0InEGKEgw0JIQjGgnjfRg8Pj7GZOWtmX1&#x2B;fey36/e//&#x2B;P733zdt2rQJbqvrenNTyxNPPNXe1qEosmmaldMqS0tLRr3M5/MFAoHIYNRhrL293TB0VdVGvoBz3tbWPjA46NN8Pp&#x2B;vtnbGqLFfjsMGBgYQQiAEABruVYoQUhRl&#x2B;AqZTqdPNehnzZq1Y8cO23ZaW9tMw4STpwIwxobNk9O1K0EIYYwxxqfufNiVM86kLSFEOp02DBNjlEgmx3zNubF7z95DBw9rPjUUCs2fP6&#x2B;ocHSpAOfcMAzOuSzLkiS9PWeBeZwrhCMESM8SHWqs2entNAYNbnEv3f8t45lcFwbDMBhzMCaapp351ecZTdNMs7uxsdGy7eKyMuD86Sefeue71JtvucU0Lc4dxjjnnDHOBRPctfZ5BiEEd//n/swZY88/&#x2B;1xpWZlljVUBDMAF13y&#x2B;nNzc/v7&#x2B;YFbGF8W5cBibwoP28PC4lFh/5ZqjR450dXVLktTd0/M///vd1auvWLt2ddnp0&#x2B;UZ55FIJB5P7Ny58803txuGriiyEMJx2Lw5c07VD7m5uQUFBeFwv6ooDQ2NTzz5zK233qzIijQ0vKmtrX3Dy6/IkoIynGR/WJZVX99QX9/gOu9HufADgcBw2PPY8fpkMjlq8PmM6dP37Nlr2w7noru7u6Agf2RXNN0wGWMACCFk2RY7xcc/okzi3HuaE0IoJcOpUBMhlUodPXYcASiKEggESktLTh3R0NXV9ebWrYQQ9xM&#x2B;VQDouv7aa69v27FdU9WysrK733FHwJsJ4zGU7m/5oc&#x2B;fbjqR7u9ghPHkJg1cdt5/AE8AnA&#x2B;EEOFw&#x2B;C&#x2B;PPLJv775EMtHf3z979uxPf/avamtnAMDOHTuam5pM02xpaSkvL5&#x2B;/YOHceXMvbM8HgrGe1ufMmT173tzysnKMSW9PT3Yo2&#x2B;fTfD5t&#x2B;KBcC18IwRh3LX7GGGPcYYwx5ti24ziWbVNKE4lEbk5Of//gmG/HGS8uLl6yZPGG5567/4MfNHT98ou8eXh4nB15eXnXXH3VU08/G4vF3EY6mzdvefPNrbm5oZKS0sLCwuzsLEVRCMaEENu2Hcai0VhrW9uxo0dTqbTP53MNU13Xly9bsnr1KumUmaz5&#x2B;XlVVVX79h9QVZVz/sorr&#x2B;7cubOkpESSJEolyzL7&#x2B;/sjkagsSwBgWdbOnbuZ40ybVpmdnc05b2ppfu7ZF92YgCRJM6bXjNy5JNGqqmktLa0Iof7&#x2B;/mefff6666/NzTkxM7iwqMA1uzFGA5GI22B0&#x2B;Nm&#x2B;3j5dNzBGADgyEDFNc9TiLctyHEeSJMMwLHu080UIwRkf/nnMT3ik333iPniCyYYNL3d2dmKMfT7fJz/xscrKitHvPpSeZFk2G8vRI4SIx&#x2B;Ptbe2KojDGTNv2JsJc5rjp/o4KA0HbTfeP8/SkpPuPyWU4BAA8AXA&#x2B;OHTo0EPf&#x2B;e4DH3h/SWnpnx/589e/8U0qSR0dHZ2dncDZ4cOHKZVeeeklQqntsPDAYDJtrFi&#x2B;5AKGAhBCtmMrqlpeVpaVFQQAf8DPbDbqNcM&#x2B;odON4BQAzGEIgd/vRwjphj7mXUQIkZ2dfeX6dRtefLGzs6OwoNDdP/bCvhcZtsMIwd7fxeMiYdWqlaZpb9y4sX9gwE1l4Zz39w8ODkaPHj1GKSWEIAABQteNeDzutumUZdnv97vOC8uylyxefOedd&#x2B;Tnj9G4hlK6cP78Xbt29/b2qqqqKIphmE1NzcNJNYxz1yh3331goP/Z557XNC0QCCSTSdepjzEWQqiqsnz58pE7Rwhdf921D33/h6qqUko3vPRKPJG44opVBfl5sqzIsqTIstvnFCFk6sZIPzpjbMfOXdFIxPXNt3d0dHR0lZSUDCuEVCrZ3z/gPptOp08dlKbreiQaIYQwxmzLMk1zzCJjXdfdgx2V2jQOqqYWFhZ0dHTYtt3R2RmNRSthtABwDx8hRAg&#x2B;3bAXd/Fj5i95XG4Mp/u3SgNNVm&#x2B;YxQxhIwSTle4/Jvzy80R6AmCS6e3tfei73/3Gf/x7e1vb9x/6/jf&#x2B;8z9lSfJpvnRhwfPPvdDW2nz/Aw8cPXJkem3dRz/x8cqKCozQG29s3bz5jauvXn&#x2B;hep9ZplWQn9/V1fXE44/Nnz9fUdSOtvZp06rG34pzvnvXLtu2NU1VFFXVNPfG5jhO5bRpQkA6nT7dXcS27dra2gc//rEf//DH73rv&#x2B;8rLSgHAG/14UeEw9tBfXvrb//5VQX7uF95/&#x2B;5sH6&#x2B;s7eqeXFf7myx/XlIkaBx4ek8v69WsrKyuefuaZ1tY227ZdZ7bbb8A0TfdXIdxGZH6EMqFL27ZlWaZUuvqq9ddff10g4D&#x2B;dlVldU3XXO&#x2B;549LHHY7E459xNqYchr7krhm0748ZWFNnn83HOY7EYxjgYDLpv5/P5li5ZXFs7feSeMcZz5sxetXLlm1u3qqqqaeq2bdvffHNrcVGRoqkSpQgh1/6mlO7eszceT/j8PlVRAEFfX3jfvv2mZbn3CCHEhg0vBbOC1VXTZFkmhGx6/Y1Dhw67Nj2l9MCBg4sWLhz2xFuW1dDQMDAw4PcHASCeSNQ3NM6bO2fUsYf7&#x2B;03T9Pl8CEA7m6B0TU3N8eP1yWSSEDI4GDm1zIAxzjlz7w5jRgA8PFyG0/071Xiz09tpDOiZdP/zKwuFgHPPnLtk8QTAJPPwb3/3vvvu03y&#x2B;7z/0/Q999EHBuRACYRyPJXq6Ot//gQ8Agueff&#x2B;E999&#x2B;vqWpfX59P01asXLZl8xv79x9YsmTxBVlzOp0yTWPBosXHjh45dPCQZTtcQGnZGRpRp9PpJx5/vKSkFBAwxjjj7o3w6JHDt91xpxB8nJp69zO54cYbZUn&#x2B;7ne&#x2B;c/W115ZXVHp9gC42JEKBEMtx0qbVGY7sPdzU2tNvMzYyVhVP6a/vOxZL6uWFuYtqK7P8F76mxePtTXX1tM9&#x2B;5lPHjh/funXboUNH4vG4EIILASIzKcx9mfuDT/OFQiFVVSorKq699pry8rIz7n/JksWhnJxXX32to6PDMEzbtt3KY8aYZVkYkwUL5q1auaK&#x2B;sfH1TVsMIyVJEkKYcY4RUlU1FAotX7b0lltuOnXPlNK77roDE7xt23YAcDM/o7EYxGIAMOz8JoSEw&#x2B;GBwUGMACHkdiWilEqSxDl364m7ursfeugHxcVFWVlZkUgkFksw5rhBWlmWe3p6//inR5YuWZKfn4cQam1r37Rps6b5EAJCSH//wCuvvFo7fboyopVqMpl88cWX3LADxjhnRG7SGSkpLpJlmXNBCRnoHzQMY1RA27RMzgEhZBjmqclLAMAYt2zL8/1fzmTS/X0Q9qebeF&#x2B;r2Zdi5yfd/1TQ5dgCCDwBMLn09PTW19f/v7/7261btwoB06qmMcYQQpZpdHS0SbJcM336L3/&#x2B;y5zc/KqqqnQ67fP5hBAIUFlFWW9PbyqV8vv9U7/slatXP/n4kzu3b5dkybZsWZaXr1jJHKexocHn82s&#x2B;zR0RMGor0zQFoJtvvUWSJPcOyRxm2fbBAwdmzJhxRjeP2wXoqmuuXr5yxdf/9WtPP/nUJz75yfN1hB7nhE&#x2B;V/ZoCAIxx3bQgbSRUeaSbxLSdR17Z/tF//RFWlNws/3988t4P377uwq3X4zJiZl3dzLo6AOjp7W1taY1EIolEMpFIMsYABCaEECJLss/nKysrmTN3zshu/WekprqqpvqDjm13dnUnk8l0WrdthwumqWpeXm52dnZOTs7s2bNrqqpbWloGI5mMfEmSSkqKV6&#x2B;&#x2B;oqT4tB30c3Jy7rnn7oL8/L379nd2dnLOMSYYZ2qKh18mhHBsG4ZkjOvatyyLEMyYcKMEANDXFw6H&#x2B;4dbNrsvdnfV2NjU0tIaDAZN00gkUooiu4UTAEAIqa9v&#x2B;Oq/fr2urrakuDgWjyNAXd1djY1NkiQJIQBBTU31xD&#x2B;u7OxsiVL3E2hsahwcHCwrOyG0BgcHB/oHCMGEkEQiERmMnroHyzIjkUE32IIQkr1BYJcTI9P9m1G4yeqN8dT5S/f3GMY7zSaTJ5944n333ccYe/rJp6669lrLtFRVwRiHw&#x2B;GDBw7e98D9DY2NBw4evOmWW5OJpDKUR2FZVu306V0dXU1NzfNHzEWfMmpnzLj7nXfv3bsnmUjatm2aZkPDsf379pim6di2EKK7u&#x2B;urX/taTc1JNW1ZWVnNzU3FRcWa7yRtcGDPnpLi4om09BFCMMb8fv83/&#x2B;Pff/SDH25&#x2B;fdNd77xrko/N41whhDxw85o7r1xk2kyW6HuuW9HVHzNtWxvhNTRM&#x2B;4VtB/xZgZ987kPBgBby&#x2B;y3bkU&#x2B;prTxPjNPQ0OPyobioqCA/nzHmXk8450KAAKEqqlute85QSZo2rdL9WQjBuQAQw6VQgYB/1aoVK1cuj8Ziju1omhYITMh9E/D7b7315pkz6/bu3dfR2ZlMJk3TsizLMIxhN6RlWYyxTEKTAC44CCgtLVm0cMHA4EBDQ5Ou60OdiDKnAGMcY8SYwxiTJEWWZbeyFiHk9nJwnTLDRnYimayvb0in0seOH8cYG8aJqoNAIDhjRs2pKz8dOOOiFZIk1dc3bNz0&#x2B;tVXXxUMBmVJIgS/&#x2B;urGo8fqXQ0jSXTvvn0L5s&#x2B;rqCwfuYe29o7GxmZJktzRMT6/VwN8uSAxzAgkc3mrNNhk9faxmCGs853uPyaXYRDAEwCTyc7t2x/8&#x2B;MdSyeSxo8fuufc9GS84Qql0ururq7S09I033kgmEyWlJYw5ACclUvt8mmXbF8SmwRhPn14zbVql7Tjufc7t8MkYY4ypqvpvX/uafUpPT0mSrrn62m9&#x2B;4xtf&#x2B;vI/j8z1b25puTM353Q9QE/FTbS98eabmpqbN2x46frrr5u0A/N4CyAAieC87EwzvvzsQF3lKX3TVfmW1Qtf3nXYdphM6ZObd0eSyTvWLpmaFb688/CD//nzktzQdcvnfukDd8pSxjKr7&#x2B;h9YduBUMBXU1qwdGaVMq4VuGH7wV/&#x2B;6cX88sKrl8zODviaWrqmVRQvm10dCpyFw9jjwuJ2uI/FYpZlE0ooIVmnDPl6iyCECBnjyowQygmFzmGHM2ZMnzFjuuM4g4MD6bTR0tr6zDPPGYYBAEKIG264QVUU0zQM0wQASqnf5ystK120cIFt26&#x2B;&#x2B;tnH//gPu8boZSrqu5&#x2B;fn33D9tZWVFW&#x2B;&#x2B;uW3LG2/G4ylZlhHGGCHbtgmh2dlZOTk5nPPu7m53De513rZtSqkrGEzT1DTtumuuVpSzqAEwDH14rovP53vlldfeeOPNwqIiTVUHBgbT6bQQGeEhy3JPT8/vH/7D4iWL8vPyZFkmlEQjsU2bNqV13S08CAQChHh&#x2B;37c/hGMEYARFpxZvdvo6jAGdm1OQ7j8W6DIsAABPAEwi0Wg0Ly8PAXR1dmbnhGzHkSUJIWTq&#x2B;sBA/&#x2B;w5swGgo709Py&#x2B;fMUZP7rLMhaisrGhqbh0cjOTl5V6Q9VNKT1eF7PbQOPXx9973vv/72c&#x2B;&#x2B;9e//8fkvfIEO&#x2B;X37&#x2B;vo0TYtEomf17tXV1VesXv3qK696AuDiJKmbn/mfXxeGgnnZwY/cvj4/OwAAjHPLZoMD0Q/&#x2B;/X/LhbnTSvJyswOTKAA27Tv2g18/XVBWuHLO9MrivN2HGirLitYsqC3KzQaAeFpvOdTYFvTnBH1MMIDMOXWoqeOz//5zRMk1K&#x2B;b&#x2B;4osPVhTljfMWrT39v3/4OSjO7xmIBX3q//33r4tWzf/NVz55/fK5k3UUHlPDq6&#x2B;&#x2B;duDgIUqpIivvevc7K8rLz7zNhYZSWlhYZNv2pk2bHccBAMZY3cza9evWBAJBzhljHCFwx2O5m0iSdMP1191w/XX9/QP9/f2WZRFC8vJyg8Gg&#x2B;7LCwsLFSxa1tLSGw/26rru71VTf7NkzV69elYgn/vzoo3v37ueM2bZt27ZhGBgTt0i3rq5u2bIlV65be1ZHkUwm3WRXd/1uamtfbx&#x2B;cCDjAcHoSADS3tLS1d7il2I7jJBIJAOTTNMdxgoFAXW3tZH7EHhcZAoBywAwsv&#x2B;gPGM2ir9nsSzPDAodMQbr/6VblCQCPt8KeXXuWr1wphNi1a1dlZZVgDCQJIZRKpTrb2letvmJgYKCpqbmyusaxbUqIm8c5PJ2xqKiooaEpErlgAmAcTndu&#x2B;HzaRz76kR98/wf/&#x2B;z//&#x2B;8D771c1DWPMGcMYn1VFlxv3yM7OSqdTg5Fobk5o0pbu8RZwGEsbFiVEVSTHYb9/8jU16M8PBe&#x2B;8cokrAGyHHW7uWDGvdt6MirUL626&#x2B;YkFxbmgSF9DRN/jHP70AhXn165bMm17&#x2B;31/7ac7iWb/4pwfvvHIxDNWMc7cAdAScc7As4RDddBg/w2XddhgYFjgOABCMQVX8mkI9B&#x2B;QlSDKV6urqYcwRAIlE4kIvZ0Jwzvv6whs3vb5z9y7BBULItu2r11&#x2B;Vk5NzunaZw&#x2B;Tn5&#x2B;XnjyFug8Hg3Dlz5s6Zk0ymLMsCEP6AX5EzmXtZ2Vkf/tAHTdNsamqORmOMsbq6WoSRqqg5OTmFhQUTqZMeRXd3j2mabldWTdPcmb4jG3q6tcuO4zDGFUV2ow2JRBJAuC1HEUJuEld&#x2B;Yf7yZUvPdgEelwQCAAvQLJHyk3QImlhHkx2Osky6P7mA6f4os7zLDU8ATBr79&#x2B;&#x2B;98x13cc4P7N8/d8FixhkAIITSab2rs3POnDlHjxzp7OhcumKV65IxTdOyLEWWNU2VZNmnaYZhJFMZV8oZr/5TyXBFb319/c9&#x2B;/JOBgYH7H3hg7borKaU&#x2B;n&#x2B;8Tn/rUQ9/93p/&#x2B;9Ijf71dkOZlKIoQsa/SgyjNCMBZC9Pb02JaBECaEUEoxIRghjLEby3Y9SMNFb6N&#x2B;8JhEuvujG3Yeemn7wYFEKjfLN6Os2EZImFbKMIfD/X5V&#x2B;bv33WK/y6kpGz3ac1KwHAZpAyybu6lxiqQp8hmtc4QQEAKEUHLmYPKNq&#x2B;b/4AdfNAGqSwo4CCOezCvKy8seIwXZspnDGKVYogR5HasuPhzHsW2bc3bBrwac83Q6LQQKBseuCojH4/F4IhqN9fT0vLl1a2dnl5tF6TjO2rVrpk&#x2B;vnvj1f6RnfRSBgB/AP7wkN78IYyJJVFGUWbNmDo1z5wDgeqPO/lgBAOrrG9JpAwAIIatXXxGNRFpaWy3TcptD6LpeUlJ84w3Xl5QUv755y5Y33kyn0q7RPzT9BWGMFFUpLSm57tprQ54D6G2KZglLxi3laoff6I/W91n9hrDhQqT7j4W4DIMAngCYNLo6uyoqKhhjvb19VxUWjvgyCdf/wRizLHvI2&#x2B;Hs3LG9tbm5qrpGViRVVYOB4NGjR0M5OdxxEELSEK4d7AYKMCEYY4IzIPdfhIYeOF9nEXOcWCwGAA//9nfhgQHbNH/6058uXLQoJzcHAAJ&#x2B;32f/6rNvvvlmKpUydD0eiwGANVavt/HhnMfjic2vb06nEpmjIpgSSt0GeJIky7LrPZIVRVFUWZYVWZYVxX3KTWHKfFBDnwxy/x2hGWBIMFxwK&#x2B;FiJpHW//77D//&#x2B;kQ3g14AQjLFEsazIQpyUoIkxqijMbejs23qoMagpxXmhMU3nc&#x2B;amFfN/9&#x2B;uvJx2enx0I&#x2B;NTIB&#x2B;/05WQV5kxmendNaeEn771x&#x2B;Ne71p3W&#x2B;/jSjgOf/d/fYsN63x1Xzaoq&#x2B;e1jr5RWltx/0&#x2B;r1i2ZN4nrOH6ZlDyZSflUJaMpF5V&#x2B;YLObNm6cqqmmatu1kBYMXcCW247y2cdPjTzxVWlKcnZ3t9naTZckdUIAxMk0rkUx2dXZFo1FFUWRZdl3mdbUz7rzj9kDgLE6i7u7uF17Y0NnVVVZWes01V0&#x2B;rrGxqbjlw4AACVF1dNXv2LDexc3Awum37tngsLklSWVnZFVesdGc7nrPRP0xTU1NnVzdjjHOnoqLimquvys7OikZjfb29NnMkKuXm5gYCfvf6nJeXt2zZ0rbW9r6&#x2B;vnRaNy2LM0cIoBKtrKy4cs2a3IsvAO7xFhEAsgMIoLdQbcnhvSIa1rsMs5cBv0imTF62Dh1PAEwajuMQSpjFGONo1EwJBADAuXCY4zZrI4Tquh4OD5RVTktG0kJEkehOpVLJZLK/PwwCXEPVdX67Zj&#x2B;hVKLuv5IkU0olWZIkWZaGjOMhO3m0ZiBDuxilF9yfJmIH33DTjS&#x2B;&#x2B;8MLMWbMopaFQaPmKFX/&#x2B;wx8cxx5&#x2B;gd/vu&#x2B;66a92fN23cCACWbVM60VsLQqg/HG5tbauoqKicNm3x4sW6Ydi2bVuWbVmWZZnu/0zDtMx4PGlZA7Zl247t9h7lnA27wdyjHvmxZFAy2kFWFFmSZFmWhjSDG2cgQ0GGkcBlqRk456/sPPz7R19W8kIY49wsv27aacMcc1h6NJn&#x2B;5q&#x2B;e3Lz3WH5O1oduvfKjd1zlPu4w9vr&#x2B;479&#x2B;dkt&#x2B;tr&#x2B;2svhjd1x96rYt3eGkbiEEPlUOamrAp6onF&#x2B;wW52W/79YTfUVvWHF&#x2B;e2RFE6lDzV26ZednB6pLC7JPnmngMN4zGEv3DTZ19ckyffa5zbi0cE516aUiAI60dl39mW9G23sXr5j32Xfd8Llv/TK/tOA91636yoffcaGXNjksXDB/9qxZbvOCC9JPeRjmOL09vbIkRaOxWCzuXvOFELbjMMcRQrg&#x2B;b0qp3&#x2B;93ey34/f55c2ffc8/dPt/ZrdxxWH//QEtLq2laK1YkASAc7tu06fVYLL5y5Yrp02tcAZBKJXfu3NXU3IIRmjt3zhVXrHQ3HxgcfOqpZyghuXk566680u/39/T2tbW2aj5fKDt7eJTY6dB1/dlnn4/F44TgdNpatGiB290uFMoOhbJPfX0wGJw9a9bsWbNSqZRl2Y7jIASapl3Yv5fHecJN95cdEQnJrfm4m6TCRm86HbasOEJwodL9x&#x2B;ay8/4DeAJgMhnyqTHOTjj/hWCcDfnbxNCgSqGqSig7O5SbUzGt2nFs10qXJJoJiMIJD507WlJw7jDGmOM4DrMdh9m6biYSSYc5zGGcMcY4FyzzJUZAEEbE7YVNaEY0SBJ1/y/LskSlE2R850OagQzNZB&#x2B;OLKxfv77&#x2B;&#x2B;PGf/eSnzS0tFZWVsiwBAoxPOnsd2yGUNjc15uXnQybpc0ICACHEHGfbtu0HDhy84847bMvSfJqmqZIsSZJETuOqFADM4Q5zHMdxbMc&#x2B;gZVMJKKxmGmatmVblpVKpaPRmONO82GOO7NMDE0dHppOT6iU&#x2B;ZBcbaAoiisZFFUdFhGj9BUeIaqGGZYi5zUmc15hnD/&#x2B;&#x2B;m4U8COEFkyv&#x2B;P2/fjIn6H9&#x2B;6/73fekh6ZQZwJzztp6B48dbW7OD1y6bO&#x2B;JxUd/a8&#x2B;tHN9CAf9W8GSMFgOWwpzfv2VPfsre&#x2B;raG9ry8ScxgvzMlaVDvtgZtW33HlSTXEpmXvb2xv6ekPBXw1pYXTz0&#x2B;ukUtPJPaVn/3lwPHW2qrSL33wzptWLTj5SEU6bUA8ldRNw7IhkeaGxfglM76aYJzl16I&#x2B;lRDMOe&#x2B;PxOMgmrvDF3pdk4Z7el7oVQAAOA5r7&#x2B;gYHiE8fNmXKJUodcfics5N01RVNT8/Py8vb/2VaxYtXnQO7&#x2B;Vep93wssM4AFi2HY/Ho9FYOp0eDkQjhCilbl&#x2B;KkV5/yzT37z9gWVZ&#x2B;ft7SpUv9fn9zc/Pvfvd7RVVrqqs/8&#x2B;nxZrMMDg489vhTx&#x2B;sbOWe2bZeXlc2bO1cdMUKYcy6EGDPI4Pd7Nv/bmeF0/6SfNpdL7aoRNvsTyV7DiABwBHARzv30UoA8zh0xZPYLIQAhAHAcp7GxIZ1MSVQCAF3XFUVxC14RxqZltbe2drS1csFd65xSQihVZFmS5CGznEqSRCiVKMWYEEoowZhQjAAT6l76hQCMEQzNwsy073Qc5jiW49huozjbsizLdamn0rpju9mZrnJgQgiEAEHGaCWE0EzmTcYilihdvXr15s1botFoaVlZNBqzbScSjcmqNlyucOTIsaqqac3NzXl54zVdORWEUHNz8969e2tn1u3YvqOpof7pJ59029JlhIkkaZqmqqpP8/sDPp/P5w8E/H6/z&#x2B;fz&#x2B;/2apimqmp0dHNmK1LIszkXmf0O4912HMeYwx3Fs21E1hTNu2ZZj2aZpmqZpWaZpmKZpptN6NBp19YM7DGHoU4Khz4hIVHIDMbIkS0MKwR8IBAJBSommaXl5eZqmXXIygAto6elHCEmU3Hv9qprSQgC4adVCcBgoY7xeliiosk&#x2B;VpZNjPggB58KyHd080RO2tWfgHx56&#x2B;LU9R8KtPaDKVFNUWXY4b&#x2B;jsbejoeXTjjg/ftv6n//jh4denDOvPr&#x2B;781ROvBLIDD9y0dtLd1QOx5IvbDgwmUnlZwUgy1doz0NfRhyQaS6VHvfLOdUuiG34cS6QJJQLEitppOuOzq0a3Rr1o0RS5sigvnUgrbsMu07LSxsg/jYsQwq2cRghOJ789zoRwjXvXJ&#x2B;H6&#x2B;Iey7VEolBUM5uTl5WZlZeWEQnV1dXPnzj7ndyooKLjr7jvXX30lwaSyvAwAqquqbr/9tlg8XlFePtzYTVGUoqIiXTds2xppowshUqmUYRiKIrvFAJZlxmJx1bQHBwd7e3s1TXO9Hu5lz42CRiLRrVu3Hjh4qL29Qwi3lTO5&#x2B;eYbCwsLRq6tq6v7&#x2B;Rde6OrqLisrvf666yorK44drz9w4AAhpKa6eu6cOXSqZoZ4TDGaJSwJt5arrUErbPdF4j2GPsCFDSAuNte/ixDiMuwE6p1&#x2B;k8awn8O2bDfp3DT07W&#x2B;&#x2B;OXvWbFlRAMC0LIyJ&#x2B;8ru7m7LNBcuWqBIxHY4ty3DttycFolQSigACIwIdpP&#x2B;ESUUZ8xhMuS0lySJSrJMCJXlIblAKaVUVVXqWvHDDn2KMcLIdVWLIfktBGOMcSYYt4dawlmWZRqmZZqWZZmmYZmmaZppXT929GhpSfGyZUsH&#x2B;gePHjmaSCR37twVCuUAACYYAw4PDkSjkU2bXi8uLp74aYQxjsViW7du5ZzX1dX&#x2B;7te/zc7O1jQtEo3KijqjbmZ5WZkASKVSpmnoujEYiXX39GZWaNuObTmO4/qZAECSpPa2tn//r2&#x2B;NnEN5OqLRqFtEME6qkgAI9w1EY1HOuVti6P5rWRbnXKJkKOpg27al63GHOWo0nhUKIYS448QT8e6urtmzZ187lB91qWDZzE138qsZWcVHuLrP9uo9MnWqNxJ75I8vQNBHc7I0RV45p2bd4pn9seSmvceOtnZZtvPMG3t/8/yWB25ak3lfISLxVG97b28k0RkefEtHdQq/e/GNr/70saRhcC4UWVIkOhhPQkBT5TFCTwih7IAve2g&#x2B;QPlVl1iy8ozywle&#x2B;949pyxaME0JWPvOQYdl&#x2B;bXS793Ak8Z1HXtRkWlmS/&#x2B;5rVqjySTEfx2E25wqlowKAFw&#x2B;PvrZj&#x2B;&#x2B;EmDnDH2sWr5s64IA2dsrKyvvmNryeTyWgsFo/HLcsSHIRgCGP3kk4pzQ5lFxUWvnXvgKIoNdXVNdXVbqUZAJSWlORfn8c5x4QMu0Xy8nLvvutO3dAdx3EdUi6hUOh9731PWk9TiQb8foRQaUnJ6tWrGOPRaOxXv/5tbm5uKDtbVVUumOOIeDzW1dWt67qh62ldxxg7jo0QuunGG5YuXTIqAmPbdn//QGtrm&#x2B;OwZDIJAH29vRs3vm4YxvLly2prZ3gC4G2GAJAdgQX0FajNuTzMo&#x2B;FUj5EOO0yHzI3j4vUpXH72vycAJo9hCwlj7KbiECqVllfkFRQ0NTcBgOB8&#x2B;K5ppPXc3Nzrb7hOlmXbdlNDXfvfsWzLth3Hth03xz3jpmecc85sxzaNtBgKKwsABMKtokeAEHVd&#x2B;JRSQjAhVJKoJFFKhpN/KKVSxq9/QjNIlKqqGggEzliRU1Rc3Nraigk9fvTIunVX5uTkuAZwIpHEzSQ/L3dwYKCsrGziZxJCqKmhcdfO3Xfd8843trzR0tpGMLJMs3bW7JbW1l27dn72rz572&#x2B;23C&#x2B;FG0jkb8uUzx2GM2SPyfyzLkmT52//1X93dPeMLgLSud3d1PfXEk50dHa5bS5IkRZEVVVNVxefz&#x2B;/0&#x2B;TdMCgYDP7y8oLKyrnQ5DoXw3eI8R6ujseuGFDbJEESGapsqSLKlats8X8Psty5IVtbSkuLAgD2Oyb/&#x2B;Bxx59fOXK5aUTkCUXAwigJC8kBDAudh1tSd1gqrIkACS/5npJnJN7a46wlc/8dy8IBa&#x2B;5ac2x9u7OjrAjEUkiN61asHx2TSylv/fL339u065wJLF537FhAQAAhGCQJaJI8mnmVJwbr&#x2B;4&#x2B;8uWfPtrU3gMIQVIHywJFxlkBGCtjQQiRSBsv7zr0zJa9A7FUwKfMrCi&#x2B;Zc3iJXXTRr3SsOxE2pAI0VRZubjsGyRRmj30Gc6bPnZ690A8&#x2B;Y0f/xlS6bya8htXzh8pABjnr&#x2B;w5/NGv/qi4uOCqJbNnTSt5ZvOekoKcT9x1zbyai6Xp/o6jzd9/9OVkf0SV6JKZVZSMTlqbMgKBQCAQEKWlQ2mBgM5nt5NhLYExHunjd6GU5uaOIVk1TVu9epV7O5ElCQCqq6vvu&#x2B;99lmW9&#x2B;OJLmza93tDQ5DbrHHYnDSc1IYQSiURJSck1V1&#x2B;1fv2Vsjz6o3azJYUQtm0PhResWCyu6/rI9CSPtwEn0v2z5ZYi2osSfUZfOt1n2XH3BRd5oe3l&#x2B;W28qO5PlzhDX29KiUAAQiiKMnvOnKNHDrt9P1VVcxwGAIyxouLi5saG7377u9U11aqiqKqq&#x2B;XyKLEuyEgj4NZ8vGAwqiuL6&#x2B;ocDr64FyjhnjuMwlvFIO3Ymo2cI10Z2mGMYuhgGAA19wzFGcKJ1EJYoIZLkxgtoJuNIkiQ3&#x2B;2a4RkBSVGVgcFBRZNtmQghJkjRN0zQNALKzQ4ODkRkzZhQUFGiaNsFzCWOsp9MdHR2M8/aOznD/wLLlywEh23HycvMSiTgXor6hadfuPY5tD8kZabi6V5KoLEl&#x2B;n&#x2B;bm5LvHUllZ4brcTr0buTQ1NQ/0hx9&#x2B;&#x2B;OH7H3hA0XyZ5B/DMAzDNE1d1w3DiCdSfeF&#x2B;0zANU6eU3nHHnbPnzHZT/DHG7jmjKvLAQL/P7y8tLW1vb&#x2B;MOz83L6TKtcDicn5&#x2B;fkxNqbWnGrvdRIMext7zx5pVXri0uLj73L9hUQQi&#x2B;dtnsvzy/2SH49y&#x2B;&#x2B;WVaQM396OSY44FPjKZ0LHk/pwy/2qUpSNwEhLrhunqgLB4RO5MeP&#x2B;D6UF&#x2B;T&#x2B;6HMfbO7uf2zjrp888epzr&#x2B;xo6grv&#x2B;L9/8SvKotppz728jSk8ZZyUl3Ke7hs7jzQ3H28BTa0pL3z/zWurSwqf37b/qc17ksn/z95Zh8dxXW38Ds8si5lZRllmZrZjJw44zIxtqG36JWkDDUPDSUMOx4kdx3bMzCjLsi2LmRa0ODxzvz9GkhWRZYqTaH55ntbavTNzZ6XdPefe95y3o/gHAFBUVf/w29&#x2B;s3XaINDKyogIAGYr8eu3umxdMuvfSKe3Nhk9U1r30xaoGpyc7Ofa2&#x2B;RMGpcZrj/OCtKuguLCq3mo0DEqN0yJmT4Crd7hxHLOZDEFmw28mueFFadXOvO&#x2B;37A&#x2B;3mXPSE2&#x2B;aM&#x2B;5XT6MoIAmGIjt/Z0uyUl1rbwrwYUFmCOGPK7chNtPEIVm/nwSA5UW/1w&#x2B;avSwv/B6&#x2B;0n/nzQO0jnPtHyEIwkoQiqLUVNdo/Sq0hhFaE2bty0SWZUEQLBbzjBnTcnIGZ6RndHmL4eHhiy5b6Jw8EcewmJhoAEBaaupll10SCLAx0dHd&#x2B;U7q/LGAAKAAMAIMGPGKWKKaEe2K0&#x2B;up1uT&#x2B;4Hcf&#x2B;vdl9HfgeePUZi7S0gQIQZCYmBiDgVleUQEAoGlKEDjtM9RgMDAGA88LJksQx7K81&#x2B;9wuQWe43geAQACoEqyAlWoqpp&#x2B;AsMwDMe1wJemKIqiaIY2MAzNMDTNMAxNUZTFam3LGbRoWNslUBQtH1AUbU9Bk7JIkiRLmhpeURSZ5zlVha2FBBBCALX9Be2GEARBGIbZtW17WESkAiHHcVVV1YIgYhgKIZBEyev3NzY12ZuaUlPTep8ANDU1lZdXpKWn19XUhkdEiIKA4biqqimpKXa73e12MwydGB9PM7TUutIvy7IoShznban/lZW2HRLGYKiqqkpKTS8tLSdadFGaFAolCMLV7D6Wn19aWgohvPra68LCI2OiI9tvwcOWFAu21gwokiQVHD36/nvv3XjTjWnp6R3K1hAEwQk8JCS4qbFBRpX4&#x2B;FhZUhrq67OyMqOjon5ZvSYlLTUxIb6srExVZIqi8w7njRs31ngmPf4uChiKLhyf&#x2B;07mhoKTFSKOPfnGlwAAQFMGI42haIAVnvlk&#x2B;SPXzA4LsgIAj5XX5pVUYjgmiPLBkxU1TS6LkcFQ1BNgS2ubAIoCABTllHyIwLG0uMi0uMhxgzPK6hrXbT/s9rMf/7xlcFrCD5v3A5IMsZr7pZyKJiGEqraxgIAOO1TnsmTT7GUr6u0QIECFU4f2f3jxbCNDxUcGHzhRVtzs7TBYkpWPV21f&#x2B;csuMtgS4HggKQACwRtwN/uffn&#x2B;p1cDcOn9C22CPj92ad7KutKaiwTlr5KC2BIATxZU7Dn&#x2B;6fBNB03ddNkWLmPNLqh5/9zueE0YMSHvsujkJEaEBXvhp26GteSfDrObJQ7Mm52Z3njwniNWNLoAAI01ZTYyBonopyHH7WVlRKIJQVKWwsu6HVdsJi3H6UEf7BCDEarrziukOt9dsYkii42aIoqjAHxBQxM/ynCgBloMGSv09LZ6N6Jd6xfQxTY7mrMQY7Hccef/OUVWYnJxkMhkDLMtxvCRJWkGZosghIWEx0VGZWelxsXGhoSE9FPPSNJWYmJiYmNgmT4qJjQmPCFehiqFod2s0On8saAnKOFoVQ1dYJIdsd/kaBc6pKEKL3P8PQkvQ08fQE4DzhqK0WF9h6CmfIFmWRUGEaptXS0tPSVmWAQKCQkOiYmIUWdY6UZIEgWEoAlAMQxEU1TxSkNZeCq3huyRpMn1JFATB6/PzvCC31PiKkqxota4AQgRFMAzHcZwiSYqmSIqiaYZhGJqmtJV7hjZQNNU&#x2B;Z2jbZ2ipJFaUNuG7LEkYhjFGI0HgGIAEQXi8XrfHK4pibGyMJMkcyzqcTlGUAAJ7v&#x2B;Ll9/vr6xtS0tOa7A6T2ayqKtJaswtVlWGYysqq6pqawYMH9fKEe3Zmr/tl9f49uwkCb02ZCJKkEAwRBKmpoWHMuPFRUdEIADXV1RXl5e2b9rRWP7f0RtKqkKNiYhZcdtkXn3&#x2B;R3b/fJQsuCQoKatsKAAAABGmp6kYQ7eVCUVTLqTiBdzodsbGxCIoqqpKYlLhn166/PvSXhMRExsDwHCfLckpqanh4OE3TRoORMWgJHUPRNE3TF/fbMTLE9v7jN/9nycqSmiZvgIUQjOyXEhMe/Nb36wCBb807eaS02sTQJIFzgtjsC2AoKsjyjiNFD735ZXJUmJGhax3NSzftRw00CpDKBscTHyydN2awiaEJHIMAURTVz3FZCVHrth70BfiXv/6FFySH00PS1JgBqQ8smt42ExzFAiwPUESVFanVkE6DE6Wz3h7gRdET4AACKAMdHxliZCgAgJGhDDTZObE4Wlaz/UgRoAhRlm&#x2B;cM&#x2B;G5Oxd5fNyzn6/4YsUWn8f37cY988YNjghqaXqIoihNEoAkCPxX8SeE0M8KzXY3IHCHp8Wn1uNn9xaUKs0eiKD&#x2B;gAAAECV519Hij79dQ1nNAMDOCcDxirov1&#x2B;xcvSe/qsHBUFT/lNjb5k28bNLQnu&#x2B;XE8SthwvX7Mk/UVGHoEhMaJDL65dRRBFEXpTajwwPsrz76I1dngRD0dmjBtfsXhLgRQQgAAETBqUHBDGnkw7qInL1tJFXTB4e4AUTQ53djopWBg0BQPtwGTRB4JdffhkAQBB4f4CVZZnAMRwnGYbWVoq0feFenq1tneW8OA/o/B7QuvujENhDqYpg2AQ9jkADx9plmUW0VdA/TvSvLdr2vfhfTwDOH1ZrkM/noyiKpqj2zQFPKSZRlCAILV7kOM7r8UqC4HU3KwrEcQzHUQAAhuM41iL7wXAU07r&#x2B;YBiGYSRFmVsqewkMQzCMwHAUxzCAoDiGtvWrh9rHc2vsrhXztmhceJ7neI7jml3NgiDwQkuxryzLba30NdUmTuAtGQNNa/IkhmGCgoJIgmAMBhRDCZJgGCYyKrKpsSk&#x2B;LlaSJJZlIyPCo6KiREHovdQVwzAAIBtgO7/1IAA4jvsDrMfTcUW2B&#x2B;69/77i4hJ3s7ulipnneY4TRNHr9YSHmW688cbIyIjOR7W2TdJqfE81FRVFEcWwmOiYxdddu3Hd&#x2B;r899vhtd9wZGhoiiKLT4ZAkWRZEgRdEUVIURVNGgbZtExTBMEyWJAgBTdMQwrCw8Mx&#x2B;/aNjYiFUjAbm808/zT&#x2B;S33/gQDYQ0NIt2FrN3FaZQBAERWkZAc0wjPaLMBgNDMMYDKf&#x2B;VxtBUV316DlbRg9IW/HCQzuPFlc2OBRVvW7mGLvHvz3v5JHiKhFKnJ8FigIUFUAIcBwxMShAWLd36fLNAEJNQ4IyFI5hCIJ4Wf6N79Z9smo7QxIMTVIEQWAYANDh9qMMLUhSrd2NIAAlidiI4PGDM1ftyrMaGQNNYSiy93jZpoMnUJpSITxaUn3oZEVCZCiKIt4Af6ysGhA4AAAFZ9xXgiIJhiIBQEReYLkWxRGJEwSOd04APH62weUGKkyLjVw4bkhUiC0qxHbN9FEb9xXU1ztq7c0FpTURQ7voet4BFEUAjgECx1tjIAxFDTTpoymaJNqnzbKsqJ1CcwDA8Yrae1/6bPOmfcDIAAQBOFbb6Niwv&#x2B;Cvi2e9cPeV3V2XF6UVOw5f/9S7oscPGErrHEngGMnQstLRN9fP8fuOlxtp0moyJEaFdnBmwDE0JuyUlDwttot300Vk9e4j248UsbwQZrMkx4TNGDkwpBsv3h44Wlbz/ca9iiQPzEycM3qwuVOd9AVFVWGr4/nvAoqiKeo3fQV0fudAADAVUBJ024iqMKwOY&#x2B;1CU4BtEkUvaPUwuthz1OkVegJw3khNSy0pKRk4cGBMbEx9XZ01I117HMNxiqIkSdKqb7XlfBRFIyIjm5qa6mqqtVb0JEE22e00wwQHB2EIpjX80fIBjMBwrKWvD4qiOE5gGIq1FvqiLf/UzMIwTPsZRQmCoGjaqin78XamYEgXtb4qhFq8K0mSIAg8x2l1WgLHsSzLsqzDbq&#x2B;rqamsrHS4XIosNzubTxaeqK2pUVS1tqYaoKgkyh5Ps7PZFRoe1usvL2g2W0JCQxoaGohuglccJxwOhyRL7TtX9ExaWqq2hdABkiSxblqCaCkW1anJfXtyh&#x2B;Rs2rhpyaef3HXvPVlZWbUmI4ahOEHgBI5hmtoKKK073QiCIABBAKKoiizLCIKRJBUcElzf0GgwGoODg1JSktetWeNq9iSnZfAc11En3FpwrKot5c68KPkDrCw3Sq3V4bIsa7s9bTkDiqJt3mc0TRMEERoWtvjqxchZr2IiYMzAtDED07Sfwqymw5/9e92&#x2B;goKyGpcnwAkiKwiCKEcGW3MyEuqdnpU7Djf7AoIkC6IkSLKsKMEWY2xE6C87D4uS7Pf4W3IGVQUqBBACFAE0BUgCSDIkcAxFyuvsf339CwTDaJKgSIKhCFlRm70BgKJAVfNLq&#x2B;9&#x2B;&#x2B;fPMhEgDTdXYXbuPliImAxQli9FAkWfWAD7YYoyPCNGirbX78ifkpE8YkqUqioEiAQCipMinzDwAjmEoQAGAFIlbzC3uYBHB1tjIkPraJo4Xm32B3r2cZ0Bn7XizP/DBiq2bN&#x2B;9Hgm2RIZa02MgGp7u6ycXxwvJtB2eOHDBpSBd6IQBAVaPzlW/WiH6ODrGaDYyBIn0sH&#x2B;CFLqV69U7PLc98QFFkQlTo6w9ck5UY3f5ZXpCXbdu/Pa/Ix3Emhk6Pj5o6NHtAV/XEEAJeFAkc/2368HgD3B0vfLJ&#x2B;f4EkK4IoYRhmNTFfrN7xrzsWDc1MOqNTldfZ/7NkpVxZP3jysOFZyT0nAOX19ic//NFAEalxkZeMz129/VB4qG1gakK/pOgejuqBo2XVD//36wAv0gT&#x2B;2T/viIs4lW6t2ZNf52hmaConLSE1NuKiNDjS6ctoqmCDCAMMVhVDVjG8Q2zy&#x2B;BsE3gX/4HL/VtVz30JPAM4bQ4cN27JpU05OzqDBgw4eOJydlQkAgBAajcbo2NjiopPh4RFhYaE1NdWZGRkoig4aPDhnyBBNJaBCFUC4Y8dOxsDEx8VxHNdmfytJPMtKbdW9bZKVVtUKjmEY3trRhyQIHCcIkmjp499SwKu5gWHtzIG1VAFDUBRr7UuHoihJkgaDAe1eUJyRleX3&#x2B;wVBPFlYOG/evJCQEE0o7/X5CguLIiPDC2LzWbaLGsouUVUYHhGempr62WdLRowaBbRGGb8aAs0Ws8PhqKmqSUo&#x2B;g2/xC&#x2B;TBNXnK5ITExA/eey8rO&#x2B;v6G26Iio7y&#x2B;Xxoa4ncry7Z&#x2B;kmCoZjb7VZUta6u1uV0cgIv8LzZbLFYrCRFCYIQCAR4jgPtQr2ODsQoiqEYTlItZXhaL9fO8WFrnqO0ircURZYl6dl/P/PI44&#x2B;dx82B6cP7T87NlhVFkhXNiNlAk5qEZsG4HLvbJ8mqIEmCKAdZDMOykgEA246c3JFXxIsSx4sBQeAFiRdFBEEYigi2mHEc23&#x2B;8tN7pYXmBFyRRlgVRFmXZ7Qu43QqQVaCqhNlgYhhvg2Nvg2PvdgUgCCBwwFAARUJCbcOyzyzC0xienWwMC2Z54Xh53S3PfxwVahMlubzOjhsYl8e362jx2EFpZobGMDTIbEiODS8tqap3uMtq7RNzsgAAAU6oaXIBBJiNdHhQu&#x2B;V/CAVJApozR7udQBUC&#x2B;ZQrU7vhnf7RHYcKK75euQ0Y6WCL4YErZjx27ZzyOvuCv72Rf6Kspsm18eDx7hKARqdn/5GTgCGDLaZHrp5z72VTiqob//7&#x2B;9z9t2oeSHb8CREmuKK8BOO72swFWaHdbsLLBedX/vXO0tBpFEVlWIIAmA/Ptxr1XTh7&#x2B;0FUz259EUeHBwvL/fr8&#x2B;v7SKJPBR/VIfuXZOXHivGqdKskL02kS8ZW4A/P3973/eeZgTZZXlAEkCIcD6AvUVdawsf/L3W5Oiwk5/lnZ3iiIIIHCKIE7bGM3tCyxZsQWwfGRKbHJM&#x2B;IOPvgYiQx66bu6r919zRrfQhiBIhZX1dQ43UBQfywJw6kVb8svObzfuVQThkRsu&#x2B;ceNl1hNTA/n6ekSkszyAkOR9BmmzTp9HFqCMoZWR2tyf4fT18BzDlUV/1hy/27pc/G/ngCcP9LT0//7&#x2B;hsAgCE5Q5b9sExTOqqqajQa4&#x2B;Lid&#x2B;3Ydcsdt6elpZaUlvbv1w8AgKKowWDQWgARJIEiSEOTPSwsNCU5ubtLtDp6iaLU0rumxbyK54WWzv0Cx3NtTYG0hXCtiZvWx01rQd1iItDaU4ckcIKiWvr9EATWzhYYxzFUcxJAUZqmOZatq6snSRJCqNljaTkFgqAGgyEqMiozI&#x2B;PQocO9fMVUVSUIIiYmGkURxmAQBYEkSBRDMVUFABAEbjAYREFMSEiIT4g/D7&#x2B;h80FKSvLT//73p598eudtt0&#x2B;dMSMQaFn6VWFXjrAIUBVF4HlREGiKDguPOHbs&#x2B;Jeff4YiIDwi8mh&#x2B;XnxislbX3BZlIL/OBJC2aL/1oR7mdipnQBCMIAmKliBgDMZNGzZOnznjPEpvcQzFMbRz9BAfGRofGdr2I8uLPpanCHz8oIwx/dMkRZFlRZIVSVFkRUFR1ERTJgMNAOAE6URFbbOPC3AcL0osL7K86OcEluc5QYoKtQ3vl&#x2B;z0&#x2B;H/YtL/O6RYlmRMkQZQkRcZxfPaoQe1rBgAAsqIAPwswzM/xPdSnTh/e/6lbFj7y2hJOlGr8bE1RZVx6Qlpc5MEjJ1WG&#x2B;mb97nqnOzYsyGpkjAbaQBEIhjrdvte&#x2B;XUvgmMVAf7xqW0NTM8DQ6NCgEKup0eXBUFSU5fzSakezFyEIj5&#x2B;rc7oVVcVaK6H9LK&#x2B;5o7Vp5CAAPC8AFJEVWZQkAICiqqKkaD2U5HY1Dw6Pf&#x2B;mWA011TajFNGlI9l0LpwAAwoPMs0YMzM8rYlGhos7R3Z16AxzwscBmjg8PuWvhZBzHkqJDh2Ym/rR2J&#x2B;iUACAIAigSwXGGItsvBXj83LOfrdiXX4RThCRJgJcAAIKXdTZ7T5TXxYQFXTFlhDZShfBwUcXEe57jeAEncBRBTlTUrdx9ZOMbjyVFnyYQV1V4xT/fJnA0Oyn28olDMxOiu9u1a0&#x2B;D033gRHkgwAGWf/DWS6&#x2B;fOSavqOpfny6vqG3auv3Q5oMnkuaeQQKQmRB13xXTamqakhKj6R53BQEAigoBJwBJbrF/pAicoalzMyRGkJaGbx3&#x2B;eEVZVkQRcKIgSefStfBISdVV/3wHR5GspJhnbl80IOX30sFJ5/cJBIBUAKoCRwhVEQybgMfONvKsXZICoMVV6A8f/etFwDrnBIIgRqORY9ngkBCvz4vjuJZREgRhtdnKysoQAOLi4nZs39VWO9W2ZItD3O3xQFWleiz91OJ1Q68t1LV&#x2B;bVrK0JYhtKQNrTUAPr9XElu66yjtJCWn6mIxDMPxoCAbL4h5hw4DFDUwjCgIdbV1WhiHYZgoSizLulwukqZdzjNwa4IQZmVnT5kyOS8vP7Nff1mWERTDEESTsjA0bWCY8PDw31XdGE1Td951x5o1Cc/&#x2B;&#x2B;5n5Cxf2sNeAIIggCIqsMAYDggCDwcCygcITxzmWxVCME7jk9AwtVQNt&#x2B;hAEAQBgGAZV1e/3aY5jmrc0VNXWhrAIQeCaczNBEG2/KRRt243QMgE0EAhMmDjxu2&#x2B;/njh5ktaw9Tej0eV5&#x2B;uPlvCClxkXctXBykNmotfPvcjBDEUMyEjs8qKiqrKiSrLQlG6P7pzm9fllWRE3mgaIZCVFmQ0eFRmZi9K03XsKLckpcuInpdusDQZCHr541fUS/n7YfKiitNTLkNdNHK4p6/VPvNlbW2wP80mUbAWxxxAUMTRgZBICiqvq7X/6MInBelDACAwR2rLz20be/IXHMQFOKqh4uqhJYAWfopmbvuz9uVFQ1JiwIQ9DtR4o2HTyOGihVUo6WVZfXO8Jt5iPFVTLLIxTp8PjL6uyD0uKbvQG72wswFIiSj&#x2B;XbZnuwsPy71dsxixECJCrUZjHS2j2gWvmaqnQuGGijpY0ShCiKUCQOWvsK9PDr64w3wH27YQ9C4DRJXD1j1N&#x2B;vn9/g9Lzwxco1u/NZnv/3Jz&#x2B;1JQCiJD/9v2W8KNEUaWBIX4AXJaWm0Xnbfz7e8OZjPV&#x2B;luKZhZ/7JZh&#x2B;7fN3u0f1TsxJ7ZZ1RUFbj9rFAUaPiIy&#x2B;dkJuTnjA4LX7tvvyK6kYgKycr60VJJnvtyZCZEP3yvVf3cnBaXMTnL//V7vaSBJ4eG3ntVTNFBEmNDe/l4WcEhqIAwwCOnWNpsijKFQ12KMkAQdq39D1THnnrG04QMRy7bd6E7KSY0&#x2B;6W6PzhOCX3txLVYVgdztoFe4BtEkSPJvf/42p&#x2B;2vNnuIezQk8AziczZ89a/tNPV1555aDBg44fPz5w4EAAgKqqJpMxIjLSbneEhoYiiCoIIvNrXSmGohUVlSRJhoefz28OrcczQRA9dGrrQOecged5FEXXrllbUVFReOxYelY2TdEAgMYmOyeIiqIAAGRZdrndoigKvOh0OoEWwvYiwFBV1WQyjRs/7uCBA80uF07giqoqqirLcsAfqKmpCw629eDUexFJSEiwBgVpEqCWhzrdL4QQoADFEAihz&#x2B;8XRSng8yuyDACAQEUAAhQoy7Ki7QC0fn3KkhQdE5WclCRJMkmSwSEhpcXFGI4HBQeXlpQwDMMYmIrycqPJjKJoVVWl0WgCALjdLhzHFUUVBEFrNYsiAMNJBEM9bs9v73LiY4XPf9kesLuT0hOunjYq6MxrMTEUxVC0vZdWiNUUYj19E9WshJgX71ssyQqKIrZW497uGJAcnxEXxQmSAtUQi0lR1M&#x2B;evuunTQdKGux&#x2B;ludFmRclUZJ4SRYlWRAlSVb8LO9vF23XVNTVFFUCzSMNRQFFoCYDgaEIwA4XVd71wic4jtMUgSAIJ4gQQVAS33&#x2B;8/OZnP4wKsR0oLEcIAsXxqkbXe8s2UQS&#x2B;&#x2B;2jxxoPHEZqCAO44cvKjn7eO7J9SXN345vfrXB4/ZmBUQdyWV7i7oKRfUkxpTVN&#x2B;WTXAMYQgLJ0SoTZMNA0IHKCoy&#x2B;vfd7wsJz0BAMRAky1/sb&#x2B;O21DkVIPV9vtRAV7w2Ztxi9FsZB68YmZ6XGR6XCRDEau3HsQYqqrRWed0R4fYAAAeP7tyx2EMwxIjQw9//kxZnX3UrU/xkrzzaNHmQycmDcnq4dexds9RSVYhhLiByUyI7GV7U4&#x2B;fF2UZqGp0eHCw2ajNPCk6nKBIiRccHp87wIXbzN0dvu1w4YqdeXERIUMzEwelxndIGgVR8gY4DEMNFEWReIfCDKvRcN2sU6Z1S565rzcTvrggCIKhqHzO8frKnXkltY1ygBuRlZyZEI1ifTaO&#x2B;hPSJvdnGawkhqxiBLvY5PE2CpwLAgX8keX&#x2B;XaIbgemcK2PGjr3r9jsWL168YMHC115/feTIUYoiqaoaEhqalZ397ddf33H3nZlZWXv37pkxY8apwxAAAPB4vGaL&#x2B;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&#x2B;FBltiUuJo6e2WD8&#x2B;E3v7p9weQgi7He6QEoqiqqj&#x2B;PbD8ZQFAgSQhCgbesAAO3fCIpCADAEiW1V82fERSIEDgHAcayqwREdYoMQegJcv&#x2B;QYCJB5Y3NoksiMj3rk2jlPf/wTVOHT/1vecwKwv7BMlGVFUSfkpBrp3hauEFhLT15ektr&#x2B;4MNsZgNNejwgwIti99sjAICtR4reWfIzZWAWTB3xwt1XdkgAimsa//PFyrqm5rT4yJtmjx/Zv&#x2B;PHUUlN097jJSwvmQxkZJAtJTY8PiKklzP/QyMriiwpQJK7FkDq/JGhJahgaE0UXWGVHLLT6avnOYeiiuBPF/q30QdzAD0BOJ8QBDHvkvnff/fdpZdehqNYdVVlQmKC9nhKSsr&#x2B;vXucdufIkSM//fTzGTNmtC28EQRRUVmFokh0VNRFnX63fPfNt0OHDZ00ZcrWrdtra6rDI8O1LpltA3AcHz40V1uqD/j9AACCIEShtwkARVFjx4/LO5xXXlra1NhIEGSzy6EqqiIJkigeO3aC4zjQTpXU0qsU/5U3sNYxc/XKlWvXrJUkSSuA1lriMAxDUsSMGbNGjBpxjvvUgiAUFxWvXrW68MSJhZctMpnNitLVbbYoIxEUwwCAUIWSJEXHxsbGx584fqxlCIJAoDk7t//6RFRVURTIspwoCgACvz8gihIAvMfj5VjO5/MRFBUIsC6XS1YUlmNdLpekqBzLud0eRVElSVIUBUUxFEWDrNaL1cjcajJcO2NMZaMjyGI80xY9Fx2aJHpucAkhzIiPEkRZK4aWFEWSZFFWBEmiCCIzIQoAwAvS5kPH7W4fL8o&#x2B;lkMRZFBafEJk6PHy2uXbDlU2OHhRNDF0ZkK01cRsP1JUUWfnRFFWVFGSY8KCjAx1IO8kH&#x2B;CcjQ6gQgAgUMG4aSMuHT/06Y&#x2B;XlxaUvHisBFAUwlAAwuzEqPljc7qbbUJU6H2Lpj32&#x2B;hecn91&#x2B;4Nj2nYcBRVJGhrQYFEUtrW78z5KVk3KzbUbG5fev2HYI4BiKon6W33jweGJkKEXiGIoaKDIkKszl9YmyXFhRP3ZQGgCg2c9BWQE4BiGMDw8BACAIkhYbufd/T4uyTOI4AABFkdsXTHr&#x2B;s59lVd17rGTPsdKR/bpN6Q8XVcmyAlQ1Jy2RJHq7GhIfGWJkaEDgJ0pqvli7c/G0USYDXdngUFUIEFSUZM2CvUvqHM0FpdWcIHEBvsstI2&#x2B;A3553sqq4uig5dtKQrPYJAMeLH67c&#x2B;sXP26pdHrc/oKhquM0yPDv51nkTpw3v37mUeemmfTvyi1QIkqJC543NSf2dNVE9UxAEQVAEthrI6PwJ0OT&#x2B;mAocwVRFCGgCXjvbwLEOSfK3fald7DleGPpe9A/0BOD8giDIrFmzHn/0sdFjxjzw0AMvvvDia2&#x2B;&#x2B;qcgygDAiIiK7X/8P3n//7nvuTk1J2bF9&#x2B;7QZ07VDAATl5RU0RYaHn0Gl2m&#x2B;JJMtZWVkAgLT0tCN5eY2rf7HZbB10&#x2B;TiO8YLodDo181eaJAX&#x2B;DNSlsbGxY8eP/eSTz5KSkniOhYrMcxwCYFpayrBhudoYrS2m1rBfkmTNmVLrW&#x2B;rz&#x2B;bWgf8uWrVNnzEhOTtbESzzPcxwn8ALLsR//73/bt2&#x2B;bO3&#x2B;&#x2B;2WjUKptby55xHCe0queeJ1lbW7d7186dO3ZOmjTh3gfue&#x2B;ON/yrd73JolXwURRIk4fP5RVEyGIwGgwG2Wq1pohFVVdRTJ2nR7vMcKyuyViKiQlWFUIWKrMiqqsqKIoiSoiqiLPG8oKgqLwo4y0qyxHE8gmKqqgQCLACIJEosy3E89&#x2B;sE4zci2GL8z91X/PbX/W1AEIQmiS6bqPhYvrTOTuFYWJBl1qhTBnaSrGAoiqJISkz4yP6pzd6AIElGmkqOCQcAeALszvziJpdXVpSkqLBRA9MIDF2z5&#x2B;juglJOEFhehBAmRofNGT1oUGp8qM380Y8bKhxuThAVVY2PCH3k6lkd&#x2B;nW2x8RQt86f4HB7Nx447vT4A7yQFhsxd2zOOz9uaHB4mv3sC1&#x2B;sfH/5ZhNDQQAbnB6UoWVF9bLcG9&#x2B;sLa&#x2B;1RwSbjRSFYsjg9PgN&#x2B;wrcfvbBN7545o7LoIq8/cN6FMdwFE2JCcdxzOH2oSiKYyhF4FpjX&#x2B;2uw2yW62eN/XjVNkVVn/tsxYoXH&#x2B;pynpKsON0&#x2B;FUKgqIPT4kiyt5tXOekJKTFhBcWVGEm89cOGr9fvMdCU0&#x2B;sXZRmgrZX03VBW6yirtQMMNVhN/ZNiO5cKoCjSztmtnVeDqq7Ze/Tpt752&#x2B;ViAooDlAUnUegLLappW7jzyxZN3tBVFAABkRb7r5c9/3n44wPGSrBgYatm2gy/dc9WI7nMhHZ3fEggABgElQo&#x2B;VqA7Da3HWLjQFOLsguP9Mcn&#x2B;d9ugJwHmGoulHHn/sxef/M2/&#x2B;/Pnz5r3xyqvXXH99SGhIcUkJQVFRUVE7d&#x2B;7sP6Df1199k5iYmJ6RjmLYvn37JVEcPiz3grSuPB/QNK0Vqs6bPw9D0eLi4smTJ5stFu1ZVVVPFJ7ctHEjChCAIFwgAAAgT9c9oz2aMYLNZrPZbLlDhwX8XgRBDAZjcEgIAOj2bTtIiqIoSlvO1/oWETiB4wRFMziGodp/KIphaHx8bFRU1IgRw7X4W1G0wmZFUdWRI4bv3LHj7Tf/O/eSS4KDg01GY4vJcTfVzxiGEQRuMpsZmgEIOHrkyK5duwSO/8vDf42Li6uurj61Y6gtjXT18QgBIEiSpChZUvw&#x2B;v9FkjIiIcDmdQOvpJMuCKImi2HomqG0LNDY1URQNoUqRJIaiOIaSBGFgGIoiGZo2m4wkQdIUzRhoDNOsi3HN4AEgQIVAhaqiKiqAsqLgWEfVss6FgxfFT1dv/37t7rCwoOtnjblk3JC2p9qvB4fZzGG/lqRbjYbZ7bIFjTmjB08d1k&#x2B;SFUlWIIRWk0E7ycIJuTNGDth/vMwb4CJDrEMzk077Kw42G1&#x2B;856rS2qb8kipPgBuQHJubmRQZbL3l2Q8VRRFY3u1wA1lpWQYjyZAwm7PBUedj3/v0J4AAgKIAxxCGJgkcQlBQVnP9vz6gCNzu9mEEDgFwePz3vPI5ReAGijQxlJGhDTRpYigDTWn/2y85BgCAIMjGA8de&#x2B;fqXuaMHpydEdZh0dZOrJVWFMDEqjDwT9dqbD10nycrqHYfdfs7d4ASCCIwMYTKctj1JRYO9vKEJIEhUeIiWjPWSRqf7mw17XB4/YTalxITdNn&#x2B;Sj&#x2B;U2HTy&#x2B;Pe&#x2B;koioP//fruWNyDDQJAJAVdfWu/M9/2aEoquINAFkRTMz2/cfueeXz9W88ehblMadl/f6jq3cfzclIHJwal5UQRfTaslenD3JK7k9jJQlktUGwi3aPt5HnnRD&#x2B;CeX&#x2B;ndF8gHUJkM55IDo6&#x2B;on/&#x2B;&#x2B;fatWvzD&#x2B;cdPpxXWlqa3b/fuHHjBwwYMHfunM8&#x2B;/rSmujojI&#x2B;0/zz4zKCcnKDh4&#x2B;PARo0eP7H2d7gVCi4BPtZ7sCovFctXVi9s/IsvKoUOHXnv5lSuvuhLDMVmWs7KyOI4jiDOWniMIAlWFILDQ0BBRENlAoPhkExtgBVGQRFGSZG0lW&#x2B;uMr9kVk6SWF1CaU25wSEhRUfHkqdMgVLVmOO3t6gfnDE5JTdm6ecv&#x2B;vXuGDR82cGB/kiCRTr5oWrqgKC37DCzHFxYWbt2yGahKXHz8ZZdf7vcHSsvKm5qaFFmRBVngBZEXJVkWJbnzBwhUIY7jQUFBWVmZTqfDZgu54&#x2B;57Y2JjQ0ND3n7zDb&#x2B;fjYyIkCQJRVAERYCmFlKhKImlJSWSJGh3LUoSAgBJURzLMgxjNpt9Xm9Dfb3FYmlsaKBpxhYU5PP6WL8fxzCoqhiCkASBoyhFkqoK9QTgN0NWYUF5zfZ1O0FEyOD0uPYJwFmAoghDkV32MTJQ5ISczDM9YUpMeEq7GPfmueOnjxiwZnd&#x2B;jcPlDwisIHC8CBGQGR&#x2B;VHh&#x2B;1dm9&#x2B;fkk1x4uCJAmSLIiyIEmiJGtGb3ZvAMgywDEt8a1w&#x2B;yoKSgDQvDyQltZJGApwHOAYSRIEjomcgFOkCJVnP1thoKnUuIgO&#x2B;jSXxw8hRAAAqhobEdz&#x2B;79be7AvwAoahOIriLa6HKIogWqU4iiKx4cGrXv5rZYPzeEVtszcQGx783vKNy7cekhSVJnEM7zYPaHJ5XA4PgDAmPOi0XUrb4/FzeScrAUnazIYbZo/7y&#x2B;KZAIB5Y3Mm3fVMQJRYQdqw/&#x2B;j8cbkAAEmWv1m/V5YVAsdf/vutaXGRd774SVOz72B&#x2B;0Rdrd91z2dTz2z9HlOVfdh9958tVNrPp6nkTXrq3W4vo7jh0srK4pkFV1RCLKTosKDU2QncM&#x2B;BNDS1DBkNoousKq2GWn09/As05F5UEfCP1bQBCtiUNfQ08ALgihYWELFi6cOHFiIBBoaGgAAOTm5mgh/g033&#x2B;jxeE6eKMwdNtzpcGT3yx4wYMDFnS2EsKq6urqyCgCEMRqoVjRhvdVqFUWpy7eGKErbt2//&#x2B;KMPn/vPc4lJSZoDVV1trdvjtbTuD/QG7ZteVaAoSSmpqblDulUzSy1eBzzHshzHBQKBgN/PsmwgEAgEAjWVFUmJCcnJid3tpZjN5rnz5zEMU1hYWFxcEmQLommaYRiKomiapmiaJEmSokiS0P4DEJ44dmz9&#x2B;jUD&#x2B;g8cM25MUlIyACA4KAgAYDaZtlLbcBKnaEor3SZJQm7rz936ekEALRYLgRMIgrAcS1GE2WIlCCIkJMRisUCARkVHAwBoimIYxsDQFE2SBEWSBE3TJEngOCbJssAJvCBwbMDvD7AsF2BZjmN9Pj/P8yazpb6&#x2B;rqqyiuf5&#x2B;oYGCCHPcfX19TiO&#x2B;/3&#x2B;mpraufPn98GFjYsFAoCJpkCQxWQxMRe7oL83xIYF3TR3nLbJIMuKpCgQgAibBSDg0gm5R0urA5wgSLIgyZp9GydILC/SFN4vKZblhXX7ChqcHk4QeVHiBFEQZV6SeFHiRUkUZS1z0HIGq8m49Ln7Fzz&#x2B;huDxN/sCw7KTOke9fo6HEEIIEIYify2g/3zNjpU78xAEMTGUgSKNTMvGgpGhjK2bDCaGoikSQmA20MXVjZUNLklWgCSH2cxWY7fNoBweP&#x2B;QFgGNhNnNUiK2H1wr&#x2B;ukpQUhQ3ywIAjDSVm9FiRZcYFdYvPWH3kSIVqhUNTu1BRVW3HilUBYkxMncunEyTxDO3X3bL8//DDfRLX6xaPHVkaPcdis6CouqG/JJqUZCaZI8K1TNqAyDK8r8&#x2B;Xr52T0FFg93jZxmaTIuJuGrayJvmjO9NA642WEG0N3sBQMwGymSgSX0L4vcHBIBQAK4CRzBVGQIagc/ONnKs/c8v99dpRX9bXiiMRqMW8adnZHR4ymq1Dh85oquDLg4FRwvWr1/v83pFSZIlSXMQ055CEISiqMIThV1&#x2B;Fqxetfrnn3566aWXo2NjAABaYW5CYmJTY2NQkO2M5uB0OGrrauLi4zdu2Hjs6FEEQSmGZiiaoimKomiKJimKpEiKpAiSJEnCZLbagkO0FAX/tVWQqkJZVtDutb9Tpk1NSU3ZvWuXLMlORxPHcpovgiieunfNNw1BUavVOnfuvHHjx3c4iaoq7eycIIZhFEkq7QqjVRUqikwSpKpCXhQQFHG73ZKsMAyNIAAgAELo83sd9iYAEIqmjQaGYwwGI8MwDMMYMZygKIqiaLOZhLYWTzFZUbTya1lW/H4/x3KiJLEcywY4QRBYjmM5luc47Y4wnPD5fSSBIb3rpahz7lAEfumEoSYjg0AwOD3hYk&#x2B;nV2AoipFd2LoBAAakxHV5iKpC7Y2Vm5nIC5KkKJKkSIoiSrIoK6Io85IkiDIvipqtGyeIuZmJQzIS93zwfz9tPyhKSk5qQuf3ZtuGAIZ0TOBLaxq37MkHsgwwHAAIVAhEEQAAWlvjAxzDCYIicZokKIJQIfQEWFmSAYpmJ8V0Notow89p7mww2GwMtnS/DYsClhcaXR5V8wkGwGYyJkaGNjU1C5Jkd3tbRqFIgBMAACiCtOUwBopc/sKDfpZDQMvrfNW0Uc99/nNlg6O6pnHF9kM3zhnfy4anvaGizl5a1wQwNDwqLCftDP4IOUH6at3OF5eslHgRKCoAQPIGDrr9Bw&#x2B;dKKuzv/7gNb2M42vtzd9t3PvN&#x2B;j1ldXajgZozetDDi2f3vLvi8Pjr7M0ogpgMdJDFaGKoi9W9oC8AEYCpkBKBx0LUhOG1JGsX7H62qY/L/XUjMJ2&#x2B;yOHDh3iOmzp9Os/zJpMRRTEcJ9LSUimK5DiOY9kAy0Z16lAkiuLXX3/5&#x2B;utvREX/6qnk5OSThSez&#x2B;2X38uraav3Bg4d27tx1/Y03&#x2B;NweQfMr4zi7xy0IgmZ/rCn122T6La2ACJwkKYIkaIqmac1VmSYpSksdNG0QQZCa6XGLsTGKoigan5iUmJTU5XwghIIgiK37DCiGxsd38SWKIAiB4xBCVVEhBCpUERQDGCrJCoqiKIbiBG4wGjWhAk4QgihWV1YdyzvU7GhUFFUSxYKjR0mSLMjLkxUZRTEcx3CcICmSJAiSohmGYRiaYRiKpgmCIHCCIAkUwxBEuwNUkSWtbEFWtDoGGUEQiqSgCgFANEdnWVEMRmNUZOTvtrzkTwaOYWMGpo8ZmH6xJ3JhaYtWzQbGbOiVwZxmlDs4LT41NlxVYZf&#x2B;vpotNECAzAm&#x2B;gABOmUqDSUOzvRy/fl&#x2B;B28tq&#x2B;XZabDiEoGW3QRMmSTIvSoEABxQVyDLgRWA13XbNnFmdiivakBSFFyWtYN/Qc9CJYU6P/4OfNlMknhAeajHSsqIOyUjcl3fS5Ql8vHJbdlK0zWTYcqjwRHktimE0SWQnxQqipKmVhmX&#x2B;6tOGIvAHLp/x8Ntf4wz94lerLps03GpiWl8o7SMOQFntGI&#x2B;0RmU97&#x2B;lVNjhrapoAgsRHBGfER/YwsgM&#x2B;lnvtu3WSJDMmw6C0&#x2B;NmjBp2sql&#x2B;6eT9kqHe/X3fHJRMHpiacVqwkq&#x2B;pr36x59ZtfICcAinT50He&#x2B;XH2kuOq9R2/un9yFrZsky5sOnli6Yc&#x2B;WvCK722c20iOyk2&#x2B;dN3HGyAG6dvG80yL351WOwUoT6SqGd0gOt0eT&#x2B;2t&#x2B;lH30NYcXo1XGRUdPAHSA0WC0WCwF&#x2B;fk1NdUxMdE8L&#x2B;7aufPe&#x2B;&#x2B;8fP2E8QRDdiXl8Pl9mZhZJUzzPaza0Whed1NTU5T8um3vJfBRFTys&#x2B;wTBMkeWvvvzq8OHDi664IiIiYsTw4Z2HQQjlVlW&#x2B;2GJjzAu8wPGc1uSH41iO430&#x2B;t90uiKIgCqLWDbMtZ2hxNcYJgiRITeijyX6olvoBpkUCdKrUmKIZg9Ec8Pvq6htaNMdapS2KEjguSnJMdDTPC5VVlSaTGQFqSXGxJMlRUZGVVTV&#x2B;fyA&#x2B;LsFgNLo9HrPJiGJYWUlJXFzc3HlzY2JjeZ6rqa651O0JDw/DMIzjOJZl2QDLciwbCHAsF2BZlmV9Xo&#x2B;9sVEUxV/5NAOAtDrAIpr/L4ahSEvZMoIiWpigQgghiIuNXvLJZ4uvWXzR/SV0&#x2B;jhtsZyJ6XYxPiEqlND0Khi2fPuBB6Nmar7FAIDZowaNHpB298Ip1z79XkW9A0jyA1fM7J8U4&#x2B;cFXpR4QWIFgeVEVhBYXgzwPEkQEcGWpKiw3IzEsKBu5YjwlCEyJE9jOIjgGHaysv6elz&#x2B;jCIKhCIokIIQEQymquiO/6K6XPgsyG/OKK2VZIQgcApBXXFlQUmVgaCNNalXRDEVSBE4ROIHjowemmhjKo3AnS6o/Xrn18inDrUYDhPB4Vb0oKwiCAEnq4O4sSjJQFAAAgWM9lA00ujwyywECjwqxJZ9Jp1GHx3&#x2B;8sAKnKQNNvXj3leMGZwAATlTWFZTW4BT545YD/ZJjTysoyiuqXLUrD3JCdFxkqMVU7/J4cXznnqOfrtr2wj1Xdk6x1u4tuP/FT8pPVgCzAQDE4wvU1NnX7i14&#x2B;taFf1k8q/eT1&#x2B;kNtAQVFKmNsVQEA4dod/jrBdYht8j9Aeir0b9GH9TK6gmADiBIwm63Dxs&#x2B;/JrrrjWZTAAAg9HIcWzPR5EkKQjCL6t/MZvMRGs1rtFkomiytq4ORRCKohVF7vZ4BFFVdfu2be&#x2B;&#x2B;8&#x2B;6wESNGjRkrSXJEN0bI2nI7geM0TQNzr/SyquYoLEnaBoKg9QQVBJ7jOI7T2oPyHOduDnAcpzkfazlDazsgBMVQDMMABDiB4zhBkgRJUq13SjEMExsbSxAEhuOopjcCgKJImqGbGu2SJMfGxSII8Pt8jY1NTU2NFrNl3LixVpsNAGBgDGlpaVrvo97ci4YkSTzPCzzPcpxWAtGSNrBsa00EK/ACz/OCICiiyHFcUbPz2uuu69e/v74DoPP7J9hszEqMduYXERTxj/eXWo3GOxdO0p4y0pSRpsJsZiNDQQAlHxsaZB7RyZMLQiApsiQrEAKaxE8brRI4hmMoABAgiNSNVwCEUFUhAABDUYYiZEUVJJnzCEBWgKpquweyqu7ZcgAoCjAbAE2JolTX6Hzg3x8AHAM4DghMEyYxFEGTpIEmGYqwmgx2lwcgKMEw//zwh30nylJiImRF/nHrAY&#x2B;PRVFUMTJPfLD0htnjs&#x2B;IjAYIUlNWcrGpAMAwqgslA01TXVbmirDg8foAgQFFDrKbQXgv3VQgbXR6oKAAAisS16B9COHvkoILSGgSAo2V1igpPa8u&#x2B;fOvB0jo78AZunz/pyVsW/LBl/z2vLGkMcMu3HZozevCk3F/ZwJ2srH9&#x2B;ycrykioqMjQ2LCgmPLimyVXd5PJz/Ds/blo0eXgfsVS70LTI/RXgDKEqg9QGirOzdbyvThR9utwf9OG8R08AdAAAACdwgefr6xviE&#x2B;IxFBVF8bRvCqPROHHihPq6ujqvWxRFrVGP1&#x2B;tzOZ12ux1BEJom/f6uEwAURQVBWLlixcqfV1597XWNjY2NjQ0oijBMr&#x2B;QEvUHTyRA43vtzqqrW/EfW8gGB5wWhJXFoSxg4nhcEwe/1CIIgiqIsa2vzqqaKxjAsIiIyOjYORdGK8jIMx0ReECUpISGhf/9sk&#x2B;lU6tJzb/Iu0QoezL3LfzQkSWrbmdHR&#x2B;f3z2LVzSl9oqrW7MBS9/7XPn/l0&#x2B;ZCMxMTIUANDeQNcaW1TdaMLxzBZUWRZUVW1Q2aLIIDE8d6XnCIIEmI1A0UFFFlU3WBv9nbeLpAVxeUJAFWNCLbePG98WmxEo9Mb4AVOEAOcwIkiJ0gohkQF2zAU2X&#x2B;i3OX1c4IkSnKrNkkSJUWQJI/AetwKUJSWzEGU7r190Y9bD9TV2yUWfPPjRgAhwDBgZHAMw3EUIYmth08eOFFhMlA0SQQ4wen1ozimKEpMWHBnvwINj591&#x2B;wKaGUuwxXQGSnoIWV7QdmraPpgQBIkO0&#x2B;zekQaXu32fFBVqXeMAbCcJAwDER4ZOHdqvOT5qcm42AOCyicNW7zry8dINZcWVq3bntU8AJFlZvfvIrv0FwGSIDQt67YFr5o3N2V9YNuW&#x2B;FyRZ9rHc6l1H7lw4ubfz1&#x2B;mKtu7&#x2B;XjNRE47Xkpydb/IHXDzrBIjaZ&#x2B;X&#x2B;XaB3AdLpm8iyzDBMfWOjd8eOTGcWwzANDQ3p6WlaV9DujkJRdOasLrZoOY4bP3qM1&#x2B;slSRKAQJfHIgA5fOjQsh&#x2B;WXXPjjQ1NTekZGXU11e0raC8KLTkDQfQ&#x2B;Z1C0nEGSJFEURFEUBEmWEQSVJEmWJYEXvZKSnNxtvcGFhiD05n06fySmjxjwt&#x2B;vnvvTl6gaXR5IVu9u3Yf8xHEMRFOEFSeQEgKLAF8gakN4vKea87Gulx0WYwoP9nLBp37F/f7ri5fsWt9cCyYqy/0SZy&#x2B;UGCBJkNswfO2RQahwAQJKVNhNoWVYRBIRYTRiKVjU4nV4fL7QUJAiixAqiliqwvBjgBS1n4AXJbKSfvnXhlOH9v1y7q7rRyQmSKEm8KEmygqDIkPTEHUeKXF4fz3LOJgUoaktnMV4cPXHY6AGp3d2O1nkJAABI3NRlB9luQFE01GoGkowggBOlbXknczMTcRxr8a9AQIATeFHGMAxDEQRBPH5Ohar2lKqobZ0Ybr9k4s1zxykQkK2PzBw54Jc9R&#x2B;trm37ZdWTB&#x2B;NyxrRUyBWU1n6/ZBRTVbDUtnJA7b2wOACA2NHhSTuaKzfsFSS6uaer9/HU60Nbdn6Owsniyyig6pMZmb4PAOVVVBghETuuR0ZdQgQr0ImCdPgjPC2azJTIioqio6LiiIAji83hEUfJ4vKIoIq1lpwYDo6qQ53mCIFAUxXEcw7BWCw0VAAARBAWAoqiMzMxjBcdyuunmiWKY3W7PP5KflJrmtDvj4uIAACRJge5ddX&#x2B;3aG3ISYIAhlN9BtsqlS/evHR0/qjcsWDywgm5n67asW5fwd7jpf5mL5AVoKhAVgBDRcSEjZs49PbLpqacSc/&#x2B;HpgytN&#x2B;EnMxVG/YqFuPnv2w/XFw5ND0hKzHGYmJEST5Z1fDV&#x2B;t0IikIIQ6ympKiWwmQCxwgc6xxgx0eGxEd2rVqRFVWSZUlWZEWVZIUmcavJsGDckLED0mqamnlREiSJF0QVgBHZKcEWY3F14/r9RxucHo6XOEH0sjxNEsnRoXPGDM5K7KKaVkOSFFFSAAAAx8&#x2B;0eX9UiM0UYmMlmeXF&#x2B;15dMiwrKdhqLK91AAAQABxu35JfdtjMBpOBlhVl9a58lyeAoqhKUV&#x2B;t3xMVGpweH0HiOIljOI5jKMLJMoIgKIJMHzZgVP&#x2B;UH2saC0&#x2B;W/7I7vy0BWLXrSF5&#x2B;EWqgGYbOSGjpJAEBwDAUQKiqkBWEM5q/TntoCaooUhdJV1gVh9rs8DfwnENWONBSkKNH/53oe1sAegKgA6xWS0VZWWRkRHh4uCRLAIDZc&#x2B;cEB4eUl5XhraAY5vXiKIKoqoqiGIIgGI7hOI4AAAGQFVmWZFGSeJ4PDQmZMHHirl27hg4b1uXlUARpbnbm5x0ZO2EiaH3TqaoK4J&#x2B;kDF8P/XV0zoXwIOuj18559No5iqo2&#x2B;9iaJhcvCBAARYWKomYmREUEW8/XtWLCgv5504KqRufRwyc9RmbHweN7jhZrpstuH8u7fYDAAYragi2Th2ZbjGevUcQxFMe6sHULtZm79AFIi4tIjglrs2gQZRlD0dM6BlAkQZI4QAAQBE7odk/1lIl5u8&#x2B;q8GDrU7df9vDzH/MIyLc35&#x2B;/NBxAAA01aTQCAxmbPfS98DHAMI1pSC1lRZVnBCHzLocKapubYsCCTgWYoQvNkMDGUgaJMBiomNIihSNRAqSr8dPV2q4mZNXLgtrzC//28BcFxBEObXN5lWw&#x2B;OGZgeGxZcUe84UVEPcAzDEKux23pxne5ok/u7gsnKEKQB9dv5Jo61i1JLp1pd86PThp4A6ICRo0aFhYXxPG82mwVBEHje6XTW1tS0NZ9pW9LWFv5xHCcIgiBIgsBJrTm/5sdL0QRB2JuacocNe&#x2B;7f/8L&#x2B;8hCKIF321lUU1R8I4AQRFBSkKtrCP1SVP0kCoKOjc&#x2B;58tnpHYWU9QMBt8yceK6uRVRgdYp02vP95v9Dw7OS1rz/21dpd327cc7CwUrY3O5uaAYoABAEGOijYEhcRcvnk4X&#x2B;7bt55v3TP9GDR0B0hFlOwyQhUCBCkvL5JhSrayVRBUVVFkAAKcAxt75BAk/gdCyYlRIZuPniissHBCSIniHVOd73DDQAgCdxsMbW1W1UkBXBcRnbKydIa1uvPt7vyZaWl2ysAAEUAigIMBRgGMJQxMhiKoihwuH0vfrHqs9U73H62zt4MCAxHUdpArt6Z5wmwU3L77TlWUlhSiVKUgSazE2PP/TXsO7TJ/X1mvCaMqKE4u&#x2B;Dws0280AyACvTQv0d0J2CdPkpISEhISE/NFhRF0VrQiILA8zzHcwIvsCwr8DzH8zzP&#x2B;7xerShWyxlkWeZ5AUFQxmAQNb&#x2B;eX4MgCIRQklt8cyGEHW02dXR0&#x2B;jYbDxQs23pQ8HOTh2S&#x2B;/t268tqmuIjg5fEPJXSjsTlrEASJCrHes2jqFVNHNLm8tY7mOkezvdnHixIAMCrUNnlIdnZSt6qb3xUUiSdFhwIAMJpavevIy1/&#x2B;8ui1c9oPECT5QGE54DlgNBIYajX9yiPZxNCLJg2bNqy/w&#x2B;0TZZkXpU9Wb39/2SYAQGxY8FO3LJQVleNFP8&#x2B;zgtgvMWZwesKxspq1&#x2B;wrqHW5BlDRP6Lb6B0GSBVEKNHvuv2pmmM383Gc/O&#x2B;odTj/rrLMDAACEwMhcO3N8UnTYkx/8sHN73s4deYCmMJoGEEaHBl02qes9ZJ0uYUTIU1h5i9y/qdnbwHNOFUoA6HL/04Fom2J9LgLREwCd04NhGIZhNN3bDVlFUQKBAMeyFEkKYtc6TqRvVt3r6Oj0DgLHIQASJ0iy3OhyO2sbWVEULlirAJok4sKD48KDc0HiBbrEb8PEIZlZ2cknTlZ6UOSVr385dLJycHp8UlSoiWEggHklVW99vx6YjAgEFpOhQ59NWVEcHn9ksLXNmOztH9YDACAESdFhV08fpT2oQijJCoaiOIYmR4eNGZjuZ/kWK2jNDbo1B/BzAoogI/unRIcFjR&#x2B;UsXbv0QaXRxCVAC8QODogJe7KKSOiQ22yrK7accjhC4iSrKgwOSbs5XsWG2ndvaRXkBKEKNIQQVfYFLva7Ag08qxDVljQ0tBJj/5PR4sSrs8FJHoCoHP&#x2B;QRBkwMCB1dXVcfHxXb&#x2B;nEARFMXjK2fI3nJyOjs4fgTmjB4faLI0ud2x4yCXjckuSYs0MbaTPoLNN32REv9R/3Dj/rhc&#x2B;8TW5mgTx29Xbl26mgi1GFEVd3oDk9gIDAzAkMtQ2f9yQDsc2&#x2B;9h5j742JD0hIz4qxGpqdHlW7MgDACiqkpUYJUkyQeAAABRBqHZ9SIMtxmCL8bQTy8lIzE6KESRZlhVRVggcC2staXjylgU3zxufX1zNCUJ8ZOjw7OTz9Wr8iTkl9w8iq0KRBjRg5xtZXe5/tvxZihDPAD0B0Dn/IAgydNiw1atWXZN0XZfCHgxFSYqCmtU9AlSoKqqqS4B0dHTauHTi0EsnDpUVBUGQZ25fxPKCoqo92PrqaGAoumjS8PS4qM9/2b52T0FxRa3iaLY73QBFAY4BIxNkNUUEWRaMH/rI1bM7HGt3&#x2B;w5sO3TgyEnaZCBx3OvyAJIAADGbmAXjcjH8nNaSUQRhKJKhul7X17ZfzuX8fQcIAAoBI0KfGa9tkfs7fVyjwDdDXe5/VvTN8ENPAHTOPwiChISE5B85cv0NN5Ik2eGtBQGkaDo0LNTv80ZFR6mKAlXNE1f3q9LR0fkVmpuv1cS0iVJ0TgtF4MOyklJjw2&#x2B;bP6my0VHV4Gxq9jo9fk6UUARJj4ucPWpgv&#x2B;QuS2xh6oC0ktpGvsHJIwAQBGU2JkWFXTpp6MQhWV2N17kIMCIUSLQijq40iU7J7vI28JxDl/ufAwiEsA/mAHoCoHNB0HIARVEYmuYFvv1TqgqNBmN0dJTDYU9LT9eaZkIItboAfeVCR0dH59wJMhuDzMaBqXG9PyQ5OvzHFx&#x2B;sbHA2ON21DrcoySYDPSwraerQfhdunjq9h5QhAEhDOF0ZpNpVtyPQwLMOSWa17009&#x2B;j87NDejiz2Li4CeAOhcEDAMGzN23MnCwrT0dI7n2j8FVdVsNqekpP7w448DBw02mUwQQIIgFVkMBAJG0&#x2B;m1pDo6Ojo65x2aJAakxA1IOYOcQec3QJP7Ewp0BZFVIWgDFrDzTQHOLopeACBAdM3P2QO7/GffQM8XdS4IGIYNGz5s/bq1OI537vZDM3RkVJSzye71elAUBQASBI6gqN/vuyiz1dHR&#x2B;SOy51jJNxv2urz&#x2B;iz0RHZ0LAgQAgcAgQJ7GTiYxhyOkQrWuylPk9pSLogcAiABEj/7PC31PAaQnADoXDJIk62rrMAyjKLqjug5BKJKkKAppeRhhDAYMw3w&#x2B;PQHQ0dHpLWv3Hn30na9La5vO8Tz7j5c99s63mw6eOC&#x2B;z0tE5XzAiBAhSGcccjgPHMHu5r9jhLuZ5BwSKHvqfT/pe9A90CZDOhQPH8TFjx9bW1oaEhARYtv1TUFUZoyE2NpblOQRBUATBCQJCoCcAOjo6vcdIU6FWM4Gfpn8AL4rHK&#x2B;pNNAkhsJoMESHWDnFTeYP9raUbGIqcnKuXuur8LiAUgCigMZyuCFLt0OMINPCcQ5ICrXJ/PfQ/fyB9tAZA3wHQuVDgOD5h4oS1q1eTZMe&#x2B;b6qqhoaFDRw8qLS0FLZ75wX8gd94kjo6On967M3&#x2B;x97&#x2B;5oUvV/31ra8/XrlVVX/V8RtCOGf04KNfPHvfomlnfYmKescV//jv1rzC3gyWFeWsL6TTJ0CAz4QXJFN5QWyxUFXnPunzVUlyQJP769H/&#x2B;QS2/X&#x2B;fywH0BEDnQoEgiMFoLDxZiGIYTuDtVUCqqlrM5vT09LKSErfXTZKkxWKhadrj9V7ECevo6PwpsZiYuWNyhmQkZidGW4xMe7WvoqqFlQ1vfrfu2U9XfL9pn9vH9XCeHvBx/NItBwor6nsz&#x2B;Lb/fPyXN7&#x2B;S5JY0YOnm/e8t28QLF8rkWOcPh4yBwlClUK2v8ha53WWC6Nbl/heStlaEfQtdAqRzASFJcuq0aRVlZdExMR16AaEIYrGYcQxlAwEURXEcBwDKsnixpqqjo/MHRfviFiTZ6fGhCGo1MR3cpqxG5oErpnd5bH5p9d0vf1ZcVd8/OXb5tkNbDxf&#x2B;96/XhVrNPV0OAKhCFP1VKIYiiNlAk0SvvlKrm5xNzd62gGPd3qM78osWTR5GU0RvDtf506MAUMtWOdzFiioA0Kr60bkgQACAqqp9LvzXdwB0LigEQYweM2bpd9&#x2B;RFNXhKRVCW1BQRlaWy&#x2B;lEUVRz4eh7GbiOjs45AQGgSYLlxc9W75j&#x2B;4ItR8&#x2B;4NmXXX&#x2B;8s3y8opnU&#x2B;do/mFL1be&#x2B;MwHj73z7fYjJ9s/9dP2Q5X1zk/&#x2B;cfv6Nx5/7s5FO/JPrt17tIfLqapaWe/Yc6z0XOaMoWj7ugUjQwWZjSjSU4TnCbCrdx05WFi&#x2B;5VBhTZPrXK6u8/tHVRWObWyN/hE9&#x2B;te5EOgJgM6FBcdxFUKoKh0sgVVVjYiIGDY0t&#x2B;DIEZ7nEaTPenHo6OicPQSGKar6/vLN/3jvu9yMpJWv/HXu6MH3vfr5hgPHtAEur//xd797&#x2B;4eNVQ3On7YfuunZD3/ecbjtk6a2yZUYGTo4LYHAsaGZSSFWy9Hi6h4ux4nSuz9uvPTvb9Y73Rf2xn5NvcP9lze/evWbtTc9&#x2B;&#x2B;HKXXm9P1CS5WPltQcKy8tqG4urG9TffJVFX9k5C9qa/Oian98MqJ5&#x2B;zJ8MXQKkc2ExGAyXXb5o3Zq102fOYNlTKiCoqiRJRkVFO&#x2B;x2u90RFRkJIVD74FtQR0fnbEEQBMewt5ZuWLnz8INXzfzb9fNQBBmSnnioqHJXfvHU3Gwcx7YdPrnlUOGNc8bduWCSyxO44Zn3/7t0/agBqZHBVgAAVAGCAE3PYzUZTDTZ7Gd7uKKRpuaNz3l3&#x2B;abnP1/55kPXdjcMQlheb88vqQ6zmbMSY4It5&#x2B;pvGB0a/K/bLzPS5MDU2Kz4qN4f6Gf5t5euP1xUOSwrud7l/vz/7mA6dWXQ4AVxy6FCCMCsUQO7HBDgBUVRaZLAUBTDerV6KMlKQVlNiMUYFxGq7XBIkoIgAD9d46Y&#x2B;j77q/9vT5/JUfQdA58KComhkZOSOHdsJgkBRtMNSkM1mTUxM9Hk8LSqgvijD09HROUtMDNXo8r6/dMONc8Y/cvUsTUXDUKSBolhBUCAEAFQ3uUwMPWFwZnRoUP&#x2B;U2EsnDqt3uourG7QzZCVGFZTVfLlud3WTq6Csts7pVtTTLEMMTo2/Y8GkpZv3nazstuTX4fY/&#x2B;PqXVzzx1qy/vPyP979vq/c9U9qUyWYjfdnEobNGDnp48exxgzN7fwaaoqYN7z9vbE52cmxSVFgPK8o&#x2B;Tnju858f&#x2B;e/X3Q34ecehJz5Y&#x2B;t3GvS9&#x2B;ucrH8r25uifAXvf0e098&#x2B;IOitrwCr3&#x2B;3dsZfXiqq6lW1tI7Ob0Pf3KTSdwB0LjgGg&#x2B;GSBQv379s/OCdHEIS2x1VVjY2LGzZi&#x2B;P79B0aOGklRlCwKEEKkRy2sjo6Ozt7jpR4fl19SXdngSE2MmpCTWefwkASOY&#x2B;jPOw8X1zbcFz&#x2B;VInAAQHZSjCBL7tZ1fV&#x2B;Atxppi5HRfrx6&#x2B;uijpTX/fO&#x2B;7J97/HkURIcAFTRza86VNDH3DrLFLftn5zOc/LfnnnZ0HKIq6q6Dk57W7vnv14Sa376E3vpw9atC8sTlncZvTH3xxaFbSY9fOCTIbMVRbsGv5eGx0efYcK81JS4iPDNEeCfCCLCtmA42ip5b2GIpYMD534YShAABZUXG0209Xi4F5&#x2B;JrZTk&#x2B;3tspVjc3r9hYIkrxu79EbZ48zG&#x2B;jTzh9FEIuRoclTxc3eAFtS0xjghB6O0tH5LdHeEn1QgqwnADoXHIIg0tPTXnvl1WHDh4mi0PYmU1WVYZikpKSl3y9tqK83GA0cF5BEsXPFsI6Ojk57mj2Bd37cWFRTbzHQZgP1/GcrMAwz0mST23uioo7AsM0HCxubfQSOQ1VVFfivj5c3ON0Igvy49UB0qK3Zx56sqmco0khTnzxx2zuP3Kiq6sGTFQ&#x2B;&#x2B;/oXc1Q5AYWW90&#x2B;MbPSBNW55IjAq9Zsboz1dv311QMqp/KgBAMzTUpEQqgDSJ33jljMunjAAAbM8v&#x2B;r&#x2B;Pfpw1aiCOnbHupaLBnpuZ1D6gb6Os1n7/a1/8/fp5dyyYBAAIcMJ/vlj5wpKVCIK8dM&#x2B;V918xo22koqpr9h71&#x2B;rmrp4/qcBIIoayoOIYiCEKR&#x2B;KxRA3vYhv3rVTNunz8RAPDYtXNDbT01SuoBTbWlr/Lo/N7Q24Dq6FwQTGbznHlzDx08NGjwoPabAACAhISE7KzskpKSAQMHwN&#x2B;&#x2B;Qk1HR&#x2B;cPyKgBqQgK7G6foqgub8DlC/hY3s9yYUHmOy6ZXFHv2FVQtGZPvqqqAAKaxO1u77KtB5t9gVq7y0iTr379iwohSeAUjlMkwVAkAHDPsZJ6p2dQSnzny20/cvKRt799/9Ebxw5Mp0hckpUwm9lR0/TC5yuXv/ggAIDAMD/LaxZjBIbNGDFgxogB2rGPXTN79B3PbNh/bObIFm09iiC9iTZkRZFl1WKgia4yBwRBMK13AgAAgGXbD3y/ad99i6ZxovyfL1ZHhwUvmjRMe0qU5FU78w4UlndOAFhefG/5pk9WbT/w8dM0SRAYBjAAAOAE6dWvf5k2vP/w7OS2wXUOjyBJFElEhlhP676so/MHAsI&#x2B;uAGgJwA6vwkkSaampr7z9ttDcocgCNJ&#x2B;EyA6Jnr02FHLlq8IDQuFskTpy/86Ojqnw2oyzBjRda2qhqpCThRZTvBzAieKLC8qCvRznMPjd/tYp8fn5/gAJ/p5nuVEjz8Q4IWkqPBHr5l7yfghnc82ekBadkL04&#x2B;98NywrkSKI6ibXsdLqyMToLXmF8x99fVhW0q6jRXKz990fN9EkGWo1GWjKQJMEjtEkEWwxD0mPf&#x2B;qj5ROHZGlimKZmX1pcxGmLPHEMI3DMx3JqN2UJEEHaltIdbv&#x2B;Q9IQHrpwRGWItq2v8Yu3OhRNyW1VDAEEAinSxjeD2szvziy1Gur1KBwAgStILX6zEMLQtAcgvrb7n5c8OF1VxgpAYGfruozdOGdqv7fwfrti8YkdeQkTII9fOTogIPc2NnQ5JVnwsZ6CpDrPS0blA9MHlf6AnADq/GcEhIZctWrTy55Vz583t8FRubu7GjZvy846MHdNxgUpHR0fnLEBRxEhTRpoKC&#x2B;rtIYqqQgi7FOr0S4r5/tl7v1yz63hVrS/Ax0aELJo0/NIJQzcdOv76d2t/3uk2G5jH7128La/whS9WmhgaQxEcwwgCI3CcIgiL0bDraPH0B1/MSUuodTQfOlmxaNKwtsb/sqJ2VyWclRi9fPuhOxZONnUS3Fc0NDkanW0h&#x2B;B2XTL5x1jiLkUFRZNGkYf/6ePmK7Yc06T8EAAEI2pX638fyxTWNU3KzungBfy3TefS/31TU2z/6200RwbZnP1tx&#x2B;RNvHf70meToMADAyp15r32zNiY8eMmanc3ewBsPXXvWAiEAgCQrmw4dv&#x2B;OFj2mSeuHuKy8Zdza1Ezo6vafPCtL0BEDnNwJF0ZiYmFUrV&#x2B;blHWYDrKLIJpMpKCjIZDYLHC8IQnBI0JDc3Is9TR0dnT4K1pXUvo2YsKBHr5vT4cGrp42aNzaH40VZUawmw3UzR5fX230s7wvwAV6QZDnACU5voF9S9tXTRn&#x2B;3ee&#x2B;JyjpFUR&#x2B;/du5tl0zE0JZMw2JggsyGLvvzPHXLpZf9/c0xd/z7yqkjR2Qnh9rMFIF7A3xBWfWXa3f765o2Hz4xOC0hyGI00iRNEpwgUiQ&#x2B;e&#x2B;Sg7zbs/Wrtbi0BIAnCzwld3h0rCHUOV1ZSTOenUBRpnwvtOFr816tnXjV1FAAgITJk0HVP7D9RHh8ejOPYZ6t3RIXYXrl3cXFNw03PfDh9ZP/rZ44966Cqsdn7zg8bKisaAE0&#x2B;/s43egKg89vQBzcB9ARA57fDFhT06OOPC4LAcVzA7w&#x2B;wLM9xPM877I6QsLChw4cFh4Rc7Dnq6OhcBARRWrpl/8ScrOhQ2zkuyCmqirbTxlxQUBSxGhlra0&#x2B;h7KSY7HbBdHWTC6pqfGSLJOa6WaMBAKIsKwpkqFPilutnjZk&#x2B;or&#x2B;B6UL9OCQjYe1rj7y7fNOWQye&#x2B;XLsTqhDHMIYmVRVmJUYPvGH&#x2B;keLKu176NCYsiMAxiiQokmBIwmY2CJKydOPuq5/ExudkldU0rt51ZOKQLpb5OV70sUJbH6GOzwpi27/NBhKoUFFVDEWtJgOOYw63T1ZVHGB3LZxMkni/pJiBqXHvLd/8xZpdU4f1jwkNAt23su8h1iIwzEgzAEVRBIiSzAkiQ3VtXKCjc/7oe&#x2B;G/ngDo/PZQFEVRlM1mu9gT0dHR&#x2B;b3ACdLf3/3&#x2B;7YdviAi2nEW3nFPnEaXdR4sjg63p8ZHncp5zx&#x2B;Nn73v184KympLvXm7/OInjHb54MxKiMhK69fZKj4984e4r/Szv8vrdfrbZG2AFkSTwAcmx4cGWzQdP7Dpa7A2wnCAFOKHZ668XJW&#x2B;AHzsoffzgjB&#x2B;27i&#x2B;qauBFafSAtHsXTe18cj8n4hhq7Fx5hSCyov647cCA1PjwIDNDEv2T437emXf5lBFRIbY1e/J5QRqUFq9p9CcPzW477p83zr/myXe3HirUCo4RBOnkBIygKIrj3W62RARb7rp00qb9BQiGXjl1pB796/wG9MHlf6AnADo6Ojo6Fx0IYKPL237J&#x2B;ezwBth7Xv5scHrCGw9eGx5kOS9zOzsokpg5YmBs&#x2B;HnY1SRxLNhi7NJOuH27ofaIkiyr6m2XTPQFOE6QQm3mxKguanMpEkcA6FweoBUAVDY4nvrfjzaTgcQxQVKOldde&#x2B;9R7KTHhGw4UhNhM36zfs&#x2B;nAcYrEDTTJUCRNEgxFmg00QJBXv1kTbDEmR4eX1jU6vb56p7vB6Y0Os6EI4mU5A0UwPTZ7GDcoo2H1W03N3ov7G9TR&#x2B;XOjJwA6Ojo6OhcfAse6LFTtwD2vfAYhUFVoMtB/XTwzKsTW/tlgs&#x2B;mRa&#x2B;bYzEYjfZFXjmmSuHPh5It1dZLASQDiI06TfgSbDQxFHiqqGDswvf3jKIqIsnzTvAlD0hO8Ac7H8oIkjR2YCiCCYShJ4h4/e7yiJr9EkbXSaQhBa4//cYMzdh8t&#x2B;cubXyVHh1c02DlB3n&#x2B;87MZn3h&#x2B;Snljd5Ppx64E5owcndCM6ao8e/ev8lsDTWYD/&#x2B;dATAB0dHR2dPwwRwVaXN9Dk8tg9Ppb71Y5Bsy9QXN0YExYUGWzpoQaAF8Sfth8yMbSBoUKspn5JMT2X//aS4qqGn3fmXTNjdETwHyZyjQixThiS&#x2B;cqXv4wdkDEkI6Ht8Xd&#x2B;2MBzwhWTh48ekNbdsYqisoLI8oKfE/ws7&#x2B;cFX4BzeQO5mYl19ua9x8ucHt&#x2B;AlNgZIwbU2t0/btt/uKiSk6Sb542/fd4k3UZA53cFVPuiEYCeAOjo6Ojo/L7gRam6yUUSeHSIrUOw&#x2B;Og1cxBEaxXPB1tMbY/LivrG9&#x2B;v/&#x2B;91aUVb8bt/M8UPefeSmLnUvgqx8uXZXQJD8LBcRbF3yf3daTcy5z7m83v7SV6smDsn8IyUAQdbn7rxiwaOvD7/1ydiw4JSYcIrEa5qaC6vq507IHZQa18OxGIaaDbTZQEd0eiojPmpSbnb7R66ZMQoAIMmKrCgUoXf31/kd0UebgOoJgI6Ojo7O7wQIAY5hhVX1HyzfXFBeoyjq4qkjr5o20sSc6oJf3ejcmV&#x2B;sqHDCkIz2&#x2B;p/Cqvr3ftxwyfghL91z9fYjhYuffGfZtoMPXTmj81WsRubZu65gOcHH8VCFNHV&#x2B;4lFZVd1&#x2B;Vu6mo//vloy4yGNfPv/LniO7C0pq7M0QwoSIkPuvmD55SJaR6Wg&#x2B;cI4QOKav/ev8HtGLgHV0dHR0dC4WJgN1vLz2jpc&#x2B;bXJ6xg/JbLA33/bPdwgCv3r6KALDAABfrdv9xAdLVRViKPr0/&#x2B;Rn77z8isnDKZIAAOw5WoJj2E1zxodYjQvG547ql7r/eKnT4w&#x2B;xmtpfwu72Nrl8NqMhIshioElTNzEuhGD5toM&#x2B;jr9&#x2B;5pheTh4BAEPRs2s/&#x2B;p8vVoZazZwgJkeHTxma/Rs74KIoMmf04OnDB/CiJMoyApAuC451dP6cIAD0yRRATwB0dHR0dC4&#x2B;KIpUNzr/9b/lnCh98sRtmvp8/N3PfrZq&#x2B;4zhAyJDrACAF79YmRYb/uQtlzIU&#x2B;e9Plj/1vx9zMxK11vucKBpoqm2B2Wpimn1sgBc6JACbDp74cMWWACeQGGY1G8YPzrh6&#x2B;ujoUFuHyaiquuPIyZ&#x2B;2Hx7VLyUtLrL9U36O9wZ4m8lgOH91xgdOlNMkcbioMiU2Ynh28m&#x2B;cAGjoy/M6fRYIIOh7NQDnofJJR0dHR0fnXMBQlCLxl79YXdXkfPeRG9tqT/slxQR4UVIUAIDD46t3eeaNyx2enZKTnvDQVTPrnZ6yuiZtZHp8pCfAbj544mRVQ629GUJAYFjn7/RhmUkOt6&#x2B;wsi4&#x2B;MoTAscfe&#x2B;e6xt79l&#x2B;Y7tRzEMnZib5fT63l&#x2B;&#x2B;uf3jFfX2Zz796ZbnP3rt27UeP3va&#x2B;3K4fYWV9bX2ZkXpqcfIaw9c88ztiz79x21P3DDfYjjPwhsdHZ0e6aNVAPoOgI6Ojo7ORYMXJALHZEVFAFLe6Pzu3/eM7JcCAFBVWF5vP3CiPCEqhMRxCKGZYTAUEwRR&#x2B;762GBgEAFVtifFH90&#x2B;9bMKwD37a/OPWAwSG7T1eunD80M56HBUCs4G&#x2B;Zd7El&#x2B;&#x2B;9CgDw709/evfHjZsPHZ8zenCHkdOG9b9u5ugv1u68YfbYASlxAACWF79Ys&#x2B;uFJaumDuv/&#x2B;rdrSqob/vf3W7trXaoo6v4TZW98v76x2WM10Iunj1o4YSjRyZusqdlbUtNoMTAkgcdHhUZ06n2pqCram/aoFwBFUT9fs7Owsu4/d13RXtrU7AtQBM5Q5G9jt6yjc6HRjcB0dHR0dHR&#x2B;UwKCMPamZ1hObKq3AxT938/blm07GGQy4Bi&#x2B;u6D4QGF5/&#x2B;SYvKLKyBBrbETQmAGpH6/aPqxfak5q3Fs/bIiPDG3r82M2MK8/eM1Vx0YcL6&#x2B;3mhj3J8tVADtHqIWVdXUOd//kWO3HwWkJIVZTrb1Z&#x2B;xHCU4fQJHHFlJHLth588/v1Hz5&#x2B;MwDA7vaV1Tc9eOWM1x645tPV2x9648vbjk3srlGmJ8D&#x2B;5c2vyusdl08efrKy/sp/vLX5nb9PzMnqMGz/ibKnPlrGCZKkyGYDPSw98e7Lp2W360y6bm9Bsy8wc9TAYPMpXb7bzx44UQ4AGNkvxXTOOwaqqqoQ4FhHRQAEcNfR4s9/2fHcnZdj7V7Jv7z51aGTFckxEaW1jT&#x2B;98EBSVPg5TkBH52KCIKDdUkLfQU8AdHR0dHQuGkFm47O3L6pssPOi7GP5OkezyxuorHfIimpi6Jvnjt&#x2B;eV7R08wFJaXGckiVpxgMvmI2MvckFCPyOFz&#x2B;Niwg20VSIzRxqNUeH2uIjgivrHZ4AlxgV2rm/Z7DFqChqcXWD9mNFXRPHiwzVoubfVVDqDXDTh/XDMBQAMDI75dKJwz9fte2G2WPHDkwPthiunzU2yGQEAEwb1n9QavxLX61e9vwDnW8KQlhR79hdUPL1v&#x2B;6&#x2B;aupIAED24sc/WrG1cwIwqn8aRRK1Dvet88aLsvz&#x2B;DxtPVNd/98x9bTZYP20/eKiocnB6fFsCUFhZ/88Plh4urlIUdVJu1lO3LOzZ8Mvh9m08cMxkoMcOTLeaDJ0HlNQ2/fODHx67ds6QjMT2j&#x2B;MY9sSN86&#x2B;cMqKDT8Il44b0S4ox0GRiVAhNXmTDNR2dcwfCvlgDoCcAOjo6OjoXDRRBLhk3RFYVCIHmKQtVKKuqsbWit97p9gU4QZI5QfRzvCgpNovRF&#x2B;DK6&#x2B;wNTk&#x2B;Dy93sYxtcnqLqBi/L&#x2B;1meFyVREAekJVw/c6zZ0DEBGJASNyEn4/3lmwRRigy2/m/ltjCbeXBavPbslkPHXvhi9QeP3XzV1BEAgKKaxpoml7us5tnPVnz891ujQmxtEXx0mO2GOeMe/u/XBaU1/VNiO1xFUdWqRqeBpsYPzgAAyIo6ZlB6QWl159s3GahaR/Pdl0554sb5AIDMhJibnn63vN7RlgDgGIYgSHuFwotfrMwvrb7vsqnuAPfsZysy46MeuWZ2d2qcw0UV97/2ZUFZtcXITB3a78musgUI4eaDx0VZWfb8/R2ecnkDseFBkqy0rw9eMD5X&#x2B;4esqBdJnaSjo3Ou6AmAjo6Ojs7FBMNQrJP&#x2B;pI2oEFv7fv&#x2B;qCrWgU1ZUWVFUVYUQqhAqKlRVVZIVCIDVyLQt6nfAbKD/edOCMJtl48FjvoCQFB360JUzNYk/AOCKKSO2Hj65&#x2B;G9v3P2SlaHIAMeZjczMueMLSqsXPf7GqEHpBooMtpiCLMaIYIuBJG1G&#x2B;oHXv1jy5B3RoUHtr4KiqImhWE4oq7NHhwYpqkJgmJ8TOs&#x2B;n0empdzTnpMWrEKIIMjEn02Q2NDib24uR2rP18MmNB4/ftXDKA1fOAABsOnA8r7iKFUQjTXUYWVzdWFTdsHTzvmZvYOmz9x8qKn/l6zVpcZGPXze3w8jEyLAnbrzk7&#x2B;9/vzO/eMzAFkWTCuHTHy37duNegsBmjxr0zO2XEfipgGHVriMur3/hhKEmhgIANLm9BaW1QzISbCaDKMlVjc4wm8VqYiAA3gBH4lh3v47u4AQRRRDqYnRD0umL9LnVfwD0BEBHR0enL8OL0rGKunCbOS48&#x2B;GLPpVe0LTnjGNpZtt4bUmMjXr5vcVWjU5Tk1Nhf&#x2B;dimxUb&#x2B;8urDJyrqj5XXePwsjmOJUWGJkaEHT5Yv3bB377FSlhf9HB/gBD8nmBg6LS7iZFXDf5dueP7Oy2VFCXgDsqIAAFAESY&#x2B;PCgs23//qkkWTh5EEnldcKXXVCCg82IoAZMP&#x2B;Y3PGDAYA7Mgv8nOCxdiFUEdjyS87nG7/hJxM7cdgi5ETRa5TArDtcOFDb355orAiOi7y4atnTRmanZ0UvXLnkR35RZ3PSZH45ZOHvbts4xMf/rD5v48DACCElQ2OZz9b8eCVM4wM9a8PfhzZL2XB&#x2B;Ny2nOTHrQcOn6yYmJOpJQDHSmvveunTT/5x2&#x2B;gBqU3N3n&#x2B;89/21M8fMG5ujKMqHP22JCQu6cuoIFEEAAAdOlNfYmycNyerOfVmFsLLBsWzTfhmqN84ZH96pKlpH50IA9RoAHR0dHZ2&#x2B;w9HS6rueem/Y0Ox3H7mxywGqqpbXO/YeLzMxlNb7xWpiEqPCrMauA7jeoKgq7Krq9LekO908hqL9kqIzEyJVFeI4poWtydFhC8bn&#x2B;lkeACgrqiQrgigTOBYbHhzgBY4XAAC5mUkf/t/tidEtFbHRoUHvPHzDV&#x2B;v2LN10QJQle7M3PNja&#x2B;XIUgd&#x2B;&#x2B;YPK7yzcV1zQmRIUu3bh3cFpCelxkW6iNooggyo0ub2ZC5JK1u9fuOxpodK7alZeTntDY7C2qbhiWlWTotPxf0eDkBDktPcHh9pI4DgBAECTMZnZ5A9oASZb9nGA20DiGAQBCbZa/XTfvjpc&#x2B;Xbkzb&#x2B;6YwRDCBqdnYGrcc3ddQeLYsfLaJz9aNnVYf3NrwTGBY&#x2B;0LA3hRKq1t8rM8AIAVxA0Hjo3QWjlB&#x2B;N3GvRkJUZdPHoZiGABg1a68pVsOfP3UnVZTXJevv8fPvvnd&#x2B;tff/gYEW1fvObrlrb&#x2B;d9lf5p0RXVv1mIHoXIB0dHR2dPgUniNvyTh7cf8whyw0uT2RXEaqsqvtPlD3w4icmi4nAUBzHrCbmrkundrDIhQCoqtqhWrQ7DhdVNjjds0cN/n0qyBEEwTEM/LpjJ4FhQeYu/HGNNKWtvkeF2K6fORZv1crjGLpo0vBFk4ZrAvo7Xvi4oLy2y8v988b5GfGRG/YXFJRWTx2afedl09o3AyUJvLyuafqDL1AEwXr9I3Ozb79k0orth1bvzBNFuaLJ8cAVMwydBDZ&#x2B;jqcI/MlbFq7ff/SZj5cPTk9AADhRUdcvKUYbUGtvfnfZpglDMmeNGIQgAMfQSblZsiz/65Plc8cMRlF0YErcF0/eSeIYAOCZ2xf1u/pvmw4ev2TckO5eMQLHMBQBAGAoamJoisQBAAgARoZq72umqGqA4&#x2B;XuXRFYXiiqrgdWE4KhFXUOl9cfbDF1N1hH53zRBzMAPQHQ0dHR6aM4vYEDheVJQ7PDrKZ1&#x2B;wo6xPRtcILISsr79y8mMMzp8bv9XKi1Y0wmiNJbS9ebDTRDkiYDfenEoT1cd8manV&#x2B;t2129/PVzt7z1&#x2B;FmWFyiShBBajMxF9LJFEIQkTn2lKopaUW9nBSkyxNrg9OwuKBmQEt/lgaE2892XTrl88nBBlGI7CbECASEzIeq&#x2B;y6eFWM0ogqTGRUQGWyfnZi/fdsDrY&#x2B;/JnLZgfNdBuawokSHWx6&#x2B;bl19SPfH2py0WkwLhoknDtGdVCDYeOP7Dlv1vPAhiw4N4UVq756jMC4dPVvz93e&#x2B;fvu1SI0Nlt2YLmQlR88cPef6zFbmZiTGhQSqEgigFBKEtZtI2c7RCDgQBbVXLXbdWQZAeFlyDzKY5owbtOXRCwfGkmFA9&#x2B;te54CAI7Ivxv54A6Ojo6PwZafYGtuadFAQxLT4yKzG6yypMj489dLLyyolDK5tc6/cd7S4BAABQNDFpSFaXS&#x2B;AaiqKu3JmH45isqDSB95wAMBRpYs6P3&#x2B;0PWw4s3bxvcFpCZb3j8evmDkjtWljy2yMpyvr9Be8u2xQZYnP5Ak5v4KopI3oYH2Yzt//R4&#x2B;cAAiRZPlZRGxVqGzcoIy48GABE2zMZMzBtZL8UFcDOzmLtEUQpLjx4yf/duX5vfp3TMzg9YfqI/tpTSVGhbzx47f2vfX7t0&#x2B;8JoqSoKk3gs8cPHZKZ&#x2B;My7S79av9vIUBYjYzMZLEYm2GJEAdh7rPTJD3&#x2B;cNrw/ieO78ouLquo37j8&#x2B;b2wOQxHr9x3l/WxBWc3EIVnVTS5PgKtscAIAnO6AL8B5/JyfE20mBkIoqypNEAzdbU2wgSZvXzDJYjI0Ot2LZ4zu/Quuo3Mu9EEVkJ4A6Ojo6PzZUFT1je/W/uuTn6wGWgHgX7de&#x2B;sAV0zt0lVEhPFlV7/L454/P3XigYMmaXYqidtuNBwJelHq4opGhNvz3b4IosbzACz2NPL8kRYf1T461mY2VDQ7l91TGR&#x2B;DYiH4p1U0uh9ufEBny9&#x2B;vnzhuX0/vDl287mF9WXVFn33&#x2B;i7Nk7FoXZLOiv5VUYhp52s0N7ORKjQm9dMFlR1PZFFwiCjBmYdvCTfzc6PXa3F8exYIvJZjLIqjptWL9DRVVur7/Zz3oDnMfPFlU1RIXaHr1uzupd&#x2B;T/vzBNFOSU2fMzAjPtfX3L3K5&#x2B;SOM4LYnCQ9ZlPf1qx43BlgyPA8T9s2W9kKJc3UOdwOz2&#x2B;z1ZtmzlyYK29ecvBwlCbOcjc07o&#x2B;jmHX6qG/zm9IH4z&#x2B;gZ4A6Ojo6PyZKKtr&#x2B;mnbYYfH9/2mvU/esuCaGaP/74MfXvt2zfWzxgZbfrV&#x2B;7w1wO/KLgizGIRmJzb7AS1&#x2B;uLq5uyEyM9vhZWVFpkiAJvDeKGgihj&#x2B;U9ftZmNhhoytj94u6FYMyAtNyMRARBeEE0MlR33TN/ezAUzUlPHJgaf6Kirs14&#x2B;IzYnV/s5fgHrphx/exxhnN7VRHQbcl1RIg1IuRU7QcJwPjBmSP6pbZaMkAIoaqqWmOiJ25a0OwN4DgaHRIEACiubiiqbuAEKSrEZjMbtuWd3F1QnBQV9tfFs46W1ny3ca8kK9OH93d6/f/30Y&#x2B;PvvOtJMs2s/HpWy/rsN2ho3PR6YM5gJ4A6Ojo6PxJYAVx&#x2B;bZDf33ufwDASRNyn7x5IQDghjnjVu08UlzTMCI7pf1gp9d/oLA8JyOBIvCkqDAjQ288eDwzMfq7Tft2Hy0xG5i4iOCHrpqBni6eVlS45dCJS&#x2B;59HpAEwVChNvOkIVn//ev1bc61EMKlm/fLirp42sjzfsskgWvK&#x2B;8oGx/c/7L925ui0X3f2vIjIirJix&#x2B;Ernnjru2fuvXRCT5qo6iYXQxKKCkkCt5oYFEFumD32htljz/rS55gDUUTXsYGZoc3ttFtpcZHJMeEQQq2VUFZi9OJpI085uDmaMQzT&#x2B;ng63L6aJheKotFhtiCz8fdZ/K3Td&#x2B;l70T/QEwAdHR2dPw1&#x2B;lj9aWp2SFjdqYEZecWWjyxsRbIEqVKAqCkqHwc5m37GymqunjQIAWIxM/5S4dfsK7rlsKonjnCC4/QFOECCEpw0mcRTJzUyaNH5IZYPjkWvm&#x2B;gLsm9&#x2B;vv&#x2B;qfb697/VFtAATg&#x2B;037Smubrpo6orvl&#x2B;Yfe&#x2B;IoVhFfvu9rIUAAAb4B7d9mmRqdn5IDUBeOHkHi3X1UHC8t3F5RYTExBac2b360fnp10jgnAedxDwDFseFbyw1fPTmntDdodt//n4wEpccXVDZkJUY9fP&#x2B;8sWqyKkgwAIAhcm7rVZIgJC6K7iePPI&#x2B;37PqEIYjOdcjCIameOFmozUyS&#x2B;73iZl&#x2B;UYirCZjCkxp3lNdHR&#x2B;MyDUdwB0dHR0dP6wyIrK8eLA9MS3/nrdiFufuv2Fjx&#x2B;9Zs76/QU2kyEy9FctPkVJPlxcCQHQLKWsJkNOWvzX63bzotRh7VmU5dNcFUFokjhcVPXCXVfcvmCSLCvBFuP9r39Z1ehs67VvNtAdBEgdcHn9dU63orZ0h3z1mzUf/rQlPNjy2rdrlj5334JxuV0WJ3y5dtfzn6&#x2B;QFRBkMVQ1OgAC2jfErHO47W5fRJAlMqSL9qbdUVTd4PaxQ7OTMORcbQoESS6qbrhkXM5pBTxThvYLMht4UaIpsjfpx3Of/TxxSOboAWltjyzbdkCSlUsnDNOuFR8ZMm5whrU1HBcl2ctyNElotdcqhKIkIwjS3Ur/haC6wfXE&#x2B;z8oUCUwbGBK7LuP3vSbXVpHR6czegKgo6Oj86dCkmWryfDSvYsfevPLG/79foAT5o4dnBb3q3Vxlzewbn9BqNWkPW6gyVH9U1/7du3&#x2B;E&#x2B;XjBqWf6RU9Ac4TYGPCgwEAGIYOTkuQZaXe0dyd2VZnEARpL1J/9rMVf1086/7Lp93/6hf/99GPw7KSuzzVe8s3h1otD10102SgPl29Y9nWg22LeOX19lue&#x2B;2jz/mMAIB/87ebbLpnU/sCNB47tOVa6cHxuW6fLNr7ZsPetpeu/f/a&#x2B;ia1uu2eH2xe4//Uvdx8ttpkMCAr&#x2B;ctWsq6Z2q4C669LJCEAumzRMUSFDEuB0&#x2B;y7bjpz8at2uVS//NSEqVHvk2w37qhudU4b2M9CkKMl5xVWfrNqem5GUlRgNACiqbnjhi5XDspLvv3w6AMDl8S/dvN/AkNfP7KgyUlS11t5MEXhEV6YQ50JidOjrD17N8iIniBT5mxaK6Oj0TB9c/gcAXEwjRh0dHR2d846qqgCAeWNzlj57/92XTnnzL9f/9683dBgjiBKKoJeMHaKpt1EEyU6MSYgM3XustPMJIYSSLPfwHWk20EaK2n&#x2B;ijBclWVHyy2oghFrZ6FkAIXj1/qvvWjglOjTohbuvLK1p2nTweNvmQBueAFfd5JwyrN&#x2B;8cTlThva7ZNyQYItRanWYev3btU6Pf9mLD9156ZTnlqzcfqSo/bHHy2vf/XHjkZKqzlefO3qQ2UB/tGJLd9Nz&#x2B;wPr9xXkFXdxbBuCLP&#x2B;8M2/Jym23zp/4t&#x2B;vnhdrMNz/7UbMv0N14I00ZaNJmMqzYfvB/P2/1cXwPJwcA3DJvQmmd/an/LWs7p9lA20wGrWBj48Fjzb7AnQsnHzxZUVrTCADgBPFoaU1hZb022ONnl6zd9dFPWzuf2cdyj7z99T8//KHnCZwFBpoa0S914pDsGSMHTsjJOO/n19E5B/piAqDvAOjo6PQ5IAQAQHA6sUV1k8vh9mUmRDPUufpVXRQGp8UPTuvafCo2PPiNB69tv&#x2B;geGx782v1Xd9aEoAgSExY8ZlAGSXT7IlgMzI1zxr3x7dryOgeOIcu3HRycFteDFl&#x2B;FUO3UshPDUIuRAQAgCLhv0TTtwZTY8KunjXr7hw1Th/WPDQtqP57EMQABSeBa1AsBRJFTqh0cwxZOGDpvbM74nMwdR4t/2LxvdP80DGv5hZMEbjMbqK5syHIzk&#x2B;5YMOn5z39esePQ/LFdeGyV1dpv/8/HE4ZkfvrE7d3doCDIO48WZybHPHbtHADA0KykpMv&#x2B;svVQ4YIJuV2O/2r97lp7c0pU&#x2B;EcrthIEPn/cELOhJ5&#x2B;E&#x2B;WMGP3rN7Be&#x2B;WDU2J/2WORM6PFvd2Lz54HETQ5&#x2B;oqBuYGpcSG6Gpfdp8ylAUtRoZrKtKXAhBs49lebH1R1hWZy&#x2B;paRw3OKOz3zCE4EzLJRAEnLu2Skfn/NP3NgH0BEBHR6cPoarwaGm1l&#x2B;XDg80EisVHhnbXHhEA8PPOw699vWbps/cN6iaM7gFOEFUVGhjq99nuBMPQ6FBb&#x2B;0cMNDl3zODOI3EMmzas36j&#x2B;qT1Yd1Ek/saD10aH2tYfOCbL8nWzx/7lypl4uxaiKPor81eGIk0G6tfzQU6U193zyudBZqOJocwG2shQJoYyGZj&#x2B;KbGf/LzlizU771o42WIytL2eNEnGhAV9/PPWxKjQsQPT7c1eb4BtKxd&#x2B;5b7F2j&#x2B;CzcZLJwz9ZsOeK6eWjuqf2psXZ96YIV&#x2B;t2/3FLzu7TAAaXV5PgJ87pqem/oqqur2BuFbZUnxECE0SNXZXl4MXP/nulkPHY0KDFVUtrm4cPySjreBBlOTimkaOF1JiIoLaFVFQJPHglTO2HDzx3rLNk4dkJ0WFtT/h7ZdMvO2SibwgsYJAd5&#x2B;2dQeKIO1Le9fsyf/HB0v3/&#x2B;/p1NiIDn/MJypr31&#x2B;2&#x2B;fLJw0YOSMNRPazX&#x2B;QPT58J/PQHQ0dHpU6gQfr1h9/Jth7ISo6sanMv/80Bc9zp1SVK8AU5WOvbP6Q3Lthx4&#x2B;8eNrz94zbCsZABAfkn1D1v3T8nNHj/4nJTlPaNC6GN5b4A7v6dF0Za1&#x2B;R7HIH&#x2B;7ft7frp8HAFBVFf11cxhOkNpX8U4ekhVkMmC/9qXiBPFISRWAQFYVVYUqhNp3ssXITBra78kPf0iKDrt0wtA2awIEAS/cc8WDr31523/&#x2B;ZzMw00YM4CX5g583&#x2B;3k&#x2B;xGo2G2gjTTIUaaCpa2aM&#x2B;mHL/mVbD3aXAJysqnd4/DlpCVoFbXZS9KJJwz9eufV4RV12YnT7kYqqVjY4cAzpn9yT5TCGIRYjs&#x2B;3IyZNV9aFWs8vrpwjCzwmdRx4uqly54/Dfbpg/eUiWw&#x2B;v7x3vftw&#x2B;yl207&#x2B;Mhb31TXNUWEBf/0woMj&#x2B;p1q5BpkNt62YNI9r3y&#x2B;6eDxW&#x2B;Z23AQQRQnH0BBLT35bvQFBkCEZiTfMHGtiqM4L/k0u30c/b0mKCR2WlYyTegKg80elb9YA6AmAjo5OHwLH0Jvnjp&#x2B;Qk0URWJPLZzX1FNeiKELg2Nk1hfTzQmWDI8C1SCmcXv/aPUejgm0XNAGwGplrZo5u9narNf9t6OBZCyHce7y0vQvBhJzMCb8usXU2&#x2B;3Izkl6&#x2B;bzGGIj6W93MCywt&#x2B;jvcFeARFZo4Y&#x2B;MueI5OGZHUwJhvVP23pc/eX1jbVNrmSY8IzEqKW/LLjSEmVkaYxFMEwjMAwksBMDB3g&#x2B;Jc&#x2B;XgYA/Nt187SldNhuzW9b3slH3/72sevmXDtjtImmNW8Bjpeamr0dEgBekCobncFWU3xEcA&#x2B;vgJGmFk8ftWzbocX/93aYzWqkKUlRupS&#x2B;lNQ0coJ47YzR2gm/37jX7ee0cERW1Mfe/nb8oIyb/3nbw29&#x2B;/fznP7/98A0x7XRQc0cPfuWr1XlFVeDX7TgBAO8t3/zK17&#x2B;89&#x2B;hNs0cN7GGevWFU/9TuEqdRA1KPfvG82UD3xjBOR&#x2B;f3CaLJf/peDqAnADo6On0FH8s3OD1Gmh7dP43AsXN0V&#x2B;2ZDjoKCKGsKEon4ftZoEIIVYiiXTh0mRhq4fjc83KVc0dWlH9&#x2B;8OO2I4UsJ5ZUNbz&#x2B;wDWdU6l6p9tAkc2&#x2B;wI6jRVdPG50YGdKlLh8AcOPscZ0fxFA0MSo0sbUTzqgBqRMHZx6rqG32sQFe4ASRE0QfKwQ4/uX7Fh8rrYkNCzJrZQYAwVEUa53PtGH9Z48qfPXrNev2HrWaDFX1jkMnK2aPzRmamdjhioIku7x&#x2B;hiLb/nggBLKiQADbmxVgKDppSNa61x85UFhe09Ts53h5r6JZHHS8BQwFCGCIlgBabedCIMpydlL0rfMnTByS9a9bL7vhmff3nyhvnwDYzIakqPA6h1tVYYc2qVoOc&#x2B;7rmt9v2vfT9kMIAnLSEm6aOz7IfEqGxAkiL0o0gQVZjKiu/9H544IgAOmLmwB6AqCjo9NXKK&#x2B;3v7BkZVWD02xkwqymEf1Sr5gyPNRmbhtwpLiqxt48OTe7u6pfWVF7qBnoGQQ5/V6C1usG6z6ckmRl6&#x2B;HCqibngnG5nTvrIwjCdKrUvFigKDpqQIrL51dV&#x2B;Mg1s2eMGNB5zLOfrfh2w163n6UI4obZY4nuDb96A4aiw/ulDG&#x2B;nk3H7WJOB1n5l88cOUdSWX5&#x2B;sKhiKUq36&#x2B;MSo0HcfueHnnYcPFVZ4AlxceMj9V86YNWJg57IHCKEsK&#x2B;317pKirNt79JVvfgm3WQw0SZGEkaaMNGlk6KgQa2SINSk6rLzezvNSckwY6ERuRgJU4T8&#x2B;WHr97HGJkaGeAOfy&#x2B;M0MBQAwUOTqVx7Whs0dO3hActySNTtG9UuJaGdroKiqgSRBq39Zz39hvQ9xtLO8/cOGJz9alpUYbTUxD7/9TXWT64W7r9QqiVlefOL9pZ&#x2B;u3u5lORLHH7561uPXzTXQLRnO/hNlP249gEjKvElDh2WltH/L9KZuOMALpbVNZoaOCrXR3SSEOjrnlz4X/usJgI6OTt8h1Gr2cfyOIycnDMmqk&#x2B;X7X1&#x2B;yclfe98/ea2wNXDYdOvHTtoM56fEMFdTlGX7ceqCqwXnPZVO0OFtR1K2HC/NKqqYO7TcwtSdR&#x2B;GlRVBVAkFdc&#x2B;e6yTXPH5CwY30X5KQBAVpQN&#x2B;wu&#x2B;Wr8nNyOpZ2ut7hAk2e0N0CRBkjhJ4D0kG&#x2B;cIiiAzRwwcOzADANDdVO&#x2B;5bNrYAWkqBOMHZ0SF2NCu&#x2B;tKcNXa3b9K9z&#x2B;ekxb/50PVBFgOBYwRoWWjPL60WRCnEekoibzEy10wffc300T2fkyZxq9nACqKqQm22KAKMDCVI8s87DseFB6XERrC8KCmKoqqqAlUIIVS9Af7aWWPGD&#x2B;6i92VcROi/br/sraXrv9u0Pz4iJCkm7HBx1X&#x2B;/3zA0K9FiZIwMbWQohiQMNHXj3HGPvfPdgZMVc0YP0o49Xl7b1Oy97ZKJKIpwgiSrStuuEOwQ7kOIoSjZW9svRIVwxbZDf3vnu3svn3bL3AnBVuMLS1a&#x2B;sGTlvYumJUeHIwhYumX/u8s33b9o2rxxOev2HH31mzWpsRFXTx&#x2B;NY6jL63/qf8tKa5sCbt&#x2B;Pu/I&#x2B;&#x2B;ceto/qfMix77rOflm879PE/bh2Q0vX7hRelZVsPXPd/7wIU&#x2B;fcdi5648ZLezVlH5&#x2B;zpg8v/QE8AdHR0&#x2B;g5mhooKtk0bPmDdG48CAL7btO/uFz9duml/m/FtgBcanG5Z7rbqd/&#x2B;x0i15hbfMG68lAJ&#x2B;v2fF/H/4oK8rX63a/fN/iCWdlHSVIUn5J9dGSaiNDuf3s0bKaHnIJhiJvu2TSxCFZbbqXM6W83n7zsx9BqAaZjYPS4p&#x2B;/84qzOw8AAEKoqCrapRoJAAAASeDBPQadWQlRWQlRZz2BnqFJct6YwaE2M463JDnfbNjz&#x2B;rdrm72BoqqGuy6dknnml2YoalBq/DtLN/ywZf&#x2B;iScMRBOAYNmlI1obXH3vs7W/X7sv/8qm7ApwQ4IUAJ2iVDKIkm43MuEEZXe4doQjy4JUzFozPrW50NvsCSdHhVgPz&#x2B;Zod32/eR&#x2B;AYiiI4huEYRlM4gIgoSZf9/c33HrmB5aVdBcVHiis5Ua61N7&#x2B;/fNOugmKWE1bvPjKqfxpJYNUNjsoGp8vj064CAeL0&#x2B;nuzO4QARFXVvOK6u1/5/JqZo/5x43wtPb5l3oRXv15TXm9PigpDEGRH3snM&#x2B;Kj7r5geExY0PCt59Z781buPzBgxICLYuunQicNFlf&#x2B;69dKh2clX/P2td37cNDAlvk3&#x2B;hCAIL0pS928xh8f3zYa9QFYATby7bNMj18ymzryRkY7OGaInADo6Ojp/XqqaXHnFlbkZidqPydFhSTHh5fX2tgEoguBYT1W/GHYq2K1scPywZf/A1Pi/Lp75749/&#x2B;venPw1JTzQbe2rf3iW7C0puff7j&#x2B;nqH2WpyuH0hNhPdvU&#x2B;qrCiiLKfGRqhKR2OsXhIeZL5t/gQ/K6gqPLs9BA0FwqMlVf/9fv2dCydrnY5&#x2B;b5gN1PN3/Sq9GZSWMGf0oKpG132XT79kXM5pWxt1BkWRyUOyhvdLueflz2rtzcOykkJtZrOBKalp2HWsmCKIILOxvVC&#x2B;Nxhpql9STL9WT&#x2B;LkqLDDxZVVjU5vgAvwAidInCC6/azZQN916eTNBwuHZiZvPng8r6gywAtWk2H17iMuXyA9LtLPcv/6eHlUaJCf4&#x2B;3NXgrH/v7&#x2B;0pW7j9AEse94mcfP5aQnaJeAEEqyArFf/Z1DCBUV4jiKAKTJ5Zk1auC7j9zY5ki8u6AExdC48GBt34PAcZoiNMs5ksCjQ23NPo4VRABAv8SYV&#x2B;67esLgjOiwoAeunP6fJT9vOHDsknFd72h1xkTTGXFRqwAAANhMBkVRgR7/6&#x2B;hcAPQEQEdHp6&#x2B;gdZevqHfwokSTRIPTE2B5kjjLBiYIgkzIyc6Mj5ycm93sC9z36hc/bT907czTaEg6IEryql1HPD52w7v/GNU/9cMVW57/7Oe2xqN2t&#x2B;&#x2B;rtbttZuaG2eMAAOX19le&#x2B;/mX30RJZUXIzkp646ZLk6BZZebMvsH7fUZOBmT1qUNvJi6oayuqbcAyLCQ1KiAzV6laDzaab5owHAKgqFCTp7O4dAIBA6GP5X3bnTx3Wv&#x2B;cEQFHV6fe/uGjK8L0FJdNHDlw8dcTZNVY6dzLiIv&#x2B;yeJYoyRYDg51tLUdcRMgHj930zCcr3vhuLcsLJEGwvOjxs/GRIa/cf/W5TzI82NKhXsLh9rVVqkwfPgDH0LiI4GkjBgiS5GcFj59VIByamago6i978svr7JKsjOqfmhAdumpH3v4TZW4fOyA1duaIgVOH9tNOgmNYqM2M/HrV0xPgnvhgaXWjK7&#x2B;0WpIVWVH//ekKEscpEm90eT//ZQeKoWW1TSwvmhiqf0rskjXbT1bWxUWEiJJ8sqr&#x2B;knG5CZFhAICsxOis1tZJN8we9&#x2B;XaXcu2Hpg5cqDmMScpiigrbXlFZ2xmw92XTskrqfQGuLsXTm2rK9DR0Tm/6AmAjo5OXyEy2Dpr5KBnP1vxfx/&#x2B;kJOWsGTtTl4Sz3T1GsIWvWh8RMj9l08jMBQAMHvU4G8G7P109fbLpwzXAh3N&#x2B;qpDoNtZaOrn&#x2B;OpG59DMRK3TYr&#x2B;k2LBgS1sCwPHi5kMnDDR5w&#x2B;xx5fX2O178JK&#x2B;o6ubZ40gSf3fZplpH888vPaQ1n3H72e827reaWhKAAyfKPvp5m8PtExXF5fERGD53zODbF0zS/GUbXZ7vNu1LiQ6fPXpQh/nwglRW1xQeZGlfG90lKIrmpCesfvXhqBBbzyMRBLGZDaIsl9Y1ldY0qBBiFykBQFHESFPGc44pMxOiv3jqzvyy6sMnKxUFQqCmxUbmpMef&#x2B;5k78&#x2B;36vVc/9c4nT9x6/axxAADtr8tqMlhNhs6Db5s/sf2PuemJkqxwgigrioGm2gpqQ23muxdOFiS5/WADRU4akvXxyu2DUuNYQfSx/Jo9&#x2B;YqiIgjC8uKwrKRah/up/y1HUECgmIEhCYK47B9vjeiXWl7fVFLVcDS6&#x2B;on3v2do0sTQZgNlpGmTgQqxmlLjIn7admj8oMy5YwdTBF7vcBM4RvdorZ0SG77xzcfP7WXT0ektiF4DoKOjo/PnhiTwG2aPdXh8P287uOSXncFW06PXzps2rH/bgA5hKSeIzb6A1plHg8Axe7Nve15hXEQwjmEMTdIkgaGozWyYNCTrnx/98Mnq7TfMHCPJSp3D7fazzT5WUVUUQURZFiWF7NQunSQImiSqWV5RVa0eV1VVtbWPJwIAVFWGIlQV/vODHwpKa7588s5pw/sDAOIiQv7&#x2B;3vd5xVXDWxMYLdQDAKgQHi2vff&#x2B;T5WiI7fHr5uakx6/Yfvjfn/4UZDHePHc8AMDt575au2t4v5TOCUCD0/P4O99dM3P0lVNGdHhKVpS84uqDheU3zxtPYBgAAMcwAEB7LwVBkgMcz1Bke7k5iiBv/uW6MJv5krFDCBw9i7LjpmZvWV3T4LSE309PGEmWCyvqft5xeMH43H3HKy&#x2B;dMNRsOGNBUW9IiQ2/ctrImNCebAd6gMAxAu84MQNNjutUkUwS&#x2B;GUThy0cP5QTRU6QOF4I8IKfE3hRInE8NTZi/4myouoGH8trRQ5psZEkgYcHWcpqQ&#x2B;LDQzhR2pFfJMmKqqoqbAuoYESwLTos&#x2B;IkPl362ZrsvIOQVV948b3xGfOTZ3Y6OzoVATwB0dHR0/uSEB1leuPvK/7tpgZflooJtHUJ&#x2B;WVXb91IcOzD9vkXTQ62n1sJpkqgqrbrq/97R&#x2B;rVjKEqTOE0SJgMdYjHRBPG3d77blV&#x2B;EIejh4kpZlD/4aTOKAJLEv1q32&#x2B;H2hQdbOszHyFBDMhJ/2HLg9W/XTsjJtDd7UQRxeltqN1UEcKJU73QvWbtz2&#x2B;GTb//1ei36BwCEBZkhhC7Przy/tJkjCDJzxICv3nzsx60H80uqnrpl4axRgwqr6nbkF2kJAAIABEDpqorAx3EbDx27dOLQzk8pinrwRNlzS36&#x2B;buYYLQGoczRf96/3P/3HbbmZiQAAThA/WbVj2db9sWHB/7hxfmpsRNuxMWFBG/Yfy0yIigk7s0BW09jkl1Tf/cqnP7/4l4z4C1Ux3Jl6h9vPC/ERwV0WoUKAQAidHn9FvWPr4RNu/wyb2Xgh9jWGZiV99dRdF&#x2B;DEXXNqk8Ta0UV4xogBXfZylWSFFUSOF/0cz/KinxMCHO/n&#x2B;AAvOty&#x2B;nPQEm8mw8cCxopoGDMHuXTR11qiBF673lI6OTi/REwAdHZ0&#x2B;h5Gh2rsyaS0dJVmpdzTTFGExtBTyjh6QNnpAWvsDG1ze3OEDvn36bpLAXN6AJ8C5faw3wDa4vAaaigm17TlWkldc5eeE4VnJCycMXb714DVPvydKMkngd1wyaebIjrasCAALxuXuP172wpJVL3&#x2B;1OiYs2O0PrNlzdOzAjJjQoE2Hjh8oLPdzfIPLs3Bi7pzRg3wcB1VQ3eT6YfMBi4FJjPxVLyCtQBkBICrEtnjaqPS4yGuffv/dZRsz4qNYXhqQHNt&#x2B;cJdLXooKoQojg61dPQlkRfUEuLbVMlGSC05WegMsAECFcP&#x2B;J8nue&#x2B;3DB1JE7jxZf8ujr&#x2B;V8&#x2B;1yb1gRA&#x2B;/b9ll08Zft&#x2B;iab0sAHB6A899&#x2B;tPRshqbyYAiSEWtXW6XsbRtmFw4Pvhpy0crt/z43P1disRIHLtyysgrp4zkRGn6iP5QBWW1TRFBFpPhjKvA/&#x2B;gQOGbFGauRAaDrPxsAwKC0eACAJCsYip7fZq86OucOBIjuBKyjo6PT59hVUPz9pr0sL361bs/iaSNNnZrD2N0&#x2B;lzfg8vrzS6pjQoOSosMAANGhQQC0rrq3Mm9sTvsDn7x5AcuJkiozJIkgCNFJAgQAiI8MWfLknXlFVU1uT3p8lN3lXfzkO7P&#x2B;8hKGYgSOxYYHm43M4d35Tc2&#x2B;/JIqAscMNFXZ4Kiod9y3aGpmYsuKOAIQgAC7x&#x2B;dwe1lexHFMUVWXNxBkNr7xzZqYiJDk6LBrpo8SJRkggBVESVaDLV2IyDEMRRG0odnT&#x2B;SkIAAQAbWc2haIowZCaEEhWlENFleOG91/2nwdqmlz9rvnb&#x2B;z9uvPuyqW2HVze5HG5/l68/K4iGTh0qn/9sxSert88aMRDFkG15JyVJbov4BUn&#x2B;fuPeX3bnx4QHP3rN7A7lCnUOt8vrT4wKM3XlvNt7Rg9IE2Qp2NJxIbwDJdUNlz7&#x2B;xphB6dsOFT5&#x2B;/bwHrph&#x2B;Lhf9E3Oisu7&#x2B;V5eYGcbEUFGhthfuufJiz0hHp5Xfh3v6b4yeAOjo6PR1mly&#x2B;r9ftsZiYuy&#x2B;d8uCVMzp3tV&#x2B;3/&#x2B;gb366T/5&#x2B;9uw5v6moDAH6ux5O6u3tpSw1398FgG7IN5j7m7sqUCQMG24Ax3N1dWwqUUhfqksZvcvX7I5B1NYpvH&#x2B;f37NlDk5ubmzRtz3vO&#x2B;76H4&#x2B;u0hneGZNhv7OJMtkxKAnD1/uuJ4f72fwR6uhat/FJrMDfpjQSOUyRupm3nSirLqhvqmw1ao9looRNC/Z&#x2B;fPPSBIT0cD0cQgCLI9gNZQffMJnFMQpE4imIoiqBIRW1TSUXtQ2P7L952iMRxhZTKLqgor2sI8GxnJwEnpTw2xHf&#x2B;&#x2B;n2ZcWFBXm72iMVe98xxfH5FDYaiGHY5jBFFAYDLhc4kjg9Mic6ICQEAeLtqHhzZe87y7S0DAIrAsfamfs8WVew&#x2B;nffEuP7UP/P7V&#x2B;49MbZX8hdPT3ZRKX5cs/uVH5bzV6boNhzMevXnFaHeHusPZdVp9V89c1/LLb0OnLm4dv/pl&#x2B;8fYU9Maml/1sXCytohaXF&#x2B;Hi6t7hIEsbqpmcAwjyurH4NSYwalxlx1XODn4fL1s/c7KWV9E6O6XfkmQm2pZNLkyCBeEHheuO7WWxB0892tK1IwAIAg6G43vm/y&#x2B;L7JHC9wPN9umamvm3OItztJYm/1Sh7Xp538&#x2B;JvOWSVv2aS/ZT59u6wMR9vYMQPTPnp0YnFVnd5EMyyHIIiTUmayModz8ouqGk5eLDFarGYrg6PIPf26Tx/Wq&#x2B;153J2Urz4w8sk5v03/YN6IzMSoQG9vVydBEOqaDduPn5u/fi9FkvPX7x3fN8XGcOsOZLE0c&#x2B;BMfkKYP4ZhMUE&#x2B;CIIwLIcg4KkJA39eu&#x2B;fPHcemDE4HACAIYqSteHsLIE/N&#x2B;X1wWmzbcbbRQidFBKjlUgCAv4cLRRCONfodJ84NSIn5/vmp&#x2B;7Pzpn4wb1L/1BE9Eh0PbNQZc4oqdCZzm1OCfWfydp44Hxvi1zYAsDLsz2v3IAD54JEJjmc5llvy6Nh&#x2B;Hk6XKzeyC8sP5xQkRwbZWzbZaRSyif1TGZYb2KKaHGrLx83p08cnAQBEUWQ63ggMgqDbAwYAEARBAACAY2i7e7UCAPokRvZJvJ5dfm81jhcsVhuCgNomXWV90&#x2B;jeSS23lHKYOuTy7gSiKPKiiHecPU/i&#x2B;Ng&#x2B;ySSJ/77l0PJdx5v0JtrGcBwvAFEtl00f3lMUkae//O3DxRsIHNOb6ZiwgDnLt56&#x2B;WOaslmuUco1CplHI1AqpXEp1jwp65acVLhpFgIfz2aLK2iadS5u6UgBAUWXdp49PotpsGEwSxLniSnt&#x2B;kUouZTgOv7LyMLpnkrNKThH4iB7d4kP8F2zanxIV5Ji5xzFMSpHtVgho9SZeEO37IbQiCMLZokss&#x2B;/fANLuw4tdN&#x2B;yf07W4PAPZkXXjii9&#x2B;MZquzWvHG9NGTB/7dJamiTvvpHxvH901xNNrvHMfzJouNInGSwDuvZCipajBb6XB/77bvzw0qr21cuuNokKcrLwjxYf7xIR1uPn3TIQhy018OBN0I8S6sAIABAARB0H9Xo864ZPvhc8WXckurLTZmUMpVJqERBMG7kLk0PCNheEYCw/GlVfU1TTo3jUqjlPq4OXM8b2W45ycPLbxUY7BYFVLK391135m8rPyysppGfeElg4WmbYyZtrE8nxkXigBxxOw5FIFbGTYq0GdoWnzbvCkURR/6ZOGJBe&#x2B;p/rmJ8pSBGQs27qtt0sWG&#x2B;BotVqPBdL640ttVQxK4vdBCEEUUQZ6dOPjRzxflllR5dFC43JIIAAIQAmtnIUIEgCKJlqGRPRPMXvHcbDCv2nNSFMT5rz20ZPuR139e2TMhzPdKRyO92bJ817EwP48uBgDVjbq3569BUUQulbg7KZLDA4dnJrZ75Kq9J5ZuP7z4rUcdm/jeLCbatuVIjo&#x2B;r08Xy6okD0m4kALCybF2T3kklV0qlnX&#x2B;4RACACO7QJhAQ1BEEtgGFIAiC/ktwDDPRtuyCimAf9zdnjO6T1NkyBcvzTTqTfTvkrpycxDEjTf&#x2B;29dDzk4fa23fiGKaQYgmhfgmhf48X02NDWj6qQWdEACAJXCWX0gxbWFGrNZpwDHNRKQK92qk6iAvxo0i8bWeY16eN8nV32ns672BOfr&#x2B;k6PjI4Lfmrzp0tsDHXaOWS9VymVIuUcqk4QGebhrVa/NWziGnZMSEdr6/r6&#x2B;788ZDZ2qb9I6tav9&#x2B;czjOYKYV7S0OAAB4QYgM8I4J9h2ekeDt6jTmla9/XL3748cm2u9FEURCEmh7c/kMy58uKM2ICW15IwKQU3klFytqvFw0conko0Ubpw7L/P6FaW3Tz1Kig99esGbd/lPRgd6OGolarX71vlM94sISw/4uORBFkFtS2ag3Bni5&#x2B;nu4XLVFUpC32w&#x2B;zp8soskFndFa2Uw7edQXltSNnz5k1pu/zk4d1XnhdVl0viEAupQgM0yhlsBko9G9xN47/YQAAQRD0n&#x2B;WqUbz78Lh3Hx531SONFuvOk&#x2B;dPXCjp0y1yWJtupO3iebFBb9pzOm98n5QuzhCzHP/pH5tc1crXpo0EAEhJIi7EF3RaML15zos8L7QtD3BzUj4zcfCUQRl6kyUq0HtIWtzPa/fuz87Tm2mL1UbbWIbjeF5gbezAtLidJ84u33UsNthXo5B18lzD0uP&#x2B;2Hroqa/&#x2B;&#x2B;OSxe/qnxDhGq5UNzWv3nTqdWxwd4nupXuvlomY53mSxCoIoCAIAwFWjnDW6r/3EcSF&#x2B;04f3/G3L4dlThjmrFcCx63Obp7NYbXOWb&#x2B;M4oVUA4OfhHBXk4&#x2B;vmvOHLFzAU&#x2B;Xr59rfmr3p83IBuEYGtTtI/KWrq0B4/rts7LDMxPeZyoNXQbPz2r&#x2B;0oAloGAIs275&#x2B;/YX&#x2B;T3hjo6Tb7vmEDu8faYyozbd18NGfb0bP9kqPvH5LpKHCXUWRCqF95bWNyZEC7Gx10natGObZPSpifR7tF3i3N&#x2B;XP70fOFXq6ayvrmxW/Oann9EHSndLGdw/8fGABAEATdeXVafaPOGOrnaU&#x2B;PZjkeANBu29Dr06Q3rT9w2kwzIV5uzUazk1J&#x2B;1YdgGNKvW9Shn99wVl6lFaYDx/HZBWVSigRgpP2Wq/5xRREE7eBlEjjm7arxdtWAFnsyiEDkOMHGskazleF5C2111ai0BjNAgIyiAACCICAI0m5nj7gQ/x9enD77h&#x2B;X3vPm9q1rp7qTSKGQEjutMlqoGrVomqWvWz/7&#x2B;z8GpsXVa/ZajOfXNhkWbDz46ph&#x2B;GIxKSoAjcYEYUErJXQvgPq3d/&#x2B;efW16eNQlG0Xqu3MVzbHQBoG/vnjqNL3mlnG6&#x2B;NB7M/e3ISAgCGotOH93z317W5JVVxIX5tv&#x2B;Mv3z9i0&#x2B;HsZTuOxgb7KKQSAIAoiharzcqwjmMOnLn46ZLN/h4uo3t2W7Bh/1vz10QGevt7uIiiuHTH0ZfmLnfTqDYfzSmsrHt/5njHowou1b7644oxvZKmD&#x2B;/Z6kmtDLdgw77eieHxoe2M0U20VW&#x2B;iPV3U9il8b1fNt8/db8/Iavf76DBlUHpmXCiKItWNOhf11T&#x2B;BEATdOjAAgCAIuvP2ZeXN37B/3qsPhni7AwD2ZV9cvvPoG9NHB/u4d/5AnheMFitBYHJJp4k9CEAQRBCEkpqGHSfP39s/rbODr5CQhJ9764Y5nR1PEcvee5IXbmGPFwQgBI4JorBw04GoIO&#x2B;haXFyCeXWYiuA&#x2B;mYjy3EE3v5ft16JEbu&#x2B;faXwUm12QXlVY7PRTOvNVhxDpwxM6xYReK740sL1&#x2B;w6dLbAxXFyI7/g&#x2B;KfPW7flh9S6SwCgCl1KklCLVCqlKLnVWKb5dsb1Rb3RRKk4XlClkVHRA69prEYhVDdp9WReSIlpn8JME3qQ3CaIIrhQzWBlWEAQAsJLqep3RkhQRaD8yzM9jVI9u89bvGdMrqX9ytH2M3XK/al4QFm0&#x2B;qJZL574wLTLAy8NZ/f6idVn5Zf4eLs0G88EzBb0SI5a8/dhPa/fMXb1zZGZCavTllQQLzRy/UBT7z&#x2B;3h7EwW&#x2B;t2Fa759/oF2A4DjuSVz/tzy6xszPZ01AADaxny/cufA1NhuV2b0aSuzNzvPxnB9kyJbhpo94sN6xIfZr7n9EO2KWq0eQ1FXteKunZ2FbidRFO/CNCAYAEAQBN15TQbzmcJyi4Wxf1le27h2/6lHxvS7agCgNZp&#x2B;WL0bQcA7D7WfCGRlWCvDummU4f5etI25b3BGVIC30WKVkMRNXGGwQxDE01l1c8/ZLivDLd1xJC06pHdChD3yyS2tKq9pajIYf9tyMMzPo6PNjBEEUcmlyZFBCWH&#x2B;h88VmmkmNSrIsZVYv6SoZyYO5jjekZJksNBl1Q3NJlpvMhvMVpbjqhqarTY21N/zYmnVwZwCk8UqlZLPTx7WqhYCACCIoqFeu2LP8RemDGt115D02N&#x2B;3Hu6TGBnu7/nJH5uNelNcqB9J4ACAExdKvli6&#x2B;ZPHJvVMiCBwjLYxPu7OjI2dt35PVKCXl6sTxwuCKGLI5QT6I&#x2B;cKNx7KnjwoPTLACwCgkEo0CpmZtgEAUBQd2zuJInGNUjamV7c1&#x2B;07&#x2B;sHq3IwBAUUQmodr9DOhMFr3Jom6zI55ddWPz1n2nTM9PBc4AAEAz7I9rd6uVsvgQPxxDAABvzV&#x2B;95djZZoN5bO/kdx8e59HiI7Fm36kLZdWPje3vqml/WYnhuNMXS79fsZMk8WcmDnYEQhB064h33&#x2B;gfwAAAgiDo3wDHUClFOmphMRTF2zSrOXWx9Jvl28b0Tp7YP9Vxo43hsvPL2I4bq&#x2B;uM5lV7T8WH&#x2B;r8&#x2B;bZT9lkt12m/&#x2B;2tYtIvCBIZm0jdl5Mre0uuG/tYWtUipZ&#x2B;/EzOI5rFJcLWHNLqj5dsqmirsnPzempewb6t&#x2B;n03wqOYUu3H7lQWv37W4&#x2B;02ku4ZUGCSiaNC/EDACAIojWYcworesZHhPldZVsGO41c&#x2B;tsnzzqp2sl1&#x2B;fzJKZPe&#x2B;H7ky18Jgsiw7IvTRkYH&#x2B;thnuzNiQzlBeOyLxckRQZ4uaobjdxw7G&#x2B;zrvmbvKS9nzcT&#x2B;qSv3nqht0m05erZHQphcQn23cmdTZf3pi2Un8krign0vVlRbGVZKkRzPK&#x2B;WSCf26258xOshn6tDMT37fnFdeHRXgDQCgSAKIItmmI6doz0BDkLbbM9sRGI5KqZZz8yzHc/zlT&#x2B;Ce0xfW7Ds5vm93P3fndxauDfRymX3fcEe978mLJesOZE3qn9pRANCkN33917aVK3cDpfRMQUX27x/CJQAIuhVgAABBEPTfYKJte7LyfN2dWwYACIK0HcO1JCHJC2VVny/ZtHnOi/axrNlqPXi2wD71y7D8wZyCbcfOdj0A0Jssc1ftGtcnJTqodS&#x2B;d2wZFkch/dvIZkhYb4utep9X7uDnFBfu1bSvU1pheSfEhfmqlrLqxuVFnCvZxsyfZt&#x2B;IY6RZX1j311e/DMxO&#x2B;eHJyVy6SJIhpw9vZbQ0AEOTlevLX93JLq5oNlgAvFxeVXEpdzuAK8HRd9PqsTYdzzhZXnC&#x2B;5ZLGxqTHBb84Ys2rvyZ/X7vlhzS4Cx/onR18oq&#x2B;zx6AcykjBamacfGtPQbHzwo/nJoQHHL5bwvHCmoNzKsgSGqeQSpUwqpQiNQhbg5SahiDfmrfzhhelSCXmmsFxrMLs7KVtdGwKAq0aJAJBTfKl/e41NDRZaFETH2yIKYsvmnrSNHds75YkJA4K93bMLy5fvOj66Z5Kj7RKGop2XCogioK0skFIAx420lWHZG6xRhqAuufvWAGAAAEEQdPtwPH&#x2B;&#x2B;pNLGcGkxrTNGrqpXQviBH9&#x2B;4Sq5/GyqFdOqwHgeyLz7w3s/LP3gyKsAbQRAJScivDHZ5XrBYbV0/oYm2/rB6V7i/51UDAEEUd508vz8r/6PH7rmma74OaoUs&#x2B;RrTRQanxomieOR80dr9p7yc1ZMGprcbADj4ujvPHN3Xx01zI9fZUtst2&#x2B;ySIgLbpr7Ehfi989C4&#x2B;ma9TEpRBKE3WbILymubmtVyed/kKL3J8v3KnblFFf2Tor1cNXuyLny3aqcgiizHCYIIAMBQxEmpUMio7cfO93vqExe1orpJ5&#x2B;miSYkMansBcgk5MrPb&#x2B;7&#x2B;uc1ErhqUnOEosLFamtLp&#x2B;85Fs0cZW1Wt93ZwwDNUaTILAM6xg30dvQEp0ZlyofWXmyXsG3fvm3A0Hs9r2Xe2Ii1oxbVjPguJLHIr2T46Go3/oNoD7AEAQBEG3VnWT7u35a2QSavn7T1zrYwsu1VbUNQV4uHq5arr&#x2B;KBRBMmJCf31j5owP58/4cP6aj58hcJzn&#x2B;ZYJHtdUaikCYLHaGPbqlb6iKOaWVC3ecvA2BADXwb4GUt3YXFnfhKHI3qw8J6Wsk/5IHi7qx8f1v2qvm1sHRZHc0mqjhUYQRCmXpMeEqhWX0/Q1CtmXT09xHPn2Q2OtDMtyHG1j7S2DdCYLbWVc1Mparf7w2QKjxUoReK&#x2B;E8Lj2GrzKJNTcF6c&#x2B;&#x2B;vmiJ7/83d1J5evu7KZRSklCEMXckqqaJr2Hu/MHi9dP6Jvi7&#x2B;G65cgZncm6/sCp&#x2B;BDfcD9PksAogjCYaQQByREByZFBf&#x2B;0&#x2B;PiQtPibYh&#x2B;V4rd4spchO1qwoAp/YPzXAy01vNA3qHnfT30MIagcMACAIgqBbqry2qapBNzjtKlv2ttJkMH/159Z5q3cRJCmhiCmD0l9&#x2B;YIQj/d2BF4TaJv2e0xcsVtuAlJhQ379T1VOjQxa&#x2B;NnPKOz&#x2B;&#x2B;8P3SJ8cP0hrNwT5u1/0qWjShuTpHdjgAYNfJC/M37v3s8UmBXm4WK7PhUFZciK/BREcG&#x2B;miUsjsysjbR1opara&#x2B;7iyiIFivTSQBg3/Drdl5bW5uPnMkpqmjUGWUS6tvnH0iNCu7oSAlJSEhCKZNW1DUdOFMQ4efVLzkaABAP/AanXv3j5&#x2B;3m9Osbswov1Z66WFpa3aA1mA0WmmG56CCfZ&#x2B;8dgmPYj2t2vvbzKhvDAABG9&#x2B;p29FzhsBfmqOQSCUnIpZRSJlHJpJ7OKtrGXCiteuab3&#x2B;8fnFndqNtyLKd7ZJC7y1W2bU6NamddAoKgmwgGABD0nyeK4vmSygBPN6XscmWe2WaTEATcaPNfqLZRZ7TQccHt53505Oi5wl/W7b1/WM/xfVN2n8r9ae1uD2fVs5OGOA7AMFQQxY2Hzzz&#x2B;xeImnUlGka4a5aePT7ynRbVARlzoD7OnPf7F4oul1SRO2Nvqd47leZ3R4qxSXHWPpy7SGo2bD595cfKwQC83k8X6yKeLHh7d&#x2B;/sVOxa&#x2B;Puu&#x2B;wRk3vStRVwzuHldW3SiXUKN7dnO/LS2MbsSrU0cazVadmbbabCHeXQrhKmqbPv194&#x2B;C0uD5JEdf0XG4apZtGmREbWlHfdCa/IiHMz8fN2fE9mjo0k2E5s9Vmz5symq35FTU1Wl2zwdxsNFtsjMFEl9c2Job5p0QG7jyZ&#x2B;8Hi9VYrExno/di4/rI7HUdBUCt34RIADAAg6L/ExrLni6s8XdReLhpHmSPL8X2f&#x2B;uTrZ&#x2B;&#x2B;fMjDd/ud53CvfPn/vkMGpcRgGY4B/l2aj2cowV&#x2B;1RgyBIyzLWoso6uZR6fHz/yADv&#x2B;FD/rILytftPOwIAFEE5kT9XfOmJLxanRAT99vYjWr3psc8WfbNix6ie3agWg60RmYn3Dkj/cu7yRx4c49FBo0wHThAOnS1YtefknKenYFcbsVkZtqCiViGVdL6wMDQ9/vC8t4K93QEAarn0&#x2B;xenhvt5ejipY0P8sDuUWhPo5RoT7Ltu/6nqpuZ/fwDg7qRyd1KJoii2qLvtXFyI36K3Zl1r6YgDgiBFFXXPf7f0x9nTA73&#x2B;8c0lCdyRzOOslmfE/b3hcWFlLW1lwv09JSQJAHj34fGdbM4AQXeWcFemAMHBAQT9lzTpTTM/XfjblkMWG9PydgxFBUFwfHn4bGFZTeMt/qUmchzf8kmhrtCbaBzDXNStW6&#x2B;0IpcQUoo0W632Lwkc4wVBLqUAABSJ&#x2B;7k5m&#x2B;jLZbsIglAknnWh9I15qxLC/Fd//LSzUh7q6zFlcEZ&#x2B;RU1RVV3L0248nJ1dWBYY5l9a02ixMqBTZtq2Zu&#x2B;pFbuOd573IgjiueJL973z40MfzZ/5ycIf1&#x2B;xuuUltKwhA5BLKvmUvRRHTh/WMD/F7derI5IgA9M4Fq3VN&#x2B;vOlVQaz9U5dwLWyx4ddTMNSK6S9EiK6hbfejKzrvNycBqfFKmQSvss/79&#x2B;v2Dnr018vlFY7boGjfwj6V4EBAAT9l0gpqldCuIezqvM//V3Z4&#x2B;nw2cL3fl2nN9PXdyXNRvqNX1at2X/6&#x2B;h7e0l3VgYEXBIrA207HIgjSci9KT2eNKIJVe0416I0cz0cFeUsocvHmQwCAnMKKU/llvRIvp3NISRxBQEVZldFsnf/Kw3&#x2B;XVyIIAgDPXz6l2Wr75PeNr/200sfN6btXH6qs167df6rzSzXTtryy6r5JUZ0fRtuYdxauPXi2YFTPRD8P5ye/WLzt2LmODj6VV3LPG3OrG7X277nBTD/7zZLjuUUtR5ZWhl2z7&#x2B;S8dXsLLtV1dB4AAMfzFivTyQYIXYeiCEXgXekcejuV1zWdvFjSKtS/PiiC3EhCYIS/55yn70uLCen6SZIig1KigjtvUAtB0B0Efzgh6HaramyubtAF&#x2B;7i5qC5vhbMv6&#x2B;LJiyVqmTQ1JjgmyLeTsbuTUvbd81NvymXkFFZ88Ou66cN7drTfZ&#x2B;dsDLv5SA7Dcvdc2Wno&#x2B;hgt1sLKWncnla&#x2B;b842c579CJiXNVsZAt467BEFEEeDoMJMQ5j9tWM9vf984f&#x2B;M&#x2B;BCAoithszLsL1y7ectBitdXWNNI227NfL1ErZIIonC2qxDTK3t0iUBRU1DVJSGJ/9sWPf9vg7eYU7u9pY9kdJy&#x2B;s3XdSb6Kfu3fwzFF9DWY6zMf9WG7R/UMyO7lUK8NW1DX2Tgzv/BUZLPSWIzkfPTbxxclDAQCFlXW/bto/tndSuwebaFtOQZljUGtj2IVrdqfFhCRFBNkXAFiOHz57TlZ&#x2B;mSCIMhRd/N4Tg7rHtM1ka9Sbdp88fzq/nKKI&#x2B;wZlRAV4tft0FitD2xilTHKbR6KiKJ7OL7v/nR/nPHP/yB6J13eSfVl5y3Ye&#x2B;e65qRH&#x2B;7b&#x2B;62wZD0WvNIJoyKH1i/&#x2B;4S2MQT&#x2B;k&#x2B;4myahHGAAAEG31ZYjOd/8tb1Wq39t2qgpg9IBAGsPnH7tpxUWK8PYWImUXPzmI30SI&#x2B;yL&#x2B;yba2qgzerk4USQOALAyzIIN&#x2B;3OKL/m4Ok3sn9pRE/EumjwwLTkq0MPpOpOeEQRRSClpB3uFOjTojLtO5MaG&#x2B;NRqDYmhvm5OrfPOS2sapn/wy8CUmK&#x2B;fvf/6rsSO43gRATiG3ZFZXLPFOuevbd8s2/bqjFEv3z&#x2B;ikyNDvNxZltuXdTE2yLfl7RX1TVKK1CgvN/ZRyaXvzxr/2Lj&#x2B;BeU1VoY10VYjbUNRhMCwirqmmoZmrdF8vqTSaLFaGRZDkegA71/W7/18yWZRFEUREUQ&#x2B;LsTv62fvl5DEkfOF9z3/hYnjhvXtTuLEr5sOFF6qzb9UMzj9Kj0WOY5v1JtapX23IgLQpDfzPN8nIRwAwPJ8j7iwbcfPdnQ8iiAESTjiHARBZEo51WJ0/u2KHdn5Zas/eiYm2Gfo85//sn5vanSQs6r1rrGf/L5x/vp9Xq7qZpPl8z827fru1V4J7QQqe05fOJRTMHVYD/sPC8fzzSZzaWVDnc4go8i4EF/3Nh9IO9rGiKIolZAIuL4PFEIRGC&#x2B;Cq&#x2B;ZZdUJrsBRU1NI3cIbrI4jijbc6pQicgtP/0H8FDAAgCLrV8itqfN2d57/2MMtxOpNFIZUs2LBfJqEWvjZTJZdMfHPuL&#x2B;v2JoT4OankAIBTF8se/GDe4rce7dMtsklvmvXpwjOFFWF&#x2B;Hit3n9h&#x2B;9OyS9x4P8XG/1gvIKawI9nFXyiTOakWqSnGrCy/Lahsf&#x2B;nj&#x2B;kxMGLdl&#x2B;&#x2B;KeXZozrk9zqAAxFpRR54w2LVuw5cehswfszx7tqWqfXMxxXWFnHcbxGKcMQ1MfduaMXLYqiIIoocs3jn/xLtXqT5aeXH4wI9Cqtrg/y7vD7khEXNjQz4cXvllXUNo3u1c3LRWOxMVuP5Mxbu6dXQoTbP7dl9XbVeLtq7BfG8QIAAMNQjuNpG8MLAi8IPC9wvMByPMtxNpazMaw9K8bVSRXk5WqftXXXqCYN7UEppDaGW77zaLPJYqZtg9Pjpw/vBQBAEICiCM&#x2B;3k9vNCYKJtrV9P1tCAFBIKc7GFFc3pkQFExiG46iJtjrupUicbdEG1D4TT5G4/R22L3ZhGGqPeGkb8/3KHfcNykyJClLLpcMzEjYfzrHYmFZrQwYzvWT74WnDes59cSoAIHLyK0u3H4kL9nWETw4bD2fvPX1hZM9u9i&#x2B;Pnit67pulWXnFAEWd1YqfX36w5Z7KLe06daG8pvHhUb1bhrj1OsO&#x2B;rDxPZ03P&#x2B;PB284VEUeQFAUNRBEGiA30P/PiGQnqdpbcAABxDJSRxmxOTOF44lJO/YveJz56arLyBi4cg6F8OBgAQdFtNHdbzhW&#x2B;X9nj0PV93ly&#x2B;fnhIb5FtW03BPv9Qe8WEAgHv6dd969FxFfZM9AEAAsLGcPUX&#x2B;4Y8X5pZVfvDIhP7J0Xll1YOf&#x2B;WzjoewnJgwgr6W0rk5rSJzyyl&#x2B;fPzexX6qjlbsoim/MW4Wh6AePTHAcyXL8ntMXDBZrmI97mL/ndbcQCff1XPruYz5uzgGezqF&#x2B;Hld/wPUqrqpfu//07CnD2g5YzRbbl0u3nLpYFhPoY6LpNZ88Q3aQmVDdqCuqrIsM8Lpqh5xWvN2cGnTG&#x2B;9//acqgDHsmTEecVfIvn5zsrlH&#x2B;unH/V39ulUlIe7&#x2B;fXgkRr00fRWDtZ38hCOJIDGvZeqUrgrzcvpw9TRRFluM5XkAQxFmlkJCXzyCTULNG9R6QHN3eQ0UAAHq12MxJKY8OC3j26yV7TucSOHYyt4Rjroz4EcTfw8VM27YdO2fP5DmWW8RyfFZ&#x2B;ub&#x2B;HKwCgvLaR54U6rcEeci3YsK&#x2B;mSR8b4mMfdivlEgGIotB6ci63tMpitTmCyZTIoNKaeq3B1DYAKKqsjwnyDfO9HI8t2nKw2Wje/PXLA7pHG8xWKdVhgsqeU7mbDp&#x2B;ZPCjNEQAczCl48KNfqht1Cgl1T//Uz5&#x2B;4VyFrvW2wyWLbfDQ70Ms9PSYEw9ArwRto0Bn0JkuYn2fLg3UmC4ogFEmQOHZNG7HdUoIglFTV/7H98Lszx8EAALqb3HWLADAAgKDb6lBOfsGl2kkDMx4Ykhnq4643WViOc1VfznDwcFajCHDUNVoZVhCBWiF/Y96qo7lFP8&#x2B;eMa5vMgDAy0UTG&#x2B;p3tviSmbaRymv4Kd5z6gIpk2bEhLXqIHihrNpM/6MFys9rd785fzWF40ba&#x2B;vr00W9OH92VMUp&#x2B;RU1tk8HLVR3g6WpPAFAppOP7dgcApMWE3NJiXwLHlDJJu9Olcik1Y3ivfklREorQG2m845DpeG7xyz8sf3PGmBkjenXxeS1WGwCI2cr06xY1c1TfUF8PlVxC2xgCw3AcAwDYy1tbLnG4qBWfPXHv2w&#x2B;Nq2rQVjdoGZYnSSLE293P45ZUQWAY2snmVjiGRgR4RwR4t72LwnGNQnq28NLQtH8kC/GCaGVZR9dOpUyy5J3Hlm4/fLG8luE4rdHsaDyKIkj/5NjIQO8xr3xNEbiEJJoMJieF7JHPFs1bt9fdSVVUVYehyMIN&#x2B;zVyqZNK8cnvmzycVXOWbc2IDYsL8d1z&#x2B;qKEJDG0dVCEoagoAl64/GPirJJXNTbbWK7VYVqjuUFn6Bbmbw&#x2B;nAQAm2hrm55kUEUgRhJums/R0KUUqZRLHZ76spuGbv7apZbJV857edfLCx79v6BUfMWVweqtH1Wr1z3/75&#x2B;Pj&#x2B;qfHhDhu5Hh&#x2B;06Eza/af3PTli/ZbaBuz6fCZA2fyBVH083DqnxSTEhV0TatOizcfpEhiVM9uN7LC0BEEQVr&#x2B;qNY06WZ98uujY/qN6JHQKhrkeKFBZ3BSyu/4/mgQdCNE8S4c/8MAAIJur9G9koakxSMIsP/JJAncWaVYtPmgl6vaz93lUn2TjeVKaxq8XTUSkiitaWQ5/q35K8&#x2B;XVH7zzH320T8AwETbjBarn7uTSi4FANhYThAEvM04qa3swnIfN423u6bVWKNlkxBRBCXV9W/&#x2B;smrasF6Pjx/ww&#x2B;pd7y1c&#x2B;/iYfq6dVgsIonihtGrGh79k55drlLJ3Hh7/9D0D7WsMuaVVT8/5fc4z99kbEdY3G7YdPxsb5JcUcf19Ca8JSeB9ukUCADieN9MMLwhoBxPtJIGr5NJr2o6quKp&#x2B;2Y6jQ9MTZozoJQKAIsiF0qovl2/tFR/&#x2B;4IjevCCs3ndSazDPGt23VZqTXEKG&#x2B;3mG/3NW&#x2B;F/FWa0YlBLz/YrtaTHBscG&#x2B;UopEUcTKsAeyL6IIGuDtaj8MRZFu4QHdwgMsVhuKIq/9tHLP6TzHSWQSIue3Dw&#x2B;cya&#x2B;obTTSNi9nVbCPx6bD2RdKq&#x2B;ub9e4a1Xuzxu86mfvOwrUm2qZWSNd88ty781dnPvo&#x2B;iiDmRt0XrzykbjOvH&#x2B;jl6uWiWbz5kEYu9/d00RpN7caW9VqD0Ux7uWocq2RpMSFvzVv989o9r88YTXb5uyyK4vHc4uPniz98dGJiWIBCKlm558ShswWtAgBRFCsbtFqDqc8/&#x2B;yaJQKxp0h0&#x2B;W&#x2B;i4Zc2&#x2B;Uw&#x2B;893NEgLdGKV2z7&#x2B;Rr3y/f9v1rA1Oiu54IdzyvZO2&#x2B;U/4ezj3i/658MFpoo8WqUcplLdKW7LMJN7LDGs8LR88X9kuKHCbEt7pArcEYOeWVCX26f/H0ZJc2dRoQ9F8h3oXDfxgAQNBthiJIy8QDCUm88sCIr/7c9vFvm9w0yor6prom/ed/bPJydRJFMaf4ksVq23z4TIiPx&#x2B;FzhZfqtXIpSdu4fdkXS0oqGUY4dr5IJZfmldeYaZu7s/KqA4iiytrIQG&#x2B;BF7E2P/qOuXMEAT&#x2B;u2eWkUnz&#x2B;5GQpRbx03/Bf1u29UFbdu70AwDFrabRYF2zYV17XtPWrl/ZkXXhnweoJ/VJ8XJ0AALSVOZiTX9uktx9Zp9W/t3DthL6pnQQApy6Wvv3LGp3RPDgt7vFx/T1cLifkWKy2wso6DEH8PV1VXW5eJALAshyGoYIgvr9obU2jftl7j3fxsVfl7qzOr6hdsefE2k&#x2B;fiw/xBQBYrExuSZWnkxoAIIpg27Fzx3OLZozo9Z/bmFmtkM2&#x2B;f3h&#x2B;Rc3U937u0y0yxMddIZNcLK9ZuedEfIhfatTlSW5BFCvrmmqa9GF&#x2B;nuU1Dfuy8kLa7AXWOzGC58N4QcBxDEWQ6CBvk8XG8bxCKpFQxOz7hpfWNFhtbLCPG0UQG754/tj5ouLK&#x2B;kAvt9gQX5mkdaG5u5PqyXsG/rRmd7&#x2B;nPxZFQFusGQntJOWbaZuV4VSyvz8nz9wzpNlo&#x2B;WjRuhV7T8x9YWr/9hOfrriyF1tFXdPKvSflMqpvUgQAAMcwdyclbbO1OtzKcOeKKhUySWyb6nwcw1pO1f&#x2B;yfm9aTMjheW/ZPxK7TuUmRQRe08fjqQkDtx87u2zH0aSIQEeS0rHcko2HsiYNSOsZHw4AaDKYLtU2nS&#x2B;pKqluIHC0Z0JEyzppM22ratT5uTtdtY7f1935&#x2B;IJ3nVVyvE0UIZdKpg3tGRXo1VHqGgRB/1owAICgO2xMr6ToQJ&#x2B;88hqd0bz&#x2B;YJbRTEcGeqsVUp2RfmhEr&#x2B;7RwbtPXjiRW3wyr&#x2B;R4bjEvCCiKyqVkj&#x2B;7RB85c3J&#x2B;TR2BYYWW9n4dLuJ&#x2B;XYwzE8YLQJnMaAFCnNYT5ebSXzCPqjBb7vyobtAs2HvD3cLEHKva5VXObViQIAkQROJ5FZzRvOJT1&#x2B;NgBg9NiIwI856/feyA7397mCACAoqjjSVEUlUuoTjqEFFTUPvX1HzqDuXtk8A&#x2B;rdxks9FfP3AcAsLHsmn2nnvrqD73W0Dc9bsk7j/m4OV317RUEoaiybuXek0WVdX4eztmFFfhNHYh7OKnenzl&#x2B;0ltzp77304oPn47w9xQBkEsohezygE8upZyU8nbTO2qadMfOF0lIUiElXdTK6Btr69Que7N8iiTsb7gIgCAICNKlMmcUQbqFBy5778nftx06fLYwq6DcTNskJPHImH4v3T/c8WETBOHYhZInvljs5&#x2B;5isdlsDPvR6Iltz4ZhqKObJ45hrfL1g/7Zayg9NrR7dDCKdLjX1XOThjw2tn/hpVpPF/Wz3yxt0BrbHoMgiAhEpEVgQODoh7MmPDA48&#x2B;k5v4&#x2B;Y/dWi12dOHpQOAKBtrM5k4VoUKxM41txsOH6&#x2B;JMzfY/Wek2v3n5ZSxKItB997eHxNU/P5kqrxfVuXs7McV9mglVKEi7r1XLgIxJbt/G0sFxPs6xjxD0yJafc1diImyGdS/7Sf1&#x2B;0d3ydlQPfLD69qaN5xIjclKrhnfLjRYv3mrx0fLlgjkUoSwvx1JvNb81Y9Mq7fj7Nn2A&#x2B;&#x2B;WF4ze&#x2B;7yz5&#x2B;8t3tUUOfPVVxVV17baGO5tr2YCAz7/oWpoij&#x2B;e2oYIAjqIhgAQNAdJoogIsArIsALAJBXXl3ZoH1/1oSW46ERGYn2RpBm2mZv&#x2B;6hWyFiOyymsqNPqDWZ6aHr8Pf26B3i6OB6SFBHgpJa3bWDIcpxKJm1n&#x2B;A/AmcKK575d6u/hsv3YWYPeaFbJv1&#x2B;1s3tU0L7TF3EMDfB0bfUQ&#x2B;1KGI2ywWG21TfoxvRIBAEazVUJRzJWcbPvgoGXnx1aTnS1HDzaW23Aoq7K2acWHT0UGeL&#x2B;/aN3a/afemD7aRa0oqW6Yv3Ffr4TwmaP7vjx3&#x2B;cs//Ln03Seu&#x2B;vZWNjS//MOKjQdPZ8SHncgtvpBXMmlkb8e9B87kn8ormTGit7Oqwyz5q4oN8V350VPjX/1uxofzts55iSIwEYiyLpRNV9Q1ffzbRhxDVXJpXIjfl09Pue5r6MjF8ppXfvxrdM9uj47tDwCo1xr&#x2B;3HkkyNt9TK/2&#x2B;/S3Fe7v&#x2B;eEj97S6sWXKDYaifRIjvn72/qKqegSAlMig4RkJN37lnc&#x2B;Iaw1mHEdjg32tDNukN1FUO4XRPu5OKpmk7W5ikQFeKz9&#x2B;euwr32w6cmZc3xSKwHsmhIui4O36dzwpJYny0qp73viO4XiRF8b3TRndM&#x2B;mpLxf/snYvzbAyCTmuT0qr0/I8b7TQTsp2MmEQACw29lK91s/dGQBw74C037Yerqhr8vdwaXtwR6wMiyAIiV9uoPT4&#x2B;AGbjpxZvPVwclSQRiEDV8pgKBwHAJitNovV5u/h3DMp&#x2B;q0HR0cGeH&#x2B;2ZPMPq3ZOG1qYHhsGANCZLftOnqttGtLR09l/Jt&#x2B;cv2rB&#x2B;v0ohpIYPnNU79dnjHb8IBdX1W06nFNcVa9WyKYMTo/&#x2B;ZxlJ4aXaBp0pOTKA&#x2B;mfBfRdTkqwMy3K8sk2ZNQTdErANKARBt9&#x2B;BM/mLtxxSySUUQcxfv2fSwDSFtPWfPQlJSEjCVf2P/jbRgR1OGG&#x2B;Z8yKCIHibdXmZhNIazG23VRJF0VmtOHq&#x2B;cH92no3hPn/2fk8XzQe/rnVRK8pqGgelxkQHtS4SpQgixMd9yY4jEQHe3q6aC2VVKIKW1TVZGX7T4WwTTfu4OVkZVkISRgvNcbzxytZXcglltFgddaIEjklJguEuRwv55TVLth8d0D0mMy4MANA7IWLJtiPltY0uagWGoqlRwYNSYwenxumMlld/&#x2B;uvoucKMuLDO396cwkun80u/fWHqU/cM0pvpxz9b1GgwOe7NLij79I/NQ9Lj2w0ArDamyWBWyqQq&#x2B;eXvyLoDWVuP5agVsuHp8b0SIxyD1Jgg3&#x2B;UfPDHh9bnPfPPHgO6xzQZzV/Y1iwnymfviNDNtY1iWvDVllCzHl1TXVzY02780mOg/dx6LDPDuegDQFs8LB88W/LJ&#x2B;73sPjwvz80QQxMNZPXVoj1aHCaLIchyOYaII8DYfuRu0NytvT9YFX1en8trGg2fy35g&#x2B;2r1Nipq7kzIjNmzJ1kPhfu5DUuOd1fLLmSoIsDEcgiAMy9uHs2nRwYlh/pIWuXnNJktYTPCvrz5M4ThJkSE&#x2B;bhKSSAr333b8nCiK3aOC02NDWz2dCADHC9L2vo8IgtgYZszLXydHBrmoFSgCci6WPPfN0gdH9Ar0clXKpCq5VK2Qdh7z7MvKq27QjeiR6OGsAgAEeLr0S4pauHL7vQO6j&#x2B;zRDQCAYyjHX16S83RWz3l6yvOTh9z75g8zP/714M9vxAb7iAhS2aCznw1DUVIq6ajFEwIQThBe&#x2B;2nF3NW7Xps6MjUmZNWekx/&#x2B;tmFg95jU6BAURQxmevoHv&#x2B;SWVgd5u9U0NX/02/qtc2YPuVIsvnDT/rmrdtY06sb0Snrn4XEtI6sTecXFVQ3D0&#x2B;M7ai/LC0JeWfWKnUcRFL1vSI8I/39vkQz0/wG5y3ajd4ABAATdYf4eLk4q2am8UovVNqJH4nP3DnHrtPN6V3SU15seF7pk65HiqvpWGwhU1mv7JER88sQkvckiiiA6yBvHMA8n1bniS2q59J72eqUrZNSLU4ZVNWp/Wb9XQuJag5kXxS&#x2B;XbaWtbOGlGpVctnb/6cVbDgg8yC4sF2jbOwvWlFQ2kCSeXVBe12xw/F2XSymNSp5bUqkzmlEU25d9Mef42YArM6M0w0opwj7iCffz/OKpy3PkfbtFhvh4/LRuryMAuJKR0np5w0TTJIGH&#x2B;nkCAAgMlcuoumaD414cw2QSsqN8mAtlNc9&#x2B;88eAlJh3Hx5H25hPl2xasGG/n7tzndawfMfRubOnje759zC6W3jgj7OnP/b5oo17TqQnRfX7ZyVoW7wgKKSStBbtYm4RHMMc428URVRy6Q1OrIpAbGg2rN136rGx/cM6LmKubtSt2nO8T7eo4qq6XomR173lXLvcNIqSyvr1B06LInhkTN&#x2B;HR/Vp26kWAcjs&#x2B;4brzZaPFm9Yvz8rNsTP201N4YTBQq8/lH3yQsmXT02xT0U7OqsaLLTZytRr9SfzSkK83FuW2AIAYoJ9Q3w9EACo9kb5BI67qhT1zQb7VgAt7xIBUMqkKVFBxZX1Z4sqrAybGheWlV&#x2B;2&#x2B;1SujeV4QRAFsWDFF8He/8iDsjKswUzbu0gBAIoq61//eWWtVvfYuP5KmbS&#x2B;WV9W3UA36r9YtiU62DfYy61Oqy8pq2po8fH2dXN&#x2B;csLAz5Zs/nXjgY1Hsl1V8r7dIu13kTiGIki73XsQBDAct3jzwW9Xbv/&#x2B;&#x2B;Wn3Dc6QUmRqVPCfO4/uPHG&#x2B;W3ggReKHzhacuFC6/IMnxvdJAQCkz3r3h9W7YoN9fdycapv0X/&#x2B;1vVtYwANDeny0eIOni&#x2B;aNGaMdddg7j59fuuNoTKBPRwFAs9E8d9WuefNWALVy16ncgz&#x2B;9dZt3QoDuTndhBAADAAi6w4K83d56cExDs4HnhTB/z2vq63&#x2B;tHh7Z&#x2B;88dx2Z&#x2B;uvC5SUNDfdw1SpmUIpZsP3y26NKDI/v4e7iAFjkJg1NjB6fGdnQqBEGignzmvzqzorbJYLbkFFW89tOK2CDfXokR&#x2B;eXVXyzdkl1Q5uGisTFsn26Rr08btWrfyWU7j4qiCBDw8Kg&#x2B;joGIi0oxKCX2lR//uueN73EcP5VXGhwb1qAzjn312&#x2B;6RQct2HjWY6Z0nc92dVDIJZd97WEaRSrl0RGbityt3ZBWUJ4UHAACsDEvgWNuuiHIJxfNCVX0zx/MIghA47hhRAQBE8R8JSG17QVgZ1sawAIDvVu74cc3uWaP7Pjyyj5m2Pfjh/DnLtg5MiW1Zojo0PW7W6L5vfvZr98jgtongrXy/cucL3y4N8naTSaggH7cHhvSY9M9Aq7CyrqCiRkpREf6eHs7qmz6Jft1QFB3Zo1vNpu9b1te2IopibZPurflrXnlg5IeL1q386OlRV3bjOnS24LM/NiWGBbw/a8J1p473TozsnRh51cPiQnwXvPbwmn2nth0/t/nIGYOFttAMQEBMsM/Sdx&#x2B;zT5y3tGrvyUWrdtIIWlmvfW3ayLYn7KTfpYwiU2OCv1u9c/ep3IEpsY5hK4nj2QXlPq5O3z0/1WCmeV7geJ7leIbjbAxnY1jaxuA47tumoKVbuP/E/mkaxeW1qYdH9r5QVvnJH5venr8WRYEgiHIZNXHS4DPFl3rOfC82zL/wUp2h2fDrpgNWhnVWy9VyKUUQ54sry2saZn4wr39a/KI3ZzmG3dmF5SSGtU3rRxAEAISxMR//vvGFycOnDetpj5FUcilJYFaWtf&#x2B;EVNZrpSSREnm5fqBPUvTuk&#x2B;ebjSYfN6fqxuZgb7cZI3oNSI4ur21cuefE6J5JyZGBl98NApeQRCffdxvDVdQ2ArUSUER5bZPZalV2/DGDoJvirlwAgAEABN1pKIq4qBS3p4lemK/n3Bemzlm&#x2B;9eFPFkhJQi6happ0DMsNSo19cHhXO987IAD4uTvb05ozYsOWbj9qZdipQzL/3HE0MsD7yC9v2w8TRFEQhBE9EpuNZnter7uTypEELCGJWaP7UAS2NyvPYmUeHdfviXEDKuq0b/6ycvmuo0FebsMy4udv2EfbWAJDMQwlMIwkcClFchxPW22T3pw7IjNBZzRvOJjdPTq4bcP7qECfIC&#x2B;3r//aRpG4h7NKazBbGZbhOHugxQsCy/F/xwAi0Jss/3iNCCKhyL1Zed/8tWPGsJ5vTh9tT&#x2B;6/b0jG3FW7ymoaHJW7NoZduuPIwk37KXenE3klDc0Gt07nvJPCA8L9PQ1m67CMhJKahie//K2&#x2B;yfDUxIH2e3MKy5/7dtmhswUYigZ4uHz93P2OxPriqvq5q3ZGBXg/Mraf/ZbKhuaTF0r0ZotCJgnxdg/ydrMnhd8KNpY7nFOwZMcRjuNTIoOenjQIaVtrAgBAkHA/rzWfPOvv4Rzq65EQ6ue454fVuyb07e7n7txkMLqolTc4u1te21hW29QtLMCepmVlWIuVUckkjpY1rmrlI2P6PTKmHwDAniCDoQgAoN3S1VAfj1BvdzOCzBzVp&#x2B;t7QdhhGNovKSolIvDeN394fMLAjNhQX1dNg8G05cjZNftOPT1xoD2Rr&#x2B;sn7BkfnhQe6Eg/k0rIH2fPeOvBsedLKk0WK0USob4ebhplQUXt5sNnqht1vRMivNw0x84XL9p8wEzbbCzLcrxSLvHzcCEJYu&#x2B;ZvF6Pf6SQUnIJRRJ4TZMuOsgn2Pvv2h5eEKobdZV1TXXNBgTDesaFvf3gGPvPqYW2/brloN5M9&#x2B;kWZd9Crlt4AIIiRZV1fu7OgigajDSB4QiCAgCig3zmvjDNnlP3xPiB246dXXfgdFJEgOPd7nys5aKS3zswPediKYeimXFhcPQPQbcIDAAg6O4yqme3UT27Hc8tKaqs1ZksSpmkW0RAbKAPcmO9cRQy6uPHJj748YKp7/3cLSLQPviwjx5QBEExzFkld1bJj50vXrr9SGp0SG2z/r5B6fa0DZLAZ47uO3N0X8fZvFw0f73/ZLPRLCFJhZQ6kVfSqDOaaKvRYjVarAYzrTWYQnw8Hp8w4LfNB09fLBVFcWzflMfG9mtb3hDm5/H&#x2B;rPEvfL/s8U9&#x2B;9fVx9Xd3ya&#x2B;oGfPKN70TIky0dd2BrKpLtd&#x2B;t2DG2dxKGY/uyL5aUV&#x2B;cUVgzsHiOhyGaTSWc0r9p74ui5wpE9Ej9/cnKLnaEaKRKXSkgAgCAIVQ26uat2Ldi0780ZY5Mi/N/8edXGw2cealFt3JbZxuA49uq0kQ&#x2B;P7KM1mZ//Zunv2w7dPzTDSSmnGWb5rmMnL5QsfeexIC&#x2B;3F75f9ua8VQNSou31lDaGzSm6ZC&#x2B;mZDhuw6Hsn/7cVm&#x2B;mSQKradKbaNuUQenfPvfAte7NJIrgqvPxgiCcyisd8OynMUG&#x2B;4X6e7yxcc&#x2B;R84fL3n2x7JAKASi4Z1D0GABDh73Wu&#x2B;JLFythXSzyd1fPW7VXKqWcnDhmaHt/2W9aJi&#x2B;U1OIqKQJRRpIeLBsfQLUdyXvlxxYbPn&#x2B;&#x2B;bFAkAOJRT8PrPKz97YlK/9lp8FlyquVhW7axSoCgS7udlTy1rqXdiRO/EiK5fTysapXzTly&#x2B;&#x2B;MW/lok0HP1&#x2B;yGUMRBABXjeqhkb1emDzsWs/WbsDg5aLxctGAFgFMWkxIfKhffbPRSSFVKWSTB6Zr9SaW5QVRpCjC21WDoWiz0ZyVX1bd2NxssOjNFgvNeLio&#x2B;yZFqVsEioIgHj1XeP8b31NyqUxC7jp9wW34kxRJyKUUhiDltU0cbZ27aueWozluGqWzSo6h6Os/r3j34QkiEFfvPzllULqni9p&#x2B;2Y7i5sgArzG9kjceyhrXNzkpPBAAYLYyPM930oRKQpH3DcmgKEJnNN/Tr/u1vmkQdF3uxiUAGABA0N0oLSY4LSb4Jp4Qx7BRPbt99/zUD35du&#x2B;HwGbmELKysbVWmzAtCUVXdos0HGnTGQ&#x2B;cKRmTEt83btkNRxFWjdKQrDPnnTrQtjerRjecFi40RBKGjnQF6JUacXPgeAMDKsihAft96ePGWQ6v2nuQFITrIu0d82IGciyfyinlB5HghLsx/zf5T50oq5VKqqLK2sKIOiEKT3uThpJq7aidJEggAZwor/tp1fGzvJF93l5om/c7jZ79asd1qY1d9&#x2B;HS/5Kjy2ia1QpZbWtn5O1bXpDdZbPEh/nIpJZdSfbpFfrF0S22T3kkpb9QZc4oqB6TETBqQBgB4/t4hT3z527HzJX26RTjeH/u4GQGI0UznFF3SOKtenTZ&#x2B;cGrs/PX7v1i2OTEs8PFx/Tq/gFYu1TU99&#x2B;3SYF/3L5&#x2B;c3NExZqvtrz3HfFydzv3xIYKg89btfeXH5aU1jUFerZtEAQBsLFvdoKNIvFFnTLjvtXVfvjCmdzIAAEOxsb2Tk8IDIgK8rjW9e86fWwVBqNMaAj1d3nxwrKeLmiKJljtAW1muuKq&#x2B;2WBp9&#x2B;Gn8kq/XbHDRS2v0xqenTT4wRGdRWjXRymTfPf81O&#x2B;en6ozmqubdBiCIgjiopa7qG&#x2B;0sKeVlssXUor8ae1uo4UmMNxVo3zpvmGtqhSclPL&#x2B;ydG8IPC8wAsiw3EW2qb4ZykIgWOTBqSF&#x2B;HlYLDaL1WaxMQYzbTDTRosVx3EfVyetwbjr5IVTeSVGs9VE2/zcneq0xgfe&#x2B;8nKsACAn9bsWbhxv4wiZRJKKZOoFFKNQublqqlrMpwrqXpp7oonx/fneGHP6QueLprOE&#x2B;QIDJs8IO2mvlsQ1BlYBAxBEHRD7huUnhjm99mSzfVaA8&#x2B;3/pWKoejIHolRAd5SihjXN/lmpalgGNrFqlYJQQAAHhrZe9KAVIuNwVBUIaUkJHGmsOJs8SULbfN2c4rw9zpyrnB/9kXaxvROiJo9ZURpTf3Gw2dyy6pyy6oEQeQFURCF0b26PTNxMIGh246efejFL8MSIx4YnHmu&#x2B;NLJvJI9WRfOFlWO7X25T7w94bvtxcikFMNyjbrLJZtGM41eac/PsLyNYV1dLw&#x2B;SZBJKKZfVanX2L0VRdOzyQODY&#x2B;D4pAV5uP6za&#x2B;clvmyb07T51aI81&#x2B;0&#x2B;V1zZc69vYbDIfOVfQq9P5b5bjL9VqE8MC7Mkeg1NjnpxjO19yqVUAIAKgNZi&#x2B;W7njUE6hQkJ6uzmRUsoxYH1jxqi2mVpdlB4bYjDRJFFHkrjQ3t9sBAAcQzuKKwakRPt7uIgi0JnMrcqXbSyXX1EjCKJcShEYFuDpcoO97TVKuVoh7&#x2B;I5urL80jk/d&#x2B;fKeq3ZytQ26YwWum2Zsr0tmL0zmLnZ9uHiDbVa/ZpPnml1WHJ44JVLEh0BA46h9iLp&#x2B;wZnshzP8TzH8zaWAwAEeLpUN&#x2B;pLq&#x2B;qNFqvBQhvNtN5M60203mzRmyylVQ3B3m7PTRpy5Hzho58v4gXBSSl/bdoov2vpfwpBt9bduosFDAAgCLqZogN9fnvzkYZmo5tTO1OeGoXMXg54Kza96iJ7JxwTbVuwYQ&#x2B;GYj5uTu7OqunDejoOiAzwapm9wwvCMxMHm2ibPQfJvhlWbLCvXEoBABJC/R6dOQ4B4FzpJQttE0TRVa38/IlJY6/0idcoZM4qedtE&#x2B;bhg3wAv1zd/WdWoN11qaP5x1c702FB/TxcAgFohc1ErTuaVHD1f5OmsbjSYBEHQ6k0cz&#x2B;MYJgJQVd/s6OOkVsj6J0UFebqOfeWbL5Zu8XBWm2hrRuzfzYUw9OrbfokiqKhtMtOMo6yzXQiCkDhmY1iW4zEMlUkkFEnoja2n23le&#x2B;GvXsfd/WjlhSKZKJt1x8nzLwbSTUj79g18Gp8ZOHpRu75azP&#x2B;uixWYb2D3WnjPG8YKNYQkCAyJo1d1/xvDe9gx&#x2B;XhC6spdZK96uTvaWlGYr02wwW22M5Eq/LIPZ8vmSzQ3NBh83Z5LAvn9h2lV71V9V1y&#x2B;wvtlQcKkm2NvdYLYEeLnJrrY7b1vThvVkOc6&#x2B;A6Cmvb0IWsJw1Nfd2Xal9267WgYMDu3O3Ad7u9n7F3G8wAuCIAi8IPCCKPACw3HOSjlB4M1Gc3VDMy&#x2B;KgZ5uKrlEEMXr&#x2B;PZB0C0iiuJdmAUEAwAIgm6&#x2B;dkf//yq0jTmRV2IwWT1c1FKSGNpxlhGGomqFTN3BekVSZODPkTNa3tJyqyMMRWaO6lPfbGy7J0NUoPdPL09/9YeV7yxYQ&#x2B;DYqJ5JL9431N6/1UkpmzwoPaew4rlvlvh5uNQ3Gxp1xl83H8guKBcBKKqqK8gv1ZksXi6r/T1dSRwjcLysppFmmHcXrFHIJNOH9&#x2B;yfHGO0WKUUyXK8zmRVya&#x2B;y2GJj2aLKWoVMEhno1clhEpJMCAv4bOmmJTuOhHi7l9c0EhjWdiKe5/kNB7N7p8Wu&#x2B;uhpAEBNky5w/AstDzh6vtDHzcmx7L5s59HjF4oy4sI0CpnRYt15/Nyfu4/vz75oMNMyihzZM/HrZ&#x2B;&#x2B;3V8ljKLJ67ykCRwenxV1rkQMAgLYxOpNFQpJbjp75YumWl&#x2B;4ffv/gTPtdCqlkRI/E6oZmAIDRQl/rmW/QiQsl973z4/OTh363csf6z57r3S3yWkfH19TaVaOQPTlhINNpAHAdcAztqFeVk1IupcgtR3Mq65okFOmskieGBdzcZ4cg6JrAAACCoLtRoJfrvJcfNNE2jruczHCztJw5RhAkxMcjxMej3SMTQwO2fT2btrFm2ophqCMxBkPRMb2SPJ01R88XNjQbGZZFUZTE8QadwWC2uijln7wwrV5nXL3vJEkQCAJQBEURxMNZjWMYy/N1WsPU936mSAJBwPmSKo7j4kMuN&#x2B;ERRZHleI4XWl0Jw3I1TQYpRbh1mqoupYjHxw84lV86&#x2B;/s/GZZFAMBxom3vVBEAg8Uac2WRh2nz9qIo2rJTvoQi5BLKPiV8obTqsS8Xs7zw9oNjkiMCT18se/fXNT5uTq9PG20f4/629WCjzhgX4hf0z675V1Xd2Lxsx9EDZ/KdVAozbeU4ruWyjJQipwxMv6YT3kSJYX5fPjUlMshLFEUfNyfHZYkiOHmxxEWlCPB0ccSQDMsBBCFwrOtBAstyVY06HEN93Z0BAAiCKOSSjuovBEFEEHCDGVBt1WkN89fvZ1gWw1A3jXLpu4/f3PND0PW7GxcAYAAAQdBdCUNRezeVO05KEVKq9WQ2hqKZcaGZcaEAgI2Hs3OKKt&#x2B;dOd7eVIfnBQxDaRszc1Qfo8Vqoq0WK6OQSXzdnPUmy4Gci2U1TQaTxWJjTDQTH&#x2B;I3tndyj4TL26XhOOaiVrSdLRZE0UwzLUMXlufPFl06nlvk7qQmcUxCkXIJKZNQarl06TuPAwRYGba6Xps44622G1cjCOLhpM7KL6vT6lVyKQCI&#x2B;M8yO0EUebHFDaKIIpfjgeggn/mvPrxgw77Xf1px4Mc3n5446OTFkmPni41m2n7ZFInLJOR1bA714&#x2B;rd367YnhIVjKHo0fOFji5VdrVa/cIN&#x2B;0/ll3o6q4dlJAzqHuv4ppitNobl1ArZrcta8fNweXRcP0EQUyKCACI6SgIEUXjmqz/SY0PfnjHG&#x2B;Ur6zc4T58&#x2B;XVrupFQiC9E&#x2B;JDvC8ej59k8H80tw/9SbLjm9fAQBYrLbftx46nlv86&#x2B;szW20GzHBcTsEllUIS4d/ZWtB18HJRz3l6ipVhOZ6/K0suIejfBQYAEARB/zr5FTXrD2S5OSnlEmrxlkMqmSTI6/KE9x/bDv&#x2B;6&#x2B;eDXT9&#x2B;XHBXY9oEpUa2T&#x2B;FtuTOvlon77wbFom5avKIKQJCqILR8l5pZWvTN/jSgCPw9nksARBCEwjCBwksAkBCEC8Uxhhbta2SshvNXZCAy7f0jm9A/mPfb54sRwf08nDY6ipbWNnCDgKAoAaDaYtHqTY/xtsth0JotMSgEAlDLJmF5JY3olxU19fcWeE0kRgaXVjR7OKke3UAxDcezvye8uzlXbGHb/mYuDUuNWfPgkjmEbD2W/&#x2B;ctqG8va723Smz9YtH7NvpPdwgOz8ss2HMx&#x2B;Y8boJ8YPsN&#x2B;7/mDW898t&#x2B;/2NR4akxwEAii7VfbFsS/fooJmj&#x2B;uqMlm3HzyqlkhE9EhmOK6tpBCII9&#x2B;9wd&#x2B;SO8Lxgf2lNBtOIF7/86eUHe8aHAwAQAPokRXo5O7UMeC6UV/&#x2B;1&#x2B;6hSJtGbaHdnVVcCAARBEARxrHQJglhSWb/92Lm243CTxfri3GU&#x2B;rk5/vv/Etb6KzpEEHh3kfXPPCUE3RdtlzLsBDAAgCIL&#x2B;jY5dKM7OL&#x2B;MFUUqRL943NNT3ctUvy/PltQ3NRnMXz9My2YYiiYQw/7bHUCQe7OVmMNN1zQYPJxUAgMKx4RnxTgrpl8u21TTpnr13iM5kMZqtJtpqMNNm2mZl2In90u4bku7o1uqAosi4vsnVjZM2Hc5evfdUuL/nwO4xHy3acDy3WC2Xldc0Njbql24/4uGs8nN35kVxx8nzlXVNq/eeDPfzlEspKUmQBN4rIfxAdn7Sg29bGeb7F6Z6OKvtJ7fZuGaTRXqlgSzHCRTZMiJon8lqpW1skJerPZGGEwQcQx3z0GeLyvdnXRzbO&#x2B;Wdh8bSNualucu/W7F9eGZCoKcrAABDUCCIjg2kaYY5dbGUInEAgMFC/7b1EAqQET0SjWbruwvWHsstKlk1x/G8erP12W/&#x2B;OHgm38/D&#x2B;anxA&#x2B;/552bPdlaG3XHi/J7TFzAM9XHV5JbVmK4UIaAo&#x2B;tnj97Y6/qnxA&#x2B;8flGFjORNt83JRd/7CO0LgmLzNttkAAARB5FLKUXstiuKJvJKzRZVTh2ZIyNalyRYbY7JYNUrZLd2/HIKgWwH&#x2B;0EIQBP3rhPh4fPPs/UWVdSzHxwT7&#x2B;ro5Oe6aOarP5IHp5A33qGmJIog&#x2B;SVFvzFv11Je/LXpjlkImQRDEVa0c1TNp0ZZD9TrDjGvcKBpDkGcmDnpm4iD7l0aL9fMlm88UVdQ3G1AU&#x2B;f7lGafySjcezhZFwHJ8iI97VKD3OwvWuqoVEhLHUMxM02W1TVqD2WpjhmbGr9p7cueJ80qZxMZyR84V1jfplu44khoVLJOQh88VyChSRra/oYSDXCJRySV55dWV9VpPFw16ZRNo&#x2B;70NOqMIxMy4UPtWVhP7px7LLcrKL7MHAAC0XmRAUcQeViEIIqVIe4SFIIiEJKQtSpMttO2dBas3Hsx6cGSfY7lFL81dHhviFxnQOrVm5e7jj36&#x2B;2M/d2VWtyC2rEk0WHPv7T/O8dXujg7zTYkIcg2yW50kCV8gk11oFcX22HT33/qJ1o3omejq3DgBOXyz7YtmWFycP7ZUY0ZX8KL2JFoFIEjiOoq36O0HQHQT3AYAgCIL&#x2B;FXAM9fdw8W&#x2B;vXTqCINfU8qWLogO9f3xpxsyPF3qOfDrM39PP3VkQxEsN2qLK&#x2B;ieucU&#x2B;xtpQyyQePTAAAiKJI21gMRe4bnFHVqNObLDaGTQwLEEVxw&#x2B;HsyjqtwWK1MayEIB4d7y&#x2B;jiJ0ncour6vZl5XE8LwiileF6JUaYLfTCDfuX7zyGIEh&#x2B;RfXEfmmO9QEAAMcLbbcIkJDEqJ7dPly8/rlvl47ISKhqbG4ymLVGk/3eiAAvisCrG5vtXzYbTQqpxMPpyjkRILQYICAIwFDUERIgACDg8hoL2uJ2AEBJTePCjfvfnD7miQkDKuu1yQ&#x2B;&#x2B;vfd0XtsAYOGmA8mRQVvnvCCTSPZnXxzx4peC8HeV9ke/bRjYPSYmyNdZhQMAqhqb35y3auWek2aj2c/b7ZvnHxh/peEsAGDXydy1&#x2B;095uWruHZge5tt&#x2B;6fk1QRDk3oGpgd4uqvY&#x2B;cgzD5ZZUVjfpBEFEu1CT/OfOo5fqte5OKivDTh3Ww/vfUYQDQXcnGABAEARBAMewB4ZkjshMWH8wO7&#x2B;8uq7ZQOCYt5vmqfEDR/dKulnPgiCITEICACiScFYpAABWhpu3bk&#x2B;/5KiH2tuXd1yfFNrKmGibmbYaaavRbPXzcAGIeCK3pLy20WCxTh/Wc/LAdI3ycp9TjVKeEOavlLczWn14ZB&#x2B;W4ZftOvrqj3/1TY4K9XH/cumWnIIKX3dnXhAYlpu7ehfHCUqZZPHWgwARdSbLueJLBI4XVtY16gzVDc2iKCIIgiBoZUMzx/MAABlF6owWe9t&#x2B;CYnzPO&#x2B;IPQwW&#x2B;tsV26UU&#x2B;cKUoQSOhft7&#x2B;rg5VdQ1tb2w2ib9kIw4gCAoini7aXAcE1pkJMskpIQgHWHFuwvWrj&#x2B;Q9drUkZnx4d/8tf2pOb9rFLL&#x2B;ydEAgGO5RR8tXl9SU2&#x2B;02LLyy39&#x2B;ebq703UmCLUUGeAdGdB&#x2B;7v6A7tHZiz&#x2B;gSLyj7p&#x2B;tNOiM2fnlSrmksLJuUPcYGABA/xZ34wIADAAgCIKgK9RyaVywT0OzITMutKpBP6ZPNy9nzS19xsp67QvfLn1txuhwP8&#x2B;2rf1RBJFLKbmUAkDV8vYAD1fQnszYkA2fP0e02XUBAKCSS1&#x2B;eOuLlqSPsX1bUNX6zYsfpi2XF1fX2jZUxBN11KlcQhMJLdZ4uqq/&#x2B;3MqLgo3hGpoNLkr5R79vOHa&#x2B;mCDQvPKaquLKzQTePSqopslwICvP002zLztP4MWcooq6ZkNJdYOTUlZQUbt4y0G5hKpqaA70csVQ1GSxEu0NlNUKWWOz0Z6PZK/PbjmXjiAIhv29rpBdUDY8M&#x2B;HJCQM0SrmHk3LUy18dPldoDwBW7z1VUa9d&#x2B;Posrd78/HdL52/Y/8b00Vf/BnRMEMXvVu6Yv34vxwu9EyO/eHKyI9ACAFyq05bXNgIAvFzV3q5O0i5sXvbS/cN5QRB4QW&#x2B;2umiuslsZBN1Od2EIAAMACIIg6DKOF07nl741f/X04T23Hj07aUD3W/2MXq7qpe89Huzj3navtOuAIEjbtqTt8vdw/erp&#x2B;3heMFlttJUx0VbaxvICT9vYOq1eazA16U0Gi5W2MrHBvrEhviv3nDiVV8oLvJer00cvTjuaW/TuwrVyiaRnYgSKos98vUQhldRrDV4umpGz54T7eZzOL1fKJEPT4vo&#x2B;&#x2B;fH04T0LK&#x2B;pq6xqT29toeXhGwtzVO35cs6dnfJiJtnGCYLBY/35FAGFYzlGAK6VIAsftXUJdNUonhbyh2Wi/a2zvpNSY4AHJ0QiC7Dx5ftWeE7NG93V3UrV9xi68j4DnhWe&#x2B;XrJoy4EpAzOc1fJ56/ZYGW7h6w/bi0&#x2B;qG5tf/P7PvVkXLDbGyjBPjx/01kNjHfsEbz9&#x2B;7ruVO1gb&#x2B;9yUYcMyExzxjIQkGnVGThB83Z06eGIAANCZLHuzLmgU8qSIAPXV9rCDoBsHuwBBEARBdzUCxyb0TY0L9VPJZCMyE7oyrXuD5BJq8p3bgQvDULVcqpZLAegwW0ZrMCMAfPbEvQAAluMZlkNQZIbRXFbTyHK8l6vGxnDbjuWYaSYh1C/Yx33xloO1Wv3wjPipQ3smhPu/NW/11mNneUF4cfqYfslRbc//ygPDC6tq5yzb8uY888ge3eQU&#x2B;frPK7PyywM8XarqtcVVdWardcWu45GB3goZ5eWiPnGhOKfwUlpM8JnCigadIdzvctfRHvF/92N9aGSffVl5izYffOWByysegigibdq/tgsBwEzbvly25dfN&#x2B;xe9Pmt4ZgKCICq59MNF6z&#x2B;YNT7A0wVBkD&#x2B;2Hd58JPvDRycOTInaevTcK98viw31e2hkbxRBymoa3v91HUHgRqPlma//WKyQ9mxxYZ8v3bx2/&#x2B;nNc150XHYrRrN18eaDs79bihPEWw&#x2B;OucFFDAiCOgIDAAiCIOgyBEFc1Ip0VagIQGSAF9a1IeMNMlqs24&#x2B;f65kQ7uGkuukb0N6girqmx75YbLUxe75/DQBA4Jh9&#x2B;wIZRXq7/j2NHRfi6/j318/e3/IMHz82sdlotjKsi1qhkkvbPoWEIpe8/RgAoKqh2Uklv1Ba9eWyLduOnQVApK3slEHp&#x2B;eU1ny/bopZLpRKStjKlNQ2Pfb4oNtj3eF6JwWI9mJOvM5kpgpBLKbmEkkpIhYQEAPFwVv&#x2B;6cf/wjAR3Z1V5bWNtk75lAk9HSBznBfHouaKdJ8598&#x2B;z99/RPtef3D0mNfW/h2gadwb7twLHzxWnRIQ&#x2B;P7K2SS&#x2B;NC/FfsOb7n5PlRPRI9nNV7TudpDab3Z01ICPMf//q3P6/dExfsp1ZcfuEEjhM41sl8q9ZgWrPvFE8zPC98/dd2GABAtwHsAgRBEARBALEPw2/XWFxrML343bKfX35wUGrMTUkEuonkUkl6TEiT3nTdZ5BJSHvd81X5uDkBAJIjAn&#x2B;cPb1BZzSYrVaGifT3qms2nsgrqWvSmWir1cYmhPlLSAJFEAQBVQ3aitrGspoGjhfseysjAKAIIqVIlVxa1agd88pXCWH&#x2B;5TWNlQ3NL0we5ngunheYK/uC2TEsV1RZx/K8hbY16AzTh/d8dGx/x73bj58jCTzU18P&#x2B;0fBxc2poNthYFgCp/V3iBMDxAgBgSFpcdJBPhL&#x2B;Xk1L2yOh&#x2B;ny/ZfDCnYGSPBPt5rrpxm0YlS4kMOrj/FMDREG93QRCvY9dnCLp2d10MAAMACIIg6E7ieL66sdlitV790NvORSV/&#x2B;8Gxt/MZEQRxVinsLZLs3JxUscE&#x2B;7R5sYzmL1WambSbaarRYjRarwUzb/4sM9JZLqGU7jupNlsSwgNlTRtw7KM3&#x2B;KBRFnDUKHzenljGe2cp8tXx74aWa0poGCUUaLNZZn/4qpQiKwC&#x2B;U1ew&#x2B;eV4uk6zYfdxFrZRLKLVCeqaoYsPB7D7dIg1muqCiNjMuTK2QAQB83Jx8rmxb8fi4AWv2nVq55/jg1Bh743&#x2B;O41EU7WRMr5bLnrxnoNZosjHc5IHpcPQP3Q7i3VgFAAMACIIg6E5CEIQkcPRa0o1EUXzv13Vhvh5jeicrruxoK4iCzkjLJRRJYNeUSpRXVk0SeIiPu&#x2B;OWqobmstrGSH8vF7WC43m9iSYJ/FZsv3CDKAKnCNxJKe/ogIzY0LY3SinyoZF9RmQmtty9Sy4hx/VO3nQkOzLQ20LbdGaLVm&#x2B;ysZwoihKCePbeIQdzCuat2wsAwDCUInCKJF758a/0mNAzBeVag&#x2B;lcUcXs7/8kCUxGUTIJKZNQMgnp7qSSUOSK3cejAr0Hp8YhCDhXUumskrebCuUQ4uO&#x2B;&#x2B;M1HbuBdgaBrc1dmAMEAAIIgCLpdOJ5HEKTrpQWCILabNCKK4oaDWcHe7v2Sox0BAG1jBzz9SUJYwMm80hEZ8W8&#x2B;OKbzgabDhdKqXzcdeGP6mMz4y8PlrPyyr5dvf&#x2B;n&#x2B;4cMy4ht0xi&#x2B;WbCYI4rMnJnXxsnlBMJqtSrmkk1cqikAQBQRBBEHEUOR2Fj&#x2B;gCOKmUbpplC1vJAl8RI&#x2B;EEVdydeysDGuxMgzLySTkpXptdWOzwUwbzVYjbWVYjhcEmYSKDvKpadLpTZbiqjoby7Ecz/G8IAiCCFiOjw32SY4M&#x2B;mnt7s1HzuiMlurG5qfuGXSdvYkgCLp5YAAAQRAE3Q60jV2998TR88UeLurHxvZ3d1Je9SE5BeWv/Lxi0RszfdycW96OouiiN2ahKOJoPQkAIDDs3oHpLiq5lCJ93J1RpKthRkpk0Hcrd0x598fVHz2dEhUEALDYmFpts5VhAAAMyxVU1AH0GiYJm/Smqe/Ne/mBYQNSYjs6pry2cdGWA0NS4y6UVg3NSPBxdfqX1T8DAICEJBybM8QE&#x2B;cQEtZ&#x2B;J5EDbGLM9JcliNVqsTQaTj5sziWPHcovLaxsZjkuOCBqWHn/rLxyCrsHdmAAEAwAIgiDoVrNYGUEUf9ty6PlvlySE&#x2B;RdX1i3Zdjjrtw8UEqrzBxpt1mPni/7ceeypewa13CbMZLEJoiinKIr4&#x2B;68YSeCvTh0JAOB4nmF5CdV6W7GO&#x2B;Hu6fPP81Ic&#x2B;mn/fuz&#x2B;t&#x2B;PCpxDB/QRAlJCmXUgAABEEIHBORaxgi2Fj2UE7&#x2B;A0MyOzmm2WhasH6fhCDeX7R&#x2B;qUo&#x2B;ulfSv60A&#x2B;jpIKVJKka7q1qFd9NUiBwi6k0TxLiwCvh0t3iAIgqC7ls5o/nzppi&#x2B;Wbn5v4Zo3HxxzcuF7W796qaKu6dCZfEEUOn9s74TIkT27fb5kc01Ts&#x2B;NGo8X63LdLZnzwy7hXv/lz59FW3WyWbT9y&#x2B;mKZhMTtCe4XK2pySyutDAsA0BrMNY06G8sBAFiOtzKsIIoAAARBEkP9fnn1IQmJz/pkYV2zQUoRtI1VyrqUQdSWvaqh86yexPDAFR89PaZXt&#x2B;XvP5EaHdL19YouOp1f9vvWQzWNupt7WgiC/j/AAACCIAi6VQRRPHyu6L3vln2&#x2B;ZLPRQj89cTAAIC0mBEWRwkt1PH/1WbePH50oArBg/X6L1Wa/ZcXuY9tPnJs4IDXIx3323D9zii61PH7O8q2r9520XYkKft24/9M/NtvHwduPnf1syaaiyjoAQE5R&#x2B;cKN&#x2B;/IrauyHIQiSEhH4/YvTTFbrzE8WrDuYpZJLwvw8btob0capvJKcwooNh85ISEIpkyAdtLu5WFb99Fd/rNhzYs6fW88VX2r3mHadL6l8d8HacyWVVz2SF4SS6oYj5wrtX4oA2FjOaPk3NmWCIOhmgQEABEEQdAsVV9Yp3Zx/emkGSRC7Tp7nOJ7jBCACDEPbnSKnbUxNk86xNU&#x2B;gl&#x2B;v4ft3nrt5VXttkv6XZYLlvUMYrU0cse/dxDEX/2n3cYmMcD0cQhBcER2BR3dh8sbzGfsDFipoNh7KrGrQAgHPFVT&#x2B;u2XuuRfCAIEivhIgvnpxcUFG7/sDpYRkJbVNZWuEFoby28Vhu0bVuJFRa3TDzk4Wf/r7xr93Hhz772QvfLTN1MOA229i9WXnHzhXOWbb1UE5BF89/KKfgYnnN0IyE8tpGvYluda8oijz/99oLy/I7jp974svf7V8KgnD8QvGE179rNprbnvlkXsn24&#x2B;ds/1x1aUUQRaPFSjOMjWF5nu/iNUPQnXJ3dgGCAQAEQRB0C/GCIJeQM0b0emBIjye&#x2B;&#x2B;G3dwdNzlm9lOC7Qy7XdCOBSfdNLc5dn5ZfxvCACIIji6J7dUAz9&#x2B;q9t9kye6cN7zr5vOIHhCqnksXEDVu45fr64w3luHMPs22YBACgCV8kk9lR7AsekFNGqzTyKIOF&#x2B;XizH6xqa/T1drvrS9CbLL&#x2B;v3vffruqu8A7yw9/SF7IIyxy0r95wovFS/9N3Hsxd/8NVzU39du7e4ur7dxyZHBKz88Knn7h2y9L3HB6fFXfWS7M6VVB48k2&#x2B;mrT&#x2B;u2XUir6TVvQWXagc///nDH823fykCUW&#x2B;mS65cgCgCrd6093SejWHbnnnDwewPFq8zmFsHFS1p9ab73/3phW&#x2B;XTXnnx1827OOFv4ONRp2xulHH8VdJ/YKg2wkWAUMQBEHQTYYgiD3V/ofZ02qadA9&#x2B;NJ/h&#x2B;P4p0b0TIuy9/3lBsFzeVhYAAJRS6b7svIrapsfG9Q/yceM4YenWw1Yrs2DVrrTo0LG9kzRKOYahLM8jAJk5uu8Pq3et3HM8MsBLKZNoDWaG5a0M55jSw1BUEAT7QB9FERFBOtlb6lR&#x2B;2XNfL/F1cw72ctt8&#x2B;MykfqmKTnv/NxstB3LylRJJ5&#x2B;n&#x2B;LM9/&#x2B;edWP3eXn1&#x2B;eYb8lp6giJSqwV2IEAGDWmL5vL1idlVcaHehD4v&#x2B;oA84pqrDaWCel3MZy3cICNEpZqzPbt/5ta3TPbskRgQSO1TXrY4K8W90rpQgvFzXe4rlwDG1ZY42iCIG3X5FsNNO1Wj3f6QieJPGYYB8ZRemMllapRH/uPLbjxLmvnrkvzM&#x2B;zkzNAEHSrwQAAgiAIuk3WfPJMTaPOxrC&#x2B;Hs6OpjfuTuovXp4RF&#x2B;JvL4T1ctV8/8K0r5dve&#x2B;7bpWbaxgu8KICPH5u448S5Z7/54835q9RyqVImUcmlziqFn7uTl4vm&#x2B;1W7BBH0S4o6fbG0UWfYn33xwJm8zNjwumZdwaW6vPIandECAKhrNlTXNJppGwBAazAxLEsRf496567e9fmSzekxwW8/NK6kquHdhWtP5JX2T47q5OUYzXRZTcOTEwZe9YUbLbTW8HdGDc8LOHZ5BV4hpQgcazSaBUEA4B/D7t&#x2B;3Htp7&#x2B;qLRQsukpEoqHd4j8ZEx/VxUl7f9om3Mmn2nQnzc06/s9lVUWW&#x2B;x2iICvHzcnDyc1UYL3S08AADA8jzHCRSB24MfX3eXH1&#x2B;awXPXMw2PYSiJ4513LFXJpG8/OK5Oq8dwzFUlb7kZQk1Tc3ZhRUf5ThB0p9yFWUAwAIAg6P&#x2B;ffV8iHMP&#x2B;ha3W7zZerppWt6jk0ufvHdpyan5c7&#x2B;RxvZO1BnOj3ojjmJezhiSwR8b2O55bXF7XqNWbmo2WZqNZazBlXSwb0yspIsBz7b6Ti7ccZGxcn&#x2B;TIgoraUbO/kkslHM87qxQmCz3jw1&#x2B;SIwOPni9urNcu2LCfYbl1B07hOObt5gQA2H7s3Ee/b5QS&#x2B;C&#x2B;vPjQ0LQ4AkF1YYWWY2hath9plsFib9OZI/9ZT7G0hCIK1WHmIC/H76LcNP6/dHerrieMox/NAbGcIMjwj8ae1e/onR/dMCM8rrX597nKKwJ&#x2B;aMJAkcACAxcZ89de2gd1jHAHAit3Hsgsqvnn2fh93p02HszcdPvPClKHRgT4FFbVbjp4dmBJtjwcsNJNfViuXkU6qDrcQvhFbj56d8&#x2B;eW4sp6Xxf1k5OGjOub7Ai0cAyjrtYfCYJut7uyDSgMACAI&#x2B;v&#x2B;3P/vi1qNnn500xNfd6U5fy11HEMWWWeBtIQC0u2Ous0ru3GKEqpRJBqREC0LLcbLI8yJF4gAAi5Ux0laZhFRKJTaWu1BaVdXYzHG8r5uTwWLdciSnuLr&#x2B;3oFpspF99p7OffyL35QS8rkpw5IjAmkbs2Lv8YP7TwKFLLesytvVCUWQsrqm&#x2B;BBf&#x2B;8BaFEWG5ZD2MmKajSYMRXzahDQIQARBaDQYBVFEEQRDUVEQhRYjjBkjehVW1i3ceEAqIYwWq9FMt1sOUVJVH&#x2B;Dh&#x2B;vq0UZlxYQCA&#x2B;mbDxkPZY3olhfi42983FEFaFDyDOq0hr7zaXilRXFm3dt&#x2B;pyQMzogN9iivrvv1rm1JK2QOARr3x25XbnZSy71&#x2B;Y1sn3pYvMtA1BEClF2If1xVX1b81fTZH4q9NHbj6Y/ew3S1Ry6fDMhKueB4LulGst4v//AAMACIL&#x2B;/1U1aDcfybl/SKavu5MoimU1jRzPB/u4tzvuvFl4QWA5niKJu3y2E0dREr85f2sQBMGwf7ydjkx1mYSUSUj7vykCTwzzjw/1QxDEPrDuGR9OM6xaLgUAvPrAiKoGrberkz3NnSSItx8cO3VIDxvH0jbWZLE1600IiqTFhAR7uwMApBQZE&#x2B;xjYRjQhsXKkDiuUrROzQcA0DZ26fYj3cIDlDJJo86UlV/uVt9cVtPg5qTCUNTHzenLp6fklVU16IxGs3XmpwvlUrJtbcLFihq5lPJyUdu/jAryPpJT2EkBLoGjEgK3V1aQBK6SS&#x2B;2JRjiGSSnS8WkXRFFntHA3qT/P2v2nzFZmYv/uzioFAGB/dl69zvDxoxMfGJI5JDV&#x2B;4LOfbTpyZlBqbEdFBe2qbtJxLN&#x2B;VOmwIukF37e9nGABAEPT/D8cwhZSyD4B4UZy/cf/p/NK/3n9S097Q7Wa5VNf0xbKt0YHeLXPEOV4QBIHAsbskCwJBkD5JnaXR37rnbZnvRRI4eWXPYBxDAzxdHXdhKBLg6ern4VLXpP/yz63bjp19&#x2B;6Gx9w5IcxzgplG&#x2B;P2sC396eZTIJxXAcx7UeSSMIYDmutKZx2PNf8oKAIIini9pgtqTOfE&#x2B;jkKkVUpVc6q5RuTur3DSqrPwypZSKC/ZrO0T2dtUUV9WXVDcEebvzgphXVk2SWCc7HIsAEQGw/89eYmH/mCFI6/wGDENbbjzcfkPWrtl&#x2B;4lxFbdOA5Gh7AFBZr3NVKYK93QAAgV6uscE&#x2B;lfVag5l2USu6cjaW5w/nFH6/fAuCEzNH9xmaHn/dFwZBUCdgAABB0N0FRZDUqCCKwG7W9L8oikfOFdXrDK5qhUYhjwvxvXwHgtY26Vo2VwEA7M/O23jozOPj&#x2B;0f4e92UZ/&#x2B;XQwBICPVLCPW70xdyFSiC5JVXC4Lw/L1DXJTyynqtr7uz/S4EQToac3s6qxmW23nyfEywT8vba5v0GIb99uashDB/vYkWBDHY261Rb9x/Jr&#x2B;h2dCkNzUbzTqTpaCi9nhuMYair00blRodjLb5QE4f1nPhpv2zPv21b1KUmbbtPXXhpQdGeLv8ncZG4Hi91lBR16iUSasbdeeKL5XVNlY36IK83OqbDY06Q7PBBAAwWRmTiWZ4zt41CAHAQtscHYcIDOOEf6ZWXQspRUop0hHQKmUSs5VxrPmo5LKqei1ta6ejaLu0etOCjfvWrN8HFLKcoorcZZ/crOUjCOqICO7CEgAYAEAQdJdBEWRUz25jeifbBywcL4iieE35Ca0Igrj7VO6242d93V18XDVfP3s/AIDjeRlF/P72oxLiH2PHBp3xwJmLE/p2v0sCgP8QD2f1mYKKNftPPTSil697l5JPQn3dx/dJef2H5VaGHZAS7apRIgCpatD&#x2B;smGfs1oeFeDt6&#x2B;bs6wbKa5vWHTg9KC3ugcGZLcbZoigCXhBahYgtuWqUf773xLIdR7PyyzheeHri4EfG9FMrpI4DnFXy39fvXbHnOEUQDMupFFIbw03/4JfuUUE5xRUmk&#x2B;XndXtQFNl8&#x2B;Ex9dcO2o2d7J0RIKepUfunh80XB3m51TXoXjaKysfnEhRLqBn4EWsqMD/tu5Y5Jb84dlBqLosieU7kJoQGdF4H8E8JyPCAIgGG0jTHTNlIJByrQrYQgd&#x2B;PwHwYAEATdhZZuP1Jwqfbdh8fhGJZbWrl670kXlVIupeQSSkoRaqUsIcTPuYOMBXsHdAz7e7IWRZF7B6ZnxoWKIrDvkCoIwt6svA8WrT9bWOGmUb310Nhpw3rYD8ZQVEqRLR8O/UugCDJtWA93Z3WQt2uAV5cCAGeV4sNH75FLyJ/W7P596yGlTKqQUlqDqaZJ/&#x2B;CI3sE&#x2B;7gAAXhAulFU&#x2B;9PGCDZ89NyQ9Hv1nyjEBrjLsTgj1jw70adKbCBxrlUVjZdiaJt2Msf0eGz&#x2B;gQWdkGNbb1dlEWzcfOVNYWTc8PXHqkB7bj5&#x2B;b&#x2B;clCL1fN6GGZhRU1idPfwlAExzGZhNSbLN0efMvTWS2KoKiqbtqwno4zX7VuuxVRFAVBsFc8p0UHL3n30XX7s2q1OrVcyguClCLwLn/gndXyWaP7lFTUWDh&#x2B;cFqck/KW9CmCIAgGABAE3XVyiip2njj/1oNjcAyrrG/&#x2B;YukWCUU4qxRNepOXiwZBAMPyz08e0ra/u41h92Xlrz90Oj0m5P4hmfYkIgRBIvw9XdQKFCDOajkAoLpR992KnRYbu3nO7BW7j3/yx8YwP/eM2LA78FKhLgv39wzydutkPr4tBEFCfNw/f2ry6fyy/PKa8tomo8XqpJL1T4oelBprPwZFkG5hgQtefSgy4OrdQttF4JjnlTpgAIAoijqTBUWQ3JKq2ib95IHpqVHB9sG3PQ&#x2B;nT7dIs9Vmr295&#x2B;YERl&#x2B;qb3NQquZQSAbhYXm2yWFEU8XLRNOlN&#x2B;7LzGnQmk8U6fUTPe/p1v/yiAKKUSXzcnNotUzFarFqDqWW&#x2B;EIFhDXrTvjMXtSazhCTkEsrP3eWxcf0EERRV1W0&#x2B;kkMSmFOXi20IDBvYPdb5zVnNelPfO1E9At2FYBcgCIKg/1MiaDlkkVKkQiaxD2/cnJSD02KHZyY8PLLPyz/8dSqv9OdXZszfsO/HNbu7hQfY2y86HMjOf/mn5QzHrz&#x2B;Qdfpi2bfPP2C/nbYx367YTlvZL5&#x2B;eDAAoqqzTmcyPjOnbIz5MLiFzSyuP5hbDAOBfDkNRjLyelRlnlWJQ99hB3WPbvddeATxlcOaNFNq2ZLGxP6zaVdXQfDy3mCTwuBDfVhXPBI45qtsxFA30dLt8JQBEBXiLAABRRBDE29UpJshHEEUMRVuO9TEU6ZUQeeSXt13UyrbPPql/ari/l1xCOW7BMbS0pv65b5YKoiAIIoIgBI7JKFIll5rMFk4Eg1JjZdLLx7Mcz3DcVYdbSWEB1/HOQBDUdTAAgCDo/x9JEhiKtJzmQa60SWnUmWw2LibQB8ewxIiAnKIKdyf1wyN7HztffPhsQasAoKqxOcjLbd2nz67Zf/qdBav3Z1/s0y0SACCIYnFlXaPeZD&#x2B;M5XheEOQUBQBQyCQKqaS&#x2B;SX/7Xi3079P1HJirEkWx2WTZfuKcp4vm64fHDkmNu6aHX&#x2B;4KBAAAAG1bdwwAQACJY57O6rb3AAD6p8T0S45umcPWoDOmRAR/8Mh4b1eNzkSbaKvBTOtNdJPehADB39O9Z/zfP0SRgd7JEUHSjhsZQRB0e8AAAIKg/3/erk46E/3yj39NG9qDZpidJ86X1jRsPHQmJshHEAURES&#x2B;UVfeID2/SGYEIXNWKOq2&#x2B;3XnKEZkJmXFhgiD2SggP8/P8feshewCAIIiEJKRXskf8PV2VEsmmg1mJYX7VTfpmo9m&#x2B;NxME3TiFlJrz9JQ5T0&#x2B;5I8&#x2B;OovY2QqCqQQsAojfTWfll6bFhIT4ebhqlvwcQRVEQRSACEYgtO40CAMy0LdDTdcaInvaGoRAE3UEwAIAg6P9fUrj/uw&#x2B;Pm79h/29bD9JWVqOUJ6kU7y1cG&#x2B;DpAgByqa75w8XrNxzKOpNf4aJRvPDdsq1Hz6Io6JvcOgVZrZQbzPTWYzlABJ7O6v3ZeedKKuOCfSUkwfK8Yzo1wt/ziXsGvvPzyn5Pf2KmbbwgDuwgPwSC/qN&#x2B;33r4WG5xZUNzXbNhaHq8RnG5WrdVPlJLJy&#x2B;UzPlza0WD9onxAx4e2ecmropA0I2ANQAQBEH/nyiSuKdf95TIoAadwcZwgd6uCqlkx/FzNU06G8vFh/pZrIzRYnVRKW0MV99sGJoRNzwjISk8sOVJrAz7167jr/28Qm&#x2B;yuKiVLMfV1jVNe3/e2N7JDc2GDQezCRz7Zd2&#x2B;AC8XuYSKDvReN2c2x3OFFbXfr9rZav9aCPqviw7yKaysk1DEUxMGju2dROBXH81rTWaNUnZP/&#x2B;4ezqrSmvowX8/bcJ0QdFXiXbkRAAwAIAi6KxA4FubnEebn4bjl/iGZrY4RRNHKsDaGRRFE3aZvSeGl2l827O3TLfLP956w33Iir2Teuj1Z&#x2B;aWiCB4a2ZvlhEVbDqjlMhGIGIIQBI6hSH5FrYTEM69UAPOCYGVYQbjr/thA/2fG9Eoa0yvpmh7i7&#x2B;Fistq&#x2B;X7XzgSE9UqNDbtGFQdB1uAt/I8MAAIIg6DIUQWQUKaPIdu&#x2B;tbdILAhiRmeC4pXtkUPRzU0201cawGoVMBOBMYbnOSNM2xkRbTbTNTNsGdo/pnxITeWXbr2Bvt2EZCZ4uqtvxeiDo38TDWfX5k5PDfD2ufigEQbcYDAAgCIK6xM1JiWPo6YvlIzITZRIKx1AMRRVSSiH9uyVi325X6Vxe3ag7X3Ipr7w6FA6DoLuMX9f2V4agO&#x2B;DuWwKAAQAEQVCXRAZ4D0uP&#x2B;3bFTr3ZkhDmT&#x2B;JYaXWDm5PqoZG9XbrW1SS/ouZMQfmQtLgIf0&#x2B;LlZFJ2l9qgCAIgm4bWAQMQRAEdUhCErPvH&#x2B;7j5rx817HT&#x2B;aUCLyqk1ND0eAR0tcDXRa2sazZ&#x2B;89f2maP7Pj9lKAwAIAiCoDsCBgAQBEFdReL49OE9pw/v6biF5Xisy90MbQzbOzF8dK9uEf6eXVw0gCAIgm4puAIAQRAEXRsCx65&#x2B;0BU&#x2B;bk739EvFMBTtoFE6BEEQBN0GMACAIAi6fa4pYIAgCIKgWwHuwwdBEARBEATdve7CHCAYAEAQBEEQBEF3KVEU78IQAAYAEARBEARBEHQXgQEABEEQBEEQdLe6K7sAwQAAgiAIgiAIukvdjQlAMACAIAiCIAiC7mp3XwQAAwAIgiAIgiDoLnV3bgQGAwAIgiAIgiAIuovAAACCIAiCIAi6W4l3Yx0wDAAgCIIgCIKgu5EoigxjI0nyTl/I7Ybf6QuAIAiCIAiCoNvNarV6eXsPGz5cKoEBAARBEARBEAT9/xJFkWGYHr169evf39PTMyMz405f0e0GAwAIgiAIgiDobmGzWj08PYcMGxYWHh4XF5ecknynr&#x2B;gOgAEABEEQBEEQdFewWa3pPXr0HzDAw8Mjs0emp6fnnb6iOwMGABAEQRAEQf8WyJ2&#x2B;gP9XNpvNzc1t8L33RkRExMTGpKam3ukrupNgAABBEARBEAT9P7NarWnp6QMGDXJ3d8/skent7X2nr&#x2B;gOgwEABEEQBEEQ9P/JZrO5uLiMv&#x2B;eeqOjo6Ojo7qndURQ2wYcBAARBEARBEPT/yErTKWlpAwcPdnd3y8zI9PXzvdNX9G8BA4A7Jrek6oc1u4alx4/q2e1mnVOEuYMQBEEQBN31GIbRaDRjx4&#x2B;Pjo2NjIxIS0vDMOxOX9S/CAwA7pgmvXHtvlMuasXNCgAEUczOLyu4VN8nMdzbzemmnBOCIAiCIOi/habplO7dBw4e7O7unpGZ4e/vf6ev6F8HZkHdMSIAHM9zvHCzTsjzwqbDOQ9/PP/wucKbdU4IgiAIgqD/CoZhpFLppClTxowbl5SUNH7CeDj6bxdcAbjDup6x8/Sc33lR6J0QdfR84TOTBgf7uCH/fDSOocmRAeP7png6q278wmqadGXVDTHBviq59MbPBkEQBEEQdEvRNN0tOXnwkCFubm4ZmRmBgYF3&#x2B;or&#x2B;vWAA8J9x7EJxdWMzAOhPv60fmh4X5OWG/HP9xkTb&#x2B;nSLGpaRgN2M8vZDOQVPfPnbH&#x2B;88OjQtvosPKaioVcgob1eYfQRBEARB0O3DsqxCoRgxalRCYmJYWFhqWipFUXf6ov7VYADwn7Hm42d0Jpoi8P7JkfGhfgjyj&#x2B;n/ynrtNyt2bDt2DgChe1TwWw&#x2B;ODfZ2u5Gns9qYxoZmC810/SEzP12oUUg3fP6C/UuL1fbsN0tignyeu3fojVwJBEEQBEFQR2iLJaFbt8FDh7q7u6dnpAcHB9/pK/oPgAHAv8jerLxzxZUeTqqBqTEuKkWre/08XPw8AAAg3L/tttXi6z&#x2B;t/GPj/l6psa4q&#x2B;fJdx45fKD76yzvqG8jeQVEUEDiKXkNXoap6rcH89zNyvLDlyNk6rR4GABAEQRAE3XQsy8pksqETJ3br1i00NDQtPU0ikdzpi/pvgAHAv0J1o&#x2B;6dBWtW7jxqsNpIghiRFvf5M1NCfDwcB1iszOp9J/dl59kYLiki8Kl7BpA44bi3UW9auvPIyP7dN37&#x2B;PABg/cHT41797vcth56eOKjz5xUE8VK9lsAwbzfNjb8KksAJ/B89tnhB6EqVM&#x2B;xeCkEQBEHQNaEtltj4&#x2B;CHDhnl4eqSlpYWGht7pK/ovgQHAHSYhCUEUZ8/988/tR56cMHBIevyBM/lf/r7Ry93508fvVcgoAADDcg9&#x2B;NH/9wdMyiiQIfPmuY8t3Ht329UvOV1YJCipqAUDG90m2f5kZF&#x2B;6slB/LLbpqANBsND355W82lv3rg6ecVfJb&#x2B;ko7YTLTX6/YnldWnR4TeuJC8YwRvQZ1j71TFwNBEARB0L8Zx3EURY2dMCEpOTk4ODgtPU0mk93pi/qPgW1A7ySCwLVG08e/bfhzx7EPH5v48eOTRvXs9tGj9wzpkbjuYFZxVb39sBMXineeODe6V3L&#x2B;8i9KVs5Z9MbM7IKKH1bv5jjefoDJasUwVK24/OlHAHDVKOubDVe9ABe1Mj7Ub9f&#x2B;0&#x2B;sPZnXlghmOE0Xxul5rZ0QAapv0p/JKT&#x2B;eXLdu4/8SF4us4yd6svKXbjxRU1B46W1DbpL8V1wlBEARB0J1FWyxh4eEzH3sss0ePXr169evfD47&#x2B;rwNcAbhjEASRUeSvGw/gOP7K/cNfmDxUSpEAAJLAw/09D&#x2B;bkm602&#x2B;5G5pVXNRsus0X1cNQoEQSYPzPho8cYNh7Jeum84jmMAAC8XJ5a2nsgt7p0QQZGEibZhKKI30V25jHsHpq3cc/yP7YcGp8X6dNrAx2ih563bt&#x2B;d0roez&#x2B;r2ZE/w9nG/4PbhMKZN&#x2B;/uRk3TSzAMRHxvT1ctFcx0kWbT7wx/p97zw&#x2B;6eu/tr0&#x2B;bdSzEwdLKLKT4/dl5dVq9UPS4pyUN3/pgxeE8ppGQRQDPF1bpUVBEHT3sBlpU61OFEWcIggZRUhJXEKg8HcCBF0XjuNIkhw1dmxK9&#x2B;6BgYHpGekKReuCSaiLYABwuwmCaLbaEARYGZbleVN987R7B70&#x2B;Y7S0xWi1qqHZRaVQyi8XssgoCkUQFAB75x8CxzxdNJX1WhFcnuQO8/VIT4yc8&#x2B;fWS/XN7k4qnclc3aiLDvTuyvUkhPrPGt33lc8Xb&#x2B;yX/di4/p0c&#x2B;dkfm75fuUshlzY0XziUU3B0/juu6uv/wWM4rqZRh2OYj5sTggCFlFJIKREAPzfnVg2OuujeAWnuGlVyROCoHt183VyuepKf1&#x2B;39a92efb992KdbZLsHGMz0D6t3Ejg&#x2B;sHvsueJLwzPiXdTKLl6MjeW&#x2B;X7Xz1MXSX159OCrAy37j/A37jueWvHTfsIgrt0AQ9P9Kf6mxcGtWfd6l5uI6WmdCAMAlBC4hCTlFyiSkUkLKJaT8yj8UEkJKkQoJKZcQMoqQU4SUwqUkISUxEv6ZhiAAAKAtlsjo6CHDhnl7e6ekpERGtf&#x2B;3G&#x2B;oi&#x2B;JvldhNF8fDZwk0HTxutTJPB5B7gFeTlfvpiGYYiCplEZ7KsP3B6x6HsfunxoiBqDSYURaODfdycVTtO5qZEBavkUgRBiqvqYoJ8HDGDhCQWvzHr&#x2B;1U7swvLzxVfom0My/EqZVdbAI3plbx057FFWw4NTI0JvVJ53Gr4bGO5JTuO9k2KWvPpMzuOnZ/wxne/bjzw3OTBJH6dH6FGnfGDRetJAv9x9nTHjQgA4MrA3cqwp/PLKAJPCPV3TKJzPK830QSOKWQS9J9D/BGZiSMyEwEAo3p268oFjOqRSBKYm6bDMb3Zyny/cqfWaBFF5OUf/9w39/WOQoW2RFFsNpoq67UMwzpuzCuv2XAw64EhGdcaABw5V3jwbMG0oT2ub20EgqDbLG/diVPzt106mm/Vm3GKRDEUIAiCIgiCIBiKYiiCoyiKIiiKYAiCoiiG2m9HCQzDcYzCMRLHJSQhuxwVkHKKVEhJuYSQU/aAgVRISDlFyChCJiFkJCElcSlFSAhwXRMoEPRvxnMchuMjRo9OTUvzD/BPT09XqW7Chqd3ORgA3G4YhlIEvvP4eZrnPTQqi4357I9NH/&#x2B;2AUUQHMcEXrSYzSiKnimseOqr351Vco1c5ufpIqOoz3/faLWx3aODl&#x2B;04Wt2oe2xsv7NFFRKSJAmMwHEfN6e5L07Tm2kEgGajuddjH0nI9hNgymsbj&#x2B;cW90wId&#x2B;zYFRHgNaZXtw8&#x2B;W7T5UOqzV1p28qIIRNExyLZYbbFBvpMGpHG8MCwzvndi&#x2B;OdLNz88qrfLPxcBup54bzRbd53MDfRy7egAM239ac1uFEG&#x2B;efZ&#x2B;Z7UCAMDy/JajOfPW7qlu1E0f3nPm6L5K6T&#x2B;6fdU06Yoq65IiAuWSq2//MWVQ&#x2B;qSBaXjHm6Y5q&#x2B;QLXnu4XmeMDfZ7Y/qYa93gDMcwksBbLkSIosjxvHDtxQnHcovf&#x2B;WlFj9iwrgcAzUbz3tMXYkP8Qn09UDgggKDbReD4wq2nd7y6uLmkjlJKZS7tDFNEURRZnhc5IAJRFIEoiqJ45d/gcl80BCDo5djAER4gKIpgKIIiKIaiGIbgKEbgGIFhFIFLCEJCEm2iBUopJRUSQiYh5RQht4cKlD0ZiZCSCAbrAKF/O9piCY&#x2B;MHDJsmI&#x2B;PT3JycnRM9J2&#x2B;ov8TMAC4A/omRR5a8E6T3shxgpVhLFbGYmUMZtpktQoC8PNwwnF85/HzuaWVOqOlsl575HyRhMRD/LyW7Ty6cNN&#x2B;luMFnv9g8Yavlm&#x2B;XUoRcSskllEou1ShkLmoFhqHnSyqbDKa&#x2B;HUxXF1XWPfLpr1OH9nz74bEquQSIgOF4lVwKVIr5G/YPSImJDfEDANgYFnCcY7DqpJRv&#x2B;vIFx0leemDkqJe&#x2B;&#x2B;mv3iUdG98GvTM&#x2B;jKEJ0&#x2B;c8Jw3Ecz/u7d1hIIIhibZOO5XmWv1zrfKaw4uW5fxlMFpVC&#x2B;sInC1mWn33/8Jaj20NnC96ev&#x2B;a3N2elRoe0e84f1&#x2B;xx08jH903FUARF/x77Wxm2SW9yVSupFqvtFIEPz0y0/zslMrCLr&#x2B;tWYDneZrZyV96HrqjT6p/&#x2B;&#x2B;o&#x2B;nJgx&#x2B;YcoQiiCu/gAIgm4GXXnD9pd&#x2B;M1xqkjjJQafBPoIg9nH&#x2B;Vc8p8ALgeE60hw6ieOUf/4gWEHu0gCAYZg8YLq8toFfWFnAMtQcMJI5LCFxKETKSlEkIBUUppJeTkRRSQkqSCikpp2AyEnTH8TyPoujQESPSMzL8/PzSM9I1Gs2dvqj/H/Dn&#x2B;Q5AEMRNo2yVfCKKIi8Iogjs6S4ZMaEWq83eR5/lOIblRBF4OKvkUiq7oKKitlFvsuhMFp3JYjDTOpNFZ6INZrqyQWtlOJLAZ43u&#x2B;&#x2B;ykIe0&#x2B;e3SgT2Zc2Ny/ttVoddGB3gopVVrTuPXYWVIhyy0sf33equcnD9XIZVuO5gCa2Xg4OyrQ21WjQBEUwxyzUeiA5OiEEP8vlm16cEQvRwBgtNjcndRdfBNEADheEDubnEYIHEcQxDGJvnbf6ap67eavXuyTGDnxzbmfLd08KDWuW7i/4wE6k&#x2B;ViQZne3H71M88LH/&#x2B;2oXe38DG9kzH070&#x2B;&#x2B;CEBJVf2Lc/&#x2B;cPWXYgJSYlg/ZcvTs6fxSKUmmRQf3SoxodUKW4wEAt6HGF0EQgKHXVBrB84LWYDHTNtgMCYJuG5vefPrXXc1l9ZRK2vno/5pd/kV49d8CoiDwvHB5QUEEQBCvLDIAYL8m&#x2B;2/VK8sLl5ORriws2BcZWkYLGInb84tIGUUqpa2WF64kKcFkpP9zoiheX3nedaNpOjQ0dPCwYX5&#x2B;fklJSbFxsDn4TQYDgH8LBEFw7O&#x2B;hpExCyiTt5/CkRgd3jwrieIEXBEEQeEHgeZEXBI7nOV7AMNRVpcA7HpV6uWq&#x2B;ee6BYF&#x2B;PExeKT&#x2B;WV2lhOEARXjfK3tx65UFr1waL1O0/kkgRmsNAe/p7Ldhw5mVcS5O2mlEqcVXL7OoNSLnXXKNNjQn5cu/uZr3&#x2B;fObqfRiE9X1JZp9VnxHZ1Gw4pRTip5BV1TbwgYO3l4TAMx7Achv39GycqwHPWmL7&#x2B;Hq4AgKcmDNx54vzmI9nxIb7YlWUHDEMBRbZ7NgDAkXOFWoMpIdS/dUqMKDabzNsOnJ7QJ8Vxm8FCv/LDX0u2HaZtLEURCgn19KRBrz4wCr/yXHozvWrPiT&#x2B;2HfZy1Tw7cVB6bFgXX/jtgSAIgWMYXN&#x2B;HoNvIaqDPrzhMyK6egnhrIVcWBQAAnU5QtJ&#x2B;MJDiCBfFy74mWyUg4hqJIq2QklMBQHOskGcle60zI7F/CZKT/GFEUOY5DERTFUBRFb3WXbZ7nEQAGDx2a0aOHr69PRnqGk/O1peBCXQEDgP8k&#x2B;/CO6PxXe8fC/T3nvjC1vtnQqDOKADgpZN5ul3&#x2B;6xvdNOZVXarbagr3dvVw1x3OL92dfrG82VNZrjRarxcrQNsbGcjaWc1LI4oJ9ft10YNXekzIJ1WwwcbwwdUhmyyfieaGj3xTerk7D0uN/&#x2B;HPLgg37xvZOcVbJ7VPpjl2Ba5p0F8trYoJ9UOTyH4apw3pOHdbT/u8&#x2B;3SIHpkTPW7d3fJ&#x2B;U6CCfK88HLv8Za09WQTnLcalRwW0jBAxFcanEEYCJoni26NLCtXsGZSa8&#x2B;/A4vZlevOXg27&#x2B;sifT3vqdfdwAAxwsbD2XPfOcnD2&#x2B;3UxdLz5VUzn/loa4HP&#x2B;3ieP5SnVYllzqr5Ld5ogWCoJvCWNOsr6iXqO/YporX5waSkdorXXAkI&#x2B;HYlSUF5MoiA4ril/OR7GsLOPV3MtLlhkhKKSEl/y5dUEhIGUXIKFxGkjIJTEa6IxiWiYyM1DZpL1686OPjc0sDAJqmg0NCBg8dGhAQkJiYGJ8Qf&#x2B;ue6y4Hf4ruXu5OKnen1gVqiWEBscG&#x2B;vCDYE8dTIoOmDu1B2xh7JhLHCRzPm602vckS5O3u4azafTqvsLzGSFsJAo8M8HYkzQMAUBQJ8HJ1bE/WilxCzRzd58Cxs499&#x2B;uuOE&#x2B;f7JUVHBHi6aZQEjhvN1v3ZeX/tPl5dUcNw3LqDWSMy4h3r0uiVdNZ7B6RtOJS98&#x2B;R5RwBgsdkAy3W0&#x2B;lFUVcdxfHSQz1WH1wzLHc8toqTUc5OGdI8KBgD4uDptOZKzYMM&#x2B;ewDQoDOu2nsyLjbk7O8f5RRW9Hzsw29XbL/BAKCoqv7lucv7J0c/Nq6/hOxS1n5tk57hOKVMopRJWi4fQRB0&#x2B;wkcb6zRXkMnhP&#x2B;oricj8QLPXUlGciQl/R0t/DMZCW9d5XwlYGhRukAR9uqFy52RFBJCRlEKaYvlBZiMdHMgCOIY5SMAGTBw4OQpUyovVc569BGOZVEMuxUZQYIgCIIwcNCgzF69fLy9MzIzXFxcbu5TQC3BAABqDcewlqNJlVyqkl/uKMoL4vELxR4aVXJkkP2W4RnxbPcYQRAJHGuVDS&#x2B;TkEveeQxFO/wdER3os/jDp39cu&#x2B;vQmYJ92ReNZprjBftAn2FYjUoxYUTPM0WXnvhsYXxYgFwmUckkGoVMJZdqlDJ3jZIiyQh/r3cWrAUA7ZUYzjDsmv2ngSgqZe33Py2vbnRSKRT/bBzUEsdzjn/TNhbHMN8rNcrOKkWor2d5XaP9SwQBPm5OId5uAIDYEN8X7xv&#x2B;zfJt&#x2B;89c7JN4/W2JT10o3XggKz02lOra6H/nifM/rdtTUFErk5D39E15YsIghfQqiQcMy5lom5QipRQsC4agm0wURNZiBQhMZWnBkYx0tXdFFERe4MWWyUjClfXcfyQjoSiKXE5D6iQZibxc69w6GUl5ub4ZdkZqF4IggiBwHIfay8cRRBAEbx&#x2B;vBb/&#x2B;&#x2B;t13340bMxYAgBOE/RjipraXoGk6MCho8NChQUFB8fHxid0Sb&#x2B;LJoXbBAAC6BqXV9T1mvhMXFrD7&#x2B;9fsRcwYimJk&#x2B;78uUQSNvFrD&#x2B;9hgnx9fnK41mPMramoadc1GC8fzUpII9HYL9naXSojKOu3Wozl55TV6k8VgpmuadGbaZqJtZquNtjIDU2NMtO35b5fIpRSKIIbKuimTBvt10FnIbGVcnZQdzVkIvJBVUG4w0ySBAxHEh/qZrLYLZVVRgd4AABRFahp1kQGe9oM9ndU/vDjN/m8MRYdnxH3z19bFmw86AgCkhc7fAYezxRUojiaG&#x2B;XflAQWX6mZ8NJ9h2eTI4Nom3Stf/dFssrz14FhZx5sfsxz3x7bDS7YfRRDxsXH9J/VPa/cwg5kuqqyXkLi7s8q1yxufQRAEALjJhb93n64mI4miwIs3IxkJQwkMI7C2yUiUQkrIqL&#x2B;3aZNJHJ2RHMlIuITA/48mUxAEoWmaIAi5XG42m202m0wms9lsPXr2fP3V1zZu2piZnu6s1rzw0uwvP/sMu3lrzoIgCDzfb8CAXr17e3l5ZWRmuLm53ayTQ524WwIAmFR9U2iUsqkjeqtkEuKmJpw4q&#x2B;St8mcclQAuKkVMsK&#x2B;JtvI8z/ECxwscx9tYzmKzkTgeHeRTp9Ufyy2ubdJxguDr6pQcGdTR/sQWqw1D0TZbnF0m8PzizYdInPB1d9IoZKIIXNXKV39cgWOYRilftuOowWzpkxjZpDeJoujIRMIwFEPRuBC/h0f1WbLtyKmLpSmRQQAAAsMEQeR5oeXnThRFFEU66spfWtPg6apx03Rpc5PFmw/WNOqWf/CEfRw/Yvacb1fseHL8IJl7hwHAgTP5Mz&#x2B;aHxnsqzdZ7n3zB/XXssGpsa1&#x2B;Lqrqte8sWLPjZC6CID3iwj54dEKIt3tXrgeCIOh2u45kJKHzPqptk5FQ1LFTG45hOIY6ooUryUiUwlHcLLlKMpK0w9/P/3hZHS&#x2B;b31I0TavV6v4DBoSEhpSWlPz153KO4xQKhauL&#x2B;65dO12cnV3d3A4cPvTXsmUSidRoNKId76LTdVaa9vP3HzR0aEhISFx8XFJS0o2fE&#x2B;qiuyUAoK00wzAAAejlzRjbn5qFcULnXNXK39969DY8UctvA46hmg4KCQAAHs7q0T27cbwgiiJJdPZ5dnNSVtQ1tjv&#x2B;ZxgOxdBQX4&#x2B;Nh7P1JouN5Xhe4AWhtkk38Y3vMQy1mixAEJdsP7I3K08mIR2ZSBqFTCWTerqonZTyeq3&#x2B;9Z9XfDBrgruz5mxhxamLpZfqtUfOFfq6O&#x2B;MYaqZtNY06lUIqay9Rx8ZyTXqzv7uzRtGl/ZtzSyrdNMrM2HD7l6N6dNtyJKe8ttHXvcNWCT&#x2B;t3ePmrM75/UMcxSKnvPzM10vyl3/W6ph3FqxduHLH5JF9rSy7Zv&#x2B;p3NLKrMUfdNRVCYIg6D/DvrCAdaWP6jUmI9m3abuSjITa85FwzP7f352RZBQhu7KLs1ziiBb&#x2B;Tka6susCbTPf&#x2B;rejzasWRTc3t6&#x2B;&#x2B;&#x2B;SYwKPDwocPu7u4H9h&#x2B;oq6vz8PAEoujj4zNuwvjqmprvvvpap9PZE4Ru9BkFgeO43n379unXz93DPTMj08PT46a8FqiL/v8DAAQggiCcPnX63NlzOIETBEESJEESjn&#x2B;QJOn42g674vKUAIDRwr&#x2B;avSfSVQ9LjQredPjMhZKqlKigVg&#x2B;vbNDiOP7&#x2B;zPFpsSGNOpONYSxWxkzbRCCqFHJBFE5eKKlrMjTqDU16k9FidWQi2Xsi0TbWx03TLTJw5/Fzx3JL1HKpzmSx10W8Pm/lgTMXXdXK0prGbcfPDs9I8HJpZ6sEo8Vqpq0ezmpZF/YwBgDoLbSTSo5dmSjycXOSkHiNVsfxgr1Rqb30omUBRqS/Z3Sgt/2P1PszJ0z/8Jd1B06P6Z3sOCKnqOKP7Ycnj&#x2B;7753tPAACe&#x2B;OK3XzftP1d8KTEsoCuXBEEQdMdxLAZEgKAAQQUUvf6UrGtIRuJ4wHJc55s6IwjSekdnxLFHG2JfTcbRy7su&#x2B;KtBD811X/l1EEVRJpN98vln2dnZk&#x2B;65Z9DgwQkJiRiGC4IAAJDKpF9&#x2B;8/WiBQsW/DIfJ4gffvpx4rgJStUNJYharVYfH5/Bw4aFhITExsamdE&#x2B;5&#x2B;mOgm&#x2B;3/PwCQK&#x2B;QZmRk8z7MMy3Isy7B2FrNFx&#x2B;o4lmM5lud4nucF4XLPSoIgcBy/HA10GirYj8QwDEWvLC3AaOHf6r4hmT&#x2B;s2TXprbmL35jVu8U2yWU1jQs3HRBFkBDm7&#x2B;Wi8XLROO6y/yZHESQ1KphhOUEQecGeicSzHM&#x2B;wPMNyVoYx0lZXtTLcz&#x2B;vo&#x2B;cJTeaUGM43jWHSgD46jq/adzCutNlpKOUFIjQyaNbqfn3s7bQ1oq83GsjIJ1fkihoNaIcvKL7tYXqOUSSgSx3EMRTGThXZ8yFiORwBgWd7RUOjDRyc6Hj55UPprP6/4aPGGsb2THTd&#x2B;&#x2B;scmEsc&#x2B;fOQeAIAgisMz4xdu2l9cVQ8DAAiC/v0EAeU5xMOvmaA4jsVoM0WbKFG4LX95kSvxwtXY/4SIf5cutElGQoHU5KK8vQGAzWodNGRwSXHxSy/NViuUWq1WRESGYRAEsVmtTU1NM6fPyDp92sYwr77x&#x2B;oq/Vkg76LTRFaIosgzTo1evfv37u7u7p2eke3t738TXAnXd/38AQJJkcHAwuNJhShRFx/8deJ4XeIHjuctYjrEHCgzLsizHcSaTieVYlmU5luM4jud5&#x2B;88ugiD2UAEncJIg7f9vGSqQFNkyVGgZLdjb28No4bYJ9nab8/R9z3zzx&#x2B;AXvvBx0cSG&#x2B;CplUovVVlbTlH0mb/qEwUHerQuPHL/TJSTRldacvRMj02NDeUEgMMw&#x2B;lB/TO7mmsZlhOKmE8nDuML&#x2B;fwPFO/3iIrVqLTBmQtvlw9nPfLOmbFBXo5VLZoEMQcOJCqVoud1LKKQJfvPmAkbb&#x2B;r737jq&#x2B;6vhc//vmOM7M3ZDEygLAJCURAUJaIuPV22V47tPbW1g6tHXbb9q723murba2rw9r1U9yroigqKkP2HrJCCBlnfc93//74hpOwBBFE&#x2B;L6e9sEjZYScBMJ55TPejy9afvG5Y6pLi1RF8Y4rKAeOLnz1Ixfe/Ks/P//m6hlNw4UQ67bvefTlpbIkDS4vEULIkuQK4QphmPYxHzUAnF62qaghq3po2&#x2B;hzNxb1jymKs2tz8eKnh3fsyVNU53S/dQd796MLkpBP/XT5Q&#x2B;QXFEyeNPlXv/plWUmpcN3KyorKispUMqGqqqZpjz/2mGEY3bHYuHHjJk&#x2B;Z8sPvfb&#x2B;wsPDERgGk0&#x2B;n&#x2B;5eUzZ8&#x2B;uq6sbPnx4U3MTz3ZOo7M/ADKOf9ea9&#x2B;S&#x2B;byf0BoPt2I5t27Z9IBcM07C8ODBN0zQNw9Bimm3ahmnYtn1ILfRdWwgGg2pAPWIq9N2JlLmNSxwpDPjL8558bFbLeeOG3f/EywvfXr9tT3tC01VF7l9U8OObrvn0Ree&#x2B;/9cvy9IhnSAJUV587BGGRXnZ&#x2B;TlZq7fu1HTj8B/VTUsKKH3381w2dfwvv/bJR19e&#x2B;tybq2JJLZ5Km5Z97&#x2B;ML73nsJUmSVEVOdsVHDa99e/XGf7ntzqqSwtyscF52tPfoQlY0NyssS9IXf/7Af33xY7lZ0R/f/0iqO5lXlHfrXX/98tWzXdd9cek6SYiK43jjAeA0sk0lnG0MHrlz3PnrispjgZClqpasuLs27Ut0RS1dld7HXqCznmEYo8eMWblyZVdnVyQSmXfxxd/9/ve/cP31Qpa9L102NTdfefXVb7zx&#x2B;tAhQ2/52tcDwWAikQiHw&#x2B;/pIiDXdQ3DOGfSpGnTp5eWlExsmVhZWXnqHhSOh48C4Pj1DCc5/lpwXMc90vLCgVrILCz0lMKBzUiGaWgpzVtksCzLsi3btl3HdV1XUZSetQVVDQaDmWbILC948dC7DUn1vsJLLRxD/&#x2B;L8b35q3k367ISmx1OaadkBVR182Nf&#x2B;P2ABVRk7ZMAv/vjEn597/UtXzep7T79lO2u27opEgtFw7w0SoaD6&#x2B;UvP/8xFU/d2xizLmv/y0lvu/Os3PjG3edjgVFpP6nppfl59db9VW3cueGvt9tb2WFJr7ejuO8vZsu05LaMffmnJVd&#x2B;5I6iqsbaOyy6cPL1x&#x2B;Bf/6/43127NiYaffHV5bWW/xqEDT8O7AwCOj23L4agxtHnr6Cmbiss7hSRsU7bNQF5RomHCtj3bitreKVRlVjKPyrKs7JxsVVVrBg/&#x2B;6s03F5cUXzhr1q7du0OhkOM4kiTl5eXt2LZ97ty5ATXwgx/&#x2B;sLW19Vu33qpp2vEHgJ5Ol/brN3P27CFDhgwbNqypuekk3iKKE0YAvF&#x2B;SJEmKJIv3XgsHv2Dbdu9OJLN3UaFnP5JhmqaZSqV6a8GyMr9YUZTetYUjHVoIhoKZkPDSoicWJJ/WQiQUjISC3iiDD4l/u3zGorc3fOfuv2/e1XZhy6jqsqLsaDgrHLr38YWPv7J8/NCawtyDrjd1HCegKpUlBUIIw7QNw5w2dth5jcNc1/WOAkuSVFtZNqt5pJbWvRtUTcsyLTttmLphqooypn7Aik3vLFm/rTuhlRbmTR5VV16UL8ni8UXLW/d3zWkZ/dl5U7OONVwMAE4X15XUgD1i0uaRUzYWlsWEEMKVZMVxbFmS7WDEUBTHdc/mf8tOCsd2BtXUfOd73/3Pn/37XXfe6X21UQjhOE48kXjwj38YMGjQ5KkP/Oj7Pxg3vlEIUVBQYFnWsV6rEN4X/nW9uaXl/BkzSkqKWya2VFVXndoHg&#x2B;NGAHyg3mst9K4qHKiFvmsL3v6iQ9cWTNMwDd3Qk8mkYRheTliW5b0eIURmbaHn6EIw6AVDzwsH70TyDi30nFuQJH/WwgejpqL0zpv/9Zd/f&#x2B;7RV5be/8TLedkRVZXbOuKu65YV5n7rkxdVlx10evjbv/17VjhUV1Wmysqv/9/zhbnZNZWl4rA7kaKh4LtMBxtVWz1sYIXjOIGA6g0o&#x2B;MLlMz4&#x2B;e1JS08uL80/VQwWA988VriM1zlo34pwtecVxSRaGrlq6ahlKOEdXhSR7FwGx/ecoHMfxdjoktaSqKtOnTtu1e3fj&#x2B;PFvvvGGqqqyLIdCIdu2Tdv59Gc&#x2B;e8PnP7/y7RWvvrqorr4&#x2B;racNwwiHw&#x2B;/&#x2B;&#x2B;nVdLy4pmTlr1tCGhqFDhjQ1N53c4cF4nwiADy9Jko5/meyQ4woHnXK2He/MglcL3hqCYfQcXTAMQ0/riXgis7ZgW7bt2N4Rn961hWAgc8o5sxOpd2NS5ojzgZ1IPbVwpIsRqIWjaRwy8De3XLtk3da3N&#x2B;3YsqtNM8yAqjQMLL/k3MbivOxD3m879nY8&#x2B;vJSIYl4QhtQUnD79Vee2IJGQFWEOOiPWV5WJC/rxC95AIAPgGmoky99u27cO7mFSVl2dS2gxUNvL6zPytOGNm2LZOmukNSALSsUgBBCeAcRe152HMuyAsGgruuyLG/ZtOUX//XfQogpU6YMHDhw8euvS32&#x2B;BDl12tQhQ&#x2B;rfXrZcEkKS5DlzLnzwT3/qkDre/bdLp9NNzc3TZ84sKSmZOHHigIHcJvehQwCcJbxaOM5gOEIt2I7j9iwsOLbjrS2YB29FMnTDtExN02KxWE9I2JZt9V6f6jXAIUeZg6Fg7&#x2B;CFYPCQtYXMoQVqwRMMqC0j61pG1h3zZ/7wc1d8ZMbEXfs6LNuZOKK2ccjAU//WAcCHgm0qky55u3JIa35JXA2ZWiIc25&#x2B;18uXat54f1jR7jaL03PwTihpqwHYcSZL8ngG2bYdCIV3XhesqitK/f/&#x2B;ikpLXFi0qKCzMzclpbBq/&#x2B;PXXC4sKk6lkYUHBhJaW1xYtEkJIQtQNqbvm45&#x2B;IRqJz5130l4ceysrJdlxXHP0WIF3XC4uKLr388obhw&#x2B;vr65ubm4NHX4XGaUQA&#x2B;NF7qoXDVxW8QYmZG1QzO5H6nm/2eLXQu7Zg27ZjewuymetTA2qf882ZEwx9Djr3vT41Uwtcnzq4vOS0n10GgA&#x2B;eK6Qx520oreooq&#x2B;pMp4J7txeHs7Vtq8s3LqtOJ4OuI3nT5BXZDUVMRbUdXT2OO/rPZpIklffvL6nK20uXlZeXT5027VOf&#x2B;fSPv//DvPx8Xdcrq6qi0aht2YZhjhrd8LVbGlauWCGEcGw7v6Dghef/mZ&#x2B;fn19QcPlVV/7lLw85jiMf/Z/atKY1NjXNmDWrpLR0woTmQYMGHe1n4rQjAHAM3h7B46&#x2B;FQ4IhUwuZI8621bO24B1tziwyJJPJQ0azZWqhZ4uRN2Yh0DvM2TuxkAmHvten9gxyphYAnBUszbAMMxgNK0H1xG5hP2tU1LZV1OyrHtIWihrtu/JzC5LhHC23KDGkaWtReXdWbjoVDwWjhiQ7gZApK47rSpK/jwIkk8nv//CHj85/ZN/etq/dcvOAAQPu/e3vtm7dEggEvF1Almnl5eefP/38rGjW0iVLXlywQJIky7bT6XRDeUMgFOpob4/H47ZlC1ekUinpsGsSDcPIy8&#x2B;/&#x2B;NJLR4wcWVtb2zyh&#x2B;ZiHBHB6EQA4mU7OsAWn504k27a9E8w9qwp91hZ6RrMZvWsLh49mC6iZ65ACmbPOmZczt6z2HnGWGeQM4EPH1s2Cmv4zbv9EIBp65pb729ftVEPHPkzpWLapGUpQDYSDZ1Mw5BSkxk3bMHD4bjVgJ7siji2ZlpLcnV9Z21ZVv9e2FctQEvGwsUOVJTcQshXfnwGQJGlv&#x2B;76GEQ3btm699jOfWbN69Y9&#x2B;8MMd77yT2Qjgum6/fv2uu&#x2B;GGro6Ohx78866dO//109f&#x2B;&#x2B;s67QqFQdnZ2yznnLFq0yFvnnzR58qQpk//9pz895DivpmnjGhtnzJpVWlraPKG5pqbmND1WvAcEAE6PUzVsweodypY55azFNO//ZjYseRciZUazZQ439x3N1vegM4OcAZwupmYMu6S5qmVIODfaf/TAfWt3CFf03dPi2o4rhCQf&#x2B;PqFK2zTKm&#x2B;sqZ7csHPx&#x2B;h2vrlfDx3v7iuu6RlwzdUMSkqwosqrIqiwrsqQqva//9FFUu2Xein41&#x2B;2TFScRCXW25sY7sUMSMdWZ17cvuP2h/OGrkF8UL&#x2B;0tt7xTqWmDgyF2Kaq99fVBHW64kuYrqnGWHAby0e/ePiyRJjutu3rT53GnTfvFf/71q1cru7u7CwsJEImFZliRJlmVlZWdvXLfuL39&#x2B;6MJ5c//nl//3uWs/7ThOOp2WZTkejzuu67juxIkThw0b9r3v3ObNB/BeuWEYubm5c&#x2B;fNGzVmTE3N4AkTJkQi3CFxZiAAcAY48WELh51b6DtsoWdt4cAIZ2&#x2B;R4Yij2YQQsiwf4YjzwXeneicWenYiHcdotqN9JwB4XNsJRIL1cxpd25VkqWbG6G0L1yT2dioBVZIkM206phXKywpEAlbatE1LkiTXcSRZGnpR06hPTH1qyx7bMA8NANcVR/rM47puIBIc/fGpFY21qf3xZHtM64hrnQltf0LrSqS7knos5X0&#x2B;PD0kUTagI5qdjkb1ZHe0qy264O9NRip4/r&#x2B;8Gc3Sl7wwdOWrtWVVHcOatmXlaUX9uxXVkWUnNz9VWt2ZioV2bijbuKxKS4ZCEfPsyADv6XswGNQ0zbu5/2gkIRRF/f39Dzz91JMVlZWf/uxnk8nE6lWr3lz8Rm5e3p7du//2l7/EYrE7f/vrbdu2XXrhRXvb2sLhsOM43mHfUSNHXv3Rjzz5&#x2B;BP33XPv3r2tmX&#x2B;2NE0bM3bsjNmzy0pLm5qb6uqOfX0FPjwIAJxtTu6whSOsLRiZNYae0WzeoYWjjmbzprOpgWAo2Hcn0kEXIqmKoiiyxCBnAAfxvvxf3FC5&#x2B;JdPVjbX1V0wbtl9L3Rtb1ODAT2h5VeXDDp/ZHF9ZTArtG/dzh2vrevY1OpKkp02hBDB7Ii2P57SY6oZNBJpIUQwK2SbthoOyKriFYUkSY5lu64rq4okJOGKSH5W7eyxSlBVI0E1qPZNhX/e9qel9/3T1s0j9sOpJkvu4JG7BzTsTXSGWrcXvvT3cYmuiGUom1eW14/dWVW7d8HfG3dtKE2nggOHteaXxXMLk2rAzilI5eSnJFmUVHT1G7R/&#x2B;5r&#x2B;29f2d2xZPnBT0JnIdV3btlVFGdbQoKqBRYteefcAcIUoLSvZtm1rbV3d408/1dXZsad1bzAQfG3Rq6qq7tmz59xpU&#x2B;&#x2B;5777bf/zjeCx20byLx4wb97Wv3KTIsiRJZWX9Lrxo7q233PLmG2/E4/FQKCSEMA0jKzv7grlzx44dO2jQoOYJzdnZ2e/yBuBDiACAr53wsIUj1MJhwxYyqWAYhmEayWTSuzu1dzSb6wi3dzRbZt7CIf8dMm9BySwt&#x2B;HWQM&#x2B;AXrrBNa&#x2B;glE0JZke2L1u5bu2PglOH9x9fseGODpZvh3OiEf7tw7LXT47s69ER6xL9MlmT50et&#x2B;leqMz/2/6/KrS5SAcunvbqz/f&#x2B;OXPfDCwHOHO5a9&#x2B;bm3K1uGuI6z841NRjyVW1lUNmKAJMtta97Z9cYmNaxKirTqr4t2LN6gBNRANBiIhNRwIFqUM/66C3LKC7TOpOu6QkjCdS3dcmxbkmU1FJBkb&#x2B;uR657iTz6JrkiiO5yIRQ1N1ZMBy1QU1Vn7xqB&#x2B;AzsGNOxpnL7urecatq2qqKzZ59jS7s3FgaBdXN4VztaFK5VUdZZWdfYbsF&#x2B;S3e1r&#x2B;zm2fIauA1iWJctyYWHhtPOmXXHVVXf/&#x2B;jfHs&#x2B;umu6s7Nzf37nvv&#x2B;dY3btmyeeuNX/5Sdk6OJMuBQKCquvqWW2997bVXm5ubN65f33LOOQ/9&#x2B;c&#x2B;SJAlJ0rT00qVL7r33nr2trZZlec/&#x2B;tVRq5Jgxs2bPLisra2pqqh9Sf&#x2B;ofNE4&#x2B;AgA4Xu/n&#x2B;tRDDi0cciFS351IlmllRrOZpmnb9tFGs/Wecs7coxo88iBn79ACtQCcWWzTKqrrXz2lYccbG5J7One/ubFz696hc8dveOKtvW9vLx9fO/yqSXuWbfn7J36xe/vmIRObZv3smvoLx73&#x2B;yycXfPfBlq9c3H/M4Pb1u7p37Q9mh4deMqG6Zeiqv7866qNTura1PX3zfUX15TNvv8Y2bCORCuVlbX95zRNfvju&#x2B;c3&#x2B;8tbNz&#x2B;z7hOm7PiBfRdN3s3KqiDY&#x2B;/te6xNx3Dsi3bsZzK5rqs4tzuXfv3LNuqqLISCnhP/x3bkWRJCaqu7bq203tWQRKu7Vi65dqOrMpKUD38Jpl35zjSipdrs/NSuUWJ8rp9Mz7x5pZV/de8VqPHA289N2za1dqwpu1dbTl73ylMxsNDq7bu352//q2q1ncKKwbvK&#x2B;rfHYyYQojywe3jZ6xNJ4M7NpQFgtbJ/Xh9AFzXVVV19OjR506dOmbcmH5lpc8880xOTo53sO1owmrgm7d847ov3PD9226b//D8hJ7&#x2B;bCrl3ZyRSqVc1/3fX/x81YpV8UR89uwLBgxu/cff/qGqqmEYaT39/PPPpRLJUDisqqppmpFI5JLLLx83fvzAAQMmTJyQk3MiAyjxYUAAAKfEiV2ferRhC7blbTKy&#x2B;l6c6t2jetCwhaOMZuu9QTVzd&#x2B;rBg5x7rk9lkDPwYWIk08OvPCevomjJ757t2tneubd107PLxl83u7iufPeyzaam24YZyo2Wj69Tguq&#x2B;tTvum/7dYHZIyPL&#x2B;DbsHTh1ROrx6xZ8XrvzLK0V15UYiLQeUspHVL93&#x2B;1z3Ltyb2dA6ZO379428&#x2B;fO0dsirXzhpzyT03zvrZJ/98xb&#x2B;HssNBtecTl21YQy5qmnvH59rW7Hjqq/damu6YTlXLkJk/&#x2B;UReVWm6K6lGg1tfWPnS7X/t2t42aNqovAElu97aGM6J9hs9wHXF1gUrO7fuVcNBSZbSMU1RlbIRA7L75Sf3du3fvMfSDhxO6FlUcB3DcmxHkmUlpGY&#x2B;1TiW7Vi2kCRZkV1HWfC38SVVHU3T10bztFGTNlcMbl/92uAtq8rfeHr4xAtXDm/ZogYt4Uq2qagBe9vqim1r&#x2B;0&#x2B;&#x2B;5O2Jc1dKkuvYshqy8kvj2Xkpx5LFGTifKhwOX3rZZcOGDdvb1pabl/&#x2B;lG78UjUZt2z78M3PmfLBt25WVlYZpVlVW/OCJJyuqKtdv2pSdnbOvrS0/P19VlB07dix5883cvLxBgwdVDaj62pe/fOFFc59&#x2B;6qlgMOg4jmM5oXBYCKGlUsNHjpw5e3b//v0bGxuHNQw7DY8fJw8BAJx&#x2B;x399qjjmsAXH8UKgd2XBm7pgHFYLRxzNduDcQt/LkBjkDBwP6bj3Ex4P13HVUKDugkbXdUdePWXw1JF6Mp0/oEQJqhVNdVtfXNm&#x2B;Zuebv376nK9ccsX9X9r8/PLNz63Y/dam7l3tlmZ4892FEEZc02JJx7AkSejdqVf/&#x2B;5HX7n88O1KghNT5198lB5RgNGTr5vZX121&#x2B;dln1pIacfvl6XPP&#x2B;5jqWXd5YM/f/Ppds6370&#x2B;jvT3UnXdgpryy773Rf1lP7UV&#x2B;5JdcT6jRw4/UcfkxT5sS/cVTt7TMuX521/ZW1uv/zc6hIloLiueO6bv19yz/NaR6Jy4pBJX724eEilbZi2bm59cdWyBxbE93TIqiLLUrgwp2J8bb/RA42EvuP1ddsXrpaDqhoMWLoRyssqHFzmukLriKfa46pkdrbmPfvgxLKq/eNnrC0p7xo3fV3VkNY1rw9e9sKQkVM2jTt/vZCE48iWoQQj1jkXrRg8apdjyUIISXYtQ9HiIctSzsTRYK7rjmtsHD169DPPPCOESMTjTz3zTH1NbSqVOuQMgG3brhD5eXm2bcdisWQy&#x2B;d&#x2B;/&#x2B;MXv731A13XLtAZWVkqy9NKCBcFgMBgM2rZdVFxcPXDAz//nF08&#x2B;9sSPf/LTRx5&#x2B;2HEc718lWZZN0wyHw/MuvXR8U1NVddXEiRPz8vJOz7sAJw8BAJxhTuKwhZ4LkayeYwmGYWSGLViW5R1a8F72RrNl1hYOH83WNxVCwVDmOzOj2WSl59ACo9lwVpJVJas45yRekmNpes3MscX15e1rd3ZsaZUDSignku5KObZTd8G4tfNf3/nGpmX3v9C5pW3YJc1lowcNndcshFj080df&#x2B;9/H9FjKeyWSLCmS7G0&#x2B;TO7r3vnGpry8YiWgukLKrcgORENqUI0W5&#x2B;aUFyoBVZalcEG23p0SiuQ6bl5V8ez/vDaUE57/&#x2B;bv2rdkhKbJt2Y2fm51TUfTElf&#x2B;&#x2B;8amlRiq99snFWaX553z14uUP/FOPpSzdKBlaufCnf9v07PKykQNm/uSaqd&#x2B;&#x2B;es/b27rfaZvxo48VD61Y&#x2B;ZdX2tftqp40rOWmiwtr&#x2B;j32xd/Yull17vDZ/3ltcX357iWbHctpuWnuO6&#x2B;sW/CDh7p3tNfMGD38qsmFg8oMTde7kmsfe3PrP1eYmi6E2Lez4J9/bi6p6hx73vohje9Ec/R9Owo3r6gYMu6dksrOZHfYNpWWC1dG87X84oQkud5XOtKp4JZV5Xu2lKiBM2z/j&#x2B;u6wnUd277j//6vfd&#x2B;&#x2B;Pzz4p6suv2LuBXNMy1yxfEUmADIjcVpaWqZOm/bbu&#x2B;5SFWV/d9fosWMenT8/Jzunvb3917/9zYb1G/ILCnbv2VNSUiJJUmlZ2QN/&#x2B;MNLC14sLCp6dP78xa&#x2B;/nvl9tVSqYcSIGbNmlVdUjBs3dvjw4afpHYCTjAAAzlonfdiCtw&#x2B;pd13B7D26kNSTXUaXaR17NFvfiWx9&#x2B;4FawBlNkqWc8qKe47Ang6Wbw69siRbnPvGl365/fIkaCQQiITOlz/jJNeM/O7NkWPXOxRsT&#x2B;2LLH1rw9kMv5VUWD5g8fNJXL55886Wmbvzztj8e8tpcV7iucA&#x2B;8kD&#x2B;odNy154/&#x2B;2Lnh/GzHsmO7O2RFdmwnGA25rpBcVw0Hpt32L&#x2B;XjBr/68/mr//qKGgkJIVzbqRhX69h28dDyYHbYNq10VzK5PyaEqJowJJSbpYaCz978wJJ7n1dUZe&#x2B;q7bnVxbN/9qm8yqLiIeUDpw5f&#x2B;NN/PPOd&#x2B;01hBH8T6n5n39RvX7X1xVWbnls&#x2B;&#x2B;ebLc/sVzP/sL9c8sji7NLdm5tjzvvuR6nOGrfzbKzUzxgy9uHn5Ay/o8VRVy9DL773xtf95bOHP/uE6jutKaS24a3NJbH9W/8HtwyZs6z&#x2B;ofePy6rYd&#x2B;fGOrPyymKy6JVWdkSzdtmVVtRPd0VQivGl5xfIX65PdEfVMOwDgfTp95ZVXOjs7733g/p/c/tPzpk9vam5&#x2B;&#x2B;qknvbO5QgjvJEBBQcHlV1xxxZVXrlu/vjsWUwMBIYRhmI2Njfl5ebPnzAmHwxs3bBg3vnHZ0qWuEI5jf/0bt8S6YxvWrVv06qvr163LysoSQliWFQgE5l58cVNzc1VV1YSJEwoKCk7jewAnFwEAQIj3PWzB23LguD1TnPuuLfSUQp9ZzrF0zDRN27J7TjkfZTSbN5fN2310&#x2B;E4k74SDLMuKojDIGR8G0aLsygn1bau2y&#x2B;r73Qtkm3ZhTb/amWM6Nrd2bN4rJCFcYSZ1PaGtm794&#x2B;BUtVS1DWldsK6rtF2/t2rNkc6K1682HnjFT6X/5yy1Ftf1CWRHHdnqe72dIQpIkx3KyyrLHf3Zm0/Wz1z/25qv/&#x2B;9j&#x2B;tTvDRdnn3HTxyI9MkRTZdV3XEZO&#x2B;cvHwK89Z&#x2B;/DrL97&#x2B;N&#x2B;/ZvyeQHXQdd8RVU2zDFEI4li2pipU2g7mRQDQoXDfR1u1YdiAaUgJqujPpOE52WX52WZ4ky8Gc8NDZzYFIMN7amdjbJYQYOHV457a2gVMaVv3t1aX3vxApzE7ui63&#x2B;&#x2B;6ttq97RYynXcdbOX7zt5TVLH3peFQE1GPjMyz9r&#x2B;fK81&#x2B;94XI9rQghJcl1H6mzLTXRHWrcVNUzcOmDYHkl2hSuK&#x2B;ndn5aZtW7YsRVHt9j35e98p3LC06p11/Q1NPeOe/YsD58ocx/nkpz41cOCg&#x2B;qH1jeMaFy9&#x2B;feOGjWkjnaVmeT9t0uTJcy68cMvmzbZj33jDDYFgUJZlSYinn3qyaXzT1R/5yGPz59/&#x2B;ox/9zy/vWLZ0qSzLjmUNG9ZgGsZ//PSnb775ZjKZ9J79a6nUkKFDZ15wQUVFxdixY0eOGnk6HzxOAQIAwHt20oYtOD3BYNt239uQLNMyTMP79oij2VzX9a5PVVXVm7/WEwbBox5aYJAzTrVwXva4fz3/sRt&#x2B;HcqLvs9X5VhW1cShZtpY8dDC5L5uWZGFEEISwazQthdXta/fNeqj5259YUXtBeMGTG54&#x2B;48Ldry&#x2B;QY9rdbPHSZLUtWVvOpkUjqtEApblpNy492sPvGonkp9dOb420dr1z&#x2B;89uH/jHiWoKpqRW1kkHO/kgDvqo&#x2B;e2fOXinYs3PH3L/a7juJL3F0MSQugxzUobT9z4WyOlRwqyQzmRYE44EAm1rdo&#x2B;4urJruvKityzDCJJVsqwUkakICeUExVCDDp3ROnwaklIlmEGI8F0dyqYFS4fO0gIsW/N9gOniSTbtHYt2STLsqTIG59d6gi7X&#x2B;2AYHZYDqity7dUNdflDSjZt3qHe6Bt1ICd6MzKytNSiXAkS8/K06I5aVlxbUsWQupsz9a6IxuWVm1aXpVOBr2bQ9/nR&#x2B;d0cV03Nzf3O9/77mOPPVpTU3PfPb8rLCqeOOmcZ596WgghSdJHP/rR4SNHvvTii5dcesl//uw/1EDAOwRckJN35x13zLlw7vp16&#x2B;LxeErTNC3tuq7tOOl0ur29/b/&#x2B;/T/27NkTjUbD4bBlWaqqXjB37oSWlsqKigkTJxQVFZ3uh46TjwAAcGqdomELB60tmKZhGoZpvLfRbAffnZqZtMAgZ5wYJaQOvbj5rd8&#x2B;u2/dTiX4vv55VQJq&#x2B;8bdz976&#x2B;9blW/W4Jh/4GyTJsmM7S&#x2B;5&#x2B;dsTVk/S4tuTe54JZ4RFXTR4yb0IkLxrMiSy97/ml970gCTnR3i3L8mX33DhwUsOqf7yqBJRgdkSSJEmRtc74rqVbxo&#x2B;rGfXRcxf9/JFQbrTx2hm1s8am9scD4WB1y7Bzv31VqiPx8k//biTSodyocF2vumVL3fnGxsoJ9a7r7t&#x2B;wS5Ikx3a0ZNwWtiSk&#x2B;oua&#x2B;t7sKQnhuo4kCVM3hCLr8dSKP7&#x2B;8b&#x2B;2OrNK8UG4kEAltXbgmvrsjr7pYCGGmzczuKUmS1FDAtR0hxMirpwyYPCy/utS7CKhkaIUQQg2q3pKI99uk4qHhLZsHDNtTXtte1K9bDdpCCD0dUCRn3&#x2B;78PVuKVy6qbd&#x2B;VLyuO60pn7rN/IYSu61&#x2B;88YtbNm9eu3rNyy8tvPXb38rJyfnmLd8Ih8NCiEAgIKvq7x94QNNSQ9YPfeSRhxsaGtLpdGdnZ1FxUSqZnP/ww7l5ed4QsYKCAkmSI5FIKBzev3&#x2B;/YRiZL/zX1tfPuuCCqqqq0WNGjx49&#x2B;nQ/aJwqBACAD5H3M2yh9wW7Z23BOvBf5riCFw0HjWY7wPu1QojM2kLv&#x2B;eZg792pRx7kTC1ACCFEtDj34t984Q9zf2DE00oocMKvRw6o&#x2B;9bsaF2&#x2B;VQ0HZfWgpbZAVmjTs8t3L9lsJNPdO9r3rnyn3/Dq3OoS4bqty7Z2bNmjhIPRwtzVf11kxNNlIwd0bGtNdya2LliV2NNp6aYcUFLt8bfufqb/2EEtN82b9PVLHdPuemffsgcWjP3UeYWDywpq&#x2B;uX0L3RsZ&#x2B;THpo746LnprmS6O6XHUulYav/aHcsfeKHx2ulzfv6Zv338v9s37pSENOH6edmleW/d/exB240OkGTZiGvxHe2hnGh8T8fyxxbkhAts0zZt3RGOIpSWf7tYCOH9jplf5dhOIBwcfP6o6bd/PLssf/sra&#x2B;M725NtsUA0VNJQ1ff1p5PB0VM31I/dWVbdkV2QlBXXsSVTD&#x2B;zaXJKKhbMLk8WVXTWjdqbikVhHJBg683b&#x2B;ZHinqpYsWfLwww8PHlxz3x9&#x2B;/9QTT/z&#x2B;vvuTqZSiKN5nvPmPPBKLdT&#x2B;/YMFFF1z49VtumThx4he/8AXvRyPRaDgScV3XMIzPf&#x2B;GG8c1Nd//613l5ed7OIu8uIFmWZ82Z03LOOeXl5RMmTigpKTndDxqnEAEA4Ex1ioYtZI45e6lgmmZaS7/LaLbeVOhzyrl3S1KfnUjeT2Y029mt36gBH3vkW/Ovv6t12ZZgTkQNquIEPqCuqwTVIy4jSJJkakbn9jZJlkN5Ucdydr650Xl9vSRJSkgNZIW9n6Z1Jlb9bdH6x96wLdvWzdX/eDUQDurxlKIqQpLa1&#x2B;96YPb3a6aPyqkoSuzu2PH6hqzSvK6te7t2tKc6Eyv&#x2B;9FIwO1IwuCwYDSnhQDAaDkSDSiiw&#x2B;fm3H73&#x2B;zvk33DXvV9d9fvF/7lmxTQmoVRPr1z78uqIq3smHw8d7BSLBjc8sHfvpGefcNG/XW5t2r90UjebVnjs6XJi97aU1&#x2B;9bu1GPagEnDIvlZru1IsuxYlqmZSkAd&#x2B;bEp&#x2B;dUlj3zmjuV/eNE0dVUJzPnfz9WJsVJmTIEtD27YUz20td&#x2B;g9uw8TQg3GYvIkrNna/HuzSVr3xxYUddWN2ZH1ZC2skH7ly&#x2B;o3766XAnY7/lj8eHgum40Gl2&#x2B;bPkPf3x7UXHhrV&#x2B;/ee2aNVo6nZOTo&#x2B;u6qqq2bbe17v3Wbd&#x2B;&#x2B;5Wtfv/u&#x2B;e7Zt2/qv13wyGAo6jqOqquM46XS6tq7upq/cJEnSbd/81tYtW1RV9T6PaZpWU1s7c/bsAQMGjBw5cuy4saf74eKUIwAA&#x2B;MLJGrbQs7Zg9Vlb6HO&#x2B;2auFeCzed9jC0Uazed/2LCyEDpriHOgzyLl32AK1cEaQpPJxtR&#x2B;f/61Vf1204sGFu5dsFsKVJElWFEmRZVWWFVny/neiHztJlhRZFUIIV8iKLEdDR/xpjmGldVMIIUmStj&#x2B;eclwloHg1ooYCruNufGaZJEned3a/s2/pfc87jitcd&#x2B;/b2yRZkhVFSMKxHTmgKAFVDQcdw3BsZ9Ozy&#x2B;8977uDZ4wqrOkXiIQ2Pb1kw1PLUh3xjs2tO15bn&#x2B;5KHjgDIIQrlFAgUpi9/bV1C37w0MyfXHPN49/ZvGClLMs1549Kx1Px3Xfvemvjq7&#x2B;YP/U7V8/71fVPfe2&#x2B;VEdsyNymc756yc7FG8yULlxhpo1Qdjg7O7&#x2B;wtnzIheOFEMHscM8OI1sa0LB7wNDWrFytZw6xJTtCCufo/Wvay2v3mYbiOJIs2&#x2B;UDuyJzVxnpwK6NpYEzcx1AlmXHcS674vKNG9bf8tVfm7ZtWVZ9fb2iKKtXr87OzhZCzJk750s33TRn7tyvfOnLZWWlV1x95eLXXm9tbRVC2LZ9zSc/Oe&#x2B;Si1968aXnn31u3do10aws7/slIWbMmnXOpEn9y/tPmDChrKzsND9UfCAIAAA41CkctmAafS9RzYxm884tvMtotsx0tiOecj7CIGdq4fSRZCmvsrj58xfUz2ncv2lP55bWVHs83Z3UY6l0V0qPp/SYpsc1M5k2UrqVNmzDcizHFY7ouaqnTy2oiiRLJ1gLUu9H/PCLiSRZUvtsUnJd10jpQgjhCiOpe3&#x2B;yhXd4WOp5Qi8rivfkvuudthV/eikQDQnXTeztEkIKREMbnlyy5fm3jZQeCIeEEMHsyI7X1v1x7o9SHfFQVmTdo2/Ed&#x2B;&#x2B;vnTW2ZHi1GlS3v7p2xZ9e2rl4vRIKvHXPc3IocO4tlw&#x2B;/epKVNiVF7ti8Z/vC1a7j1M0aO&#x2B;9Xn1/9j1dd2&#x2B;03epD3Bvdd9AtFjex8TVFt21KEENn5KUlx8kvikixcR1im6jiSotpde3O72nLe8zvww8T73PLKwpdLSks373inoX7IuMbG884//5/PP79lyxYhRCAQuPXb3/qfn//iB9/73mevu27W7Fm5OTnr1q1v37fPsqyL5s1ram6&#x2B;&#x2B;ze/fWPx4u7ubu/Zv6ZpgwYNmnnBBQMHDhwxYkTj&#x2B;MbT/SjxwSEAAODEndiwhSPUwsHDFno2Ih28tpBMJc3unpMMmetT&#x2B;45my6wtvMuFSIoacGQlO6hKDHI&#x2B;xQLRUMmwypJhlYd8v&#x2B;sKx7RswzI13UikjURaj6X0uJbuTqW7knosle5O6jEt3ZXUY1o6ltRjmpFIGwnN1AxLM2zz1NRC5iMuCUU&#x2B;xrY6SZIs3fRGDiuhgPcLjWRajzne2yCEkGRJT6R3L90shFCCqm1YW19ctXPxxkhRjm1Y8d0druOE8rKEcK2U8fJP/rbkN89UNNdF8rKT&#x2B;7u7tu/r3LJXCSpPfPl3tbPGlDfWurazdcGqLS&#x2B;uuPS3/xYtyZUk4QohK&#x2B;7uLSUlVV15xYncwpRtSWktYFuKJAtv8lf7roJYRzQQMlu3FW1eXhXrzPKOCJ&#x2B;JJEkKBgMTWiamtfTwocMuu&#x2B;yyCy&#x2B;a&#x2B;/LChS8vXBgOh23bVlX1q1&#x2B;&#x2B;qa1tX0lJyZy5F/7b52/45re/pSqK7Tj79&#x2B;9v39/&#x2B;qzvuWLduXSQSiUQijm07rnv&#x2B;jBmTp0wpLSttmdjSr3&#x2B;/0/0Q8YEiAADgA/I&#x2B;hy1kXsg8&#x2B;/d2ImVOLPQ95ZxMHHU0m6KqwczawsFTnA&#x2B;ZztZ7fSqj2U4eSRLe/v5gdjirJM913d6vsh&#x2B;mby2YSV2Pa0ZCS3eneg7mdiUztZDuTupxrbcWkrqlm7ZhObbtTcHtrQVVlpWTUQvKQb9SVmShHPpnO3NZpyRLajjoWHZ8d4cQIhANSbLknRv2fshIpre9tEqSZceybcNSAqpjOSseXLj24dcjRTmp9m4joYfzonc1fd11bNd2hRCy4mxZWdG2s6CoX6ywX7cku5ahGroqS0KSHUkSXfuy9mwt1pIhVXUcR3JdSZJO2qjmD5jjOMFgMCcnt7amtmH48Nq62tt/9ONnn3lm0KBBuq4ripJKpbZv3XbDF298&#x2B;OF/rF6xcueOHQUF&#x2B;V2dnZIk5ebkLF&#x2B;2LB6LR6NRIYSmaQMGDpwxa9bgmpoRw4c3jm/k768PEQAA8GF0coct9OxEMi0vCTLXIpmGaZhGTIt5P9JzvOFdRrMFeu9OZZDzSfHu742&#x2B;tSBKxPHXQmZtIR1LHVhPSB1HLfRZW/DWiE5GLfQ&#x2B;HEVWDouE3rffcV3HFkJ4p58lSQrlRlzbSbXHZEWJFGYLV9i60fecsWkoHa253ftytq7uL1zJdSXblE1DdYWQJFdRHUV1ZNl1HO/ddqY&#x2B;&#x2B;xdCeF8KUFV1xqxZf/rTH7/77W8bptnSco4siY2bNnlTEW/62tcef&#x2B;yxCRMmrlq1auzYsY7ltrW1ybIczcoyDTMSiXifDaadd96UadNKS0omtkwsLy8/3Y8MpwcBAABnvJM7bMF27MztqJlOyGxG0rQjjGYTQsiy3Ht9aiAQDPaZ5RwIHnIh0kGj2fo44kM7me&#x2B;pM9zx18J7Wls42k6knm1ImVqIa0YybSZ1K23Ypv1uawtKTwOehIfctxkkIUkH9YMkCUlyHUcIW3GFkISQFDcUNd7/7/uhI0mGYQQDgcfmz//ObbcNq6tvam6ac&#x2B;GFv7//Ae&#x2B;9HAgEyvqVvbhgwXU3fP5H3//Bdddf//3v3uY4jiRJ3tKfpmlV1dUzZs2qra1taGhoHN94/J80cPYhAADAX07OsIXDRrN5VZA5seDNck4lUweGtvUsLDiuI1why/IhR5x7zyocnAqH1gKDnI/be6&#x2B;Fw0&#x2B;C9HBd1zFtSzfNlG6mdD2uGXEts7Zw4HzzUWrh8J1Ih6wtvO9akCQhJPes/9jLkpRIJNra2voVF48b3/jVm78e644VF5ckkslQOOy6rqZpF110UX1dvXDdpUuWdHV3e3/NHcexLWvK1KlTp00rKSmZOHFiZdWhR1PgNwQAAOCoTsqwBe/bnhEKtt27DckwTcs0DMMyLcM4vtFsfc43Z5YXvKUGVe35ltFsJ&#x2B;BYtSB5tRDKiQhxzJ1IrmPYlmGaKd1IpI3kgbWFLm8PUuqgWuhO6Ym0EdeMhGamjCOsLZzsWjhDua4bCofT6fSa1as/&#x2B;al/rR444L577&#x2B;3s6GyeOOHh//cP76xFMBC87MorPvmJT3R0dDz04IN5&#x2B;flCiLSmlVdUzJg9u66ubujQoU3NTarKcz8QAACAk&#x2B;TUDVvIXJzq3aOaTqcTiZ7RbJZtOZZzhNFsvSsLB/3Xu0PpAPkAauE4HbsWQqoSUkM5EVEmjr22cKAW&#x2B;q4tpLtSfbYhpQ6thQ9qbeFDxbKsZ555&#x2B;pOf&#x2B;pSqqKZpvrJwYU1NnazIwWDQ&#x2B;wn33HNPdlZ0186dqqrm5ee7rmsaxqQpU6aed15xSfHEiROrq6tP70PAhwcBAAA4DU76sAXbsr29RgeuQ7Iyg5x7R7PZlm0dOppNVdXMIOe&#x2B;U5wPuUG190IkWX6XQc5H&#x2B;07feg&#x2B;1II5VC463E8kwNSOztpDuPpAHsQOnF7pS6e6kEdcOW1vwTjn3qQVFlpQzoxYURYnH49UDqiuqKr/zjW9&#x2B;/JprkolURWXl6lWrsnNyhBCGaa5ZtSqRSOTk5Agh0ul0v379ps&#x2B;aNXTo0Poh9U1NTZlOAAQBAAD4kDv5wxZs27sfte&#x2B;wBW9XUkpLdce6vY44fDTboWsLmelsBzrBW1gIMMj5RB2jFuQDtZAbFaXCFcdXCynDSB5hJ1K6q/eUc28tHO2U8&#x2B;muBUVROjs75118ycIFL1mWddeddxYWFk47b9pNX7wxEAgIIbw7VXNyclzXNQxj4jnnnHf&#x2B;&#x2B;cXFxRMmThg4cOAH9nbiTEEAAADOHid&#x2B;fWqfcwuO63hHljM7kXrXFfpIaanurm7TPsJotsxctkPuSz3idDZVVWVFZpDze/Muz/29H&#x2B;9bC&#x2B;9xbSEzb6Hv2sJBtRDTjGTaSGhGUrd18wNYW3BdNz8vf//&#x2B;/alUatP2bXWDBn/xxhu3bdlqO4584IiOJEl6Ol1aVjZ95syhDQ31dXXjm8aHw&#x2B;H38/vibEUAAAB86gSuTz32sIUD1x71HbZgmmY8HrdN&#x2B;4ij2Q5dW&#x2B;ithEDfe1T7ri1kDi0wyPk4ndy1Bdu0bN00U4ae0DI3qOrdyXRMO6QW9FjKiKf1hGYm00c95ZyphYAibOeIv6llWWX9ymRJGt80vquzc&#x2B;CggTl5uT/62tczz&#x2B;9d1zV0fXxz8/kzZ5aUlDQ3NQ2uGfy&#x2B;3mU4qxEAAAAc2wkPWzjk0MIRhy14N6h6d6f2Hc3mpULf0Wy9awvqoalwyGi2vtenUgvvwXGsLaihgBoKhHKj2W7&#x2B;sWrBsU3bqwUj2WdtoTuZzgxoy6wtJDQ7WzniuDLHcbq7usPh8KjRo8eMHZtIpr596zdCoZD3o7quFxcXT585s2H48Nra2qbmpkgk8j7fDTi7EQAAAJxk72fYwuG1kBm20Lu2YPQOWzjaaDZvkPNB8xYO7D46fIpzz04kWVYUhdFs78Gxa0FWQ7JXC8I99trC3tbWRx999PAfUlV1b&#x2B;veRx55eNmyZcFg8MknngiFQoFAQLhuWtcbm5qmz5hRUlLS1NxUW1t7Uh4Zzm4EAAAAp9P7H7bguAcdce65EOnAIGcvGrwbVFPJlHd3at/RbK7jKoqSSQVvokKgz2i2ww8tHDTIWZa8YcCHv7XUwkGOZ20hGDjiDymKEomEN27YuHvnrlg8npeXJ4TQdb2wsHDeZZeNGDmypmZwU1NTVlbWKXnLcdYhAAAAOGOc3GEL3qSFAzcimd43JzCaLaAGetcV3nWQs7cPiVo4Gm/15gjf77o5ubne0RHv2X9a08Y2Nk6fNau0pGR80/j6&#x2B;voP9i3FmY0AAADg7PTehi0c7fpUp&#x2B;dOpMyFSIcPW9B1PZFIeGsOPSOf&#x2B;4xmO2gb0sFLCn2ns3k/p/f6VFmSJVkwbOEA27aFEJIkGbqel58/d968UaNHDxw0sLm52bv7Hzh&#x2B;BAAAAH73Xq9PzdyDdPi5BTuzEcmyvHPM3u6jzNVIB41ms6xDrk89ZDTboSec&#x2B;ywveAsRsiLLko8GOWuaNmbcuBkzZ5aWljaObxw6dOjpfotwRiIAAADAe3DiwxYOzobecws9&#x2B;5AOOuLs0TQtFou9&#x2B;2g2NaBm1hHeZSfSmT7I2TCMnNzcOXPnjhk7dsCAAU3NTd5eIOAEEAAAAOBUef/DFjLnFo42bCHzUiqV6u7qzgxbyOxlEkL0nEYIqIHAgRMLmR1IB0rhwzzIWdO0UaNHz5g1q6ysbFzjuIaGhg/st8ZZiQAAAAAfCidz2MKBvUheDhxhNFsibppmZvHhiKPZetcW&#x2B;oxcOHwnkqIqp26Qs2EY2dnZs&#x2B;fMGTtuXFV11YQJE/Lz80/sVQEZBAAAADjzfBDDFqyeb9OxdN9DC4fUQqDPaLaDYuHgkQvHM5rNW6/I0DRtxMiRM2bN6te//9ixY0aMGHGS34nwKwIAAACc5d7/sAXbsXs2I9lOphYyU5wPLC0YlmnFtFjf61O9X&#x2B;i67qHXpx5&#x2B;IVIgoGma9zaYphmJROZdckljU1NVZWXzhObCwsJT&#x2B;A6CzxAAAAAAvd7b9amHLSwcz7CFnhtUjUNHs3krAOl0un7IkOkzZ1ZUVIweM3rUqFGn&#x2B;BHDd6RDFpsAAABw0h3PsIV0Ov3cM8&#x2B;uXLWqoaGhoqKieUJzcXHx6X7DcRZiBQAAAOCUO57rUw3DyMrOHjNmzJgxY0aPGf2BvW3wGwIAAADgwyISiUw7b1pZWdnpfkNwNmMLEAAAwIeCbdvHfxEqcMIIAAAAAMBHjuuQOwAAAICzAwEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPgIAQAAAAD4CAEAAAAA&#x2B;AgBAAAAAPjI/wfmLndS/YL0LAAAAABJRU5ErkJggg==" />
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>